Want to use our logo?

Download the ICS Branding Pack

ICS Background

Mr Dominic Alexander Turner
The International Continence Society

ICS 2012

Podium Session 2 LUTS Women 10 Urodynanic features of female patients with non-neurogenic lower urinary tract symptoms

Podium Poster Session 10 Prolapse Surgical Treatment 103 Point of Ba is the factor associated with preoperative voiding dysfunction in patients with cystocele

Podium Poster Session 10 Prolapse Surgical Treatment 105 LAPAROSCOPIC TREATMENT OF UTERINE PROLAPSE FOR YOUNG WOMEN WISHING PREGNANCY

Podium Poster Session 10 Prolapse Surgical Treatment 108 Laparoscopic Sacrocolpopexy (LSCP) vs Transvaginal Mesh (TVM) repair: comparison of anatomical and functional results in the medium term. Bi-center retrospective study about 122 cases.

Podium Session 3 Bladder Mechanoreceptors 11 The role of TRPA1 channels in activation of single unit mechanosensitive bladder afferent activities in the rat

Podium Poster Session 11 Rehabilitation and Conservative Treatments I 114 Transperineal Ultrasound measurements of the bladder and urethra in pre-menopausal urinary incontinent and continent women

Podium Poster Session 11 Rehabilitation and Conservative Treatments I 118 A Research on Prophylactic Tolterodine Medication in Catheter-Related Bladder Discomfort After General Aneathesia Operation

Podium Poster Session 11 Rehabilitation and Conservative Treatments I 119 Decrease of severity of stress urinary incontinence after surface electrical stimulation in older women

Podium Session 3 Bladder Mechanoreceptors 12 Vesicular nucleotide transporter (VNUT) is a key molecule for mechanosensing in the human urinary bladder: Negative correlation between VNUT expression in human bladder mucosa and first desire to void

Podium Poster Session 11 Rehabilitation and Conservative Treatments I 120 Combination Therapy of Electro-acupuncture and Tolterodine for Mixed Urinary Incontinence in Women

Podium Poster Session 11 Rehabilitation and Conservative Treatments I 122 The effect of virtual reality rehabilitation on the gait parameters of older women with mixed urinary incontinence: a feasibility study

Podium Session 12 Neurourology: Clinical II 123 OVERACTIVE BLADDER AND THE PONS

Podium Session 12 Neurourology: Clinical II 128 An in vitro model to measure bioactivity of botulinum neurotoxin type A

Podium Poster Session 13 Molecular Signalling 134 The influences of 5alpha-reductase inhibitor dutasteride on contraction and alpha1-adrenoceptor expression in rat prostate

Podium Poster Session 13 Molecular Signalling 136 INFLUENCE OF URETHANE ANAESTHESIA ON THE EFFECT OF RESINIFERATOXIN TREATMENT ON DETRUSOR OVERACTIVITY IN RATS WITH SPINAL CORD INJURY

Podium Poster Session 13 Molecular Signalling 137 Impaired Neutrophil Recruitment Driven by Decreased and Interrupted Expression Level of MIP-2, KC, IL-6 and MCP-1 Prolongs UTI in Diabetes

Podium Poster Session 13 Molecular Signalling 138 PTHrP signalling system is activated by acute bladder distension

Podium Poster Session 13 Molecular Signalling 139 The identification of T-type calcium channels on the interstitial cells of Cajal in rat bladder

Podium Session 3 Bladder Mechanoreceptors 14 Expression of Transient Receptor Potential Vanilloid 4 and Effects of Ruthenium Red on Detrusor overactivity associated with Bladder Outlet Obstruction in Rat

Podium Poster Session 14 Prolapse Evaluation, Lower Bowel Dysfunction and Basic Science 141 Treatment for Pelvic Organ Prolapse: Repair, mesh or nothing? A quantitative questionnaire based study

Podium Poster Session 14 Prolapse Evaluation, Lower Bowel Dysfunction and Basic Science 143 A Comparison of Pelvic Organ Prolapse Quantification (POP-Q) Findings and Patient Position

Podium Poster Session 14 Prolapse Evaluation, Lower Bowel Dysfunction and Basic Science 144 Residual defects of the external anal sphincter are common after OASIS repair

Podium Poster Session 14 Prolapse Evaluation, Lower Bowel Dysfunction and Basic Science 147 DEVELOPING AN AUTOLOGOUS ENGINEERED CONNECTIVE TISSUE USING A BIODEGRADABLE SCAFFOLD FOR THE TREATMENT OF STRESS URINARY INCONTINENCE AND PELVIC ORGAN PROLAPSE

Podium Poster Session 4 Male I 15 Non invasive urodynamics: the penile cuff test in patients candidate to TURP

Podium Video Session 16 Videos 157 Robotic Sacrocolpopexies: Minimizing Knot Tying with Barbed Sutures

Podium Video Session 16 Videos 159 BLADDER NECK CLOSURE WITH SIGMOIDO-CYSTOPLASTY AND CONTINENT APPENDICOSTOMY

Podium Video Session 16 Videos 161 Proper mesh placement with less dissection and tension adjustment could be improving the success rate in patients undergoing transobturator adjustable tape sling procedure for stress urinary incontinence

Podium Session 17 Rehabilitation and Conservative Treatments II 164 Virtual reality as a treatment approach for older women with mixed urinary incontinence: a feasibility study

Podium Session 17 Rehabilitation and Conservative Treatments II 165 A new ehealth service for women with urinary incontinence: an online Diagnostic Expert Program combined with a consult at home by a continence nurse.

Podium Session 18 Pelvic Organ Prolapse 169 ON THE RELATIVE CONTRIBUTIONS OF MUSCULAR AND CONNECTIVE TISSUE SUPPORT SYSTEM TO THE ANTERIOR VAGINAL WALL SUPPORT: A BIOMECHANICAL 3D FINITE ELEMENT MODEL SENSITIVITY ANALYSIS

Podium Poster Session 4 Male I 17 Sigmoidorectaldynamic and Radiological Assessments in Sigmoidorectal pouch Patients

Podium Session 18 Pelvic Organ Prolapse 170 Results of Salvage Surgery after Complications of Mesh Sling and Prolapse Repairs Using a Validated Outcome Score

Podium Session 19 Epidemiology and Outcomes Research II 174 Effect of occupational stress on Overactive Bladder symptoms: a cross-sectional study among female nurses of Beijing

Podium Session 20 Neurophysiology II 175 The effect of TRPM8 agonists on bladder afferent firing

Podium Session 20 Neurophysiology II 176 Aged related changes in purinergic signalling, afferent firing and receptor expression in the mouse bladder.

Podium Poster Session 4 Male I 18 Urodynamic Effects of the Association of Tamsulosin and Daily Tadalafil in Men with Bladder Outlet Obstruction Secondary to Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled Clinical Trial.

Podium Session 21 Male II 182 Preoperative pelvic floor physiotherapy improves continence following radical prostatectomy.

Podium Session 21 Male II 184 The influence of bladder outlet obstruction on bladder sensation: a retrospective study of urodynamic data

Podium Session 21 Male II 185 Does bladder neck elevation represent bladder outlet obstruction in patients with benign prostatic hyperplasia?

Podium Poster Session 22 Gerontology 187 A comparative evaluation of conservative methods of continence management among home- bound women over the age of 65 years: a review of the literature.

Podium Poster Session 4 Male I 19 Changes of a1-adrenoceptor subtypes mRNA amount in human benign prostatic hyperplasia concomitant with hypertension

Podium Poster Session 22 Gerontology 190 Virtual reality rehabilitation improves dual-task walking ability in older women with mixed urinary incontinence.

Podium Poster Session 22 Gerontology 191 Evaluating the impact of implementing of a new wireless telemonitoring system for urinary continence management for older people living in nursing homes

Podium Poster Session 22 Gerontology 193 Association between urinary incontinence and pain in community-dwelling elderly women

Podium Poster Session 22 Gerontology 195 The use of botulinum toxin A in refractory non-neurogenic overactive bladder in the elderly: A prospective review of intermediate term outcome with quality of life outcome assessment.

Podium Poster Session 22 Gerontology 196 Development and Evaluation of the Chronic Constipation PRO Rating Scale(CC-PRO)

Podium Session 1 Surgery for Stress Incontinence I Single incision mini-slings versus standard mid-urethral slings in surgical management of female stress urinary incontinence: A cost-effectiveness analysis alongside a randomised controlled trial.

Podium Poster Session 24 LUTS Evaluation and Treatment 211 Correlation of overactive bladder symptom score, voiding diary and urodynamic parameters in patients with overactive bladder

Podium Poster Session 24 LUTS Evaluation and Treatment 212 Perceptions about female urinary incontinence in different racial and ethnic groups: a systematic review

Podium Poster Session 24 LUTS Evaluation and Treatment 213 Do lower urinary tract symptoms (LUTS) predispose the individuals to more admissions in Taiwanese women? – A preliminary report

Podium Poster Session 24 LUTS Evaluation and Treatment 216 Validation of a new screening instrument for assessment of urinary incontinence in women: the Self-Assessment Leakage Circumstances Questionnaire (LCQ)

Podium Poster Session 24 LUTS Evaluation and Treatment 217 The patients with ketamine-induced cystitis (KIC) have more severe lower urinary tract symptoms and smaller bladder capacity than the patients with Interstitial cystitis / Bladder Painful Syndrome (IC/BPS)

Podium Poster Session 24 LUTS Evaluation and Treatment 218 Cost-effectiveness study of diagnostic tools for the evaluation of female with overactive bladder symptoms

Podium Poster Session 24 LUTS Evaluation and Treatment 221 Correlation of the ICIQ/UI-SF to urodynamic diagnosis in women with urinary incontinence

Podium Poster Session 24 LUTS Evaluation and Treatment 222 Efficacy of mirabegron in patients with overactive bladder (OAB): Pre-specified analysis of three randomised, double-blind, placebo-controlled, Phase III studies

Podium Poster Session 25 Urothelial Signalling 224 Piezo1, a novel mechanosensor in the bladder urothelium

Podium Poster Session 25 Urothelial Signalling 226 Acrolein, a metabolite of cyclophosphamide enhances basal ATP release and reactive oxygen species formation in cultured human urothelial cells

Podium Poster Session 25 Urothelial Signalling 227 Is the release of urothelial ATP, acetylcholine and prostaglandin E2 affected by the chemotherapeutic agent doxorubicin?

Podium Poster Session 25 Urothelial Signalling 228 PRIMARY MOUSE UROTHELIAL CELL RESPONSE TO ATP IS MEDIATED BY P2X BUT NOT TRPV1 RECEPTORS

Podium Poster Session 4 Male I 23 The prevalence and risk factors of male urinary incontinence in Korea: a population-based study

Podium Poster Session 25 Urothelial Signalling 233 The effect of heating (37-41°C) on detrusor contractile function in rabbit mucosa-intact and denuded preparations.

Podium Poster Session 25 Urothelial Signalling 234 Functional and structural changes in the chronic ischemic bladder and the protective effect of alpha adrenergic receptor blocker: in vivo / in vitro study

Podium Poster Session 26 Neurophysiology III 237 The vasodilating drugs ameliorate detrusor overactivity via improving pelvic blood flow in the male spontaneously hypertensive rat.

Podium Poster Session 26 Neurophysiology III 238 EFFECTS OF SENSORY NEURON-SPECIFIC RECEPTOR AGONIST ON VOIDING FUNCTION IN A RAT MODEL OF CYSTITIS INDUCED BY CYCLOPHOSPHAMIDE

Podium Poster Session 26 Neurophysiology III 239 ASSOCIATIONS BETWEEN LOWER URINARY TRACT SYMPTOMS AND METABOLIC SYNDROME IN OLETTF RATS

Podium Poster Session 26 Neurophysiology III 240 Roles of polyuria and hyperglycemia in bladder dysfunction in long-term diabetic rat

Podium Poster Session 26 Neurophysiology III 241 THE SPECIFIC TYPE 4 PHOSPHODIESTERASE INHIBITOR ROLIPRAM ACTIVATES LARGE AND INTERMEDIATE CONDUCTANCE Ca2+-ACTIVATED K+ CHANNELS IN PIG BLADDER NECK: A POSSIBLE THERAPEUTICAL TARGET FOR TYPE III STRESS URINARY INCONTINENCE.

Podium Poster Session 26 Neurophysiology III 244 Beta-catenin signaling contributes to PDGF-elicited bladder smooth muscle cell contraction through upregulation of Cx43 expression

Podium Poster Session 26 Neurophysiology III 246 Angiotensin II Modulates Detrusor Contraction by Up-regulating Caveolin Proteins

Podium Poster Session 27 Surgery for Stress Incontinence II 255 Retropubic vs Transobturator slings for stress incontinence: A comprehensive systematic review and meta-analysis of efficacy and adverse events

Podium Poster Session 27 Surgery for Stress Incontinence II 256 Still urinary incontinent after mid-urethral sling operation – what’s the impact?

Podium Poster Session 28 Pregnancy and Pediatrics 262 To review the long-term results of Malone Antegrade Continence Enema (MACE) procedure in Chinese paediatric patients with neurogenic bowel dysfunction associated with spinal dysraphism.

Podium Poster Session 28 Pregnancy and Pediatrics 264 Changes of external anal sphincter innervation pattern after episiotomy evaluated with multichannel EMG. (Results of the multicenter study TASI-2)

Podium Poster Session 5 Epidemiology and Outcomes Research I 27 Reliability and validity of the Chinese Version of Women’s Toileting Behavior Scale in community-dwelling women with urinary incontinence

Podium Poster Session 28 Pregnancy and Pediatrics 270 An MRI study: Do pelvic floor morphological and functional deficit differ in women with stress compared to mixed urinary incontinence?

Podium Poster Session 29 Painful Bladder Syndromes/IC and QoL 271 Long-term Ketamine abuse induce interstitial cystitis in rat by impairing bladder epithelium barrier

Podium Poster Session 29 Painful Bladder Syndromes/IC and QoL 273 The prevalence of non-bladder related conditions in patients with interstitial cystitis/painful bladder syndrome: The impact of gender and age

Podium Poster Session 29 Painful Bladder Syndromes/IC and QoL 277 Responsiveness of Chinese Urogenital Distress Inventory and Incontinence Impact Questionnaire short form in women undergoing pelvic floor exercise

Podium Poster Session 29 Painful Bladder Syndromes/IC and QoL 278 Anal Incontinence and Quality of Life in Patients treated with Sacral Nerve Stimulation

Podium Poster Session 5 Epidemiology and Outcomes Research I 28 An Update on the Current and Future Demand for Care for Pelvic Floor Disorders in the United States.

Podium Poster Session 29 Painful Bladder Syndromes/IC and QoL 281 The effects of Anticholinergic drugs on Health-Related Quality of life in adults with Overactive Bladder symptoms: A systematic review and meta-analysis.

Podium Poster Session 29 Painful Bladder Syndromes/IC and QoL 282 LONG-TERM MANAGEMENT OF NEUROPATHIC PATIENTS WITH INDWELLING TRANSURETHRAL CATHETER OR SUPRAPUBIC CYSTOSTOMY: WHAT IS BETTER?

Non Discussion Video Session 30 Non Discussion Video 283 Uretherovaginal fistula repair

Non Discussion Video Session 30 Non Discussion Video 285 ROBOT-ASSISTED LAPAROSCOPIC HYSTEROSACROPEXY FOR PELVIC ORGAN PROLAPSE

Non Discussion Video Session 30 Non Discussion Video 287 Improvement of operative conditions during laparoscopic sacrocolpopexy. How to avoid large peritoneal closure.

Non Discussion Poster Session 31 289 Animal study for the evaluation of a new semi-rigid and semi-absorbable composite mesh (Polypropylene, Poly-L-Lactic Acid) for transvaginal cystocele repair.

Non Discussion Poster Session 31 290 Impact of HMG-CoA Reductase Inhibitor (Statin) Use on Serum PSA and Prostate Volume in BPH Patients

Non Discussion Poster Session 31 291 A Randomised Controlled Trial Comparing the Efficacy of Withdrawing Alpha Blocker Following Initial Combination Therapy with Dual 5 Alpha-Reductase Inhibitor (5ARI) Dutasteride compared to Continuation of Combination Therapy in The Management of Benign Prostatic Hyperplasia

Non Discussion Poster Session 31 293 URINARY INCONTINENCE AND FUNCTIONAL RESULTS AFTER OPEN PROSTATECTOMY WITH FREYER AND MILLIN TECHNIQUES.

Non Discussion Poster Session 31 294 Effect of chronic prostatic inflammation on changes in serum PSA

Non Discussion Poster Session 31 295 Relationship between various clinical factors and LUTS suggestive of benign prostate hyperplasia

Non Discussion Poster Session 31 297 Remodeling of the prostate cavity on 6 months follow up after photovaporization of the prostate

Podium Session 1 Surgery for Stress Incontinence I One year results of a prospective randomized evaluator blinded multicenter study comparing TVT and TVT-Secur

Podium Poster Session 5 Epidemiology and Outcomes Research I 30 Systematic review and Meta-analysis Examining the Cure Rates of Antimuscarinic drugs used to treat Urgency Urinary Incontinence

Non Discussion Poster Session 31 300 Tolterodine Tartrate (Detrol LA) can reduce the risk of urgent urinary incontinence (UUI) after the HOLEP surgery of Benign Prostatic Hyperplasia (BPH)

Non Discussion Poster Session 31 301 Efficacy and Safety of Tolterodine Extended Release for the Treatment of Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia

Non Discussion Poster Session 31 302 Effect of TURP in patients with BPH showing non-obstructive pattern in pressure-flow study and comorbid detrusor underactivity

Non Discussion Poster Session 31 304 THE ANAYLSIS OF KEY FACTOR FOR THE SUCCESS OF THE TWOC IN MALE PATIENTS WITH ACUTE URINARY RETENTION

Non Discussion Poster Session 31 308 Moderate intraprostatic protrusion as a predictive factor for terminal dribbling in symptomatic benign prostate hyperplasia

Non Discussion Poster Session 31 309 Factors affecting enforcement of transfusion in BPH patients with TUR-P

Non Discussion Poster Session 31 310 Feasibility of ejaculation preservation technique of Holmium laser enucleation of prostate (HoLEP)

Non Discussion Poster Session 31 311 NSAIDs is more effective than Desmopressin in benign prostatic hyperplasia patients with nocturnal polyuria?

Non Discussion Poster Session 31 312 Clinical study of combination therapy with doxazosin and tolterodine for patients with overactive bladder after transurethral resection of the prostate

Non Discussion Poster Session 31 315 Comparison of short-term outcomes between transurethral resection of prostate (TURP) and Thulium:YAG (RevoLixR) vaporesection for the treatment of benign prostatic hyperplasia in Korea.

Non Discussion Poster Session 31 318 Gender-Related Differential Expression of Myosin Heavy Chain Isoforms In the Urethral Striated Muscles of Rat

Non Discussion Poster Session 31 320 Are Foley Catheters Intrinsically Obstructive? Size matters!

Non Discussion Poster Session 31 322 Predictive values of International Prostatic Symptom Score Voiding/Storage ratio, Total Prostatic Volume, Maximum Flow Rate and Postvoid Residual in the diagnosis of Bladder Outlet Obstruction in men with Lower Urinary Tract Symptoms

Non Discussion Poster Session 31 323 A Novel Staging System for Anterior Urethral Strictures

Non Discussion Poster Session 31 325 Squamous or glandular metaplasia as a feature of bladder outlet obstruction in female patients

Non Discussion Poster Session 31 327 Correlation of intraoperatively measured bladder capacity and post operative re-catheterization after Holmium laser enucleation of prostate (HoLEP)

Non Discussion Poster Session 31 328 Management of Urethral Strictures in Women

Non Discussion Poster Session 31 329 Pharmacological characterization of pig detrusor contractile responses resistant to cholinergic blockade.

Non Discussion Poster Session 31 331 Age-related efficacy of the selective ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder (OAB): pooled analysis of three prospective, randomised Phase III studies in patients aged >= 65 years

Non Discussion Poster Session 31 332 Caveolae-mediated regulation of purinergic signaling in the bladder suppresses spontaneous activity

Non Discussion Poster Session 31 333 Solifenacin treatment for neurogenic detrusor overactivity: patient-reported outcomes (PROs) from the randomised clinical trial SONIC

Non Discussion Poster Session 31 334 Adverse events of anticholinergic drugs for treating overactive bladder symptoms in adults - A Systematic Review and Meta-analysis of Randomised trials.

Non Discussion Poster Session 31 335 Developing a Competency-Based Curriculum in Sacral Nerve Stimulation for Urinary Incontinence

Non Discussion Poster Session 31 337 Effect of variuos frequency and intensity electroacupuncture on function of urethral sphincter muscle in female rats

Non Discussion Poster Session 31 338 Randomized clinical trial evaluating safety and efficacy of propiverine ER 30 mg and tolterodine ER 4 mg in the treatment of overactive bladder

Non Discussion Poster Session 31 341 Change of Cajal-like cells of interstitial in dome of bladder: the origin of Detrusor Overactivity? The result of rat experiment

Non Discussion Poster Session 31 343 Comparison of a1- blocker monotherapy or followed with antimuscarinic in the treatment of overactive bladder symptom suggestive of detrusor overactivity in BPH

Non Discussion Poster Session 31 348 Associated factors of dose escalation for the treatment of overactive bladder with solifenacin

Non Discussion Poster Session 31 349 SACRAL NEUROMODULATION FOR THE TREATMENT OF REFRACTORY LOWER URINARY TRACT DYSFUNCTION: RESULTS FROM A MULTICENTER STUDY

Podium Poster Session 5 Epidemiology and Outcomes Research I 35 Predicting help-seeking intention of women with urinary incontinence in mainland China: a model based on the theory of planned behavior

Non Discussion Poster Session 31 351 Effects of medical interfered-pelvic floor muscle training in behavioral therapy and/or tolterodine in female patients with primary overactive bladder syndrome: a single-blind randomized study

Non Discussion Poster Session 31 352 SERVICE EVALUATION FOR THE MANAGEMENT OF OVER ACTIVE BLADDER PATIENTS

Non Discussion Poster Session 31 354 Different expression levels of ß-adrenoceptor subtypes in human detrusor from bladder neck, bladder trigone and bladder body

Non Discussion Poster Session 31 355 The efficacy of Tolterodine ER was enhanced by combining low-dose vaginal estrogen treatment and bladder training for postmenopausal women with overactive bladder (OAB)

Non Discussion Poster Session 31 356 Changing the first Overactive Bladder (OAB) therapy with Tolterodine ER to Fesoterodine in daily practice: The effect of aging on patient-reported treatment benefit in the IMPACTA study

Non Discussion Poster Session 31 357 Fesoterodine escalation to 8 mg after switch from first Overactive Bladder (OAB) therapy with Tolterodine ER is associated with additional patient-reported treatment benefit in daily practice: Findings from the IMPACTA study

Non Discussion Poster Session 31 358 Prevalence of Neurogenic Detrusor Overactivity associated with Spinal Cord Injury in Taiwan

Non Discussion Poster Session 31 359 Randomised, Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy and Safety of Mirabegron 25 mg and 50 mg Once-daily in Overactive Bladder (OAB)

Non Discussion Poster Session 31 360 ROLE OF SYMPTOMS DURATION AS PROGNOSTICATOR FOR SACRAL NEUROMODULATION IN REFRACTORY OVERACTIVE BLADDER

Non Discussion Poster Session 31 364 Connexin43 expression of BPH patient with detrusor instability in the bladder wall

Non Discussion Poster Session 31 365 Non-bladder Comorbid Conditions in Female Patients with Idiopathic Overactive Bladder

Non Discussion Poster Session 31 367 Comparison of overactive bladder patients who switch between antimuscarinic therapies with those who persist on the same therapy in the absence of improved outcomes: results of a cross-sectional study in 4 European countries

Non Discussion Poster Session 31 369 Urinary Incontinence Is an Independent Risk Factor for Upper Urinary Tract Stone: A Nation-wide Population-based and with an 8-year Follow-up Study

Non Discussion Poster Session 31 371 Sacral Neuromodulation Failures

Non Discussion Poster Session 31 372 Alignment between Patients with Overactive Bladder and their Primary Care Practitioner: Real-World Observations Associated with Patient-Reported Outcomes

Non Discussion Poster Session 31 373 Preference for hysterectomy among underserved, minority women presenting with pelvic organ prolapse

Non Discussion Poster Session 31 375 The variation of LUTS after the reconstructive pelvic surgery and the significance of preoperative urodynamic examination

Non Discussion Poster Session 31 377 Efficacy and Trends in Usage of Sacral Nerve Neuromodulation in a Health Maintenance Organization Setting - Kaiser Permanente Southern California.

Non Discussion Poster Session 31 378 The Risk and Clinical Consequence of Elevated Creatine Phosphokinase after Prolonged Exaggerated Lithotomy Position for Urethroplasty

Non Discussion Poster Session 31 379 Barriers to Continence Nursing Service in Community in Hong Kong

Non Discussion Poster Session 31 384 Practice Patterns Amongst Obstetrician/Gynecologists Regarding Participation in Urogynecologic Procedures: A National Survey

Non Discussion Poster Session 31 387 Tailored Pre-operative Intervention to Improve Patient-Outcome of Radical Cystectomy; A Registry Study

Non Discussion Poster Session 31 388 Urinary incontinence 4 and 12 years after first delivery: risk factors associated with prevalence, incidence, remission and persistence in a cohort of 236 women

Non Discussion Poster Session 31 389 Outcomes of urethral transection for reconstruction of circumferential urethral diverticula

Non Discussion Poster Session 31 390 STUDY OF THE PREVALENCE OF URINARY INCONTINENCE IN SPAIN IN THE FIRST DECADE OF S. XXI

Non Discussion Poster Session 31 392 Description about surgery of pelvic organ prolapse. Meshes versus classical techniques.

Non Discussion Poster Session 31 393 Low back pain and urinary incontinence

Non Discussion Poster Session 31 395 Prolapse surgery in octogenarians: Are we pushing the limits too far?

Non Discussion Poster Session 31 396 Radiation Exposure to the Patient and Physician During Sacral Neuromodulation

Non Discussion Poster Session 31 399 Valiation of ultra-sound elastography in the postoperative follow-up of mesh grafts in vaginal vault repair

Non Discussion Poster Session 31 402 Incontinence Symptom Index (ISI) Total Bother Score Directly Proportional to Pad Usage but not 24 Hour Pad Weight

Non Discussion Poster Session 31 403 The Male Transobturator Sling for Stress Incontinence: Five Year Results in a UK Centre

Non Discussion Poster Session 31 405 Causative Factors and Characterization of Persistent and DeNovo Overactive Bladder Syndrome in Post Artificial Urinary Sphincter Implantation Patients

Non Discussion Poster Session 31 409 Does real-time pelvic sphincterial electromyographic monitoring during laparoscopic radical prostatectomy contribute to postoperative continence recovery?

Non Discussion Poster Session 31 410 CONTINENCE AND COMPLICATIONS RATES AFTER MALE SLINGS AS PRIMARY SURGERY FOR POST-PROSTATECTOMY INCONTINENCE: A SYSTEMATIC REVIEW

Non Discussion Poster Session 31 413 Adjustable Transobturator Male System (ATOMS) for Male Post-prostatectomy Stress Urinary Incontinence: Initial Multi-centre Experience in Hong Kong

Non Discussion Poster Session 31 421 SACRAL NEUROMODULATION IN THE MANAGEMENT OF LOWER URINARY TRACT DYSFUNCTIONS: A NEUROPHYSIOLOGICAL EVALUATION

Non Discussion Poster Session 31 422 Does prolactin play a role in voiding function?- A study on the hyperprolactinemic rats

Non Discussion Poster Session 31 424 Urodynamic effect of chronic administration of association of tamsulosin and tadalafil on lower urinary tract of rats.

Non Discussion Poster Session 31 425 Possible Involvement of Bladder Peripheral Clock in the Circadian Control of Voiding Function

Non Discussion Poster Session 31 426 Distribution of hyperpolarization-activated cyclic nucleotide-gated cation channel subtypes in rat urinary bladder

Non Discussion Poster Session 31 428 Assessment of lower urinary tract symptoms after Bacille Calmette-Guérin instillation therapy for non muscle-invasive bladder cancer

Non Discussion Poster Session 31 430 Predictor of successful trial without catheter for postoperative urinary retention after non-urological surgery

Non Discussion Poster Session 31 431 Effects of long-term testosterone replacement therapy in middle-aged to elderly hypogonadal men on the prostate and on urinary function

Non Discussion Poster Session 31 439 Comparison of the effects of tamsulosin and solifenacin in aiding stone expulsion after extracorporeal shockwave lithotripsy for the lower ureteral stones

Non Discussion Poster Session 31 440 Clinical outcomes of imidafenacin in addition to tamsulosin for patients with overactive bladder and benign prostatic hyperplasia (Addition study)

Non Discussion Poster Session 31 441 Clinical observation of the effects of Vesicare on cystospasm after partial cystectomy for bladder tumors

Non Discussion Poster Session 31 442 Comparison of Alfuzosin 10mg with or without propiverine 10mg, 20mg in men with LUTS and OAB: Randomized, Single-blind, Prospective study

Non Discussion Poster Session 31 446 Evaluating the long-term safety and efficacy of fixed dose combinations of solifenacin and tamsulosin OCAS™ in male LUTS with storage and voiding symptoms: results from the NEPTUNE II study

Non Discussion Poster Session 31 447 Outcomes of Palliative Transurethral Resection of the Prostate in Patients with Prostate Cancer: Age-matched Case-Control Study

Non Discussion Poster Session 31 448 Desmopressin and Tolterodine in the Treatment of Nocturia After Transurethral Resection of Prostate (TUR-P)

Non Discussion Poster Session 31 449 Lower urinary tract symptoms after High Intensity Focused Ultrasounds (HIFU) treatment for localized prostate cancer. 5 year experience of first spanish series.

Non Discussion Poster Session 31 450 Safety of a combination tablet with solifenacin and tamsulosin OCAS™ in men with LUTS associated with BPH in the NEPTUNE trial

Non Discussion Poster Session 31 453 OUTPATIENT FLEXIBLE CYSTOSCOPY: A FAST AND SAFE PROCEDURE

Non Discussion Poster Session 31 455 Is enough a standardized basic office evaluation prior to sub urethral sling surgery in a selected sample of women with mixed urinary incontinence?

Non Discussion Poster Session 31 456 Prevalence of overactive bladder syndrome, stress urinary incontinence and associated bother in women aged 40 and above – a Belgian epidemiological survey

Non Discussion Poster Session 31 457 Patient-reported outcomes of retropubic (TVT) versus trans-obturator (TOT) mid-urethral slings for urinary stress incontinence: The Ipoh Experience.

Non Discussion Poster Session 31 459 Factors affecting female patients with non-neurogenic lower urinary tract symptoms

Non Discussion Poster Session 31 461 Evolution of urinary incontinence in women between 4 and 24 months postpartum in the cohort EDEN

Non Discussion Poster Session 31 462 Patient-reported outcome of solifenacin treatment in women with overactive bladder - multicenter, open-label study

Non Discussion Poster Session 31 464 The Role of Intravesical of Sodium Hyaluronate solution (cystistat)® Installation in Preventing Recurrent Cystitis/urinary Tract Infection in Women

Non Discussion Poster Session 31 465 Psychometric Validation of a 3-day Bladder Diary for the evaluation of lower urinary tract symptoms.

Non Discussion Poster Session 31 466 Antimuscarinic treatment for female patients with overactive bladder syndrome: comparison of daytime and nighttime dosing

Non Discussion Poster Session 31 469 Measurement of the Q-tip angle before and after the transobturator tape (TOT) operation: Preoperative urethral mobility may predict surgical outcome

Podium Poster Session 6 Neurophysiology I 47 Inhibition of Bladder Overactivity by Combination of Tibial Neuromodulation and Tramadol Treatment in Cats

Non Discussion Poster Session 31 470 Solifenacin Combined with Biofeedback in the Treatment of Female Overactive Bladder

Non Discussion Poster Session 31 471 Experience of application of intravesical injections of botulotoxin A in treatment patients urinal tract tuberculosis with lower urinary tract symptoms

Non Discussion Poster Session 31 473 Higher expression of PDE5 in the anterior fibromuscular stroma of the human prostate than in other glandular zone

Non Discussion Poster Session 31 476 Neuregulin1 (NRG1) regulates Muscarinic receptor in the bladder of Rats with Detrusor Overactivity induced by Bladder Outlet Obstruction

Non Discussion Poster Session 31 477 Urodynamic effect of acute administration of sildenafil on lower urinary tract of rats.

Non Discussion Poster Session 31 478 Stress urinary incontinence in mice can be induced by vaginal distension independent on the estrous cycle

Non Discussion Poster Session 31 482 Mechanism of urinary frequency caused by noradrenalin injection into the medial frontal lobe in rats

Non Discussion Poster Session 31 484 Is the type of anesthesia significantly important to induce bladder instabilities in an animal model?

Non Discussion Poster Session 31 485 Effects of TENS on diabetic Bladder Dysfunction in diabetic rats

Non Discussion Poster Session 31 488 SACRAL NEUROMODULATION DEVICE INFECTION: ANALYSIS OF RISK FACTORS

Non Discussion Poster Session 31 490 Influence of bladder management on urinary stone formation in spinal cord injured patients

Non Discussion Poster Session 31 496 Prospective study for difference of continence between sigmoid and orthotopic ileal neobladder

Non Discussion Poster Session 31 498 Analysis on Risk Factors of Upper Urinary Tract Deterioration in Spinal Cord Injuryed Patients------ Cross Sectional Study

Podium Poster Session 6 Neurophysiology I 50 IMPACT OF RECTAL DISTENSION ON PRIMARY BLADDER MECHANOSENSITIVE AFFERENT NERVE ACTIVITIES IN THE RAT: MECHANISM OF A PERIPHERAL AFFERENT ORIGIN OF PELVIC ORGAN CLOSS-SENSITIZATION

Non Discussion Poster Session 31 500 Sigmoidocolocystoplasty with Concomitant Ureter Reimplantation on Treatment of Neurogenic Bladder Dysfunction: A Single Center Outcomes and Experience with 47 Patients

Non Discussion Poster Session 31 504 Videourodynamie Study in Neurogenic Bladder after Operation for Lumbar lntervertebral Disk Hernia

Non Discussion Poster Session 31 505 The Effect of Intra-detrusor Abobotulinumtoxin-A (Dysport®) Injection on Patients with Spinal cord Injury and Long Term Suprapubic Catheter with incotinence.

Non Discussion Poster Session 31 506 Prospective evaluation of sacral neuromodulation for therapy of Neurogenic and non-neurogenic voiding dysfuntion

Non Discussion Poster Session 31 509 Long term Efficacy of Intra-detrusor Abobotulinumtoxin-A (Dysport®) Injection, on Urodynamic Parameters of Patients with Neurogenic Bladder Dysfunction.

Podium Poster Session 6 Neurophysiology I 51 Prostatic inflammation induces bladder overactivity through prostate-to-bladder afferent cross-sensitization in rats

Non Discussion Poster Session 31 510 HABITUATION OF OBTURATOR NEVRE REFLEX DURING BLADDER TUMOR RESECTION

Non Discussion Poster Session 31 511 Clinical presentations of lower urinary tract dysfunction in patients with diabetes mellitus

Non Discussion Poster Session 31 512 Urodynamic Characteristics and Clinical Interventions of Neurogenic Bladder by Cerebrovascular Accident

Non Discussion Poster Session 31 514 The use of hyaluronic acid (HA) bladder instillation plus hydrodistension improve subjective symptoms but not urodynamic parameters in patients with Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) - Prospective case control study

Non Discussion Poster Session 31 515 MCP-1 induced histamine release from mast cells is associated with the formation of interstitial cystitis in rats

Non Discussion Poster Session 31 516 First clinical experience of intravesical electromotive botulinum toxin administration for Painful Bladder Syndrome treatment.

Non Discussion Poster Session 31 520 Urodynamic profile of patients with deep infiltrating endometriosis

Non Discussion Poster Session 31 523 Urine and tissue glycosaminoglycans as biomarkers for painful bladder syndrome/interstitial cystitis – insight on pathophysiology?

Non Discussion Poster Session 31 525 The curative effect of intravesical irrigation of hyaluronic acid for treatment of non-bacterial cystitis

Non Discussion Poster Session 31 527 Effects of Combination Treatment of Intravesical Resiniferatoxin Instillation and Hydrodistention Patients With Refractory Painful Bladder Syndrome/Interstitial Cystitis: A Pilot Study

Non Discussion Poster Session 31 528 Diagnosis and treatment of Male Interstitial Cystitis or Chronic Prostatitis by Hydrodistention and Instillation

Non Discussion Poster Session 31 529 VOIDING DIARY CAN SERVE AS THE PRIMARY TOOL TO DIFFERENTIATE INTERSTITIAL CYSTITIS FROM IDIOPATHIC OVERACTIVE BLADDER

Podium Poster Session 6 Neurophysiology I 53 Sensory nerve responses to ATP are regulated by TRPV1 receptors

Non Discussion Poster Session 31 530 Intravesical hyaluronic acid in the treatment of interstitial cystitis / painful bladder syndrome

Non Discussion Poster Session 31 532 Installation of hyaluronan via electromotive drug administration can improve the efficacy of the treatment in patients with interstitial cystitis/painful bladder syndrome: a randomized prospective study

Non Discussion Poster Session 31 534 Selective dorsal rhizotomy and bladder function in children with cerebral palsy

Non Discussion Poster Session 31 536 The loss of estrogen promotes apoptosis of periphery urethral striated muscle cells in rats with stress urinary incontinence

Podium Poster Session 6 Neurophysiology I 54 Increased Skin TRPM8 by Estrogen Deficiency May Induce Detrusor Overactivity Mediated Alpha1D-Adrenergic Receptors Triggered by Sudden Cold Stress

Non Discussion Poster Session 31 541 Transient Receptor Potential Channel M8 (TRPM8) Expressing on Skin Mediates Detrusor Overactivity Induced by Cold-stress and Menthol-spraying in Conscious Rats

Non Discussion Poster Session 31 543 An Extract of Ba-wei-die-huang-wan (THC-002) Increases Skin Temperature and Decreases TRPM8 Expression Level, and Inhibits Cold-stress Induced Detrusor Overactivity in Conscious Rats

Non Discussion Poster Session 31 546 The antagonist of transient receptor potential channel A1-HC030031 inhibits the hyper-reflexic micturition of cyclophosphamide-induced cystitis model of rats.

Podium Poster Session 6 Neurophysiology I 55 Intravesical doxorubicin enhances neurogenic responses of detrusor smooth muscle

Non Discussion Poster Session 31 550 OnabotulinumtoxinA Significantly Decreases Urinary Incontinence and Provides Treatment Benefit in Patients with Idiopathic Overactive Bladder

Non Discussion Poster Session 31 552 Clinical evaluation of the efficacy, safety, and dry mouth side effect profile of oxybutynin and pilocarpine combination therapy, in subjects with OAB and UUI voiding dysfunction

Non Discussion Poster Session 31 556 Effect of Anticholinergics Alone on the Nocturia without Nocturnal Polyuria

Podium Poster Session 6 Neurophysiology I 56 EFFECT OF TAC-302, A NOVEL NEURITE OUTGROWTH ENHANCER, ON VOIDING DYSFUNCTION IN RATS WITH STZ-INDUCED DIABETES

Non Discussion Poster Session 31 562 PSYCHOMETRIC PROPERTIES OF THE EORTC QLQ-PR25 ASSESSMENT INSTRUMENT IN PATIENTS WITH PROSTATE CANCER

Non Discussion Poster Session 31 564 Assessment of quality of life of patients supported for genital prolapse surgery: feasibility of a computerized data collection

Non Discussion Poster Session 31 567 Patient Satisfaction Survey in Urology Continence Clinics

Non Discussion Poster Session 31 569 Functional outcome expectation in the obese is worse than the normal weight patient despite optimal surgical correction for severe pelvic organ prolapse

Non Discussion Poster Session 31 571 Ultrasonographic scan evaluation of synthetic mesh used for vaginal cystocele repair comparing four arms trans obturator techniques to bilateral anterior sacrospinous ligament and arcus tendineus suspension, at 2 years follow up.

Non Discussion Poster Session 31 576 HOW MANY WOMEN, UNDERGOING VAGINAL WALL PROLAPSE REPAIR, DO NEED CONCOMITANT MID-URETHRAL SLING?

Non Discussion Poster Session 31 581 HOW DOES THE NEOBLADDER WORK IN WOMEN? A MULTICENTRIC SURVEY

Non Discussion Poster Session 31 583 Long term results of female Artificial Urinary Sphincter: Cuff only or full sphincter?

Non Discussion Poster Session 31 584 The preliminary short-term result of Single Incision Sling for female stress urinary incontinence

Non Discussion Poster Session 31 585 Bladder augmentation using small intestinal submucosa: a pilot experience in spina bifida patients

Non Discussion Poster Session 31 587 Urgency improvement after functional magnetic stimulation – MAGnolia device

Non Discussion Poster Session 31 589 Three-year continence rates, satisfaction and adverse events of Burch urethropexy and fascial sling surgery for urinary incontinence

Podium Poster Session 7 LUTS Etiology and Treatment 59 BDNF: a Potential Biomarker of Overactive Bladder

Non Discussion Poster Session 31 590 The Effects of Suburethral Sling Surgery on Nocturia

Non Discussion Poster Session 31 591 EFFICACY OF OPHIRA MINI SLING SYSTEM FOR STRESS URINARY INCONTINENCE: MIDTERM FOLLOW UP OF 124 PATIENTS IN A MULTICENTRE INTERNATIONAL CLINICAL TRIAL

Non Discussion Poster Session 31 593 Autologous adipose stem cells in treatment of female stress urinary incontinence; one year results

Non Discussion Poster Session 31 595 URODYNAMICALLY DIAGNOSED DETRUSOR HYPOCONTRACTILITY: SHOULD SUB-URETHRAL SLING BE CONTRAINDICATED ON FEMALE STRESS URINARY INCONTINENCE?

Non Discussion Poster Session 31 597 Efficacy of TVT-SECUR and factors affecting cure of female stress urinary incontinence: 3-year follow-up

Non Discussion Poster Session 31 598 Eight-year Outcomes of the IRIS Procedure for Treatment of Female Stress Urinary Incontinence: Comparison with TVT Procedure

Non Discussion Poster Session 31 599 Comparison of long term outcome of two different methods of transobturator tension free vaginal tape for women with urodynamic stress incontinence

Non Discussion Poster Session 31 600 TVT-O FOR STRESS URINARY INCONTINENCE FOLLOWING RADICAL CYSTECTOMY AND ORTHOTOPIC RECONSTRUCTION IN WOMEN

Non Discussion Poster Session 31 602 Sling removal for dyspareunia: is sling location a factor?

Non Discussion Poster Session 31 611 To evaluate the relationship between urodynamic study and urinary tract infection

Non Discussion Poster Session 31 613 the role of voltage-gated K+ channel 2 in rat bladders with detrusor instability(DI).

Non Discussion Poster Session 31 614 ADVANCED AGE AND VAGINAL INFECTION AS RISK FACTORS FOR BACTERIURIA POST URODYNAMICS STUDY

Non Discussion Poster Session 31 620 Audit of Urodynamics practice at a UK District General Hospital and treatment outcome for patients following the Tests

Non Discussion Poster Session 31 621 Assessment of idiopathic detrusor underactivity in women in the absence of neuropathy and obstruction

Non Discussion Poster Session 31 623 The mathematical operation of urine flow rate, pressure, urethral resistance, urethral diameter and urethral length in micturition

Non Discussion Poster Session 31 625 PATIENTS VIEWS ON THE USE OF COMPUTERIZED VISUAL AID TO EXPLAIN PROLAPSE

Non Discussion Poster Session 31 626 Treatment of vaginal vault prolapse: a comparison between laparoscopic sacrocolpopexy versus robotic assisted laparoscopic sacrocolpopexy

Non Discussion Poster Session 31 628 Sacrocolpopexy (SCP) - A cohort study looking at short, medium and long term functional outcome over the last decade (2002-2011).

Non Discussion Poster Session 31 629 CONSERVATIVE TREATMENT IN PELVIC ORGAN PROLAPSE

Podium Poster Session 7 LUTS Etiology and Treatment 63 Does detrusor overactivity make a difference in women with OAB symptoms?

Non Discussion Abstract Session 32 Read By Title 631 The adjuvant botox therapy for benign prostate syndrome

Non Discussion Abstract Session 32 Read By Title 632 Application of modified Clavien classification system to 120W GreenLight HPS laser for BPH: is it useful in case of less invasive procedures?

Non Discussion Abstract Session 32 Read By Title 633 Clinic significance of urodynamic analysis in patients with benign prostatic hyperplasia complicated with diabetes mellitus

Non Discussion Abstract Session 32 Read By Title 635 The therapeutic effects of solifenacin combined with tamsulosin for treatment of increased nocturia in patients with benign prostate hyperplasia

Non Discussion Abstract Session 32 Read By Title 636 The Incidence of of BPH patient with or without detrusor incontinence in Qingpu district

Podium Poster Session 7 LUTS Etiology and Treatment 64 Etiology and management of acute urinary retention in female patients.

Non Discussion Abstract Session 32 Read By Title 640 STUDY OF THE CORRELATION CRYSTALLURIA URINARY TRACT INFECTION IN SUBJECTS LITHIASIS

Non Discussion Abstract Session 32 Read By Title 641 Clinical Analysis of the Failure in the Treatment of Posterior Urethral Stricture with Holmium Laser Endourethrotomy

Non Discussion Abstract Session 32 Read By Title 642 Tamsulosin Application for The Treatment Of Advanced Prostate cancer accompanily with bladder outlet obstruction

Non Discussion Abstract Session 32 Read By Title 644 Analysis of Risk factors in the post-TURP urethral stricture

Non Discussion Abstract Session 32 Read By Title 645 Morphometric histological analysis of smooth muscle in the anterior wall in women with pelvic organ prolapse

Non Discussion Abstract Session 32 Read By Title 646 Preliminary analysis of Spanish patients with overactive bladder: Data from a national registry

Non Discussion Abstract Session 32 Read By Title 647 Effect of Solifenacin succinate in prevention of bladder spasm after TURP

Non Discussion Abstract Session 32 Read By Title 648 Treatment of idiopathic detrusor overactivity with Propiverine ER – results of a prospective open-label study

Non Discussion Abstract Session 32 Read By Title 649 The efficacy and safety of solifenacin vesicare therapy in FBNO with transurethral resection of bladder neck with overactive bladder

Podium Poster Session 7 LUTS Etiology and Treatment 65 Efficacy of tamsulosin OCAS 0.4 mg in female with lower urinary tract symptoms: A randomized, double-blind, placebo controlled trial

Non Discussion Abstract Session 32 Read By Title 650 EVALUATION OF BOTULINUM TOXIN TYPE A FOR TREATING 100 PATIENTS WITH OVERACTIVE DETRUSOR. INITIAL EXPERIENCE

Non Discussion Abstract Session 32 Read By Title 651 The therapeutic effects of solifenacin combined with indometacin suppositories in prevention of cystospasm after transurethral vaporization of the prostate

Non Discussion Abstract Session 32 Read By Title 652 Analysis of the relative Factors and Psychological Experience for Overactive Bladder Symptoms Following Surgical Treatment in Patients With Benign Prostatic Obstruction ABSTRACT

Non Discussion Abstract Session 32 Read By Title 653 Efficacy of Solifenacin with or without Tamsulosin in patients with Overactive Bladder

Non Discussion Abstract Session 32 Read By Title 654 Perioperative application of solifenacin succinate during transurethral resection of the prostate

Non Discussion Abstract Session 32 Read By Title 655 Urodynamics for diagnosis of cystitis glandularis and clinical significance

Non Discussion Abstract Session 32 Read By Title 656 The research of treatment options and prognosis’s significance of Urinary ATP quantification and urodynamic testing in patients with BPH and OAB

Non Discussion Abstract Session 32 Read By Title 657 Efficacy of solifenacin in treatment of cystospasm caused by indwelling catheter after transurethral resection of bladder tumor

Non Discussion Abstract Session 32 Read By Title 658 Expression and significance of E-cadherin/ß-catenin complex in detrusor instability

Non Discussion Abstract Session 32 Read By Title 659 Comparison of the efficacy of Tolterodine with or without Tamsulosin in OAB

Non Discussion Abstract Session 32 Read By Title 660 Efficacy and safety of solifenacin in the treatment of cystospasm after transurethral prostatic resection?

Non Discussion Abstract Session 32 Read By Title 661 Pelvic floor rehabilitation. Patients data review.

Non Discussion Abstract Session 32 Read By Title 662 Effectiveness of classical techniques. Thinking about LeFort.

Non Discussion Abstract Session 32 Read By Title 663 Vesico vaginal fistula in a West Africa’s country: Epidemiological profile and management

Non Discussion Abstract Session 32 Read By Title 665 Overactive urinary incontinence after radical prostatectomy: preliminary report after 14 consecutive cases treated with sacral neuromodulation

Non Discussion Abstract Session 32 Read By Title 667 Treatment of stress urinary incontinence in men with an adjustable transobturator male system: Early European multicenter experience

Non Discussion Abstract Session 32 Read By Title 668 Comparison of 3 different incontinence devices: Clinical outcome of Pro ACT®, ARGUS® and AMS 800® after 3 years of FU

Non Discussion Abstract Session 32 Read By Title 669 Transvesical single-port laparoscopic radical prostatectomy for organ-confined prostate cancer: an initial experience of 20 cases

Podium Poster Session 7 LUTS Etiology and Treatment 67 The therapeutic effects of orally solifenacin combined with pelvic floor muscle exercises in treatment of female overactive bladder

Non Discussion Abstract Session 32 Read By Title 670 RECOVERY OF CONTINENCE FUNCTION IN PATIENTS AFTER RADICAL RETROPUBIC NERVE-SPARING PROSTATECTOMY.

Non Discussion Abstract Session 32 Read By Title 671 Patient reported incontinence after robot assisted laparoscopic radical prostatectomy – a single centre experience

Non Discussion Abstract Session 32 Read By Title 672 Improved dry rates with a newly designed transobturator sling in male stress urinary continence

Non Discussion Abstract Session 32 Read By Title 674 Effect of Macroplastique® injection for the patients with male incontinence after treatment of prostate disease

Non Discussion Abstract Session 32 Read By Title 676 Post Radical prostatectomy incontinence – followup, investigation and management !

Non Discussion Abstract Session 32 Read By Title 677 Penoscrotal approach is not inferior to perineal approach for artificial urinary sphincter implantation in male urinary incontinence

Non Discussion Abstract Session 32 Read By Title 679 In the relation of the androgen and a bladder function, the action on a bladder blood flow of the androgen is negative.

Podium Poster Session 7 LUTS Etiology and Treatment 68 The Potent and Selective Beta3-adrenoceptor Agonist Mirabegron Improves Patient-reported Outcomes in Overactive Bladder–Results from Two Phase III Studies

Non Discussion Abstract Session 32 Read By Title 680 The Repeatability of 1-Hour Pad Test in Untreated Urinary Incontinent Women

Non Discussion Abstract Session 32 Read By Title 682 Validation of the Bladder Control Self –Assessment Questionnaire (B-SAQ) in men

Non Discussion Abstract Session 32 Read By Title 684 Urodynanic features of male patients with non-neurogenic lower urinary tract symptoms

Non Discussion Abstract Session 32 Read By Title 686 Correlation between collagen and urinary symptoms in patients with prostatic obstruction

Non Discussion Abstract Session 32 Read By Title 687 Difference in the International prostate symptom score performed by physicians and patients

Non Discussion Abstract Session 32 Read By Title 689 Efficacy of Desmopressin in the treatment of nocturnal polyuria: impact on related sleep quality in elderly male

Non Discussion Abstract Session 32 Read By Title 690 A COMPARATIVE STUDY ON THE CLINICAL EFFECTS OF SILODOSIN AND NAFTOPIDIL IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

Non Discussion Abstract Session 32 Read By Title 691 The Clinical Significance of Lower Urinary Tract Symptoms in Prostate Cancer

Non Discussion Abstract Session 32 Read By Title 692 The utilization of PSA in LUTS patients within primary care settings

Non Discussion Abstract Session 32 Read By Title 693 Clinical effectiveness and safety of combined therapy with solifenacin and tamsulosin for patients with type III prostatitis

Non Discussion Abstract Session 32 Read By Title 694 Clinical characteristics of LUTS suggestive of BPH and their impact on patients’ quality of life

Non Discussion Abstract Session 32 Read By Title 696 Clinical efficiency and safety study of therapy with an anticholinergic or an alpha-blocker for patients with OAB/BPH after transurethral resection of the prostate

Non Discussion Abstract Session 32 Read By Title 697 Comparative Evaluation of Efficacy of Use of Doxazosin Mesylate and/or Tolterodine ER for the Treatment of Chronic Prostatitis/Chronic pelvic Pain Syndrome with overactive bladder symptoms

Non Discussion Abstract Session 32 Read By Title 698 Efficacy and safety of desmopressin add-on therapy for persistent nocturia in men previously treated with alpha blocker for lower urinary tract symptoms

Non Discussion Abstract Session 32 Read By Title 699 The clinical significance of pyuria after transrectal prostate biopsy

Podium Session 2 LUTS Women Effects and cost-effectiveness of protocolized assessment and evidence-based treatment of urinary incontinence: The URinary INcontinence in Older women trial (URINO)

Podium Poster Session 7 LUTS Etiology and Treatment 70 The somatic and autonomic innervation of the clitoris; preliminary evidence of sexual dysfunction after minimal invasive slings

Non Discussion Abstract Session 32 Read By Title 701 The therapeutic effects of solifenacin succinate on postoperative cystospasm

Non Discussion Abstract Session 32 Read By Title 702 The Association between the Self-Perception Period of Overactive Bladder Symptoms and Overactive Bladder Symptom Score in non Treated Population

Non Discussion Abstract Session 32 Read By Title 703 The therapeutic effects of solifenacin succinate on cystospasm in patients with continent bladder stoma

Non Discussion Abstract Session 32 Read By Title 704 Changes in sleep quality, depression, and anxiety after treatment of nocturia in male patients with lower urinary tract symptoms

Non Discussion Abstract Session 32 Read By Title 705 The therapeutic effects of solifenacin on cystospasm after transurethral operation

Non Discussion Abstract Session 32 Read By Title 706 Sociodemographic and Lifestyle Factors Affecting the Self-Perception Period of Lower Urinary Tract Symptoms of International Prostate Symptom Score Items

Non Discussion Abstract Session 32 Read By Title 707 Solifenacin in the treatment of overactive bladder after PKVP

Non Discussion Abstract Session 32 Read By Title 708 The study on the combination therapy of Tamsulosin and Solifenacin in treating the Lower urinary tract symptoms caused by BPH

Non Discussion Abstract Session 32 Read By Title 709 Clinical study of combination theapy tamsulosin and solifenacin for benign prostatic hyperplasia with overactive bladder

Non Discussion Abstract Session 32 Read By Title 710 The diagnose and treatment strategy for the outpatient female OAB patients: the initial experience from one Chinese clinic

Non Discussion Abstract Session 32 Read By Title 712 Mao-bushi-saishin-to( Ma-hiang-fu-zi-xi-xin-tang) improves stress urinary incontinence in elderly people.

Non Discussion Abstract Session 32 Read By Title 714 The Interaction of Morphological and Functional Changes of Bladder Following Spinal Cord Injury on Canine Model

Non Discussion Abstract Session 32 Read By Title 715 The ROLE of TRPM8 in Diabetic Bladder Dysfunction

Non Discussion Abstract Session 32 Read By Title 718 The role of bladder hydrodistention and intravesical sodium hyaluronate in the treatment of interstitial cystitis

Non Discussion Abstract Session 32 Read By Title 719 Bladder Endometriosis: Clinical Presentations of an Uncommon Clinical Condition

Non Discussion Abstract Session 32 Read By Title 721 OUTCOME OF BLADDER NECK INJECTION AFTER EPISPADIAS-EXSTROPHY REPAIR IN CHILDREN

Non Discussion Abstract Session 32 Read By Title 723 Botulotoxin A in the treatment of children with neurogenic bladder: our fist experience.

Non Discussion Abstract Session 32 Read By Title 724 Comorbidity between nocturnal enuresis with nocturnal polyuria, cognitive dysfunction /attention deficit hyperactivity disorder and restless legs syndrome?

Non Discussion Abstract Session 32 Read By Title 727 Computational Simulation of Urethral Hypermobility in Women

Non Discussion Abstract Session 32 Read By Title 728 How common is pelvic floor muscle atrophy after vaginal childbirth?

Non Discussion Abstract Session 32 Read By Title 731 Combination of pelvic floor biofeedback with electric stimulation can improve chronic pelvic pain, lower urinary tract symptoms and sexual dysfunction in patients with Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) – 1 year follow-up

Non Discussion Abstract Session 32 Read By Title 733 Does physiotherapist-guided pelvic floor muscle training increase the quality of life in patients after radical prostatectomy? A randomized clinical study

Non Discussion Abstract Session 32 Read By Title 734 PSYCHOLOGICAL PREDICTORS OF PHYSIOTHERAPY TREATMENT FOR PELVIC FLOOR DYSFUNCTION:

Non Discussion Abstract Session 32 Read By Title 737 Repair of Vaginal Wall Prolapse – Using Amniotic Membrane Graft

Non Discussion Abstract Session 32 Read By Title 738 Botulinum toxin A injections into pelvic floor muscles under electromyographic guidance for women with refractory high tone pelvic floor dysfunction: Three months follow-up data of an ongoing pilot study

Non Discussion Abstract Session 32 Read By Title 739 Study of the alterations in the levator hiatus by pelvic floor ultrasound in young sport students: A preliminar study

Non Discussion Abstract Session 32 Read By Title 741 The relationship of subpubic arch angle and postpartum stress urinary incontinence

Non Discussion Abstract Session 32 Read By Title 742 Pelvic floor muscle training using extracorporeal biofeedback device for the treatment of stress urinary incontinence in women

Non Discussion Abstract Session 32 Read By Title 743 Identifying commonly acquired gynecological variables related to pubovisceral avulsion severity

Non Discussion Abstract Session 32 Read By Title 744 The dangerous downside of sit-ups: tackling incontinence in partnership with the fitness industry

Non Discussion Abstract Session 32 Read By Title 746 MRI analysis of bony pelvis dimensions in patients suffering form severe pelvic organ descent

Non Discussion Abstract Session 32 Read By Title 747 Pelvic floor electromyographic activation in normal and overweight women: a pilot study

Non Discussion Abstract Session 32 Read By Title 748 Effectiveness of Perinometer Biofeedback Pelvic Floor Muscle Exerciser with ExTT-101TM In Female Stress Urinary Incontinence

Non Discussion Abstract Session 32 Read By Title 749 Sexual dysfunction is associated with chronic pelvic pain in patients with Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

Non Discussion Abstract Session 32 Read By Title 750 Surgical repair of female genital prolapse using a synthetic mesh.

Non Discussion Abstract Session 32 Read By Title 751 Intravesical electromotive botulinum toxin administration – new approach of OAB and BPS treatment

Non Discussion Abstract Session 32 Read By Title 753 Safety, efficacy, and reduction of dry mouth side effect in OAB / UUI patients receiving combination therapy of tolterodine and pilocarpine

Non Discussion Abstract Session 32 Read By Title 754 Efficacy of Solifenacin with or without Tamsulosin in patients with overactive bladder

Non Discussion Abstract Session 32 Read By Title 755 The value of cystoscope and bladder hydrodistention under no- anesthesia in the diagnosis of interstitial cystitis

Non Discussion Abstract Session 32 Read By Title 756 QUALITY OF LIFE AFTER CONTINENT URINARY DIVERSION

Non Discussion Abstract Session 32 Read By Title 758 Using Mesh in Pelvic Floor Pathology: Our experience with complications in 7 years.

Podium Poster Session 8 Neurourology: Clinical I 76 Urine Culture Changed after Botulinum Toxin A Detrusor Injections in 26 Patients with Neurogenic Detrusor Overactivity caused by Spinal Cord Injury: A Single-center Longitudinal Perspective Study

Non Discussion Abstract Session 32 Read By Title 760 CHANGES IN ROBOTIC-ASSISTED LAPAROSCOPIC SACROCOLPOPEXY OPERATIVE TIME: AN ANALYSIS OF TECHNICAL FACTORS

Non Discussion Abstract Session 32 Read By Title 761 Medium-term functional results of laparoscopic sacrocolpopexy. A retrospective, single-center study about 81 cases.

Non Discussion Abstract Session 32 Read By Title 762 Concomitant transvaginal mesh and sling for pelvic organ prolapse, stress urinary incontinence, and occult stress urinary incontinence women

Non Discussion Abstract Session 32 Read By Title 764 Evaluation of safety and effectiveness of POP (pelvic organ prolapse) treatment using polypropylene mesh PELVIMESH® Anterior and Posterior by Herniamesh® – Italy and PROLIFT Anterior and Posterior by Johnson & Johnson depending on the technique and the kind of the mesh applied.

Non Discussion Abstract Session 32 Read By Title 767 Efficacies of vaginal prolapsed repair with tension-free vaginal tape procedure(TVT) in women with anterior vaginal wall prolapse and stress urinary incontinence over 1-year-followup

Non Discussion Abstract Session 32 Read By Title 768 Clinical and ultrasonographic study of treatment for severe prolapse with transvaginal mesh and high uteroligment susppention

Non Discussion Abstract Session 32 Read By Title 770 COMBINED SPINAL AND GENERAL ANESTHESIA REDUCES INTRA- AND POSTOPERATIVE OPIOID REQUIREMENTS IN PATIENTS UNDERGOING ROBOTIC-ASSISTED LAPAROSCOPIC SACROCOLPOPEXY

Non Discussion Abstract Session 32 Read By Title 771 Functional outcome after Laparoscopic Sacrocolpopexy

Non Discussion Abstract Session 32 Read By Title 772 ELEVATE ANTERIOR AND APICAL AND ELEVATE APICAL AND POSTERIOR: SAFETY AND EFFICACY IN SURGICAL TREATMENT OF PELVIC ORGAN PROLAPSE.

Non Discussion Abstract Session 32 Read By Title 774 Ileal Conduit Urinary Diversion Created from the Retubularized Pouch of an Augmentation Ileocystoplasty

Non Discussion Abstract Session 32 Read By Title 775 Change of prolapse and sexual matters symptoms after surgery for pelvic organ prolapse (POP)

Non Discussion Abstract Session 32 Read By Title 776 Impact of neurovascular bundle electrostimulation on penile erection – a reliable animal model

Non Discussion Abstract Session 32 Read By Title 777 Traumatic Cloaca Repair

Non Discussion Abstract Session 32 Read By Title 779 Correlation of urodynamic changes and nocturnal electrobioimpedance volumetric assessment(NEVA) in the patients with neurogenic bladder.

Podium Poster Session 8 Neurourology: Clinical I 78 Detrusorial injections of Botulinum Toxin in multiple sclerosis: long-term experience of a single centre

Non Discussion Abstract Session 32 Read By Title 780 The effect of observing the degree and the pattern of urine leakage before adjustment of the mesh during transobturator tape (TOT) procedure

Non Discussion Abstract Session 32 Read By Title 783 MONARC VERSUS MINIARC: RETROSPECTIVE STUDY

Non Discussion Abstract Session 32 Read By Title 784 Single incision contasure NEEDLELESS: as an Alternative Transobturator Tape in Female Stress Urinary Incontinence

Non Discussion Abstract Session 32 Read By Title 785 Repeat mid-urethral sling for recurrent female stress urinary incontinence

Non Discussion Abstract Session 32 Read By Title 786 Long-Term Outcomes of the Tension-Free Vaginal Tape Procedure for Treatment of Female Stress Urinary Incontinence with Intrinsic Sphincter Deficiency

Non Discussion Abstract Session 32 Read By Title 787 CISTOCELE AND URINARY INCONTINENCE CORRECTION USING SLING WITH WHIPSTITCH EDGES.

Non Discussion Abstract Session 32 Read By Title 788 Evaluation study between Tension – Free Vaginal Tape (TVT) and Transobturator Tape (TOT) in treatment stress incontinence in female

Podium Poster Session 8 Neurourology: Clinical I 79 UNILATERAL VERSUS BILATERAL TINED LEAD STIMULATION IN PATIENT’S SELECTION FOR SACRAL NERVE STIMULATION

Non Discussion Abstract Session 32 Read By Title 790 Outcomes with replacement transobturator sling after midurethral sling removal for dyspareunia

Non Discussion Abstract Session 32 Read By Title 791 Short term clinical outcome of mid-urethral tapes.

Non Discussion Abstract Session 32 Read By Title 792 The use of autologous rectus fascia and polypropylene mesh as a combined sling for treatment of female stress urinary incontinence

Non Discussion Abstract Session 32 Read By Title 793 Readjustable Sling (Remeex System) for Female Stress Urinary Incontinence; Complications and Their Managements

Non Discussion Abstract Session 32 Read By Title 794 Transobturator Suburethral Sling (T.S.S) : For treating female stress incontinence

Non Discussion Abstract Session 32 Read By Title 795 Clinical Efficacy of Tape Cutting as a Treatment for Complication in transobturator tape

Non Discussion Abstract Session 32 Read By Title 796 Tension-free vaginal tape-SECUR(TVT-S) for the treatment of female stress urinary incontinence

Non Discussion Abstract Session 32 Read By Title 797 Management of female stress urinary incontinence after failed sling operation

Non Discussion Abstract Session 32 Read By Title 798 Voiding difficulties after transobturator mesh implantation surgery in stress urinary incontinence women

Non Discussion Abstract Session 32 Read By Title 799 Transobturator tension-free tape procedure for treatment of female stress urinary incontinence:A report of 46 cases

Podium Session 2 LUTS Women Internet-based treatment of stress urinary incontinence: a randomised controlled study.

Podium Poster Session 8 Neurourology: Clinical I 80 "Conventional" peripheral nerve evaluation test vs. "Two-stage-implantation" - comparison of response rates in sacral nerve stimulation

Non Discussion Abstract Session 32 Read By Title 800 Does Tension free vaginal tape take the tension out of woman’s life? A clinical audit on the effectiveness of TVT.

Non Discussion Abstract Session 32 Read By Title 801 Bulking Therapy in Stress Urinary Incontinence: An Analysis of 500 Cases

Non Discussion Abstract Session 32 Read By Title 802 3 YEAR OUTCOME OF TRANSOBTURATOR (I-STOP ®) TAPE PROCEDURE IN FEMALE STRESS URINARY INCONTINENCE – EXPERIENCE OF UK GENERAL HOSPITAL

Non Discussion Abstract Session 32 Read By Title 803 Medium term results of insertion of Transobturator tape for female urinary incontinence in a single urology unit

Non Discussion Abstract Session 32 Read By Title 804 Monarc transobturator sling system for the treatment of female stress urinary incontinence(SUI) (Report of 120 cases)

Non Discussion Abstract Session 32 Read By Title 805 Ambulatory Urodynamics Monitoring System for Females With Stress Urinary Incontinence

Non Discussion Abstract Session 32 Read By Title 807 Urinary incontinence and its management – do urodynamic studies play an essential role?

Non Discussion Abstract Session 32 Read By Title 808 Patient satisfaction survey in Urogynaecology Clinics at a UK District General Hospital 2011

Non Discussion Abstract Session 32 Read By Title 810 The discovering theory of powers of vesical micturition and clinical application

Non Discussion Abstract Session 32 Read By Title 814 Value of ambulant long-term urodynamic study in the context of neuro-urological diagnostics.

Non Discussion Abstract Session 32 Read By Title 815 Predicting the Need for Concomitant Mid-urethral Tape Procedure during Cystocele Repair by Vaginal Packing

Non Discussion Abstract Session 32 Read By Title 816 Urodynamics of Orthotopic Sigmoid Neobladder

Non Discussion Abstract Session 32 Read By Title 818 The influence of 45 degree semi-reclining position in the cystometry in patients with benign prostatic hyperplasia

Non Discussion Abstract Session 32 Read By Title 819 Reasons of Failure in Urodynamic Study: Analysis of 1080 Cases

Podium Poster Session 8 Neurourology: Clinical I 82 IS LONG-TERM FOLLOW-UP REQUIRED FOR ADULT MYELOMENINGOCELE PATIENTS AFTER LOWER URINARY TRACT RECONSTRUCTIVE SURGERY?

Non Discussion Abstract Session 32 Read By Title 821 The catheterization apparatus with bionic bladder

Non Discussion Abstract Session 32 Read By Title 822 Simultaneous urodynamic data recording with two sets of urodynamics –a prospective comparative trial.

Non Discussion Abstract Session 32 Read By Title 823 Urodynamic study of bladder dysfunction after radical resection of rectal carcinoma

Non Discussion Abstract Session 32 Read By Title 827 The significance of urodynamic study on the patients with pelvic organ prolapse preoperation

Non Discussion Abstract Session 32 Read By Title 828 Single-center experience with laparoscopic colposacropexy for repair of vaginal vault prolapse

Podium Poster Session 8 Neurourology: Clinical I 83 Long-term outcome of augmentation ileocystoplasty in patients with neurogenic lower urinary tract dysfunction

Podium Poster Session 8 Neurourology: Clinical I 84 Risk factors predict upper urinary tract deterioration in patients with spinal cord injury--a longitudinal study

Podium Poster Session 8 Neurourology: Clinical I 86 Prevalence of Stress Urinary Incontinence in Women with Multiple Sclerosis

Podium Poster Session 9 Imaging 88 4D ultrasound assessment of morphological characteristics of urogenital hiatus in women after elective and acute Caesarean Section

Podium Poster Session 9 Imaging 90 Prolapse assessment by ultrasound: How easy is it to teach and do?

Podium Poster Session 9 Imaging 91 Towards polypropylene mesh visualization on MRI

Podium Poster Session 9 Imaging 92 Can bladder outlet obstruction be diagnosed from the urethral cross-sectional area estimated by ultrasound imaging?

Podium Poster Session 9 Imaging 95 The Best Parameter of Bladder Diary Correlates with the Volume at Strong Desire to Void of Filling Cystometry

Podium Poster Session 10 Prolapse Surgical Treatment 99 Risk of Malignancy in patients with Uterine Prolapse

ICS 2011

Podium Session 1 Stress Urinary Incontinence A Systematic Review and Meta-Analysis of Single-Incision Mini-Slings versus Standard Mid-Urethral Slings in Surgical Management of Female Stress Urinary Incontinence.

Podium Poster Session 9 Pregnancy 100 Does a regular exercise program including pelvic floor muscle exercises prevent urinary incontinence in pregnancy?

Podium Poster Session 9 Pregnancy 102 Does a mediolateral episiotomy prevent a third or fourth degree perineal tear during an assisted instrumental vaginal delivery?

Podium Poster Session 9 Pregnancy 104 Inter-rater agreement between researchers when observing signs of toilet readiness.

Podium Poster Session 9 Pregnancy 105 Effect of antenatal pelvic floor exercises on bladder neck descent in nulliparous pregnant women

Podium Poster Session 9 Pregnancy 108 INTER-OBSERVER REPEATABILITY OF THREE-DIMENSIONAL PERINEAL ULTRASOUND IN PREGNANT WOMEN

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 11 Consenting for tape procedures

Podium Poster Session 9 Pregnancy 110 Can the abdominal and pelvic muscle training trigger the co-activation between the transversus abdominis / internal oblique muscle and the muscles of the pelvic floor during pregnancy and postpartum?

Podium Poster Session 10 Diagnosis and Management 114 Surgical management of mesh-related complications after prior pelvic floor reconstructive surgery with mesh.

Podium Poster Session 10 Diagnosis and Management 116 'What does Asymptomatic post Obstetric Anal Sphincter Injuries really mean'?

Podium Poster Session 10 Diagnosis and Management 117 Effectiveness of perineal exercises in controlling urinary incontinence and improving pelvic floor muscle function during pregnancy

Podium Poster Session 10 Diagnosis and Management 120 FEASIBILITY STUDY FOR EVALUATING LEVATOR ANI TEAR STATUS AFTER SECOND VAGINAL DELIVERY

Podium Poster Session 10 Diagnosis and Management 121 Functional outcomes after repair of mesh extrusion into the lower urinary tract

Podium Poster Session 10 Diagnosis and Management 122 DIFFERENCES IN SACRAL NEUROMODULATION DEVICE INFECTION RATES BASED ON PREOPERATIVE ANTIBIOTIC SELECTIONS

Podium Session 11 Integrative Physiology 128 Proinflammatory cytokines upregulate connexin43 expression and promote gap junction intercellular communication in bladder smooth muscle cells

Podium Session 12 Prolapse and Pelvic Floor 131 Open and Laparoscopic Sacrocolpopexy demonstrate clinical equivalence: one year results from the LAS Trial, an RCT comparing the two approaches for treating post hysterectomy vault prolapse

Podium Session 12 Prolapse and Pelvic Floor 132 Elucidation of Circular versus “Purse String” Morphology of External Anal Sphincter Muscle using Ultrasound, High Resolution and Diffusion Tensor Magnetic Resonance Imaging.

Podium Session 12 Prolapse and Pelvic Floor 133 Assessment of contractility of the pelvic floor – from the clinical practice of scientific research - Is there a correlation between the methods of functional evaluation and electromyography?

Podium Session 13 Male Incontinence Assessment and Treatment 137 Correlation of retrograde leak point pressure with objective severity of incontinence after radical prostatectomy

Podium Session 13 Male Incontinence Assessment and Treatment 139 INVASIVE VERSUS NON-INVASIVE EVALUATION OF SUCCESSFUL PRO-ACT TREATMENT IN POST RADICAL PROSTATECTOMY STRESS URINARY INCONTINENCE

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 14 Implantation of Autologous Bone Marrow-derived Cells Recovers Urethral Sphincter in Rabbits

Podium Session 13 Male Incontinence Assessment and Treatment 140 Transobturator male sling at the time of robotic assisted, laparoscopic radical prostatectomy yields improved continence outcomes: data from a randomized clinical trial demonstrating safety and efficacy.

Podium Poster Session 14 Epidemiology and Outcomes Research 141 An analysis of urinary incontinence work presented at the ICS/IUGA 2010 Joint meeting

Podium Poster Session 14 Epidemiology and Outcomes Research 142 Epidemiology of Primary and Repeat Surgical Treatment for Pelvic Organ Prolapse and/ or Stress Urinary Incontinence in UK

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 15 Intrasphincteric autologous myoblast injection for the treatment of stress urinary incontinence

Podium Poster Session 14 Epidemiology and Outcomes Research 151 Efficacy of ultrasound-guided pelvic muscle training

Podium Poster Session 15 Receptors and Pharmacology 153 INHIBITORY EFFECT OF TADALAFIL, A PHOSPHODIESTERASE 5 INHIBITOR, ON BLADDER MECHANOSENSITIVE AFFERENT ACTIVITY IN THE RAT

Podium Poster Session 15 Receptors and Pharmacology 155 Role of extracellular Ca2+ influx through L-type Ca2+ channels (LVOCC) to bladder dysfunction and overactive detrusor smooth muscle in obese mice

Podium Poster Session 15 Receptors and Pharmacology 156 GALANIN-MEDIATED REGULATION OF MICTURITION REFLEX IN URETHANE-ANESTHETIZED RATS

Podium Poster Session 15 Receptors and Pharmacology 159 Superiority of Desmopressin as oral lyophIlisate formulation compared to tablet, related to less interference by associated foodintake

Podium Poster Session 15 Receptors and Pharmacology 163 Pharmacokinetic characteristics of Desmopressin oral lyophilisate (melt) and tablet formulation in children

Podium Poster Session 15 Receptors and Pharmacology 164 Comparative evaluation of the safety and efficacy of long-term use of Imidafenacin and Solifenacin in patients with overactive bladder: A prospective, open, randomized, parallel-group trial (the LIST study)

Podium Poster Session 16 Pelvic Floor Imaging 166 MAJOR DEFECTS OF THE PUBOVISCERAL MUSCLE, LEVATOR HIATUS DIMENSIONS AND PELVIC FLOOR FUNCTION, A THREE AND FOUR DIMENSIONAL TRANSPERINEAL STUDY.

Podium Poster Session 16 Pelvic Floor Imaging 168 Reproducibility of pelvic floor measurements in rest and Valsalva comparing conventional three-dimensional ultrasound with virtual reality

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 17 PERIURETHRAL INJECTION OF POLYACRYLAMID HYDROGEL AS A SALVAGE THERAPY FOR SEVERE STRESS URINARY INCONTINENCE IN WOMEN”

Podium Poster Session 16 Pelvic Floor Imaging 171 A 3D statistical shape analysis of pelvic floor morphology in nulliparous women

Podium Poster Session 16 Pelvic Floor Imaging 172 Anorectal symptoms before and after surgical repair of pelvic organ prolapse.

Podium Poster Session 16 Pelvic Floor Imaging 173 Defining Pelvic Organ Prolapse: Correlation Of Symptoms With Vaginal Topography

Podium Poster Session 16 Pelvic Floor Imaging 174 Displacement of the levator ani muscle in continent and incontinent female athlete

Podium Poster Session 16 Pelvic Floor Imaging 175 The Laser Commode: A Novel Device for the Measurement of Perineal Descent

Podium Poster Session 16 Pelvic Floor Imaging 176 A Retrospective Review of Proctographic Findings in Patients with Pelvic Floor Dysfunction

Podium Poster Session 17 Urothelium and Signal Transmission 177 A next generation drug for Overactive bladder, TRK-130, in a Phase-IIb clinical trial in Japan; Preclinical data of potent pharmacological effects based on modulation of neurotransmission.

Podium Poster Session 17 Urothelium and Signal Transmission 178 HIGH-DOSE TRANILAST CREATES INTERSTITIAL CYSTITIS WITH INCREASED VESICAL VASCULAR PERMEABILITY IN RATS

Podium Poster Session 17 Urothelium and Signal Transmission 179 Enhanced bladder pain in cyclophosphamide-induced cystitis in rats- Involvement of pelvic nerve and hypogastric nerve sensitization

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 18 A Randomised Prospective Single-Blinded Study Comparing “Inside-out” versus “Outside-in” Transobturator Tapes in the Management of Female Stress Urinary Incontinence (E-TOT study); 3 years follow-up

Podium Poster Session 17 Urothelium and Signal Transmission 183 SPINAL GLYCINE TRANSPORTER-1 INHIBITION INFLUENCES THE MICTURITION REFLEX IN URETHANE-ANESTHETIZED RATS

Podium Poster Session 17 Urothelium and Signal Transmission 186 The role of the urothelium in potassium sensitivity testing in the clinic.

Podium Poster Session 17 Urothelium and Signal Transmission 188 Urothelial release of nerve growth factor (NGF): modulation by protein kinase C and mitogen-activated protein kinase pathways

Podium Video Session 18 Surgical Techniques 189 Robotic Laparoendoscopic Single Site (R-LESS) Sacrocolpopexy

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 19 A Comparative Study of Outside-In and Inside-Out Transobturator Tape Procedures for Stress Urinary Incontinence: 5-yr outcomes

Podium Video Session 18 Surgical Techniques 191 Single Incision Sling under Local Anaesthesia for Female Stress Urinary Incontinence

Podium Video Session 18 Surgical Techniques 194 Over the wire ultrasound guided ProACT implant

Podium Video Session 18 Surgical Techniques 195 Trans-vaginal Total Pelvic Floor Repair Using Customized Prolene Mesh: A Safe And Cost Effective Approach For High Grade Pelvic Organ Prolapse

Podium Video Session 18 Surgical Techniques 197 Anterior, apical and posterior compartment repair with mesh: minimally invasive sacrospinous fixation system.

Podium Session 1 Stress Urinary Incontinence Retropubic TVT compared with transobturator TVT (TVT-O) in treatment of stress urinary incontinence: five-year results of a randomized trial

Podium Session 19 Lower Urinary Tract Investigation and Treatment 200 Bony Pelvis Dimensions in Women With and Without Stress Urinary Incontinence

Podium Session 19 Lower Urinary Tract Investigation and Treatment 202 Which anticholinergic for adult Neurogenic Detrusor Overactivity: A Systematic Review and Meta-analysis.

Podium Session 20 Imaging 204 The accuracy of predicting pelvic organ prolapse quantification (POPQ) points using transperineal ultrasound in women with pelvic organ prolapse (POP)

Podium Poster Session 21 Faecal Incontinence and Pelvic Floor Dysfunction 208 Trends in Obstetric Anal Sphincter injuries over 10 years – Incidence and Risk factors

Podium Poster Session 21 Faecal Incontinence and Pelvic Floor Dysfunction 209 Obstetrical Anal Sphincter Injuries: A Survey of Clinical Practice Among Canadian Obstetricians

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 21 MECHANICAL PROPERTIES OF MINI SLING FIXATION DEVICES: OPHIRA® VERSUS MINI ARC ®

Podium Poster Session 21 Faecal Incontinence and Pelvic Floor Dysfunction 210 Correlation of Vector Volume Parameters

Podium Poster Session 21 Faecal Incontinence and Pelvic Floor Dysfunction 213 Functional results and patient satisfaction with Sacral Nerve Stimulation for idiopathic faecal incontinence

Podium Poster Session 21 Faecal Incontinence and Pelvic Floor Dysfunction 216 INTRAVENOUSLY INJECTED MESENCHYMAL STEM CELLS HOME TO PELVIC ORGANS AFTER SIMULATED CHILDBIRTH INJURY

Podium Poster Session 21 Faecal Incontinence and Pelvic Floor Dysfunction 217 Role of Puborectalis Muscle in the Genesis of Urethral Pressure

Podium Poster Session 21 Faecal Incontinence and Pelvic Floor Dysfunction 219 Long term outcomes of pessary use in women with pelvic organ prolapse

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 22 EFFICACY OF OPHIRA MINI SLING SYSTEM FOR STRESS URINARY INCONTINENCE: MIDTERM FOLLOW UP OF 176 PATIENTS IN A MULTICENTRE INTERNATIONAL CLINICAL TRIAL

Podium Poster Session 22 Imaging and the Brain 222 Transvaginal ultrasonography and urethral diverticula: a diagnostic and therapeutic tool.

Podium Poster Session 22 Imaging and the Brain 226 In Vivo 3D representation of the Levator Ani Muscle Using Diffusion Tensor Imaging with fiber tractography: Initial Results

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 23 Comparison between transobturator vaginal tape inside out and single incision sling system in the treatment of female stress urinary incontinence: Prospective randomized study

Podium Poster Session 22 Imaging and the Brain 231 DOES SURGICAL INTERVENTION FOR POST- PROSTATECTOMY URINARY INCONTINENCE IMPROVE ERECTILE FUNCTION?

Podium Poster Session 23 Continence Hotch Potch 235 Neurogenic bladder associated with Xeroderma Pigmentosum A in Japan

Podium Poster Session 23 Continence Hotch Potch 236 Are we appropriately requesting urine culture on the basis of urine dipstick results in asymptomatic pregnant women?

Podium Poster Session 23 Continence Hotch Potch 237 How transvaginal mesh surgery for advanced pelvic organ prolapse influence female sexual function?

Podium Poster Session 23 Continence Hotch Potch 238 Serum C-reactive Protein Levels Are Associated with Residual Urgency Symptoms in Patients with Benign Prostatic Hyperplasia after Medical Treatment

Podium Poster Session 24 Male Urology 244 Nocturia is the Lower Urinary Tract Symptom with greatest impact on Quality Of Life of men in a community setting

Podium Poster Session 24 Male Urology 246 Prognostic Factors for Persistent Storage Symptoms Following Surgical Treatment in Patients with Benign Prostatic Obstruction

Podium Poster Session 24 Male Urology 247 The correlation of clinical and urodynamic findings and the impact of radiation in post-radical prostatectomy incontinence

Podium Poster Session 24 Male Urology 248 Correlation of Urinary Nerve Growth Factor level with bladder outlet obstruction.

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 25 Incidence and risk factors for reoperation after surgically managed urinary incontinence: a nested case control study.

Podium Poster Session 24 Male Urology 250 Four years experience with the FlowSecure Artificial Urinary Sphincter. Problems and solutions.

Podium Poster Session 24 Male Urology 251 Difference between urethral circumference and artificial urinary sphincter cuff size does not affect decrease in postoperative incontinence

Podium Poster Session 24 Male Urology 253 Clinical efficacies and impacts on sexual function of alpha-1A/D selective blockers in patients with benign prostatic hyperplasia.

Podium Poster Session 25 Surgical Solutions 257 Results of using polyacrylamide hydrogel (Bulkamid®) for the therapy of stress urinary incontinence in selected population of women

Podium Poster Session 25 Surgical Solutions 259 The effect of midurethral sling surgery in elderly patients over 75 years old with female stress urinary incontinence

Podium Poster Session 3 Treatments for Stress Urinary Incontinence 26 Tension Free Vaginal Tape for female stress incontinence in patients who had failed Trans-Obturator tape

Podium Poster Session 25 Surgical Solutions 261 The Use of Autologous Rectus Fascia and Polypropylene mesh as a Combined Sling for Treatment of Female Stress Urinary Incontinence

Podium Poster Session 25 Surgical Solutions 262 A novel technique for one-stage anterior prolapse and stress incontinence repair with the application of labial fibroadipose flap (Martius flap) - a pilot study in 19 women –

Podium Poster Session 25 Surgical Solutions 263 Next surgical management of failed midurethral sling for female stress urinary incontinence: Tape tightening or repeat sling?

Podium Poster Session 26 Epidemiology and Outcomes Research II 265 Incidence and remission of urinary incontinence at midlife, an 18 years cohort study

Podium Poster Session 26 Epidemiology and Outcomes Research II 266 Prevalence of UI in the Norwegian EPINCONT population 10 years after

Podium Poster Session 26 Epidemiology and Outcomes Research II 268 Urinary Storage Symptoms in Patients with Chronic Heart Failure

Podium Poster Session 26 Epidemiology and Outcomes Research II 271 Longitudinal changes in isovolumetric bladder pressure in response to age related prostate growth in 1020 healthy male volunteers

Podium Poster Session 27 Molecules and Cell Signalling 273 The combinations of single nucleotide polymorphisms of the promoters of the MMP-1 and MMP-3 genes are associated with the increased risk of pelvic organ prolapse.

Podium Poster Session 27 Molecules and Cell Signalling 278 VNUT plays an important role in vesicular storage and subsequent exocytosis of ATP from bladder epithelium upon mechanical stretch stimulation

Podium Poster Session 28 Pregnancy and its consequences 281 Toilet training in day-care centres: what is their role and how is it done.

Podium Poster Session 28 Pregnancy and its consequences 282 Observing readiness signs in young, healthy children

Podium Poster Session 28 Pregnancy and its consequences 284 Validation of perineometric and bidigital test findings to predict urinary incontinence occurrence in primigravidas

Non Discussion Poster Session 29 288 Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: Randomized study comparing two dose

Non Discussion Poster Session 29 289 5-Alpha-Reductase Inhibitor Suppress the Progression of Benign Prostatic Hyperplasia; 10-Year Result

Podium Poster Session 4 Neurourology 29 Sacral neuromodulation for refractory urinary urgency/frequency : utility of reprogramming during the initial test phase

Non Discussion Poster Session 29 293 Serum C-reactive Protein Is Associated with Storage but not with Empty Symptoms in Men with Lower Urinary Tract Symptoms

Non Discussion Poster Session 29 294 The Relationship between Metabolic Syndrome and Prostate Volume in Men under 50 years in Korean

Non Discussion Poster Session 29 295 Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels

Non Discussion Poster Session 29 307 Function of Kit positive cells in the benign prostatic hyperplasia

Non Discussion Poster Session 29 308 Therapeutic Efficacy of Bipolar Radio Frequency Thermal Treatment for Patients with Benign Prostate Hyperplasia

Non Discussion Poster Session 29 309 Comparison of clinical efficacy between finasteride and dutasteride as 5-alpha reductase inhibitor.

Non Discussion Poster Session 29 313 Study of the contractile and relaxant alterations of detrusor smooth muscle in a BOO mice model: Investigation of the nitric oxide – cyclic GMP – PDE-5 signaling pathway

Non Discussion Poster Session 29 314 Reverse of bladder outlet obstruction attenuate systemic oxidative stress

Non Discussion Poster Session 29 315 Is the short-term outcome of transurethral resection of the prostate affected by the preoperative degree of bladder outlet obstruction seen on urodynamic study?

Non Discussion Poster Session 29 317 Inhibition of collagen deposit in obstructed rat bladder outlet by transplantation of human mesenchymal stem cells

Non Discussion Poster Session 29 319 Human Mesenchymal Stem Cells Encapsulated in a Dityramine Cross-linked Hydrogel Reconstitute Urinary Continence in a Pubourethral Ligament Transected Rat Model

Non Discussion Poster Session 29 320 EFFECT OF HUMAN MESENCHYMAL STEM CELLS ON THE CONTINENCE MECHANISM IN A VAGINAL DISTENTION RAT MODEL OF STRESS URINARY INCONTINENCE

Non Discussion Poster Session 29 321 BIOCHEMICAL EVALUATION ON THE SUPPORTING STRUCTURE OF PELVIC ORGANS IN PRE AND POST MENOPAUSAL WOMEN

Non Discussion Poster Session 29 328 The efficacy and tolerability of mirabegron, a potent and selective ß3-adrenoceptor agonist, compared with placebo and tolterodine slow release in patients with overactive bladder – results from a European–Australian Phase III trial

Non Discussion Poster Session 29 329 Understanding the Educational Needs and Barriers to Diagnosis, Management, and Treatment of Neurogenic Detrusor Overactivity

Non Discussion Poster Session 29 333 Improvement in Health-related Quality of Life Following Treatment with OnabotulinumtoxinA in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity

Non Discussion Poster Session 29 336 Botulinum toxin type A versus oral anticholinergic medication cost-effectiveness for the treatment of neurogenic detrusor overactivity.

Non Discussion Poster Session 29 337 OnabotulinumtoxinA Improves Urodynamic Outcomes in Patients with Neurogenic Detrusor Overactivity

Non Discussion Poster Session 29 339 Patient satisfaction following onabotulinumtoxinA treatment for refractory overactive bladder

Non Discussion Poster Session 29 341 Efficacy and Tolerability of Fesoterodine in Older People With Overactive Bladder: Results of the Open-Label Phase of the SOFIA Trial

Non Discussion Poster Session 29 345 The role of organic cation transporters (OCTs) for drug disposition of trospium chloride

Non Discussion Poster Session 29 346 Repeated onabotulinumtoxinA injections for the management of refractory idiopathic detrusor overactivity: Medium term outcomes, safety profile and discontinuation rates.

Non Discussion Poster Session 29 348 Effects of Drug Cessation in Subjects Receiving Fesoterodine for Treatment of Overactive Bladder Symptoms

Non Discussion Poster Session 29 349 Intravesical Botulinum Toxin for Overactive Bladder Syndrome without Detrusor Overactivity

Non Discussion Poster Session 29 351 TIPS™ : A new tool for InterStim™ patient selection

Non Discussion Poster Session 29 353 The bladder diary. Do women perceive it as a useful investigation?

Non Discussion Poster Session 29 360 An explorative epidemiological patient-reported survey investigating a potential relation between night time work and nocturia

Non Discussion Poster Session 29 366 Relationship between duration of ketamine exposure and urodynamic parameters in ketamine ex-users

Non Discussion Poster Session 29 368 COST-EFFECTIVENESS ANALYSIS OF RETREATMENT OF STRESS INCONTINENCE AFTER FAILED SLING WITH EITHER TVT OR PUBOVAGINAL SLING

Non Discussion Poster Session 29 371 Prevalence of Overactive Bladder and Urinary Incontinence and their Associated Factors among Middle and Elder People in Taiwan

Non Discussion Poster Session 29 372 Fesoterodine is cost-effective relative to tolterodine and solifenacin for the treatment of overactive bladder with incontinence in Spain: results of an updated economic model

Non Discussion Poster Session 29 375 RISK FACTORS OF NOCTURIA AND ASSESSMENT OF NOCTURIA-RELATED QUALITY OF LIFE IN JAPANESE POPULATION

Non Discussion Poster Session 29 376 Urinary & Bowel Incontinence in Community: Baseline Assessment on “Overall Health Status”, “Prevalence” and “Impact of Daily Living between Men & Women”

Non Discussion Poster Session 29 377 INCIDENCE AND PREVALENCE OF URINARY INCONTINENCE IN WOMEN IN EUROPE: SYSTEMATIC REVISION OF THE LITERATURE

Non Discussion Poster Session 29 379 The impact of clinically significant depressive symptoms on lower urinary tract symptoms (LUTS) in an elderly Korean population: Results from the Korean Longitudinal Study on Health and Aging (KLoSHA)

Podium Poster Session 4 Neurourology 38 Inhibition of glycine transporter-2 (GlyT-2) in the spinal cord ameliorates bladder overactivity and pain sensation in rats

Non Discussion Poster Session 29 381 The Surgical Management of Obstetric Fistula: A personal series of 299 cases.

Non Discussion Poster Session 29 389 Low testosterone levels induce apoptosis via active 3-caspase dependent signaling in the bladder wall of male rats

Non Discussion Poster Session 29 392 Male Slings in the UK: A 4 year review and follow up.

Non Discussion Poster Session 29 394 Prevalence and factors associated with urinary incontinence in community-dwelling elderly Japanese men

Non Discussion Poster Session 29 397 TRANSRECTAL ULTRASOUND-GUIDED IMPLANTATION OF THE PROACT™ SYSTEM IN PATIENTS WITH POST-RADICAL PROSTATECTOMY STRESS URINARY INCONTINENCE: LONG TERM CLINICAL RESULTS

Non Discussion Poster Session 29 398 Techniques for early recovery of continence in patients with robotic-assisted radical prostatectomy

Podium Poster Session 4 Neurourology 40 The role of TRPA1 in the bladder cooling reflex in a urethane anaesthetized and spinal cord injury rat model.

Non Discussion Poster Session 29 403 Geometrical stepper guided navigation system for ProACT implant under transrectal ultrasound control : 12 months follow up

Non Discussion Poster Session 29 404 Male bulbar urethral closure for urinary incontinence in the artificial urinary sphincter era.

Non Discussion Poster Session 29 407 Audit of Incidence and Management of Obstetric Anal Sphincter Injuries (OASIS)

Non Discussion Poster Session 29 410 Anal acoustic reflectometry – a novel method for predicting outcome of sacral nerve stimulation for faecal incontinence

Non Discussion Poster Session 29 411 TRPV4-DEFICIENT MICE EXHIBIT INCREASED FREQUENCY OF VOIDING ~EVALUATION OF MICTURITION BEHAVIOUR USING NOVEL METABOLIC CAGE SYSTEM~

Non Discussion Poster Session 29 419 Safety of solifenacin combined with tamsulosin hydrochloride oral controlled absorption system in men with lower urinary tract symptoms and bladder outlet obstruction: a urodynamic study

Non Discussion Poster Session 29 420 Operative Impacts on LUTS of Patients with BPH and Prostatitis; Comparison of Post Transurethral Resection State

Non Discussion Poster Session 29 422 Chronic Prostatitis and Depressive Disorder: A Three-year Population-based Study

Non Discussion Poster Session 29 424 Therapeutic Effect of a-blockers and Antimuscarinics in Male Lower Urinary Tract Symptoms based on International Prostate Symptom Score (IPSS) Subscore Ratio

Non Discussion Poster Session 29 425 Detrusor impaired contractility is not age related in men with bladder outlet obstruction

Non Discussion Poster Session 29 427 Urine flow rate decrease during nighttime? Preliminary results using a portable uroflowmetry.

Non Discussion Poster Session 29 428 A prospective open-label clinical observational study to evaluate the effectiveness of adding tamsulosin to solifenacin on increased daytime frequency or nocturia in the male patients without bladder outlet obstruction.

Non Discussion Poster Session 29 429 Relative long proximal prostatic urethra as a cause of obstructive urinary symptoms in patients with prostate volume less than 25 cm3

Podium Poster Session 5 Pelvic Floor Function and Surgery 43 ASSESSMENT OF INTERNET-BASED INFORMATION REGARDING URINARY INCONTINENCE

Non Discussion Poster Session 29 430 Therapeutic Efficacy of Bipolar Radio Frequency Thermal Treatment for Patients with Chronic Prostatitis

Non Discussion Poster Session 29 431 Changes in sleep pattern, psychological profile and quality of life after treatment of nocturia in male patients with lower urinary tract symptoms

Non Discussion Poster Session 29 432 Initial combination treatment using Tamsulosin and Solifenasin for BPH/OAB patients; a prospective, multi-center study

Non Discussion Poster Session 29 433 Medical Treatment Outcome of Male Lower Urinary Tract Symptoms on Patients with Prostatic Calculi

Non Discussion Poster Session 29 434 Clinical outcome in male patients with detrusor hyperactivity with impaired contractility (DHIC)

Non Discussion Poster Session 29 435 Posterior Tibial Nerve Stimulation and Overactive Bladder in Men: is it possible to get good results?

Non Discussion Poster Session 29 436 CPPS and Semen quality of Korean men in their thirties

Non Discussion Poster Session 29 437 DOES PROSTATE SIZE MATTER?-- A comparative analysis of TRUS prostate volume versus flowmetry parameters and IPSS symptom scores

Non Discussion Poster Session 29 439 The Role of Urinary Neurotrophic Factors in Overactive Bladder Syndrome

Podium Poster Session 5 Pelvic Floor Function and Surgery 44 Does hyperglycemia in pregnancy change the pelvic floor muscles function?

Non Discussion Poster Session 29 445 Evidence for Bacterial Presence in the Adult Female Bladder

Non Discussion Poster Session 29 450 Alpha 1-adrenoceptor antagonist ameliorates aging-induced memory impairment through increasing of neurogenesis in the hippocampus of rats

Non Discussion Poster Session 29 462 Involvement of TRPA1 channels in Excitatory Effects of Nitro-Oleic Acid on Rat Bladder Function

Non Discussion Poster Session 29 466 Efficacy of a transdermal amplitude-modulated signal (TAMS) in a canine overactive bladder (OAB) model

Non Discussion Poster Session 29 468 Effects of alpha-lipoic acid upon histology of urinary bladder in diabetic rats

Non Discussion Poster Session 29 470 The Effects of Mechanical Traumatic Brain Injury on Bladder Function

Non Discussion Poster Session 29 471 Association of muscarine and P2X receptor levels in urinary bladder to lower urinary tract dysfunction in the initial phase of a Streptozotocin (STZ)-treated rat diabetes model

Non Discussion Poster Session 29 472 Pudendal Nerve Stretch Reduces External Urethral Sphincter Activity in Rats

Non Discussion Poster Session 29 475 Overactive bladder in patients with Postural Tachycardia Syndrome

Non Discussion Poster Session 29 476 THE EFFECT OF OBESITY ON THE EFFICACY AND COMPLICATION RATE OF SACRAL NEUROMODULATION

Non Discussion Poster Session 29 480 Electromyography of the external urethral sphincter in premenopausal women with no urinary symptoms.

Non Discussion Poster Session 29 481 Preserved micturition in Parkinson Patients treated with botulinum toxin for neurogenic bladder dysfunction

Non Discussion Poster Session 29 484 Autonomic sympathetic system is overactive in patients with Bladder Pain Syndrome/Interstitial Cystitis.

Non Discussion Poster Session 29 487 Effect of Herpes Simplex Virus Vector-mediated Glycine Receptor Gene Therapy on Bladder Overactivity and Nociception

Non Discussion Poster Session 29 488 VISCERAL PAIN RESPONSE IN BALB-C MICE IMMUNIZED WITH UROPLAKIN UP3b AS A MURINE MODEL FOR INTERSTITIAL CYSTITIS

Non Discussion Poster Session 29 492 Painful Bladder Syndrome associated with Sexual Dysfunction may lead to suicide attempts

Non Discussion Poster Session 29 493 Pelvic organ cross-sensitization modulates expression and release of neuropeptides and neurotrophic factors in the urinary bladder of female rats: role of the estrous cycle

Non Discussion Poster Session 29 495 The Use of Cystistat® (Hyaluronic Acid) vs Uracyst® (Chondroitin) Bladder Instillations in the Treatment of Interstitial Cystitis: A Prospective Audit

Podium Session 1 Stress Urinary Incontinence A MID URETHRAL SLING PREVENTS INCONTINENCE AMONG WOMEN UNDERGOING VAGINAL PROLAPSE REPAIR– THE OPUS TRIAL

Podium Poster Session 5 Pelvic Floor Function and Surgery 50 The Value of the Preoperative Prolapse Reduction Stress Test in Women without Stress Incontinence Symptoms undergoing Vaginal Prolapse Surgery with or without a TVT: Result from the OPUS Trial

Non Discussion Poster Session 29 502 Value of an intensive in centre training program (voiding school) in childen with therapy resistant LUTS

Non Discussion Poster Session 29 506 SACROSPINOUS FIXATION AS DAY CASE PROCEDURE- A PATIENT SATISFACTION SURVEY

Non Discussion Poster Session 29 507 Single Incision Technique using RSD-Ney for insertion of Titanium Coated Extra-Light Mesh yields more favourable clinical outcomes in patients suffering from Vaginal Vault Prolapse resulting from previous Pelvic Tumor Surgery.

Non Discussion Poster Session 29 508 Animal Model of Pelvic Floor Dystonia and Cystometric Effects on Urinary Dysfunction

Non Discussion Poster Session 29 509 The Correlation Between Pelvic Floor Muscle Assessment Findings and Urinary Incontinence

Podium Poster Session 5 Pelvic Floor Function and Surgery 51 A Prospective Multi-Center Clinical Trial Evaluating Elevate Apical And Posterior In The Treatment Of Pelvic Organ prolapse: Two-Year Follow-Up

Non Discussion Poster Session 29 511 Long-term nitric oxide (NO) deficiency induces detrusor overactivity by increasing extracellular Ca2+ influx through L-Type Ca2+ channels

Non Discussion Poster Session 29 515 The muscarinic receptor subtype of M2 mediates Ca2+ sensitization via indirect activation of Rho-kinase pathway in human detrusor smooth muscle.

Non Discussion Poster Session 29 516 Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated human ureter: an in vitro study

Non Discussion Poster Session 29 517 The Relaxing Effect of Acetylcholine on Phenylephrine-Induced Contraction of Isolated Rabbit Prostate Strips Is Mediated by Neuronal Nitric Oxide Synthase (Nitrergic Nerve)

Non Discussion Poster Session 29 524 Effect of Botulinum neurotoxin-A on bladder contractile responses to activation of efferent nerve terminals, smooth muscle and afferent nerve terminals in rat bladder

Non Discussion Poster Session 29 526 Investigation of the role of TRPM8 channels in modulating contraction of pig urinary bladder.

Non Discussion Poster Session 29 527 The Effect of Korean Red Ginseng Extract on Relaxation Response on the Animal Bladder and Prostatic Urethra : in vitro and in vivo Study

Non Discussion Poster Session 29 528 NEURAL AND MUSCULAR ß3-ADRENOCEPTORS IN RAT AND HUMAN DETRUSOR SMOOTH MUSCLE: DIFFERENCES DISCLOSED BY SELECTIVE AGONISTS

Non Discussion Poster Session 29 532 Effects of a selective beta3 adrenoreceptor agonist (CL-316,243) on cystometric parameters in conscious and anesthetized female rats.

Non Discussion Poster Session 29 533 Factors affecting persistence with therapy of solifenacin treatment in patients with overactive bladder syndrome

Non Discussion Poster Session 29 537 Is there a difference in the co-activation of muscles transversus abdominis / internal oblique and pelvic floor during pregnancy?

Non Discussion Poster Session 29 541 The development and testing of two products to improve the quality of life and increase the confidence of pad wearers

Non Discussion Poster Session 29 543 Nocturia and Quality of Life. Results from the Boston Area Community Health Survey

Non Discussion Poster Session 29 544 ADAPTIVE BEHAVIORS ARE CORRELATED WITH SYMPTOM SEVERITY AND IMPROVE FOLLOWING TREATMENT

Non Discussion Poster Session 29 545 Sensitivity of the PFDI-20 to the presence or absence of anal incontinence in the general population.

Non Discussion Poster Session 29 546 Stress urinary incontinence and quality of life. Reliability of the Swedish version of the ICIQ-LUTSqol in paper and electronic form.

Non Discussion Poster Session 29 547 Evaluation of the clinical utility of the PFDI-20 among women in the general population

Non Discussion Poster Session 29 548 The Impact of nocturia with overactive bladder syndrome on quality of life: findings from the Fujiwara-kyo study.

Non Discussion Poster Session 29 549 EFFECT OF URINARY INCONTINENCE TREATMENT ON DEPRESSION SYMPTOMS

Podium Poster Session 5 Pelvic Floor Function and Surgery 55 A Review of clinical outcomes after vaginal mesh repair of recurrent genital prolapse

Non Discussion Poster Session 29 550 Quality of life amongst caregivers of dependent older people affected by incontinence

Non Discussion Poster Session 29 552 The impact of secondary conditions on health-related quality of life of spinal cord injury patients – do urinary and sexual dysfunctions really matter?

Non Discussion Poster Session 29 553 Development and validation of urinary incontinence in multiple sclerosis screening tool

Non Discussion Poster Session 29 554 A Comparative Effectiveness Study of Overactive Bladder (OAB) Treatment Using a Pelvic Floor Fitness Program for Senior Women

Non Discussion Poster Session 29 556 Clinical efficacy of a trocar guided mesh kit for the repair of anterior lateral defects.

Non Discussion Poster Session 29 557 EFFECT OF MONOCRYL FIBERS ON THE EARLY INFLAMMATORY RESPONSE AND COLLAGEN DEPOSITION AROUND A LIGHT WEIGHT POLYPROPYLEN MESH

Non Discussion Poster Session 29 559 Improved biocompatibility of meshes used for hernia, incontinence and organ prolapse repair by plasma coating – results of in vitro and in vivo studies

Non Discussion Poster Session 29 560 A trocar-free procedure for vaginal prolapse repair using mesh and a vaginal support device - an observational registry.

Non Discussion Poster Session 29 561 To prospectively evaluate the change in levator hiatus (LH) dimensions before and one year after treatment for pelvic organ prolapse (POP)

Non Discussion Poster Session 29 563 SURGERY FOR PELVIC ORGAN PROLAPSE AND CONCOMITED OAB SYMPTOMS: DO THEY IMPROVE AFTER SURGERY?

Non Discussion Poster Session 29 564 Six years experience of using mesh implants in pelvic floor reconstructive surgery

Non Discussion Poster Session 29 566 Fresh muscle fiber fragments on a scaffold: a potentially new concept for pelvic floor reconstruction?

Non Discussion Poster Session 29 568 Can we prevent erosions after trocar guided transvaginal mesh repair?

Non Discussion Poster Session 29 569 SEXUAL FUNCTION IN WOMEN BEFORE AND AFTER SURGERY FOR PELVIC ORGAN PROLAPSE

Non Discussion Poster Session 29 570 Pelvic organ prolapse surgery with non-anchored mesh implants and vaginal support device in women with moderate symptomatic prolapse: prospective study

Non Discussion Poster Session 29 571 CLINICAL OUTCOMES OF AN OBSERVATIONAL REGISTRY UTILIZING A TROCAR-GUIDED MESH REPAIR OF VAGINAL PROLAPSE USING PARTIALLY ABSORBABLE MESH

Non Discussion Poster Session 29 573 Regenerative capacities of the urinary bladder decline with age

Non Discussion Poster Session 29 574 Purified porcine collagen membrane modulates integration of polypropylene mesh implant in a rat model

Non Discussion Poster Session 29 575 Bladder augmentation using PLGA (polylactic-polyglycolic acid) scaffolds seeded with autologous mesenchymal stem cells derived from fat and skeletal muscle: Experimental Study in Rabbits.

Non Discussion Poster Session 29 576 Mesh extrusion into the lower urinary tract: correlation to intra-operative cystoscopy

Non Discussion Poster Session 29 577 Obturator foramen dissection for excision of symptomatic transobturator mesh

Non Discussion Poster Session 29 578 Follow-up after augmentation (clam) ileocystoplasty – a UK-wide practice and approach survey

Non Discussion Poster Session 29 579 Detrusor Myomectomy : Longterm functional results.

Non Discussion Poster Session 29 580 Malignancies in Augmentation Cystoplasties: A Review

Non Discussion Poster Session 29 581 TRAINING OF THE PELVIC FLOOR MUSCLES DURING PREGNANCY AND AFTER THE CHILDBIRTH WITH SWISS BALL INCREASES CONTRACTILITY OF THE PELVIC FLOOR MUSCLES ASSESSED BY ELECTROMYOGRAPHIC EVALUATION

Non Discussion Poster Session 29 586 A survey of Thai women towards Pelvic Floor Muscle Training

Non Discussion Poster Session 29 587 Pelvic floor muscle training using extracorporeal biofeedback device for the treatment of stress urinary incontinence

Non Discussion Poster Session 29 588 The early experience of the relationship between the transobturator tape (TOT) procedure and the female sexual function

Non Discussion Poster Session 29 589 Does urinary incontinence play a role on sexual satisfaction of middle age Brazilian women?

Non Discussion Poster Session 29 592 Does BMI affect the results of continence surgery? An analysis of the British Society of Urogynaecology (BSUG) database.

Non Discussion Poster Session 29 593 Functional outcomes for surgical revision of synthetic slings performed for voiding dysfunction.

Non Discussion Poster Session 29 594 Transvesical laparoendoscopic single-site surgery (LESS) for removal of eroded midurethral polypropylene sling: Experience of five cases.

Non Discussion Poster Session 29 598 Outcomes of surgical revision of synthetic slings for postoperative pain and/or sling extrusion.

Non Discussion Poster Session 29 601 UK national x-ray video urodynamics audit 2010/2011

Non Discussion Poster Session 29 603 The impact of training GPs and hospital clinicians to use a referral pathway on the care of patients with urinary incontinence. Re-audit of referrals to urodynamic services

Non Discussion Poster Session 29 605 Urine leakage detection in female athletes during physical activities

Non Discussion Poster Session 29 607 Changes of Pad Weight Results and Urethral Pressure Profiles after Reduction of Cystocele by Vaginal Gauze Packing

Non Discussion Poster Session 29 609 Consecutive cystometries during the same session using 0.9 normal saline (NS) for twice and 0.2M potassium chloride (KCL) in women with Interstitial Cystitis/ painful bladder syndrome (IC/PBS)

Podium Poster Session 6 Male Lower Urinary Tract and Surgery 61 The changes in urination status and International Prostate Symptom Score following retropubic radical prostatectomy

Non Discussion Poster Session 29 611 Is wetter worse? The relationship between severity of urodynamic stress incontinence and quality of life

Non Discussion Poster Session 29 620 Pelvic Organ Prolapse: a hidden condition. Prevalence and characteristics of undiagnosed Pelvic Organ Prolapse.

Non Discussion Poster Session 29 623 Prolapse surgery 1998 - 2003 – where are they now?

Non Discussion Poster Session 29 624 The effect of simultaneous pelvic organ prolapse repair on voiding symptoms and surgical outcome in sling operation

Non Discussion Video Session 30 Non-Discussion Videos 627 ONLAY DORSAL VAGINAL GRAFT FOR FEMALE URETHRAL STENOSIS Introduction

Non Discussion Video Session 30 Non-Discussion Videos 628 Virtue® Quadratic Male Sling: An Innovative Treatment for Post-Prostatectomy Incontinence

Podium Poster Session 6 Male Lower Urinary Tract and Surgery 63 Pelvic floor muscle surface electromyography and radical retropubic prostatectomy (RRP) : is it possible to predict any pre-operative variable related to urinary dysfunction after RRP ?

Non Discussion Video Session 30 Non-Discussion Videos 630 REMEEX SYSTEM LIFETIME ADJUSTABLE SLING

Non Discussion Video Session 30 Non-Discussion Videos 636 ENDOSCOPIC TREATMENT OF FIBROEPITHELIAL POLYP OF THE URETER

Podium Poster Session 6 Male Lower Urinary Tract and Surgery 64 Effectiveness of Sacral Surface Therapeutic Electrical Stimulation (ssTES) on early recovery of urinary incontinence after laparoscopic radical prostatectomy: A prospective study.

Non Discussion Abstract Session 31 Read by Title 642 Urodynamic characteristics of patients with lower urinary tract symptoms and small prostate

Non Discussion Abstract Session 31 Read by Title 643 Intravesical Prostatic Protrusion in Benign Prostatic Hyperplasia: Does It Make Any Difference in Results after Transurethral Resection of the Prostate?

Non Discussion Abstract Session 31 Read by Title 644 Effects of Detrusor Underactivity on Outcome of Transurethral Resection of the Prostate in patients with prostate hyperplasia

Non Discussion Abstract Session 31 Read by Title 648 The correlation between serum parathyroid hormone, vitaminD, and calcium levels and prostate size in patients with benign prostatic hyperplasia

Non Discussion Abstract Session 31 Read by Title 649 Comparison of the outcomes of holmium laser enucleation of the prostate according to baseline prostate size

Podium Poster Session 6 Male Lower Urinary Tract and Surgery 65 First-line antimuscarinic monotherapy is safe and effective for men with predominant International Prostate Symptom Score storage subscore based on IPSS-voiding/storage ratio

Non Discussion Abstract Session 31 Read by Title 650 Influence of bladder contractility on short-term outcomes of holmium laser enucleation of the prostate

Non Discussion Abstract Session 31 Read by Title 656 The ‘Bladder Button’ in patients with neurogenic detrusor overactivity

Non Discussion Abstract Session 31 Read by Title 657 The efficacy of tolterodine and tamsulosin combination therapy in female OAB patients

Non Discussion Abstract Session 31 Read by Title 658 PERIPHERAL NEUROMODULATION OF THE S3 IMPROVES BLADDER CAPACITY AND REDUCES PERCEPTION OF URGENCY IN PATIENTS WITH OVERACTIVE BLADDER .

Podium Poster Session 6 Male Lower Urinary Tract and Surgery 66 Progression of Lower Urinary Tract Symptoms after Discontinuation of One Medication From Two-Year Combined Alpha-blocker and 5-alpha-reductase Inhibitor Therapy for Benign Prostatic Hyperplasia in Men

Non Discussion Abstract Session 31 Read by Title 663 Efficacy of solifenacin succinate for frequent micturition patients with or without urgency: a multicenter prospective randomized comparative study

Non Discussion Abstract Session 31 Read by Title 664 Intermittent self catheterisation for urinary retention post-intravesical botulinum toxin A injections: Patient attitudes and preferences

Non Discussion Abstract Session 31 Read by Title 666 NECESSITY OF SELF-CATHETERISATION AFTER INTRAVESICAL BOTULINUM TOXIN-A INJECTIONS.

Non Discussion Abstract Session 31 Read by Title 668 EFFECTIVENESS OF MID-URETHRAL SLINGS IN MIXED URINARY INCONTINENCE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Non Discussion Abstract Session 31 Read by Title 670 A pragmatic approach to the use of intravesical Botulinum toxin injection treatment for idiopathic detrusor overactivity: a review of 5 years’ activity in the real world.

Non Discussion Abstract Session 31 Read by Title 671 Botulinum Toxin in OAB: A Case Series.

Non Discussion Abstract Session 31 Read by Title 673 Intravesical Botulinum Toxin Injection for Refractory Overactive Bladder

Non Discussion Abstract Session 31 Read by Title 675 Intradetrusor injection of botulinum neurotoxin type A in patients with idiopathic detrusor overactivity undergoing radical retropubic prostatectomy.

Non Discussion Abstract Session 31 Read by Title 676 Measuring bladder wall thickness in cases of detrusor instability using transvaginal ultrasound

Non Discussion Abstract Session 31 Read by Title 678 Validity of the eight-item patient-rated severity of Overactive Bladder symptom bother scale (OAB-V8) in predicting changes in Health-related Quality-of-Life in subjects with overactive bladder

Non Discussion Abstract Session 31 Read by Title 680 HOW ARE INCIDENCE AND PREVALENCE INFLUENCED BY PREGNANCY AND CHILDBIRTH? A SYSTEMATIC LITERATURE REVIEW

Non Discussion Abstract Session 31 Read by Title 682 Prevalence of Overactive Bladder Symptoms in Premenopausal Women in Campinas, Brazil

Non Discussion Abstract Session 31 Read by Title 683 RELATIONSHIP BETWEEN SOCIOECONOMIC STATUS AND FEMALE URINARY INCONTINENCE IN EUROPE

Non Discussion Abstract Session 31 Read by Title 684 Promoting Urinary and Bowel Continence in Out Patient Department

Non Discussion Abstract Session 31 Read by Title 685 Reliability and validity of time of urinary hesitancy calculated with uroflowmetry

Non Discussion Abstract Session 31 Read by Title 687 Predicting Changes in Anal Sphincter Function Following Lay Open of Anal Fistula

Non Discussion Abstract Session 31 Read by Title 688 Is female genital fistula a socio-meical problem in India: an analysis of population based data

Non Discussion Abstract Session 31 Read by Title 689 Pain on defecation following obstetric anal sphincter injury.

Non Discussion Abstract Session 31 Read by Title 692 Sacral nerve stimulation: Is it the solution for severe faecal incontinence?

Non Discussion Abstract Session 31 Read by Title 694 The Influence of Androgen on bladder function and blood vessel. - the examination including histological change of bladder and vessel in using SHR rat

Non Discussion Abstract Session 31 Read by Title 701 Test-retest reliability of twenty-minute pad test infused with strong-desire amount of water in bladder

Non Discussion Abstract Session 31 Read by Title 703 Impact of anti-incontinence surgery on overactive bladder symptoms and related quality of life in patients concomitant with stress urinary incontinence and overactive bladder symptoms

Non Discussion Abstract Session 31 Read by Title 707 Psychological distress and personality trait in female overactive bladder patients: A case-control study

Non Discussion Abstract Session 31 Read by Title 709 The Diagnostic Values of Different Methods to Distinguish Urodynamic Urinary Incontinence Subtypes

Non Discussion Abstract Session 31 Read by Title 711 Preoperative pressure flow study is a predictive factor for improved overactive bladder symptoms after anterior vaginal wall prolapse repair

Non Discussion Abstract Session 31 Read by Title 715 Determinants of long-term antimuscarinic medication use in women with overactive bladder.

Non Discussion Abstract Session 31 Read by Title 718 Change in Voiding Function During Pregnancy

Podium Poster Session 6 Male Lower Urinary Tract and Surgery 72 The efficacy of early artificial sphincter insertion for the treatment of incontinence after radical prostatectomy.

Non Discussion Abstract Session 31 Read by Title 721 BLADDER CAPACITY ASSESSMENT IN WOMEN WITH IDIOPATHIC OVERACTIVE BLADDER

Non Discussion Abstract Session 31 Read by Title 727 BLADDER FUNCTION PATTERN IN ELDERLY WOMEN WITH SPINAL CORD INJURY

Non Discussion Abstract Session 31 Read by Title 736 Significance of upper tract abnormalities identified on ultrasound during follow up of neurogenic bladder patients

Non Discussion Abstract Session 31 Read by Title 738 The lack of impact of bladder management strategies in health-related quality of life of spinal cord injury patients

Non Discussion Abstract Session 31 Read by Title 739 CORRELATION BETWEEN BLADDER WALL THICKNESS AND URODYNAMIC FINDINGS IN PATIENTS WITH SPINAL CORD INJURY

Non Discussion Abstract Session 31 Read by Title 741 Sacral Neuromodulation (SNM): certitudes and issues. Fifteen years of Italian clinical experience

Non Discussion Abstract Session 31 Read by Title 742 Physical Signs of Asymmetry: A Guide to Successful Interstim Therapy

Non Discussion Abstract Session 31 Read by Title 745 Attempt to create a checklist due to suspicion of neurological diseases. --Examination on neurological disease cases with history of visiting urological section prior to visiting neurology

Non Discussion Abstract Session 31 Read by Title 748 Bilateral Pelvic Floor EMG: A Useful Adjunct to Urodynamic Practice

Non Discussion Abstract Session 31 Read by Title 749 Can cystography predict results of botulinum toxin A injection in the treatment of spinal cord Injury patients with refractory neurogenic detrusor overactivity?

Podium Poster Session 7 Continence and Neurourology 75 Incontinence Stroke Project Inspiring Rehabilitation Excellence (INSPIRE) -a mixed methods approach to piloting a complex intervention to improve continence care following stroke

Non Discussion Abstract Session 31 Read by Title 750 THE EFFECT OF BOTILINUM NEUROTOXIN TYPE A ON URINARY CONTINENCE IN CHILDREN WITH MYELODYSPLASIA

Non Discussion Abstract Session 31 Read by Title 752 What kind of neurological disease does urologist often meet in routine work?

Non Discussion Abstract Session 31 Read by Title 754 Suprapubic catheter insertion in neurogenic bladders using an adapted (Hey Groves) urethral sound – experience from a tertiary referral centre

Non Discussion Abstract Session 31 Read by Title 756 Various findings of urodynamic study in patients with cerebrovascular accident

Podium Poster Session 7 Continence and Neurourology 76 ICONS: Identifying Continence OptioNs after Stroke: findings from the case study phase

Non Discussion Abstract Session 31 Read by Title 760 Suprapubic catheter insertion in Spinal Cord Injured patients – A challenging procedure

Non Discussion Abstract Session 31 Read by Title 761 The correlation between voiding symptoms, bladder diary and objective findings on urodynamic findings and maximum cystometric capacity during hydrodistention in females with Interstitial cystitis/ painful bladder syndrome (IC/PBS)

Non Discussion Abstract Session 31 Read by Title 762 Comparision of the efficacy between tamsulosin versus tamsulosin plus solifenacin for the management of chronic pelvic pain syndrome

Non Discussion Abstract Session 31 Read by Title 767 BLADDER ENDOMETRIOSIS: EFFECTIVENESS OF THE CLINICAL EVALUATION AND DIAGNOSTIC TESTS FOR AN ACCURATE TREATMENT.

Non Discussion Abstract Session 31 Read by Title 769 Efficacy and safety of augmentation ileocystoplasty for the treatment of interstitial cystitis.

Non Discussion Abstract Session 31 Read by Title 772 The correlation between potentially traumatic experience and subjective symptoms in women with interstitial cystitis/painful bladder syndrome (IC/PBS) in Taiwan

Non Discussion Abstract Session 31 Read by Title 774 Bladder instillation with a combinated solution of sodium halurate and chondroitin sulphate (IALURIL) in recurrence bacterial cystitis: our results

Non Discussion Abstract Session 31 Read by Title 777 The effect of olanzapine on pituitary - gonad axis and spermatogenesis in adult male rats

Non Discussion Abstract Session 31 Read by Title 779 Association of gestational hyperglycemic disorders with urinary incontinence occurrence and its influence on quality of life during pregnancy

Non Discussion Abstract Session 31 Read by Title 781 Sensitivity of the PFDI-20 to the presence or absence of urinary incontinence in the general population.

Non Discussion Abstract Session 31 Read by Title 784 Effect of complete bladder neck preservation (cBNP) on continence and QOL- a randomised controlled trial

Non Discussion Abstract Session 31 Read by Title 785 Improvement of quality of life in patients after radiation therapy treated with Botulinumtoxininjection for neurogenic bladder dysfunction

Non Discussion Abstract Session 31 Read by Title 788 Challenging Environmental Barriers to Continence

Podium Poster Session 7 Continence and Neurourology 79 Women with traumatic brain injury history have increased risk of Urinary Incontinence : a nationwide population-based study

Non Discussion Abstract Session 31 Read by Title 790 IMPACT OF NOCTURIA ON DISEASE-SPECIFIC QUALITY OF LIFE FOR MEN WITH LOCALIZED PROSTATE CANCER

Non Discussion Abstract Session 31 Read by Title 791 Urinary incontinence in women with Benign Joint Hypermobility Syndrome: impact on Quality of Life

Non Discussion Abstract Session 31 Read by Title 793 Nursing approach to potential overactive bladder patients: A prospective study

Non Discussion Abstract Session 31 Read by Title 794 Early Results from the University of Michigan Neurogenic Bladder Database: Are patients with Neurogenic Bladder satisfied with their bladder management?

Non Discussion Abstract Session 31 Read by Title 795 Improvement of quality of life in women undergoing pelvic floor training

Non Discussion Abstract Session 31 Read by Title 797 Colpocleisis- Revisited and Reproposed - Regret, patient satisfaction and symptom improvement

Non Discussion Abstract Session 31 Read by Title 798 The early experience of the simultaneous tansobturator tape (TOT) and trocar-guided tension free vaginal mesh repair (ProliftTM) procedures in patients with stress urinary incontinence (SUI) concomitant with anterior vaginal wall prolapse.

Non Discussion Abstract Session 31 Read by Title 799 EFFECT OF MESENCHIMAL STEM CELLS FILM ON THE INFLAMMATORY RESPONSE AROUND TWO DIFFERENT MESH MATERIALS

Podium Poster Session 7 Continence and Neurourology 80 Use of Intravaginal Electrical Stimulation for the Treatment of Chronic Pelvic Pain: A Randomized, Double-Blind, Crossover Clinical Trial

Non Discussion Abstract Session 31 Read by Title 801 Does midurethral sling inserted at the time of pelvic organ prolapse surgery increase the rate of de novo OAB?

Non Discussion Abstract Session 31 Read by Title 804 Governance of new procedures: the use of the BSUG Database in evaluating short term outcomes following I-stop posterior intravaginal slingplasty for prolapse.

Non Discussion Abstract Session 31 Read by Title 805 Long term outcome of laparoscopic ventral mesh rectopexy and sacrocolpopexy

Non Discussion Abstract Session 31 Read by Title 808 RISK FACTORS FOR VAGINAL MESH EXPOSURE AFTER ROBOTIC-ASSISTED LAPAROSCOPIC SACROCOLPOPEXY: A RETROSPECTIVE COHORT STUDY

Non Discussion Abstract Session 31 Read by Title 809 A.M.I. pelvic floor repair system. A novel 3 level approach for full reconstruction of complex pelvic floor prolapse.

Non Discussion Abstract Session 31 Read by Title 810 3D Ultrasonographic visualization and short term evaluation of a tension-free, single incision vaginal mesh (Prosima?) for the surgical correction of moderate symptomatic vaginal wall prolapse continence: a systematic review

Non Discussion Abstract Session 31 Read by Title 812 Pelvic Floor-Lifting: Report on twenty Operations for severe Pelvic Floor Descent and Pelvic Organ Prolapse in Female Patients

Non Discussion Abstract Session 31 Read by Title 815 Long-term outcome of Prolift polylpropylene mesh implantation for anterior pelvic organ prolapsed.

Non Discussion Abstract Session 31 Read by Title 816 Urodynamic investigation to evaluate whether there is bladder outlet obstruction on the first day after vaginal prolapse surgery

Non Discussion Abstract Session 31 Read by Title 817 Persistent vaginal polypropylene mesh extrusion : long term follow-up

Non Discussion Abstract Session 31 Read by Title 818 TRANSVAGINAL SINGLE INCISION IMPLANT FOR SEVERE APICAL AND POSTERIOR PROLAPSES: INICIAL RESULTS OF A PROSPECTIVE MUTICENTRE PROSPECTIVE TRIAL

Non Discussion Abstract Session 31 Read by Title 823 Bilateral attachment of the vaginal cuff to iliococcygeus fascia: anatomic and functional aspects

Non Discussion Abstract Session 31 Read by Title 826 Short term post operative complication after vaginal packing, a randomized controlled study.

Non Discussion Abstract Session 31 Read by Title 828 Laparoscopic pelvic floor reconstruction with a modified triple mesh

Non Discussion Abstract Session 31 Read by Title 830 SINGLE INCISION MONOPROSTHESIS FOR THE TREATMENT OF ANTERIOR PROLAPSE, STRESS URINARY INCONTINENCE AND LEVEL ONE APICAL PROLAPSE REPAIR

Non Discussion Abstract Session 31 Read by Title 831 What is the advantage of vaginal wall prolapse surgery in women with overactive bladder syndrome symptoms and pelvic organ prolapse?

Non Discussion Abstract Session 31 Read by Title 832 Intra-operative Assessment of Anterior Vaginal Prolapse at the Time of Vaginal Vault Suspension: To Fix or Not to Fix.

Non Discussion Abstract Session 31 Read by Title 833 Transvaginal Urethral Diverticulectomy Using Small Intestinal Submucosa Interposition Graft

Non Discussion Abstract Session 31 Read by Title 835 Efficacy of Extracorporeal Magnetic Stimulation for Women with SUI and OAB in Symptoms Bothersome and Symptoms Cure assessment

Non Discussion Abstract Session 31 Read by Title 836 IMPROVING ATTENDANCE: A SIMPLE APPROACH!

Non Discussion Abstract Session 31 Read by Title 838 Efficacy of Interferential Therapy in Women with Stress Urinary Incontinence

Podium Poster Session 7 Continence and Neurourology 84 Sensation of urgency; which instruments are available and which dimensions of sensation do they measure? A systematic review.

Non Discussion Abstract Session 31 Read by Title 841 Three year outcomes of the REMEEX System for treatment of re-do urinary incontinence and intrinsic sphincteric deficiency with incontinence of neurogenic factors

Non Discussion Abstract Session 31 Read by Title 844 Tape position under the urethra and subjective outcome of the outside-in transobturator sling

Non Discussion Abstract Session 31 Read by Title 847 Artificial Urinary Sphincter (AMS 800) for women: causes of failure.

Non Discussion Abstract Session 31 Read by Title 849 Randomized, comparative study of the U- and H-type approaches of the TVT-Secur® procedure for the treatment of female stress urinary incontinence: Two-year follow-up

Non Discussion Abstract Session 31 Read by Title 850 Patient Satisfaction after Tension Free Vaginal Tape Insertion for Management of Stress Urinary Incontinence: Comparison Between Transvaginal vs Transobturator Approach

Non Discussion Abstract Session 31 Read by Title 853 Efficacy of readjustable sling procedure in female stress urinary incontinence

Non Discussion Abstract Session 31 Read by Title 854 A randomized, double-blind comparison of bupivacaine containing saline with saline only for hydrodissection on voiding function and pain control in the postoperative interval following placement of tension-free vaginal tape

Non Discussion Abstract Session 31 Read by Title 856 The use of Deflux® to treat stress urinary incontinence: 3 year results.

Non Discussion Abstract Session 31 Read by Title 858 QUANTITATIVE CHANGES IN COLLAGEN FOLLOWING LONG TERM IMPLANTATION OF BIOLOGIC AND SYNTHETIC MESHES IN THE RABBIT ABDOMEN

Non Discussion Abstract Session 31 Read by Title 860 The artificial urinary sphincter for stress incontinence after prostate cancer therapy in men with or without history of neo bladder neck stenosis - efficacy, quality of life and satisfaction

Non Discussion Abstract Session 31 Read by Title 862 CONTASURE-NEEDLELESS® VS TRANSOBTURATOR-TVT®: CORRELATION BETWEEN ULTRASOUND FINDINGS AND CLINICAL RESULTS

Non Discussion Abstract Session 31 Read by Title 866 Who will benefit from TVT for genuine stress incontinence in a teaching hospital?

Non Discussion Abstract Session 31 Read by Title 867 Efficacy and safety of TVT-Secur in the treatment of female stress urinary incontinence: a systematic review

Non Discussion Abstract Session 31 Read by Title 868 Cure of women stress urinary incontinence with the Ajust single incision sling: one year results.

Non Discussion Abstract Session 31 Read by Title 871 Predictors of successful voiding trial after Transobturator Tape (TOT) Procedure for female stress urinary incontinence (SUI); The meaning of the first voiding trial

Non Discussion Abstract Session 31 Read by Title 876 Autologous adipose stem cells in treatment of female stress urinary incontinence

Non Discussion Abstract Session 31 Read by Title 877 Causes and management of failure of minisling (Epilog) for stress urinary incontinence

Non Discussion Abstract Session 31 Read by Title 878 Artificial urinary sphincter implantation in complex cases

Non Discussion Abstract Session 31 Read by Title 879 Mesh cutting after midurethral sling surgery in female stress urinary incontinence: 2-year follow up

Non Discussion Abstract Session 31 Read by Title 880 The efficacy and safety of the REMEEX system in female stress urinary incontinence patients with a VLPP less than 60cmH2O

Non Discussion Abstract Session 31 Read by Title 882 Vaginal mesh erosion after suburethral slings for stress urinary incontinence

Non Discussion Abstract Session 31 Read by Title 886 Incidence of Mesh Exposure After Surgical Use of Polypropylene Mesh

Non Discussion Abstract Session 31 Read by Title 887 VOIDING DIFFICULTIES AND OAB SYMTOMS FOLLOWING MIDURETHRAL SLINGS IN MIXED URINARY INCONTINENCE

Non Discussion Abstract Session 31 Read by Title 888 The effect of midurethral sling procedures on the postoperative voiding pattern in the patients with female stress urinary incontinence with weaker urine stream

Non Discussion Abstract Session 31 Read by Title 890 TOT: Tension-free Or Tension-low?

Non Discussion Abstract Session 31 Read by Title 891 Operative performances, safety and short term follow-up of a modified retropubic tension-free vaginal tape (TVT-Exact?)

Non Discussion Abstract Session 31 Read by Title 893 The usefulness of bladder capacity and postvoiding residual volume as a predictor of DHIC in stroke patients

Non Discussion Abstract Session 31 Read by Title 894 THE EFFECTIVENESS OF FOSFOMYCIN TROMETHAMINE AND CIPROFLOXACIN PROPHYLAXIS IN PREVENTING BACTERIURIA CAUSED BY URODYNAMIC STUDY, DO PATIENTS NEED PROPHYLAXIS

Non Discussion Abstract Session 31 Read by Title 895 Urodynamic effects of 1a-blocker tamsulosin 0,4 mg on voiding dysfunction in patients with detrusor underactivity

Non Discussion Abstract Session 31 Read by Title 897 Should urinalysis be routinely performed prior to Urodynamic studies?

Non Discussion Abstract Session 31 Read by Title 903 The penile cuff test: a non-invasive urodynamic investigation to diagnose men with lower urinary tract symptoms.

Non Discussion Abstract Session 31 Read by Title 905 Women with genital prolapse present a broad spectrum of symptoms from all organs in the pelvis

Non Discussion Abstract Session 31 Read by Title 908 Efficacy and outcome of transvaginal mesh repair of vaginal wall prolapse

Podium Poster Session 8 Investigation and Intervention 91 A Dose-Exploration Study Of The Efficacy and Safety Of OnabotulinumtoxinA in Patients With Urinary Incontinence Due To Neurogenic Detrusor Overactivity

Podium Poster Session 8 Investigation and Intervention 92 Efficacy and tolerability of once-daily mirabegron, a potent and selective ß3-adrenoceptor agonist, in patients with overactive bladder – results from a North American Phase III trial

Podium Poster Session 8 Investigation and Intervention 93 Safety and Potential Effectiveness of Cook MyoSite Autologous Muscle Derived Cells for Treatment of Stress Urinary Incontinence: Preliminary Results from a Dose Escalation Study

Podium Poster Session 9 Pregnancy 99 Female Urinary Incontinence and Urgency – Impact on Women’s and their Partners’ Sexual Life

ICS/IUGA 2010

Non Discussion Abstract Session 33 Read by Title 1002 Laparoscopic nephroureterectomy in cases of surgically treatable etiology of incontinence due to ureteral ectopia and congenital renal dysplasia: a tertiary care centre experience.

Non Discussion Abstract Session 33 Read by Title 1005 Difference between nulliparous and postpartum women´s pelvic floor muscles electrical activity

Non Discussion Abstract Session 33 Read by Title 1007 ELECTROMYOGRAPHIC ANALYSIS OF PELVIC FLOOR MUSCLE CONTRACTION USING PAULA METHOD OF EXERCISES

Non Discussion Abstract Session 33 Read by Title 1008 DETERMINATION OF PELVIC FLOOR MUSCLE OSCILATION FREQUENCY IN HEALTHY WOMEN USING A MULTIDIRECTION VAGINAL PROBE

Podium Poster Session 12 Surgery Male and Female 101 The Success and Long-term Durability of Single-incision Transurethral Incision of the Bladder Neck (TUIBN) for Functional Bladder Neck Obstruction

Non Discussion Abstract Session 33 Read by Title 1010 Co-activation of the abdominal and pelvic floor muscles in women with and without stress urinary incontinence using ultrasound imaging

Non Discussion Abstract Session 33 Read by Title 1011 MRI of Primiparous Squirrel Monkeys Demonstrate Pelvic Floor Muscle and Support Changes.

Non Discussion Abstract Session 33 Read by Title 1012 What is the importance of vaginal probe position on pelvic floor surface electromyographic assessment?

Non Discussion Abstract Session 33 Read by Title 1013 Assessment of pelvic floor symptoms and recovery after primiparous vaginal deliveries with known risk factors for levator ani injury

Non Discussion Abstract Session 33 Read by Title 1015 Which of the recumbent positions promoves better pelvic floor muscle relaxation?

Non Discussion Abstract Session 33 Read by Title 1018 Anterior prolapse surgery and Stress Urinary Incontinence. Is it worth to prevent?

Non Discussion Abstract Session 33 Read by Title 1019 Pelvic Organ Prolapse after Surgical Correction. Recurrence risk.

Podium Poster Session 12 Surgery Male and Female 102 The Argus adjustable sling for treatment of all degrees of male stress urinary incontinence: retrospective evaluation of efficacy and complications after a minimal follow-up of 14 months.

Non Discussion Abstract Session 33 Read by Title 1020 Pelvic Organ Prolapse Staging with a Full or an Empty Bladder: Does it Make a Difference?

Non Discussion Abstract Session 33 Read by Title 1021 Correlation of the perineometry with the capacity of the pelvic floor muscle contration

Non Discussion Abstract Session 33 Read by Title 1022 Correlation of Digital Palpation and Transabdominal Ultrasound for Assessment of Pelvic Floor Muscle Contraction

Non Discussion Abstract Session 33 Read by Title 1023 The Effectiveness of Pelvic Floor Muscle Training on Female Urinary Incontinence in Community

Non Discussion Abstract Session 33 Read by Title 1024 PERINEAL ELASTICITY METER

Non Discussion Abstract Session 33 Read by Title 1025 Abdominal Force of a Looped Sling Sustained from Cough in an Anti-incontinence Suburethral Sling

Non Discussion Abstract Session 33 Read by Title 1028 Assessment of urinary incontinence in climacteric women using the 1-hour pad test.

Non Discussion Abstract Session 33 Read by Title 1029 Functional and clinical evaluation of the pelvic floor in female ultramarathon runners.

Non Discussion Abstract Session 33 Read by Title 1030 Correlation between pelvic floor symptoms as measured by ePAQ with POP-Q assessment

Non Discussion Abstract Session 33 Read by Title 1032 ASSESSMENT OF A SIMPLE ANALGESIA PROTOCOL WITH A VIEW TO PERFORMING SSF AS A DAY-CASE/ 23 HOUR WARD PROCEDURE

Non Discussion Abstract Session 33 Read by Title 1033 Better clinical outcome by modifying the treatment with TiLOOP TiFour titanium coated extralight mesh for vaginal vault prolapse

Non Discussion Abstract Session 33 Read by Title 1034 Improvements in overactive bladder syndrome after polypropylene mesh surgery for cystocele (Five years follow-up study)

Non Discussion Abstract Session 33 Read by Title 1035 Perceived Pelvic Floor Muscle Contraction in Training Program on Women of Six-week Postpartum

Non Discussion Abstract Session 33 Read by Title 1037 Inter-observer variability of pubo-cocigeal test based on a 4-level scale

Non Discussion Abstract Session 33 Read by Title 1038 Pelvic floor evaluation on gynecologic and standing positions

Non Discussion Abstract Session 33 Read by Title 1039 Combined anterior transobturator mesh with four straps and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapsus and stress urinary incontinence: An experimental surgical study

Podium Poster Session 12 Surgery Male and Female 104 PRELIMINARY RESULTS OF MITOMYCIN ON RECURRENT BLADDER NECK CONTRACTURE AFTER RADICAL PROSTATECTOMY

Non Discussion Abstract Session 33 Read by Title 1042 Presence of beta3 adrenergic receptors (ß3-ARs) in the rat spinal cord and their functional relevance in micturition under normal conditions and in a model of partial urethral obstruction

Non Discussion Abstract Session 33 Read by Title 1046 Bladder Botulinum Toxin A Injection Does not Affect the Urothelial Inhibitory Activity on the Detrusor

Non Discussion Abstract Session 33 Read by Title 1047 Investigation of the role of TRPM8 channels in mediating mucosal and detrusor contraction in pig urinary bladder

Non Discussion Abstract Session 33 Read by Title 1048 HYDROGEN PEROXIDE-INDUCED DETRUSOR OVERACTIVITY INVOLVES NITROSATIVE STRESS, LOSS OF UROTHELIAL INHIBITORY FUNCTION AND UP-REGULATION OF RHO KINASE

Non Discussion Abstract Session 33 Read by Title 1049 An Evidence-based Study of Kampo Formula, Hachimi-Jio-Gan in Treatment of Lower Urinary Tract Symptoms (LUTS)

Non Discussion Abstract Session 33 Read by Title 1052 In-vitro susceptibility of Escherichia coli isolates to antimicrobials, used in the therapy of urinary tract infections in gynecologic patients

Non Discussion Abstract Session 33 Read by Title 1054 The role of pre-operative oral Vitamin B in the cystoscopic assessment of ureteric patency

Non Discussion Abstract Session 33 Read by Title 1055 Open-label non-comparative 24-week study with flexible dosing of solifenacin to patients with overactive bladder in Thailand

Non Discussion Abstract Session 33 Read by Title 1056 ELECTROMYOGRAPHIC ACTIVITY OF PELVIC FLOOR MUSCLES: IS THERE ANY DIFFERENCE BETWEEN NULIPAROUS AND PRIMIGRAVIDAES?

Non Discussion Abstract Session 33 Read by Title 1057 Parity and post-partum persistent urinary incontinence: a cross-sectional retrospective study

Non Discussion Abstract Session 33 Read by Title 1058 Prevalence and Risk Factors for Urinary Incontinence in Healthy Pregnant Brazilian Women

Podium Poster Session 12 Surgery Male and Female 106 NORMAL DISTRIBUTION OF URETHRAL RESISTANCE AND DETRUSOR CONTRACTILITY IN WOMEN WITH URINARY INCONTINENCE

Non Discussion Abstract Session 33 Read by Title 1062 Prevalence of urinary incontinence before and during pregnancy

Non Discussion Abstract Session 33 Read by Title 1063 RELATION BETWEEN VAGINAL HIATUS AND PERINEAL BODY LENGTHS WITH EPISIOTOMY IN VAGINAL DELIVERY

Non Discussion Abstract Session 33 Read by Title 1064 PREGNANCY REPERCUSSIONS ON FEMALE SEXUALITY

Non Discussion Abstract Session 33 Read by Title 1067 Assessment of risk factors of urinary incontinence in pregnancy, effect of pelvic floor muscle training

Non Discussion Abstract Session 33 Read by Title 1068 Ocurrence of urinary incontinence before and during pregnancy in physiological and diabetc pregnant women

Non Discussion Abstract Session 33 Read by Title 1069 Prolonged postpartal urinary retention after vaginal delivery: suprapubic catheterisation or clean intermittent self-catheterisation?

Non Discussion Abstract Session 33 Read by Title 1070 Urinary Incontinence in puerperal period

Non Discussion Abstract Session 33 Read by Title 1073 URINARY INCONTINENCE DURING PREGNANCY AND ITS RELATIONSHIP WITH SOCIO-DEMOGRAPHIC VARIABLES AND QUALITY OF LIFE.

Non Discussion Abstract Session 33 Read by Title 1076 An evaluation of pelvic floor disorders symptoms in pregnancy

Non Discussion Abstract Session 33 Read by Title 1079 Survey of Incontinence Screening Practices among Primary Care Physicians

Non Discussion Abstract Session 33 Read by Title 1080 Content Validity of a Patient Bladder Diary among Patients with Incontinence due to Idiopathic Overactive Bladder (IOAB)

Non Discussion Abstract Session 33 Read by Title 1081 Common Bladder Management Techniques and Mechanistic Methods.

Non Discussion Abstract Session 33 Read by Title 1082 The impact of screening urine loss on the quality of life of patients with stress urinary incontinence

Non Discussion Abstract Session 33 Read by Title 1085 Incontinence quality of life: Impact of treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse.

Non Discussion Abstract Session 33 Read by Title 1086 The Impact of Tension-free Vaginal Tape-Obturator or Tesion-free Vaginal Tape-Secur Procedure on Quality of Life and Overactive Bladder Symptoms in Women with Urinary Incontinence: Documented with Validated Questionnaires

Non Discussion Abstract Session 33 Read by Title 1087 Assessment of the quality of life after transobturator tape: Long term follow up with the King’s Health Questionnaire.

Non Discussion Abstract Session 33 Read by Title 1088 Audit to evaluate the difference in quality of life using British Female Lower Urinary Tract Symptoms(BFLUTS) questionnaire pre and post Transobturator (TOT) procedure

Non Discussion Abstract Session 33 Read by Title 1089 Clinical audit of patient satisfaction and quality of life following Prolift Mesh repair in the treatment of women with pelvic organ prolapse

Podium Poster Session 12 Surgery Male and Female 109 Risk factors for Mesh Shrinkage and Erosion in Prolift Like (PL) surgery: Can Menopausal status and Dyslipidemia explain them?

Non Discussion Abstract Session 33 Read by Title 1090 IMPACT OF VAGINAL MESH ON SEXUAL FUNCTION

Non Discussion Abstract Session 33 Read by Title 1093 Voiding functions in patients with pelvic organ prolapse undergoing TVM procedure

Non Discussion Abstract Session 33 Read by Title 1094 Symptomatic Pelvic Hematoma Following Transvaginal Reconstructive Pelvic Surgery: Incidence, Clinical Presentation, Risk Factors, and Outcome

Non Discussion Abstract Session 33 Read by Title 1095 Vaginal enterocele repair with and without bovine pericardium reinforcement

Non Discussion Abstract Session 33 Read by Title 1098 Prolapse surgery in women of 80 years and older using the Prolift technique

Non Discussion Abstract Session 33 Read by Title 1099 Laparoscopic sacrocervicopexy for uterine prolapse

Podium Poster Session 12 Surgery Male and Female 110 Bilateral high uterosacral ligament suspension compared with McCall culdoplasty for vaginal vault support at vaginal hysterectomy

Non Discussion Abstract Session 33 Read by Title 1101 Late post-surgical complication and reoperation rate after vaginal mesh surgery

Non Discussion Abstract Session 33 Read by Title 1102 Vaginal mesh repair for prolapse is as effective, in the short term as the traditional repair but carries a high erosion rate as a deterrent factor.

Non Discussion Abstract Session 33 Read by Title 1103 Management of vaginal mucosa erosion and mesh extrusion after Genital Prolapse Surgery with polypropylene mesh.

Non Discussion Abstract Session 33 Read by Title 1104 A pilot study using Magnetic Resonance Imaging (MRI) to assess mesh strap positioning following mesh augmented pelvic organ prolapse surgery with non­anchored mesh and a vaginal support device.

Non Discussion Abstract Session 33 Read by Title 1105 Trans-vaginal colposacropexy: Description of a novel method and preliminary results

Non Discussion Abstract Session 33 Read by Title 1106 Animal study for the evaluation of a semi rigid, semi absorbable composite mesh PLLA (Polypropylene / Poly-L-Lactic Acid) for transvaginal cystocele repair

Non Discussion Abstract Session 33 Read by Title 1107 Management of high grade posterior vaginal wall prolapse associated with straining to defecate using a single incision posterior vaginal mesh kit (Elevate®): a one year follow-up study

Non Discussion Abstract Session 33 Read by Title 1108 Prolift Like (PL) surgery: A management option for severe pelvic organ prolapse (POP) in a public hospital in a developing country.

Podium Poster Session 12 Surgery Male and Female 111 SUCCESS RATE OF PELVIC FLOOR CORRECTIONS WITH COLLAGEN (PELVICOL® OR PELVISOFT®) MESHES AT 12 AND 48 MONTHS – A PROSPECTIVE STUDY

Non Discussion Abstract Session 33 Read by Title 1110 Subjective and objective results of anterior wall repair. A 5-year follows up

Non Discussion Abstract Session 33 Read by Title 1111 Tensile Strength at Failure of a Surgeon’s Knot or a Flat Square Knot

Non Discussion Abstract Session 33 Read by Title 1112 Comparison between laparoscopic sacral colpopexy(LSC) and posterior intravaginal sling (PIVS) for the treatment of uterine prolapse

Non Discussion Abstract Session 33 Read by Title 1113 The Bladder Function Changes after Transvaginal Pelvic Reconstructive Surgery Using Prolift Technique for Pelvic Organ Prolapse

Non Discussion Abstract Session 33 Read by Title 1114 Anatomical and functional outcomes of a Subintestinal Submucosa (SurgiSIS) graft to augment anterior repair. A prospective observational study.

Non Discussion Abstract Session 33 Read by Title 1115 Laparoscopic Sacrocolpopexy for “Gap Failure” after Previous Anterior and Posterior Vaginal Mesh Repair

Non Discussion Abstract Session 33 Read by Title 1116 Experience of Robotic Assisted Laparoscopic Sacrocolpopexy of a Single Urogynecology Unit

Non Discussion Abstract Session 33 Read by Title 1117 THE INTERMEDIATE TERM FOLLOW UP OF CYSTOCELE REPAIR USING THE TRANSOBTURATOR APPROACHE WITH PORCINE DERMIS GRAFT (PERIGEE/INTEXEN®)

Non Discussion Abstract Session 33 Read by Title 1118 Quality of Life (QoL) in multicenter trial for POP surgery.

Non Discussion Abstract Session 33 Read by Title 1120 New single-incision trocar-less system for the treatment of pelvic organ prolapse: short and long term results of first 29 patients

Non Discussion Abstract Session 33 Read by Title 1122 SITE SPECIFIC VAGINAL REPAIR USING SURGISIS - OUR FIRST EXPERIENCE

Non Discussion Abstract Session 33 Read by Title 1124 Vaginal repair of cystocele: A comparison of traditional anterior colporraphy with and without concomitant use of a biologic graft

Non Discussion Abstract Session 33 Read by Title 1126 One-Year Outcome of Concurrent Anterior and Posterior Transvaginal Mesh Surgery for Treatment of Advanced Urogenital Prolapse: Case Series

Non Discussion Abstract Session 33 Read by Title 1127 Laparoscopic Uterine Suspension for Treatment of Pelvic Organ Prolapse in Patient with Prior Whole Pelvic Radiotherapy for Cervical Cancer.

Non Discussion Abstract Session 33 Read by Title 1128 Public Hospital Surgical approach and recurrence of POPQ stage IV Pelvic Organ Prolapse (POP) in a developing country: Another form of management is possible

Non Discussion Abstract Session 33 Read by Title 1129 Rectocele reconstruction surgery: Functional evaluation of vaginal mesh repair and laparoscopic rectopexy

Non Discussion Abstract Session 33 Read by Title 1130 Clinical audit on surgical outcomes of vaginal wall prolapse repair using mesh

Non Discussion Abstract Session 33 Read by Title 1131 Mesh implantation for female pelvic organ prolapse improves pelvic floor related quality of life in a prospective multicenter study

Non Discussion Abstract Session 33 Read by Title 1133 Tension-free vaginal mesh procedure for pelvic organ prolapse: The experience of 159 cases with 1-year follow up.

Non Discussion Abstract Session 33 Read by Title 1136 PELVIC ORGAN PROLAPSE: DOES STRESS URINARY INCONTINENCE A BAD INFLUENCE?

Non Discussion Abstract Session 33 Read by Title 1137 Assessment of overactive bladder symptoms in women who underwent Tissue Fixation System (TFS) surgery for pelvic organ prolapse.

Non Discussion Abstract Session 33 Read by Title 1138 Different pelvic organ prolapse (POP) as indication for anterior transobturator mesh (ATOM), posterior ischiorectal mesh (PIRM) or posterior ischiorectal transobturator mesh (PIRTOM): design of meshes

Non Discussion Abstract Session 33 Read by Title 1141 REVIEW OF TWO NEWS SURGICAL TECHNIQUES: TRANSOBTURATORY AND TRANSPERINEAL, FOR TREATMENT OF PELVIC ORGAN PROLAPSE.

Non Discussion Abstract Session 33 Read by Title 1142 reatment of posterior vaginal wall prolapse associated with anorectal dysfunctions using a vaginal polyprolpylene mesh kit (posterior Prolift): One year follow-up study

Non Discussion Abstract Session 33 Read by Title 1143 Transvaginal repair of genital prolapse with polyprolpylene mesh using a tension-free technique

Non Discussion Abstract Session 33 Read by Title 1144 EVALUATION OF THE LONG TERM RESULTS AND COMPLICATIONS OF THE USE OF POSTERIOR PELVIC FLOOR REPAIR SYSTEMS ON FIFTY WOMEN.

Non Discussion Abstract Session 33 Read by Title 1145 AVLEV - a novel idea of a "levator brace" during pelvic reconstructive surgery.

Non Discussion Abstract Session 33 Read by Title 1146 Treat mechanical BOO in severe POP patients with total Prolift

Non Discussion Abstract Session 33 Read by Title 1149 URODYNAMICS AS FIRST APPROACH IN MANAGEMENT OF WOMEN WITH URINARY INCONTINENCE: AN UNWANTED PRACTICE!

Non Discussion Abstract Session 33 Read by Title 1150 Intravaginal electrical stimulation as a treatment option for women with Overactive Bladder

Non Discussion Abstract Session 33 Read by Title 1152 PELVIC FLOOR MUSCLE TRAINING VERSUS HIPOPRESSIVE TECHNIC: PREVENTIVE AND CONSERVATIVE TREATMENTE OF PELVIC FLOOR DISFUNCTIONS ASSESSMENT THROUGH OF THE ELECTROMYOGRAPHY BIOFEEDBACK

Non Discussion Abstract Session 33 Read by Title 1153 Two year follow up of sexual function and quality of life symptoms after an innovative procedure - Avaulta synthetic mesh for vaginal prolapse

Non Discussion Abstract Session 33 Read by Title 1154 A prospective analysis of sexual function during pregnancy.

Non Discussion Abstract Session 33 Read by Title 1155 Female sexual function after Transvaginal mesh (TVM) reconstruction with TOT sling for vaginal prolapse concurrent with stress urinary incontinence.

Non Discussion Abstract Session 33 Read by Title 1157 Female sexual dysfunction in patients with pelvic floor disorders: A cross-sectional controlled study

Non Discussion Abstract Session 33 Read by Title 1158 Prevalence of sexual findings on the medical records of patients with chronic pelvic pain

Non Discussion Abstract Session 33 Read by Title 1159 Sexual function in female patients suffering LUTS

Podium Session 13 Assessment and Conservative Treatment 116 Pelvic floor muscle training alone or in combination with hypopressive exercises: randomized controlled trial

Non Discussion Abstract Session 33 Read by Title 1160 Impact on sexual activity and relationships in women with vulvodynia.

Non Discussion Abstract Session 33 Read by Title 1161 Female sexual function before and after SPARC-sling procedure

Non Discussion Abstract Session 33 Read by Title 1163 Vulvodynia and co-morbidity associated: a case-control study.

Non Discussion Abstract Session 33 Read by Title 1164 MEANINGS OF THE BODY AND SEXUALITY EXPERIENCED BY BRAZILIAN WOMEN WITH URINARY INCONTINENCE

Non Discussion Abstract Session 33 Read by Title 1165 Voiding disorders in women with chronic vulvar pain.

Non Discussion Abstract Session 33 Read by Title 1166 Female sexual function after modified pelvic organ prolapse repair

Non Discussion Abstract Session 33 Read by Title 1167 FEMALE SEXUAL DYSFUNCTION AFTER VAGINAL SURGERY FOR INCONTINENCE TREATMENT AND PELVIC ORGAN PROLAPSE

Non Discussion Abstract Session 33 Read by Title 1169 Effects of lumbar lordosis and pelvic inlet orientation on the outcome of the transobturator tape sling operation in women

Non Discussion Abstract Session 33 Read by Title 1170 Is Tension Free Trouble Free?

Non Discussion Abstract Session 33 Read by Title 1172 Lower tract urinary injuries associated to mid-urethral slings for stress urinary correction surgery.

Non Discussion Abstract Session 33 Read by Title 1176 Repeat operation after failed stress incontinence surgery: causes and outcomes

Non Discussion Abstract Session 33 Read by Title 1177 Risk factors of treatment failure after surgery for urinary stress incontinence

Non Discussion Abstract Session 33 Read by Title 1179 The effect of body mass index on the result of the SPARC in patients with stress urinary incontinence

Non Discussion Abstract Session 33 Read by Title 1182 Prospective Comparative Study between the TVT-Secure and TOT procedures for Treatment of Stress Urinary Incontinence Patients

Non Discussion Abstract Session 33 Read by Title 1183 Laparoscopic Implantation and Evaluation of a Telemetric Sphincter Prosthesis for Urinary Incontinence in Pigs – Evaluation of First Results.

Non Discussion Abstract Session 33 Read by Title 1185 A history of surgical procedures for female stress urinary incontinence: Examination of health episode statistics in Scotland, 1989 - 2008

Non Discussion Abstract Session 33 Read by Title 1188 Adjustable pubourethral sling (“Kharkov antenna”) in the treatment of female stress urinary incontinence

Non Discussion Abstract Session 33 Read by Title 1189 Effects of a Transvaginal Retropubic Tape and of the Transobturator Tape on the pelvic floor and the musculoskelettal system

Non Discussion Abstract Session 33 Read by Title 1190 Safety and Efficacy of Sling After Bulking Injection for Persistent Stress Urinary Incontinence

Non Discussion Abstract Session 33 Read by Title 1192 The SPARC procedure for the treatment of female stress urinary incontinence in the elderly.

Non Discussion Abstract Session 33 Read by Title 1194 Is there a place for periurethral injections (macroplastique) for the treatment of stress incontinence?-Patients’ verdict

Non Discussion Abstract Session 33 Read by Title 1195 Cadaveric Assessment of Immediate Pull Out Strength of the Three Common Synthetic Sling Approaches: Single Incision, Retropubic, and Transobturator

Non Discussion Abstract Session 33 Read by Title 1196 More than one TVT is the solution in cases with previous failed TVT?

Non Discussion Abstract Session 33 Read by Title 1197 Factors influencing the occurrence of mesh erosion after transobturator slings for stress urinary incontinence

Non Discussion Abstract Session 33 Read by Title 1198 Incidence, management and risk factors associated with vaginal erosion after surgical correction of urinary incontinence with polypropylene tapes during one year follow-up.

Podium Poster Session 14 Clinical and Basic Neurourology 120 Comparative study of two muscle derived stem cell isolation protocols in rats to stress urinary treatment.

Non Discussion Abstract Session 33 Read by Title 1200 TREATMENT OF VAGINAL EROSION OF TRANSOBTURATOR TAPE USING A PELVISOFT PATCH: A SERIES OF 6 CASES

Non Discussion Abstract Session 33 Read by Title 1201 INCIDENCE OF PERIOPERATIVE URINARY TRACT INFECTION AFTER SINGLE-DOSE ANTIBIOTIC PROPHYLAXIS FOR MIDURETHRAL SYNTHETIC SLING

Non Discussion Abstract Session 33 Read by Title 1202 TREATMENT OF RECURRENT STRESS URINARY INCONTINENCE WITH ADJUSTABLE CONTIENCE THERAPY: A SERIES OF 57 PATIENTS

Non Discussion Abstract Session 33 Read by Title 1203 Evolution of detrusor overactivity in patients with Mixed Urinary Incontinence after transobturator tape

Non Discussion Abstract Session 33 Read by Title 1204 Transobturator slings with outside in technique for Urinary stress incontinence – 3 years review in Penang Hospital, Malaysia

Non Discussion Abstract Session 33 Read by Title 1206 Prospective Multi-Center Study looking at the Safety and Efficacy of the Solyx™ SIS System

Non Discussion Abstract Session 33 Read by Title 1208 Cystocele and Stress urinary incontinence: Simultaneous repair (SIM-PAIR) by a modified surgical technique using transobturator mesh. A prospective study.

Non Discussion Abstract Session 33 Read by Title 1209 The role of bulking agent hyaluronic acid/dextranomer gel at the therapy in woman with stress urinary incontinence

Non Discussion Abstract Session 33 Read by Title 1210 STRESS URINARY INCONTINENCE: MONARC VERSUS MINIARC.

Non Discussion Abstract Session 33 Read by Title 1211 Early result of midurethral sling surgery by Remeex device for female stress incontinence

Non Discussion Abstract Session 33 Read by Title 1212 Comparison of treatment results of TOT surgery in patients with stress urinary incontinence and mixed urinary incontinence in Korean society.

Non Discussion Abstract Session 33 Read by Title 1213 PRESENTATION OF THE USE OF THE SINGLE-INCISION SLING SYSTEM, AJUST, ON 15 FEMALE PATIENTS AND THEIR FOLLOW UP IN A YEAR’S TIME.

Non Discussion Abstract Session 33 Read by Title 1214 Analysis of risk factors of urinary incontinence after TVT-O surgery for stress urinary incontinence. Can predict the risk factors in pre-orerative chain cystography?

Non Discussion Abstract Session 33 Read by Title 1215 MINIMALLY INVASIVE SLINGS FOR URINARY STRESS INCONTINENCE– WHERE WE ARE

Non Discussion Abstract Session 33 Read by Title 1216 MiniArc Activity Study (MAS) : Does early physical activity affect the cure rate of MiniArc?

Non Discussion Abstract Session 33 Read by Title 1217 Out-patient treatment of genuine stress urinary incontinence: An initial experience with a third generation midurethral sling (MiniArc®)

Non Discussion Abstract Session 33 Read by Title 1219 Urethral injury with transobturator midurethral sling

Non Discussion Abstract Session 33 Read by Title 1225 POTENTIAL OCCULT URINARY INCONTINENCE IN SEVERE CYSTOCELE EVIDENCED BY URODYNAMIC TEST WITH ANATOMY SIMULATES RESTORATION.

Non Discussion Abstract Session 33 Read by Title 1226 PREVALENCE OF URINARY INFECTION AFTER URODYNAMIC INVESTIGATION

Non Discussion Abstract Session 33 Read by Title 1228 Comparison between the clinical diagnosis and the non-multichannel urodynamic test in women admitted for urinary incontinence.

Podium Poster Session 14 Clinical and Basic Neurourology 123 Molecular mediators for inflammation-induced lymphangiogenesis in the murine bladder

Non Discussion Abstract Session 33 Read by Title 1230 The impact of voiding habits in urodynamic studies results.

Non Discussion Abstract Session 33 Read by Title 1231 Is there the best method for measurement of Q tip angle? -Q tip angle Change in Relation to Position and Bladder Filling-

Non Discussion Abstract Session 33 Read by Title 1232 IS THE JOINT STATEMENT ON MINIMUM STANDARDS FOR URODYNAMIC PRACTICE IN THE UK REASONABLE?

Non Discussion Abstract Session 33 Read by Title 1234 Does Cystometry change patient management ?

Non Discussion Abstract Session 33 Read by Title 1235 Usefulness of 1-Hour Pad Test as Preoperative Diagnostic Assessment for Stress Urinary Incontinence in Korean society.

Non Discussion Abstract Session 33 Read by Title 1237 IS LOWER BACK PAIN CORRELATED WITH PELVIC ORGAN PROLAPSE?

Non Discussion Abstract Session 33 Read by Title 1239 NEW MESH AGAINST COMPLICATIONS

Non Discussion Abstract Session 33 Read by Title 1241 Anatomopathological clinical results in patients with surgery with Prolene-Monocryl hybrid mesh (ULTRAPRO ETHICON) for total prolapse

Non Discussion Abstract Session 33 Read by Title 1242 RISK FACTORS FOR PELVIC ORGAN PROLAPSE IN PREMENOPAUSAL WOMEN

Non Discussion Abstract Session 33 Read by Title 1243 INCARCERATED RECTAL PROLAPSE- CASE REPORT

Non Discussion Abstract Session 33 Read by Title 1244 Is there relation between Pelvic Organ Prolapse and Joint Hypermobility? An observational study.

Non Discussion Abstract Session 33 Read by Title 1245 Intraperitoneal uterosacral hysteropexy for the management of uterine prolapse in young women

Non Discussion Abstract Session 33 Read by Title 1246 Abdominal sacral colpopexy: Outcome and complication in the treatment of pelvic organ prolapse

Non Discussion Abstract Session 33 Read by Title 1247 PROGRIP MESH INSERTION- A SUTURE FREE TECHNIQUE FOR ANTERIOR AND POSTERIOR VAGINAL PROLAPSE REPAIR.

Non Discussion Abstract Session 33 Read by Title 1248 Pelvic Organ Prolapse Treatment With Gynecare Prolift System – Our Experience.

Podium Poster Session 14 Clinical and Basic Neurourology 125 12 WEEK RESULTS FROM THE SUMIT TRIAL: PERCUTANEOUS TIBIAL NERVE STIMULATION VS VALIDATED SHAM IN THOSE EXPOSED TO PHARMACOLOGIC THERAPY

Non Discussion Abstract Session 33 Read by Title 1250 Postoperative stress incontinence on prolapse reduction can not predicted from preoperative urodynamic study.

Non Discussion Abstract Session 33 Read by Title 1252 Retrospective Analysis of 46 cases of Sacrospinous fixation following Urogenital Prolapse

Non Discussion Abstract Session 33 Read by Title 1253 Uterine sparring surgery – The Manchester repair experience in Penang Hospital

Podium Poster Session 14 Clinical and Basic Neurourology 126 Intermittent catheterisation with hydrophilic-coated catheters delays the onset of urinary tract infection in patients with acute spinal cord injury: An international, multicenter, randomised controlled trial.

Podium Poster Session 14 Clinical and Basic Neurourology 128 NETUPITANT, A POTENT AND HIGHLY SELECTIVE NK1 RECEPTOR ANTAGONIST IN THE GUINEA-PIG ISOLATED URINARY BLADDER: COMPARISON WITH APREPITANT

Podium Poster Session 14 Clinical and Basic Neurourology 129 Comparison of the effects of netupitant and tolterodine on overactive bladder induced by intravesical acetic acid infusion in anesthetized female guinea-pigs.

Podium Session 3 Prolapse, Non-Surgical 13 Cardinal and Uterosacral Ligament Lines of Action: MRI Based 3D Technique Development and Preliminary Findings in Normal Women

Podium Video Session 15 Videos 131 Laparoscopic Transvesical Surgery for Intravesical Pathologies

Podium Video Session 15 Videos 132 HIGH UTEROSACRAL LIGAMENT VAGINAL VAULT SUSPENSION: REVISITING THIS PELVIC ANATOMY

Podium Video Session 15 Videos 134 ROBOTIC-ASSISTED ABDOMINAL SACROCOLPOPEXY/SACROHYSTEROPEXY (RASC) – A VIABLE ALTERNATIVE FOR PELVIC ORGAN PROLAPSE REPAIR?

Podium Video Session 15 Videos 136 LONG TERM FOLLOW-UP OF THE MALE REMEEX SYSTEM FOR THE SURGICAL TREATMENT OF MALE INCONTINENCE

Podium Poster Session 16 Pelvic Floor, Clinical and Basic Science 144 Pelvic floor muscles have greater central fatigue during voluntary contractions than muscles of the limbs

Podium Poster Session 16 Pelvic Floor, Clinical and Basic Science 149 Dynamic transperineal ultrasound is comparable to MR proctography for assessing structural abnormalities in patients with rectocele

Podium Poster Session 16 Pelvic Floor, Clinical and Basic Science 150 Diagnosis of Levator avulsion injury: a comparison of three methods

Podium Poster Session 16 Pelvic Floor, Clinical and Basic Science 151 Does the Epi-No® prevent levator trauma? A randomised controlled trial

Podium Poster Session 17 Female Stress Urinary Incontinence Surgery 152 No difference in urinary continence after surgery between retropubic and transobturatoric transvaginal sling operations when correcting for predisposing factors.

Podium Poster Session 17 Female Stress Urinary Incontinence Surgery 154 RANDOMISED TRIAL OF TVTO™ AND TVTS ™ FOR THE TREATMENT OF STRESS URINARY INCONTINENCE. PRELIMINARY STUDY

Podium Poster Session 17 Female Stress Urinary Incontinence Surgery 157 Efficacy and Safety of a Transobturator Polypropylene Sling for Female Stress Urinary Incontinence

Podium Poster Session 17 Female Stress Urinary Incontinence Surgery 158 Incidence and predicting factors of early postoperative high post-void residual after mid-urethral sling procedure

Podium Poster Session 17 Female Stress Urinary Incontinence Surgery 159 TVT Sling Incision - Indications, Outcome and Recurrent Incontinence

Podium Poster Session 4 Male LUTS, Clinical and Basic Science 16 DECELLULARIZED PORCINE-DERIVED BLOOD VESSEL MATRIX GRAFT FOR URETHRAL REPLACEMENT IN A RABBIT MODEL

Podium Poster Session 17 Female Stress Urinary Incontinence Surgery 160 ONE YEAR RESULTS FROM A WORLD-WIDE REGISTRY OF TVT-SECUR™ IN WOMEN WITH STRESS URINARY INCONTINENCE (SUI)

Podium Poster Session 17 Female Stress Urinary Incontinence Surgery 161 MINIARC SINGLE-INCISION SLING FOR STRESS URINARY INCONTINENCE

Podium Poster Session 18 Assessment and Conservative Treatment 165 Caffeine Intake and Risk of Stress, Urgency, and Mixed Urinary Incontinence

Podium Poster Session 18 Assessment and Conservative Treatment 166 Pelvic floor muscle training for treatment of pelvic organ prolapse: randomized controlled trial

Podium Poster Session 18 Assessment and Conservative Treatment 167 Digital muscle testing and vaginal squeeze pressure measurements: can these be interchangeable when assessing pelvic floor muscle function of continent and incontinent primiparous women?

Podium Poster Session 19 Overactive Bladder Pelvic Floor 182 Evaluation of a new electrostim technology for the treatment of urinary incontinence in women: a randomised controlled trial

Podium Poster Session 19 Overactive Bladder Pelvic Floor 183 Interactive 3D Model of MR-Based Pelvic Support Anatomy of Normal Women in PDF Format

Podium Poster Session 20 Miscellaneous II 188 The Effect of Tamsulosin 0.2mg in Patients with Chronic Pelvic Pain Syndrome : Multicenter, Randomized, Prospective Study

Podium Poster Session 20 Miscellaneous II 189 Obstetric Fistula at the General Referral Hospital of Panzi, Bukavu, Democratic Republic of Congo: A Retrospective Review of 216 Patients

Podium Poster Session 4 Male LUTS, Clinical and Basic Science 19 Complications and outcome of sphincterotomy in male patients with non-neurogenic detrusor sphincter dyssynergia

Podium Poster Session 20 Miscellaneous II 191 Risk Preferences of Women Planning Surgical Management of Pelvic Organ Prolapse

Podium Poster Session 20 Miscellaneous II 196 “Study of Tractional Force for Various Pelvic Reconstructive Graft Materials – An Experimental Animal Model”

Podium Session 21 Male LUTS, Clinical and Basic Science 199 The Effect of Ovariectomy on Bladder Function and Myosin Isoform expression in Female Rabbits with Partial Bladder Outlet Obstruction

Podium Session 21 Male LUTS, Clinical and Basic Science 201 Changes in bladder contractility after transurethral resection of the prostate

Podium Session 21 Male LUTS, Clinical and Basic Science 202 Differences in the actions of the M3-antagonist tolterodine and the beta 3 adrenoceptor agonist mirabegron on non-voiding activity in rats with partial outflow obstruction

Podium Session 21 Male LUTS, Clinical and Basic Science 203 Effects of a new phosphodiesterase 5 inhibitor, mirodenafil, on the female rat bladder in a partial bladder outlet obstruction model: Physiological and immunohistochemical aspects

Podium Session 22 Pelvic Floor 204 Apical support: structural relationships between the cardinal and uterosacral ligaments seen in MRI and three-dimensional reconstruction

Podium Session 22 Pelvic Floor 205 Anatomical evaluation of the connective tissue between uterine cervix and ischial spine distinct from traditional uterosacral ligaments (level 1 support)

Podium Session 22 Pelvic Floor 206 A Cross-Sectional Survey to Assess the Prevalence and Symptoms Associated with Laxity of the Vaginal Introitus

Podium Session 22 Pelvic Floor 208 Effect of antenatal pelvic floor muscle exercises in prevention and treatment of urinary incontinence: A Randomized Controlled Trial

Podium Poster Session 4 Male LUTS, Clinical and Basic Science 21 The effects of Gosha-Jinki-Gan, a blended herbal medicine, and furosemide for nocturnal polyuria with elevated B-type natriuretic peptide: a crossover trial.

Podium Session 23 Brain, Hormones and Sex 214 Sexual problems in the gynaecology clinic: Are we making a mountain out of a molehill?

Podium Poster Session 4 Male LUTS, Clinical and Basic Science 22 A pilot evaluation of two non-invasive technologies in the assessment of Bladder Outlet Obstruction

Podium Poster Session 24 Female Stress Urinary Incontinence Surgery 220 ONE TO THREE YEAR PROSPECTIVE FOLLOW-UP DATA OF TVT-S PROCEDURE FOR STRESS URINARY INCONTINENCE SURGERY

Podium Poster Session 24 Female Stress Urinary Incontinence Surgery 221 Effectiveness of TVT-Secur compared with MiniArc for stress urinary incontinence: a randomized controlled trial with mini-sling.

Podium Poster Session 24 Female Stress Urinary Incontinence Surgery 226 The Effect of Postoperative Physical Activity on the Outcomes of Transobturator Tape Procedure

Podium Poster Session 25 Pathophysiology and Quality of Life 228 How reliable is history taking in diagnosing type of urinary incontinence?

Podium Poster Session 5 Quality of Life and Miscellaneous 23 The prevalence and risk factors for OAB in adolescent girls

Podium Poster Session 25 Pathophysiology and Quality of Life 235 A quantitative and qualitative study of women’s preferences for treatments of pelvic floor disorders

Podium Poster Session 25 Pathophysiology and Quality of Life 236 Effect of Herpes Simplex Virus (HSV) Vector-mediated Interleukin-4 (IL-4) Gene Therapy on Bladder Overactivity and Nociception

Podium Poster Session 25 Pathophysiology and Quality of Life 239 Painful bladder syndrome: do the different histopathological features correlate?

Podium Poster Session 5 Quality of Life and Miscellaneous 24 Pelvic floor muscle training in the treatment of women with secondary anorgasmia: functional and electromyographic valuations.

Podium Poster Session 26 Female Stress Urinary Incontinence Surgery 241 Efficacy and Safety of Transobturator Adjustable Tape (TOA) for the Surgical Treatment of patients with Severe Stress Urinary Incontinence (SUI), or Combined SUI and Voiding Dysfunction

Podium Poster Session 26 Female Stress Urinary Incontinence Surgery 244 Urodynamic changes after transobturator suburethral tape: Follow-up of minimum 3 years

Podium Poster Session 26 Female Stress Urinary Incontinence Surgery 245 The result of repeat mid urethral sling after failed mid urethral sling for the treatment of female stress urinary incontinence

Podium Poster Session 26 Female Stress Urinary Incontinence Surgery 247 Tape fixation – an important surgical step to improve surgical success rate of anti-incontinence surgery

Podium Poster Session 26 Female Stress Urinary Incontinence Surgery 249 Mesh Erosion Rate and Time To Erosion Following Vaginal Urinary Incontinence and Pelvic Prolapse Procedures

Podium Poster Session 5 Quality of Life and Miscellaneous 25 The relationship between age & the impact of pelvic floor symptoms: 'The 4,000 women study'

Podium Poster Session 26 Female Stress Urinary Incontinence Surgery 251 Presentation and evaluation for women requiring urethrolysis after anti-incontinence procedure.

Podium Poster Session 27 Non-Surgical Prolapse 252 The homozygous COL3A1 2209G>A polymorphism does not influence the risk of recurrence after surgically managed prolapse

Podium Poster Session 27 Non-Surgical Prolapse 255 The time factor in the assessment of prolapse and levator ballooning

Podium Poster Session 27 Non-Surgical Prolapse 258 Can we identify the limits of the puborectalis muscle on tomographic translabial ultrasound?

Podium Poster Session 27 Non-Surgical Prolapse 261 12 MONTH PERCUTANEOUS TIBIAL NERVE STIMULATION TREATMENT INTERVAL RESULTS: OUTCOMES FROM THE ORBIT TRIAL

Podium Poster Session 27 Non-Surgical Prolapse 262 Impaired bladder emptying in geriatric patients: Clinical significance of the evaluation of physical mobility

Podium Poster Session 28 Basic Science 264 Analysis of cell type-specific gene expression in the rat bladder using laser-capture microdissection techniques

Podium Poster Session 28 Basic Science 265 Collagen type 3 alpha 1 polymorphism as a risk factor for genital prolapse

Podium Poster Session 28 Basic Science 268 Effect of amniotic fluid and bone marrow stem cell therapy on bladder dysfunction in a Parkinson’s disease model

Podium Poster Session 28 Basic Science 269 The involvement of angiotensin II type 1 receptor on bladder hypertrophy and dysfunction in obstructed bladder of rat

Podium Poster Session 5 Quality of Life and Miscellaneous 27 Mobility of the perineal body before and after childbirth

Podium Poster Session 28 Basic Science 271 Development of acellular matrix derived from rat’s urinary bladder to urinary tract reconstruction.

Podium Poster Session 28 Basic Science 275 Vagina, abdominal skin, and aponeurosis: do they have similar biomechanical properties?

Podium Poster Session 29 Prolapse Surgery 278 Biocompatibility of a new implant type for pelvic reconstructive surgery

Podium Poster Session 29 Prolapse Surgery 279 EVALUATION OF LOCAL TOLERANCE OF LIGHTWEIGHT MESHES IN AN ANIMAL MODEL

Podium Poster Session 29 Prolapse Surgery 280 Does polypropylene mesh anisotropy persist after implantation?

Podium Poster Session 29 Prolapse Surgery 282 Laparoscopic Sacral Colpopexy: Does Posterior Mesh Extension to the Perineal Body Make a Difference?

Podium Poster Session 29 Prolapse Surgery 283 A Prospective Multicenter Study Evaluating Elevate™ Apical and Posterior for Treatment of Posterior and/or Apical Vaginal Wall Prolapse: Twelve-Month Follow-up

Podium Poster Session 29 Prolapse Surgery 286 Lefort colpocleisis and stress incontinence: Weighing the risk of voiding dysfunction against sling placement

Podium Poster Session 29 Prolapse Surgery 287 Beyond the complications: Medium term anatomical, sexual and functional outcomes following removal of Prolift.

Podium Poster Session 30 Miscellaneous III 288 Comparison of efficacy and tolerability of two selective M3 receptor antagonists solifenacin and darifenacin in women with overactive bladder – the SOLIDAR study

Podium Poster Session 30 Miscellaneous III 289 Sling Procedures after repair of obstetric vesicovaginal fistula in Niamey, Niger.

Podium Poster Session 5 Quality of Life and Miscellaneous 29 NORMAL DISTRIBUTION OF URETHRAL RESISTANCE AND DETRUSOR CONTRACTILITY IN WOMEN WITH URINARY INCONTINENCE AND ANTERIOR COMPARTMENT PELVIC ORGAN PROLAPSE

Podium Poster Session 30 Miscellaneous III 291 Mental health and the overactive bladder revisited

Podium Poster Session 30 Miscellaneous III 293 ESTROGEN INHIBITS VAGINAL SMOOTH MUSCLE CELL ELASTIN PRODUCTION: POTENTIAL ROLE IN THE PATHOPHYSIOLOGY OF STRESS URINARY INCONTINENCE

Podium Poster Session 30 Miscellaneous III 295 LEVORMELOXIFENE INHIBITS VAGINAL ELASTIN PRODUCTION

Podium Poster Session 30 Miscellaneous III 298 COMPARISON OF SAFETY AND EFFICACY BETWEEN SURGICAL PROCEDURES WITH APONEUROTIC AND TRANSOBTURATORY SLING (SAFYRE? – T) IN PATIENTS WITH STRESS URINARY INCONTINENCE (SUI)

Podium Session 1 Female Stress Urinary Incontinence Surgery A Systematic Review and Meta-analysis of the Efficacy and Complications of the “Inside-out” versus the “Outside-in” Transobturator Tapes in Management of Female Stress Urinary Incontinence.

Non Discussion Poster Session 31 304 Obstetric Anal Sphincter Laceration Repair in the United States: Is there a Common Practice Pattern?

Non Discussion Poster Session 31 305 A synthetic tridimensional pelvic model is an effective didactic tool for the study of the pelvic floor anatomy compared to cadaveric pelvis

Non Discussion Poster Session 31 306 The effects of chronic use of Doxazosin on alpha 1-adrenergic receptors in men with benign prostatic hyperplasia

Non Discussion Poster Session 31 307 Long-term effect on LUTS and sexual function of intraprostatic botulinum toxin type-A (BoNT/A) injection for treatment of patients with benign prostatic enlargement refractory to medical treatment

Non Discussion Poster Session 31 308 The effects of combination of perianal-intrarectal lidocaine-prilocaine cream and periprostatic nerve block for pain control during transrectal ultrasound guided biopsy of the prostate: A randomized, controlled trial

Podium Poster Session 5 Quality of Life and Miscellaneous 31 Utilization of the Self-Assessment Goal Achievement Questionnaire to Evaluate the Importance of Treatment Goals in Subjects With Overactive Bladder Symptoms

Non Discussion Poster Session 31 310 Investigation of the early effects of alpha 1-blockers in a comparative study focusing on patient evaluation

Non Discussion Poster Session 31 312 Comparative study of efficiency and safety of intraprostatic injections of botulinum toxin and polidocanol in men with BPH and LUTS

Non Discussion Poster Session 31 318 Bladder Compliance in Men with Lower Urinary Tract Symptoms.

Non Discussion Poster Session 31 321 POSTOPERATIVE STATUS OF BLADDER OUTFLOW AND EARLY CATHETER REMOVAL AFTER RETROPUBIC RADICAL PROSTATECTOMY.

Non Discussion Poster Session 31 324 The Effects of Chronic Variable Stress on the Bladder Function in Rats

Non Discussion Poster Session 31 327 TGF-BETA 1 IS AN IMPORTANT REGULATOR OF VAGINAL ELASTIN PRODUCTION

Non Discussion Poster Session 31 330 A Double blind randomised placebo controlled trial of the effectiveness of bladder training with oxybutynin or imipramine in the management of detrusor overactivity (DO).

Non Discussion Poster Session 31 332 Nerve Growth Factor signalling in bladder is modulated by caveolin

Non Discussion Poster Session 31 334 Neural mechanisms of bladder overactivity in early stages of bladder outflow obstruction

Non Discussion Poster Session 31 336 Interstim® sacral neuromodulation and Botox® botulinum-A toxin intradetrusor injections for refractory urge urinary incontinence: A decision analysis comparing outcomes including efficacy and complication.

Podium Poster Session 5 Quality of Life and Miscellaneous 34 A COMPARISON OF SHORT TERM SEXUAL FUNCTION OUTCOMES FOR PATIENTS UNDERGOING THE TRANSVAGINAL MESH PROCEDURE USING THE STANDARD POLYPROPYLENE MESH VS A HYBRID POLYPROPYLENE/POLIGLECAPRONE MESH

Non Discussion Poster Session 31 340 NEUROGENIC DETRUSOR OVERACTIVITY INDUCES CHANGES IN ATP LEVEL AND mRNA EXPRESSION OF SEVERAL RECEPTORS IN BLADDER

Non Discussion Poster Session 31 342 Persistency and prescription pattern of oxybutynin ER in patients with overactive bladder in real life practice: multicenter, open-label, prospective observational study

Non Discussion Poster Session 31 344 Why OAB treatment change is so common? “Impacta” study to evaluate reasons for treatment change

Non Discussion Poster Session 31 346 An electronic decision tool to support the selection of patients with overactive bladder syndrome for sacral neuromodulation

Non Discussion Poster Session 31 358 Cost-Effectiveness and Financial Impact of OnabotulinumtoxinA Treatment for Urinary Incontinence due to Neurogenic Detrusor Overactivity in Spinal Cord Injury Patients within the French Healthcare System

Non Discussion Poster Session 31 360 OVERACTIVE BLADDER IS ASSOCIATED WITH UPREGULATION OF MONOCYTE CHEMOATTRACTANT PROTEINS: A PROSPECTIVE SINGLE BLINDED CONTROLLED STUDY

Non Discussion Poster Session 31 361 'Sacral neuroprosthesis for the treatment of refractory overactive bladder - Single UK centre experience'

Non Discussion Poster Session 31 363 Immediate effect on overactive bladder symptoms following administration of Imidafenacin

Non Discussion Poster Session 31 364 Are Patients with Overactive Bladder Symptoms and Detrusor Overactivity Different from Those with Overactive Bladder Symptoms but without Detrusor Overactivity?

Non Discussion Poster Session 31 365 Cardiovascular functional assessment in female overactive bladder patients and their changes after tolterodine versus solifenancin treatment

Non Discussion Poster Session 31 366 DO PATIENTS TOLERATE REPEAT INTRAVESICAL INJECTIONS OF BOTULINUM TOXIN A FOR THE TREATMENT OF DETRUSOR OVERACTIVITY UNDER LOCAL ANAESTHETIC?

Non Discussion Poster Session 31 367 Safety and Tolerability of Sedation free flexible cystoscopy for Intradetrusor Botulinum Toxin-A Injection in patients with Neurogenic or Non-neurogenic Detrusor Overactivity.

Non Discussion Poster Session 31 374 Racial Differences in Healthcare Seeking and Treatment for Urinary Incontinence

Non Discussion Poster Session 31 376 Reoperation Rates in Patients with Interstim Therapy

Non Discussion Poster Session 31 378 Prevalence of Vitamin D deficiency in Women with Urinary and Fecal Incontinence: Results from the National Health and Nutrition Examination Survey

Podium Poster Session 6 Urodynamics and Imaging 38 Preoperative Voiding Detrusor Pressures and Stress Incontinence Surgery Outcomes

Non Discussion Poster Session 31 383 Epidemiology of surgery for pelvic organ prolapse and urinary incontinence in Israel.

Non Discussion Poster Session 31 384 Risk Factors Associated with Incidence of Urinary Incontinence in Community-dwelling Japanese Elderly Women – A 5-year Follow-up Study –

Non Discussion Poster Session 31 387 Assessment of Comorbidities in Patients with Overactive Bladder (OAB) Disorder: An Electronic Medical Record (EMR) Data Analysis

Non Discussion Poster Session 31 388 URINARY FLOW RATE OF ASSYMPTOMATIC MEN: DOES IT DECREASE WITH AGING?

Non Discussion Poster Session 31 389 Voiding dysfunction in women with relapsing neuromyelitis optica: clinical and urodynamic characterization

Podium Poster Session 6 Urodynamics and Imaging 39 The value of endovaginal and transperineal ultrasound in detecting anal sphincter defects

Non Discussion Poster Session 31 390 International Variation in Interpositional Graft use for Vesicovaginal Fistula Repair: a systematic review

Non Discussion Poster Session 31 391 Characterization of Colorectal Symptoms in Women With Vesicovaginal Fistulas in Jos, Nigeria

Non Discussion Poster Session 31 394 A pro-active approach towards older women with urinary incontinence who might profit from it

Non Discussion Poster Session 31 396 Transperineal 4D ultrasound imaging of the levator ani during labour.

Non Discussion Poster Session 31 399 3-Dimensional Evaluation of Levator Ani Muscle Morphology and Movement Using Rest And Dynamic Magnetic Resonance Imaging of The Pelvic Floor in Continent and Incontinent Women: a Proof-of-Concept Study

Podium Session 1 Female Stress Urinary Incontinence Surgery Stress incontinence surgery in the UK (1). Pre-operative work up and intra-operative complications. Analysis of the British Socciety of Urogynaecology database

Podium Poster Session 6 Urodynamics and Imaging 40 Voiding Efficiency: A New Method of Assessing Bladder Emptying Function in Women

Non Discussion Poster Session 31 400 Dynamic MRI confirms support of the mid-urethra by TVT and TVT-O surgery for stress incontinence

Non Discussion Poster Session 31 402 Reliability of three-dimensional ultrasound measurements of the levator ani hiatus using virtual reality

Non Discussion Poster Session 31 405 ANTERIOR COMPARTMENT BUT NOT POSTERIOR COMPARTMENT PROLAPSE IS ASSOCIATED WITH LEVATOR HIATUS AREA. A 3D/4D TRANSPERINEAL ULTRASOUND STUDY

Non Discussion Poster Session 31 407 Three-dimensional transperineal ultrasound imaging of the anal sphincter in nulliparous women.

Non Discussion Poster Session 31 411 Three-dimensional transperineal ultrasound imaging of anal sphincter after surgical primary repair.

Non Discussion Poster Session 31 412 Ultrasonographic scan timing in the evaluation of synthetic mesh in vaginal cystocele repair.

Non Discussion Poster Session 31 415 Female pelvic organ prolapse – value of dynamic MRI in decision about surgical technique

Non Discussion Poster Session 31 416 Reproducibility of colpo-cystodefecography and correlations to clinical examination

Non Discussion Poster Session 31 417 Negative results of three-dimensional ultrasound for assessment of voluntary pelvic floor muscle contraction

Non Discussion Poster Session 31 419 Assessment of elasticity of the urethra from cystourethroscopic video image.

Non Discussion Poster Session 31 420 Does the appearance of Miniarc sling on 2D ultrasound really matter?

Non Discussion Poster Session 31 422 Clinical and Urodynamic Results of Trans-Obturator Sling for Male Stress Urinary Incontinence Treatment: 6 months Follow-up.

Non Discussion Poster Session 31 423 LONG TERM OUTCOMES OF ARTIFICIAL URINARY SPHINCTER IN PATIENTS WITH HISTORY OF RADIATION THERAPY OR PREVIOUS URETHRAL SURGERY

Non Discussion Poster Session 31 425 MALE SLINGS: A COMPARATIVE STUDY OF TWO TECHNIQUES

Non Discussion Poster Session 31 427 LONG TERM FOLLOW-UP OF THE MALE REMEEX SYSTEM FOR THE SURGICAL TREATMENT OF MALE INCONTINENCE

Podium Poster Session 6 Urodynamics and Imaging 43 Utrasonographic scan evaluation of synthetic mesh used for vaginal cystocele repair comparing four arms trans obturator techniques to anterior bilateral sacro spinous ligament and arcus tendinous suspension.

Non Discussion Poster Session 31 432 Periurethral implantation of ProACT® device in treatment of stress incontinence (male). Single-center study about 79 consecutive patients and interest of bladder neck fibroscopy during procedure.

Non Discussion Poster Session 31 433 Anal Acoustic Reflectometry: a new clinically reliable method of assessing anal sphincter function in continent and incontinent subjects.

Non Discussion Poster Session 31 434 Assessing the anal sphincter with acoustic reflectometry:- a new reproducible method providing an improved physiological assessment of anal sphincter function.

Non Discussion Poster Session 31 435 Durable Improvement in Anal Canal Function Following Surgical Adjustment of External Anal Sphincter Sarcomere Length

Non Discussion Poster Session 31 438 A prophylactic constipation regimen prior to pelvic surgery: Interim analysis of a randomized controlled trial.

Non Discussion Poster Session 31 441 Predicting anal sphincter defects; the value of history, clinical examination and manometry

Non Discussion Poster Session 31 442 Storage symptoms of bladder and bowel and their correlation in anal continent, flatal incontinent and fecal incontinent women.

Non Discussion Poster Session 31 443 Ultrasound imaging of the posterior vaginal wall descent

Non Discussion Poster Session 31 447 The Influence of Androgen on bladder function and blood vessel ~If there is a change of Bladder Blood Flow~

Non Discussion Poster Session 31 450 Prostate Volume and Prostatitis: Effects on Lower Urinary Tract Symptoms

Non Discussion Poster Session 31 451 INTERRELATIONSHIP OF INTRAVESICAL PROSTATIC PROTRUSION AND OVERACTIVE BLADDER IN THE AGING MALE

Non Discussion Poster Session 31 452 CHANGES IN OVERACTIVE BLADDER SYMPTOMS AFTER WITHDRAWAL OF SOLIFENACIN FOLLOWING INITIAL 12-WEEK COMBINATION THERAPY WITH TAMSULOSIN: A MULTICENTER PROSPECTIVE STUDY IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND COEXISTING OVERACTIVE BLADDER

Non Discussion Poster Session 31 456 Correlation between the Overactive Bladder Symptoms (OAB) in Men and the Urodynamic (UD) Findings.

Podium Poster Session 6 Urodynamics and Imaging 46 Longitudinal changes in age dependent frequency-volume chart reference values for healthy males

Non Discussion Poster Session 31 462 Efficiency of trazodone in treatment of nocturia in men with BPH. Randomised, placebo-controlled study.

Non Discussion Poster Session 31 463 Does laparoscopic extraperitoneal inguinal hernioplasty impair postoperative voiding functions?

Non Discussion Poster Session 31 464 Tailoring Pharmacotherapy of Male Lower Urinary Tract Symptoms with a-Blockers, 5-a-Reductase Inhibitors, and Antimuscarinics

Non Discussion Poster Session 31 466 Correlation between the Overactive Bladder Symptoms (OAB) in female and the urodynamic (UDS) Findings.

Non Discussion Poster Session 31 467 Voiding and postmicturition symptoms in women with functional constipation.

Non Discussion Poster Session 31 469 REPERCUSSIONS FROM VULVECTOMY AND INGUINAL LYMPHADENECTOMY ON URINARY FUNCTION AND QUALITY OF LIFE IN WOMEN WITH VULVA CANCER.

Podium Poster Session 7 Meshes and Techniques 47 Weight of polypropylene mesh is not the only property defining in vivo mesh biomechanics.

Non Discussion Poster Session 31 472 A long-term prospective study to compare the effects of vaginal and abdominal hysterectomy on micturition and defecation

Non Discussion Poster Session 31 475 Lower urinary tract dysfunction after Radical Hysterectomy - the impact of adjuvant radiotherapy -

Non Discussion Poster Session 31 480 The long-term effectiveness and late sequelae of the Tension-free vaginal tape procedure for female urinary incontinence

Non Discussion Poster Session 31 481 Differential Diagnosis of Female Overactive Bladder

Non Discussion Poster Session 31 482 The influence of prolapse and pelvic floor reconstructive surgery on lower urinary tract symptoms.

Non Discussion Poster Session 31 484 MIDURETHRAL SYNTHETIC SLINGS IN WOMEN WITH STRESS INCONTINENCE AND SEVERE LOWER URINARY TRACT SYMPTOMS

Non Discussion Poster Session 31 485 Tension-free vaginal mesh improves lower urinary tract function for patients with pelvic organ prolapse- based on 282 cases in a single institution

Non Discussion Poster Session 31 487 IMPACT OF MID-URETHRAL SLINGS ON OAB SYMPTOMS

Podium Poster Session 7 Meshes and Techniques 49 Uniaxial Tensile Properties of Seven Vaginally Implanted Meshes for Pelvic Organ Prolapse

Non Discussion Poster Session 31 490 The Effect of Tolterodine Extended Release (ER) With or Without Tamsulosin HCl (0.2mg) on the Female Lower Urinary Tract Symptoms with Maximal Urinary Flow Rate Less Than 12ml/sec

Non Discussion Poster Session 31 491 Upregulation of connexion 43 expression and function in urinary bladder by inflammatory cytokines

Non Discussion Poster Session 31 492 Conditional Functional Electrical Stimulation for Urinary Incontinence

Non Discussion Poster Session 31 493 ANTIDIURETIC EFFECT OF ANTICHOLINERGIC AGENTS DEPEND ON C-FIBER AFFERENT NERVES IN THE BLADDER

Non Discussion Poster Session 31 494 Convergence of bladder and skin primary sensory neuron expressing TRPM8

Non Discussion Poster Session 31 495 The effects of particulate matter on the function of lower urinary tract in female rats

Podium Session 1 Female Stress Urinary Incontinence Surgery Mini-sling procedures in stress urinary incontinence: a systematic review of efficacy and complications

Podium Poster Session 7 Meshes and Techniques 50 Uniaxial Tensile Properties Prior to and After Resorption of a Partially Delayed Absorbable Mesh for Vaginal Repair of Pelvic Organ Prolapse

Non Discussion Poster Session 31 504 Platelet derived growth factor-mediated upregulation of connexin43 in bladder smooth muscle cells: a possible role in urinary bladder overactivity

Non Discussion Poster Session 31 507 C-fibers modulate release of mediators from the epithelium, and spontaneous contractions in the rat bladder

Non Discussion Poster Session 31 511 Mechanism of action of transcutaneous sacral nerve stimulation in spinal cord injured rodent model.

Non Discussion Poster Session 31 513 Transient receptor potential (TRP) channels in capsaicin sensitive afferent nerves of rat urinary bladder are targets for nitro-oleic acid.

Non Discussion Poster Session 31 518 Selective Activation of Pudendal Nerve by Skin Surface Electrodes to Inhibit Bladder Activity

Podium Poster Session 7 Meshes and Techniques 52 Incidence and risk factors for pelvic organ prolapse (POP) reoperation after previous repair: a nested case-control study

Non Discussion Poster Session 31 523 Intravesical instillation of botulinum toxin A (BTX-A) inhibited thoracic and lumbar C-fibre activity in high thoracic spinal cord injury rat model.

Non Discussion Poster Session 31 525 Morphological and histological alterations induced by PLGA (polyglycolic polylactic acid) scaffold seeded with autologous adiposed derived stem cells or muscle derived stem cells implanted in rabbit bladder wall

Non Discussion Poster Session 31 526 Comparison of intraabdominal and intravesical pressures in sitting and squatting positions.

Non Discussion Poster Session 31 528 CROSS SECTIONAL REVIEW OF EFFECT OF PERCUTANEOUS TIBIAL NERVE STIMULATION ON FECAL INCONTINENCE: RESULTS FROM TWO RECENT OVERACTIVE BLADDER TRIALS

Non Discussion Poster Session 31 530 5 Year Cost Analysis of Intra-detrusor Injection of Botulinum Toxin Type A and Augmentation Cystoplasty for Refractory Neurogenic Detrusor Overactivity.

Non Discussion Poster Session 31 531 Brain activity measured by functional magnetic resonance imaging (fMRI) during simulated episodes of urgency differs for those with a history of depression

Non Discussion Poster Session 31 536 Is there a relationship between voided volume and the urge to void?

Non Discussion Poster Session 31 542 Perineal surface electromyography to measure urethral and pelvic floor activity does not typically demonstrate expected relaxation during normal voiding

Non Discussion Poster Session 31 547 The Effect of Clean Intermittent Self-Catheterization on Serum Prostate-Specific Antigen Levels in Males with Voiding Dysfunction

Podium Poster Session 7 Meshes and Techniques 55 Optimizing post-operative healing following vaginal reconstructive surgery: A triple arm randomized clinical trial of an estradiol-releasing vaginal ring

Non Discussion Poster Session 31 558 UROLOGIC MANAGEMENT OF ADULT PATIENTS WITH NEUROGENIC BLADDER AND MYELOMENINGOCELE

Non Discussion Poster Session 31 559 Continent urinary diversion in women with spinal cord injury

Podium Poster Session 7 Meshes and Techniques 56 Trans-Vaginal Mesh Technique for treatment of pelvic organ prolapse: 5 years of prospective follow up

Non Discussion Poster Session 31 565 Long-Term Tolerability and Efficacy of Pentosan Polysulphate Sodium in the Treatment of Patients with Bladder Pain Syndrome (BPS).

Non Discussion Poster Session 31 567 Interstitial Cystitis Patients' Use and Rating of Complementary and Alternative Medicine Therapies

Non Discussion Poster Session 31 568 Honey Inhibits Mast Cell Degranulation: Implication for Management of Cystitis

Non Discussion Poster Session 31 574 New insight into the function of the striated urethral sphincter in men using a novel electromyography electrode during dynamic tasks

Non Discussion Poster Session 31 575 IMPACT OF THE GESTATION AND MODE OF BIRTH IN THE SYNERGY AMONG TRANSVERSUS ABDOMINIS/INTERNAL OBLIQUE MUSCLES AND PELVIC FLOOR: ELECTROMYOGRAPHIC EVALUATION.

Non Discussion Poster Session 31 576 Vaginel Mesh Extrusion Rates are only slightly influenced by vaginal bacterial colonisation

Non Discussion Poster Session 31 577 Changes in collagen content between different stages of anterior vaginal wall prolapse

Non Discussion Poster Session 31 579 Evaluation of pelvic floor displacements in prolapsed and non-prolapsed women using a novel technique based on a 3D computer model

Non Discussion Poster Session 31 586 Natural history of vaginal pessary use for pelvic organ prolapse: a 5 year prospective follow-up.

Non Discussion Poster Session 31 588 Comparative evaluation of isolated pelvic floor muscle contraction or associated with abdominal hypopressive technique through surface electromyography

Non Discussion Poster Session 31 589 CHANGES IN CLITORIAL BLOOD FLOW FOLLOWING SURGERY WITH TENSION-FREE VAGINAL MESH FOR PELVIC ORGAN PROLAPSE

Podium Poster Session 8 Female LUTS, Clinical and Basic Science 59 Urodynamic and clinical parameters in functional and anatomic female bladder outlet obstruction

Non Discussion Poster Session 31 592 POPQ Staging and Quality of Life in Women with Vaginal Prolapse

Non Discussion Poster Session 31 599 The effects of Botulinum neurotoxin-A on L-type and T-type voltage-gated calcium current in detrusor smooth muscles

Non Discussion Poster Session 31 600 Blood-brain barrier in aging: influence on the brain permeation of the anticholinergic OAB drug trospium chloride?

Non Discussion Poster Session 31 601 TAC-302, a novel neurite outgrowth enhancer, therapeutically improves lower urinary tact symptoms in rats with bladder outlet obstruction

Non Discussion Poster Session 31 602 Selective blockade of spinal P2X3 and P2X2/3 receptors with a novel and selective antagonist, AF-742, reveals central endogenous purinergic regulation of bladder activity

Non Discussion Poster Session 31 604 Examination of permeability and drug efflux transporter liabilities of a series of overactive bladder agents in a cell culture model of the blood-brain barrier.

Non Discussion Poster Session 31 605 INTRATHECAL ADMINISTRATION OF EP1 ANTAGONIST REDUCES BLADDER HYPERACTIVITY IN CYSTITIS MODEL RATS

Non Discussion Poster Session 31 608 In vivo bladder selectivity profile of imidafenacin, a novel antimuscarinic agent, assessed by bladder capacity-increasing activity as an effectiveness index in rats

Non Discussion Poster Session 31 612 Cyclophosphamide-induced cystitis in conscious female rats: development and pharmacological validation of an experimental model of referred visceral pain.

Non Discussion Poster Session 31 613 The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: A randomised double blind placebo controlled trial

Non Discussion Poster Session 31 614 Trospium Chloride-extended release (XR) 60 mg once daily has no effect on memory testing and is assay undetectable in the Central Nervous System of older patients with Overactive Bladder.

Non Discussion Poster Session 31 616 Interaction Between Placebo Response and Subjects’ Decision to Dose Escalate in a Trial of Flexible-Dose Antimuscarinic Treatment for Overactive Bladder Symptoms

Non Discussion Poster Session 31 618 The Pharmacologic Treatment of OAB: A systematic evidence review

Non Discussion Poster Session 31 620 Darifenacin effectively relieved overactive bladder symptoms as early as 6–8 days of initiating treatment

Non Discussion Poster Session 31 621 Does Fesoterodine Provide Efficacy, Tolerability, and Treatment Satisfaction? A Study of British Patients with the Overactive Bladder Syndrome

Non Discussion Poster Session 31 623 The Effect of Pregnancy and Parity on the Biomechanical Properties of Vaginal Tissue in the Rodent Model

Non Discussion Poster Session 31 624 Evaluation of the incision angle of mediolateral episiotomy at 60 degrees – a pilot study

Non Discussion Poster Session 31 625 Pelvic floor extensibility in parturients: a quantitative evaluation

Non Discussion Poster Session 31 627 Predicting stress urinary incontinence in primiparous women who underwent vaginal delivery using a classification tree approach.

Non Discussion Poster Session 31 628 Postnatal urinary incontinence and twin pregnancy

Non Discussion Poster Session 31 629 INCIDENCE OF THIRD AND FOURTH DEGREE OBSTETRIC TEARS: IMPACT OF A LEARNING PROGRAM ON DIAGNOSIS AND MODE OF DELIVERY.

Non Discussion Poster Session 31 630 Risk factors in prolonged postpartum retention, number or constellation?

Non Discussion Poster Session 31 631 The Pre-Operative Factors Which May Influence Post-Operative Quality of Life in Stress Incontinent Women

Non Discussion Poster Session 31 632 Incontinence quality of life instrument (I-QOL): translation and validation study of the Iranian version

Non Discussion Poster Session 31 634 Oral Desmopressin in the Treatment of Nocturia in an Aging Population

Non Discussion Poster Session 31 635 Validation of the Patient Global Impression of Change (PGIC) in a Patient Population following Vaginal Prolapse Repair with Mesh

Non Discussion Poster Session 31 637 Pad test or VLPP in women with SUI: which is better correlated with quality of Life questionnaries

Non Discussion Poster Session 31 639 The Influence of Obesity on the Patients with Stress Urinary Incontinence: Aspect of Clinical Characteristics, Quality of Life and Surgical Outcomes

Non Discussion Poster Session 31 642 Differences in prevalence of nocturia and impact on quality of life in a deprived and affluent community sample in Scotland.

Non Discussion Poster Session 31 644 Factors affecting quality of life in patients under clean intermittent catheterization

Non Discussion Poster Session 31 645 Negative impact of pelvic floor symptoms following cervical cancer treatment is predominantly related to the patient’s psychosocial status

Non Discussion Poster Session 31 647 Subjective and objective assessment of the status of quality of life before and after surgery using mesh implants

Podium Poster Session 8 Female LUTS, Clinical and Basic Science 65 A SINGLE CENTER, PROSPECTIVE, RANDOMIZED STUDY TO EVALUATE THE EFFECT OF REPEAT INTRADETRUSOR INJECTIONS OF BOTULINUM TOXIN-A FOR REFRACTORY IDIOPATHIC OVERACTIVE BLADDER PATIENTS: DOSE DIFFERENCE BETWEEN 100U VS 150U.

Non Discussion Poster Session 31 653 Does it exist a syndrome score cut off on the PFDI allowing a significant improvement of post operative functional results ?

Non Discussion Poster Session 31 657 APPLICATION OF INTERNATIONAL CONSULTATION ON INCONTINENCE QUESTIONNAIRE: SHORT FORM IN GYNECOLOGICAL PRACTICE

Non Discussion Poster Session 31 658 Diagnosis of Cystocele type by POP-Q and pelvic floor ultrasound

Non Discussion Poster Session 31 659 Vaginal prolapse surgery with synthetic mesh augmentation in the UK: analysis of the British Society of Urogynaecologists’ (BSUG) database

Non Discussion Poster Session 31 661 Vaginal Mesh Registry - Results of the Austrian Urogynecology Working Group

Non Discussion Poster Session 31 662 Is vaginal surgery using mesh a valid option in women with recurrent anterior vaginal wall prolapse after abdominal sacrocolpopexy?

Non Discussion Poster Session 31 665 Presentation and Management of Iatrogenic Foreign Bodies of the Lower Urinary Tract Following Pelvic Surgery

Non Discussion Poster Session 31 666 Retrospective review of mesh erosion associated with transvaginal mesh prolapse repair in a community setting.

Non Discussion Poster Session 31 669 A comparison of vaginal sacrospinous fixation and abdominal sacrocolpopexy for vaginal vault prolapse repair in the UK: an analysis of the British Society of Urogynaecologists’ (BSUG) database

Podium Poster Session 8 Female LUTS, Clinical and Basic Science 67 Superior Efficacy of Fesoterodine Over Tolterodine with Rapid Onset: A Prospective, Head-to-Head, Placebo-Controlled Trial

Non Discussion Poster Session 31 670 SELF-REPORTED EXPERIENCES OF RECURRENT PROLAPSE

Non Discussion Poster Session 31 673 Surgical management of enterocele in women: the abdominal or transvaginal approach?

Non Discussion Poster Session 31 675 A RANDOMISED CONTROLLED STUDY OF PATIENT-CONTROLLED SEDATION WITH PROPOFOL ONLY OR PROPOFOL AND ALFENTANIL IN OUTPATIENT UROGYNECOLOGICAL SURGERY-THE SURGEONS´ VIEW.

Non Discussion Poster Session 31 676 A light-weight, partially resorbable mesh for severe pelvic organ prolapse: 1 year anatomical and functional results

Non Discussion Poster Session 31 677 Abdominal Sacral Hysteropexy: Clinical outcomes compared to abdominal sacral colpopexy with concurrent hysterectomy.

Non Discussion Poster Session 31 678 Evaluation of a polypropylene mesh coated with antibiotics in an infectious model of vaginal surgery in rabbits.

Non Discussion Poster Session 31 679 Primary and Re-do Posterior Repair surgery in the UK: analyses of the British Society of Urogynaecologists (BSUG) database.

Podium Poster Session 8 Female LUTS, Clinical and Basic Science 68 Effectiveness of non-surgical interventions for women with stress urinary incontinence: systematic review and meta-analysis of randomised controlled trials

Non Discussion Poster Session 31 680 Analysis of recurrent cases after surgery for pelvic organ prolapse during 5 years

Non Discussion Poster Session 31 681 Laparoscopic sacrocolpopexy: a prospective study evaluating anatomical and functional outcomes.

Non Discussion Poster Session 31 682 Evaluation of force required to replace two different, trocar-less pelvic floor repair kit mesh legs from the sacrospious ligaments in a cadaver model.

Non Discussion Poster Session 31 683 Transvaginal Repair of Failed Abdominal Sacral Colpopexy Utilizing Graft.

Non Discussion Poster Session 31 684 ROBOTIC-ASSISTED ABDOMINAL SACROCOLPOPEXY/SACROHYSTEROPEXY (RASC) – A VIABLE ALTERNATIVE FOR PELVIC ORGAN PROLAPSE REPAIR?

Non Discussion Poster Session 31 685 Anterior Prolift Like (PL) surgery: Can provoke pelvic organ prolapse (POP) in unaffected posterior compartment?

Non Discussion Poster Session 31 687 Anterior Compartment Prolapse: Short Term Results and Quality of Life in Women Randomised to Mesh or Traditional Repair

Non Discussion Poster Session 31 689 CAN MESH EXPOSURE RATES BE REDUCED IN ANTERIOR PROLAPSE REPAIR?

Non Discussion Poster Session 31 690 Excretion of Colored Urine After Intravenous Injection of Indigo Carmine Dye

Non Discussion Poster Session 31 692 Hysterectomy vs no hysterectomy for uterine prolapse in conjunction with posterior infracococcygeal colpopexy- a randomised pilot study 12 months review

Non Discussion Poster Session 31 694 Prolapse cystocele surgical repair with site-specific correction reinforced with soft vaginal tension-free polypropylene mesh compared with trocar-guided soft tension free polypropylene mesh without site-specific correction.

Non Discussion Poster Session 31 695 Mesh implants in pelvic organ prolapse surgery: prospective study - one year follow-up

Non Discussion Poster Session 31 698 Does vaginal surgery alter the relationship between prolapse and prolapse symptoms?

Non Discussion Poster Session 31 699 Knot Integrity as a Function of Suture Expiration Date

Non Discussion Poster Session 31 700 Labhardt`s Colpoperineocleisis: Optimal vaginal occlusive surgical alternative in patients with high surgical risk and with no sexual activity

Non Discussion Poster Session 31 701 Avaulta Polypropylene Mesh for Repair of Recurrent Pelvic Organ Prolapse: a Prospective Follow up Study of Objective and Subjective Outcomes

Non Discussion Poster Session 31 703 Medium-term functional results of laparoscopic sacrocolpopexy. A retrospective, unicentric study of 81 cases

Non Discussion Poster Session 31 704 Transvaginal genital prolapse repair with tension free vaginal tape: a case series multicentric study with Prolift mesh.

Non Discussion Poster Session 31 705 Trans vaginal mesh : Argentine Experience over 220 consecutives cases.

Non Discussion Poster Session 31 706 Use of bovine pericardium in pelvic reconstructive surgery

Non Discussion Poster Session 31 708 The use of Avaulta Plus? for anterior repair. A multicenter randomised prospective controlled study.

Non Discussion Poster Session 31 710 Ideal stabilization of in vitro engineered urothelium with fibrin glue

Non Discussion Poster Session 31 712 Surgically-Corrected Urethral Diverticula: Long-term Voiding Dysfunction and Reoperation Rates

Non Discussion Poster Session 31 717 Simple Cystectomy: Outcomes of a New Operative Technique

Non Discussion Poster Session 31 719 Micturition Disorders amongst elderly stroke patients undergoing rehabilitation and its effect on the outcome of rehabilitation

Podium Poster Session 9 Male LUTS, Clinical and Basic Science 72 The Influence of castration on bladder blood flow and function during rapid phase of androgen deprivation

Non Discussion Poster Session 31 720 The normative value of the 24 hour pad-test adopted by the ICS is not valid for Brazilian women.

Non Discussion Poster Session 31 721 Effect of Colpexin Sphere on Pelvic Floor Muscle Strength in Women with Pelvic Organ Prolapse: A Randomized Controlled Trial

Non Discussion Poster Session 31 723 Transurethral injections for stress incontinence: Can we predict response and likelihood of repeat treatments?

Non Discussion Poster Session 31 724 Factors predictive of response to biofeedback assisted pelvic floor muscle training for urinary incontinence

Non Discussion Poster Session 31 725 Pessary for pelvic organ prolapse: quality of life, compliance and failure at one year follow up

Non Discussion Poster Session 31 726 PELVIC FLOOR MUSCLE REHABILITATION FOR FEMALE URINARY INCONTINENCE: A 6-YEARS EXPERIENCE, EVALUATING THE OUTOCOMES AND THE PARAMETERS BEFORE THE TREATMENT

Non Discussion Poster Session 31 728 Clinical efficacy of extracorporeal magnetic innervation versus pelvic floor muscle training with biofeedback for the treatment of stress urinary incontinence in women.

Non Discussion Poster Session 31 730 An Examination of Isometric Hip Muscle Strength in Women With and Without Stress Urinary Incontinence: a Case-Control Study

Non Discussion Poster Session 31 731 VAGINAL WEIGHT CONES IN THE MANAGEMENT OF OVERACTIVE BLADDER SYNDROME: THE EFFECT ON QUALITATIVE AND URODYNAMIC MEASURES

Non Discussion Poster Session 31 732 Evaluation of sexual satisfaction in women suffering from chronic pelvic pain with or without endometriosis

Non Discussion Poster Session 31 733 Creation of a neovagina by dividing labiae minorae in Rokitanski syndrome. Functionnal results at 5 years follow-up

Non Discussion Poster Session 31 735 VAGINAL SURGERY: REPERCUSSION IN FEMALE SEXUAL FUNCTION IN DECADES OF AGE.

Non Discussion Poster Session 31 736 VAGINAL SURGERY: REPERCUSSION IN FEMALE SEXUAL FUNCTION

Non Discussion Poster Session 31 737 Treatment of stress urinary incontinence (SUI) with T-Sling and correction of cystocele associated with SUI through Uromesh Tension-free slings with central absorbable portion by transobturator access (TO)

Non Discussion Poster Session 31 738 The durability of efficacy of the TVT-SECUR procedure for treatment of female stress urinary incontinence: two-year follow-up

Podium Poster Session 9 Male LUTS, Clinical and Basic Science 74 ANALYSIS OF BLADDER BLOOD FLOW BEFORE AND AFTER PROSTATIC SURGERY IN PATIENTS WITH BPH

Non Discussion Poster Session 31 740 Complications of synthetic suburethral slings in 103 women leading to revision or removal.

Non Discussion Poster Session 31 741 Preoperative Risk Factors of failure after Mid-Urethral Sling Operation for Treating Women with Mixed Incontinence

Non Discussion Poster Session 31 743 TRAINING FUTURE UROGYNAECOLOGISTS- IS SURGICAL EXPERIENCE ADEQUATE? AN ANALYSIS OF THE BRITISH SOCIETY OF UROGYNAECOLOGY (BSUG) DATABASE.

Non Discussion Poster Session 31 745 Tension-free vaginal tape versus transobturator tape: tightening of the strings?

Non Discussion Poster Session 31 749 Continence, Satisfaction and Repeat Procedures after Urethrolysis

Podium Poster Session 9 Male LUTS, Clinical and Basic Science 75 Improvement of sleep and QoL in patients with LUTS/BPH and predominant nocturia following treatment with Desmopressin.

Non Discussion Poster Session 31 752 The shortening of pre-implanted tape mesh for treatment of persistent or recurrent stress urinary incontinence after TVT-Secur with over one year follow-up; is it effective?

Non Discussion Poster Session 31 753 A paradigm shift in surgical treatment of urinary incontinence in Denmark from 2001 to 2008

Non Discussion Poster Session 31 754 SURGICAL TREATMENT OF STRESS URINARY INCONTINENCE IN WOMEN WITH A SINGLE INCISION TOT TECHNIQUE. THREE YEARS FOLLOW UP.

Non Discussion Poster Session 31 757 Treatment of stress urinary incontinence in women with intraurethral injections of a polyacrylamide hydrogel (Bulkamid®): a one year follow-up study

Non Discussion Poster Session 31 759 TVT like solution in failed obturator route slings in women with recurrent or persistent stress urinary incontinence without removal of the TOT tape.

Non Discussion Poster Session 31 763 Management of vaginal mesh erosion following the tension free vaginal tape procedure: five years experience at a UK tertiary referral centre

Non Discussion Poster Session 31 765 THE USE OF THREE TYPES OF SYNTEHTIC MESH MATERIALS IN THE SURGERY FOR STRESS INCONTINENCE: THE CLINICAL RESULTS

Non Discussion Poster Session 31 767 A Multi Centre Prospective Cohort study of Single Incision Transobturator Tape (SI-TOT) for the treatment of Stress Urinary Incontinence (SUI) under local anaesthesia

Non Discussion Poster Session 31 768 RANDOMISED TRIAL OF OPHIRA MINI-SLING SYSTEM AND UNITAPE FOR THE TREATMENT OF STRESS INCONTINENCE IN WOMEN. FIRST EXPERIENCES AFTER A FOLLOW-UP OF 6 MONTHS

Non Discussion Poster Session 31 769 Stress incontinence surgery in the UK (2). Post surgery success, follow-up and complications. Analysis of the British Society of Urogynaecology database

Non Discussion Poster Session 31 770 COST COMPARISON OF THE LAPAROSCOPIC BURCH COLPOSUSPENSION, LAPAROSCOPIC TWO-TEAM SLING AND THE TRANS-OBTURATOR TAPE PROCEDURE FOR THE TREATMENT OF STRESS URINARY INCONTINENCE

Non Discussion Poster Session 31 773 Intraoperative MUCP measurement : a new techinique of tape tension adjustment in TOT surgery?

Non Discussion Poster Session 31 775 Ajust single incision transobturator sling procedure for stress urinary incontinence in women: one year results

Non Discussion Poster Session 31 777 CLINICAL OUTCOMES IN PATIENTS UNDERGOING TVT-SECURTM FOR STRESS URINARY INCONTINENCE: AN UPDATE

Non Discussion Poster Session 31 781 AjustTM fully adjustable single incision sling for the treatment of stress urinary incontinence: 1 Year follow-up on a new minimal-invasive treatment for female SUI

Non Discussion Poster Session 31 782 AJUST™: RESULTS FROM OUR PROSPECTIVE STUDY

Non Discussion Poster Session 31 783 Six hundred meshes under the urethra in the urinary incontinence surgical treatment with three generations of sub-mid urethral tapes: comparing results.

Non Discussion Poster Session 31 785 Tape position in patients with recurrent urinary incontinence after failed suburethral slings

Non Discussion Poster Session 31 786 The use of pubovesical sling during radical retropubic prostatectomy with regulation of its tension after the operation

Non Discussion Poster Session 31 789 Is mesh shortening effective in failed midurethral sling procedures for female stress urinary incontinence ?

Podium Poster Session 9 Male LUTS, Clinical and Basic Science 79 Rate and predictive factors of the anticholinergic add-on therapy in men with residual overactive bladder symptom after 4 weeks of alpha-blocker monotherapy

Non Discussion Poster Session 31 790 Predictive factors for acute urinary retention after transobturator tape (TOT) procedure for female stress urinary incontinence

Non Discussion Poster Session 31 791 Single incision tension-free vaginal tape (TVT-Secur®) in the treatment of female stress urinary incontinence

Non Discussion Poster Session 31 792 Mean Five-Year Follow-up of the Tension-Free Vaginal Tape Procedure for Treatment of Urinary Incontinence

Non Discussion Poster Session 31 793 Post TVT-O, Is thigh pain truly a problem? Incidental Observation

Non Discussion Poster Session 31 794 VOIDING PATTERN AFTER ‘U-METHOD’ TVT-SECUR: IS IT OBSTRUCTIVE?

Non Discussion Poster Session 31 795 Is there a role for routine preoperative clean intermittent self-catheterization (CISC) training to patients prior to mid-urethral tape insertion?

Non Discussion Poster Session 31 796 EVALUATION OF BLADDER OUTLET OBSTRUCTION AFTER A PUBOVAGINAL SLING PROCEDURE

Non Discussion Poster Session 31 797 The Effects of the REMEEX System® for Treatment of Re-do Urinary Incontinence and Intrinsic Sphincteric Deficiency

Non Discussion Poster Session 31 798 Short Term Outcome of a New Surgical Treatment for Female Stress Incontinence with Ajust - Adjustable Single-Incision Sling

Non Discussion Poster Session 31 799 Effectiveness of transvaginal mesh release for management of complications after midurethral sling surgery

Podium Session 2 Basic Science MORPHOLOGIC AND METABOLIC ASSESSMENT OF ANTERIOR VAGINAL WALL AT DIFFERENT STAGES OF PELVIC ORGAN PROLAPSE

Non Discussion Poster Session 31 801 PUBOVAGINAL SLING PROCEDURE AND BLADDER OUTLET OBSTRUCTION IN WOMEN WITH ANTERIOR COMPARTMENT PELVIC ORGAN PROLAPSE

Non Discussion Poster Session 31 802 Functional results of Adjustable Continence Therapy ® in women and a new way for balloon positioning

Non Discussion Poster Session 31 806 One-year Surgical Outcomes and Quality of Life in Minimally Invasive Slings for the Treatment of Female Stress Urinary Incontinence: TVT SECUR® vs. CureMesh®

Non Discussion Poster Session 31 807 SPARC outcome based on body mass index

Non Discussion Poster Session 31 809 Readjustable Sling Procedures for Treatment of in Female Stress Urinary Incontinence with Intrinsic Sphincter Deficiency

Non Discussion Poster Session 31 816 Urodynamic Findings In Patients with Insensible Incontinence

Non Discussion Poster Session 31 820 Training Community Gynecologic Surgeons to Perform Intraoperative Cystoscopy: A Competency Based Training Experience

Non Discussion Poster Session 31 822 NON INVSIVE TRANSPERITONEAL URODYNAMIC TECHNIQUE USING DOPPLER ULTRASONOGRAPHY FOR EVALUATION OF BLADDER OUTLET OBSTRUCTION

Non Discussion Poster Session 31 823 Are symptoms of pelvic organ prolaspe more common amongst women who have undergone TRAM flap procedures compared to a control population? A case control study

Non Discussion Poster Session 31 824 Fibulin-3 expression in vaginal walls of women with pelvic organ prolapse

Non Discussion Poster Session 31 827 DOES SEXUAL FUNCTION CHANGE AFTER TENSION-FREE VAGINAL MESH PROCEDURE FOR PELVIC ORGAN PROLAPSE? : A MULTICENTERE PROSPECTIVE STUDY IN JAPAN

Non Discussion Poster Session 31 828 Does neuromuscular blockade affect the assessment of pelvic organ prolapse?

Non Discussion Poster Session 31 829 Correlation of in vivo biomechanical properties of the vaginal wall and clinical severity scores in patients with and without previous prolapse surgery

Podium Poster Session 10 Miscellaneous I 83 Prevalence study of stress urinary incontinence among women on high impact regular exercises

Non Discussion Poster Session 31 833 Biomechanical properties of pelvic ligaments

Non Discussion Poster Session 31 835 Influence of pelvic organ prolapse and prior hysterectomy on symptoms in women presenting to a urogynecology clinic at a tertiary care hospital

Non Discussion Poster Session 31 836 A prospective observational study to evaluate the effect of prolapse repair on voiding and the relationship to the overactive bladder syndrome

Non Discussion Poster Session 31 837 PELVIC ORGAN PROLAPSE AND CONCOMITANT STRESS URINARY INCONTINENCE: RESULTS OF SURGICAL TREATMENT

Non Discussion Poster Session 31 838 Feasibility and correlation of in vivo measurement of vaginal biomechanical properties using a purpose designed vaginal probe

Non Discussion Poster Session 31 840 CLINIC STUDY OF COPOCLEISIS FOR ADVANCED PELVIC ORGAN PROLAPSE IN SELECTED PATIENTS

Non Discussion Video Session 32 Non-Discussion Videos 841 Robotic-assisted sacrocolpopexy for the management of vaginal vault prolapse

Non Discussion Video Session 32 Non-Discussion Videos 843 Sacrospinous-suspended Urogenital Pelvic PrOlapse and RecTopexy (SUPPORT) Procedure

Non Discussion Video Session 32 Non-Discussion Videos 844 Ureter and Pelvic Sidewall Structures Relevant to Laparoscopic Hysterectomy

Non Discussion Video Session 32 Non-Discussion Videos 845 Steroid Injection for Hunner's Ulcer Interstitial Cystitis

Non Discussion Video Session 32 Non-Discussion Videos 847 Operative Vaginoscopy for the Management of Mesh Exposures

Non Discussion Video Session 32 Non-Discussion Videos 849 Laparoscopic Removal of Urachal Remnant in an Adult

Non Discussion Video Session 32 Non-Discussion Videos 850 Combined laparoscopic and cystoscopic excision of endometriosis involving the bladder

Non Discussion Video Session 32 Non-Discussion Videos 852 Laparoscopic enterocele repair and sacral rectopexy for bowel dysfunction.

Non Discussion Video Session 32 Non-Discussion Videos 853 Simplified management of anterior vaginal wall mesh exposure

Non Discussion Video Session 32 Non-Discussion Videos 854 Transvaginal repair of vault prolapse with full length mesh at low cost

Non Discussion Video Session 32 Non-Discussion Videos 855 Novel Knotless Sacrocolpopexy technique

Non Discussion Video Session 32 Non-Discussion Videos 857 Pelvis 3D

Non Discussion Video Session 32 Non-Discussion Videos 859 Knotless Technique for Laparoscopic Sacrocervical Colpopexy

Podium Poster Session 10 Miscellaneous I 86 IS A CONCOMITANT ANTERIOR REPAIR ALWAYS NECESARY IN PATIENTS UNDERGOING VAGINAL APICAL REPAIR SURGERY

Non Discussion Video Session 32 Non-Discussion Videos 861 Use of a resectoscope with saline irrigation during a transperineal pudendal nerve decompression

Non Discussion Video Session 32 Non-Discussion Videos 863 LAPAROSCOPIC VAGINECTOMY: SHOWING THE NORMAL FEMALE PELVIC ANATOMY

Non Discussion Video Session 32 Non-Discussion Videos 866 Laparosocpic presacral colposuspension of vault prolapse after vaginal total hysterectomy using Gynemesh thru right pelvic peritoneal tunnel: Permanent suspension

Non Discussion Video Session 32 Non-Discussion Videos 867 Dr. Son’s point: A Cystoscopic Landmark for Endoscopic Prostate Surgery

Non Discussion Video Session 32 Non-Discussion Videos 868 A New Procedure for Pelvic Floor Reconstruction with an Additional Apical Fixation of the Vagina (SureLIFT System)

Non Discussion Video Session 32 Non-Discussion Videos 869 Implantation of Avaulta Plus in patients with anterior vaginal wall prolapse

Non Discussion Video Session 32 Non-Discussion Videos 870 Removal of multiple vaginal mesh erosions after an anterior and posterior vaginal mesh placement

Non Discussion Video Session 32 Non-Discussion Videos 871 Case Report: Postpartum Traumatic Rectal Tear after Normal Vaginal Delivery with an Intact Anal sphincter.

Non Discussion Video Session 32 Non-Discussion Videos 872 Penetration Depth as a Solution to the Optimal Treatment of Benign Prostatic Hyperplasia (BPH): Significant Improvements in Patient Outcome Using Multi-disciplinary Laser DIOLAS LFD 3000

Non Discussion Video Session 32 Non-Discussion Videos 873 Trans-vaginal colposacropexy: Description of a novel method.

Non Discussion Video Session 32 Non-Discussion Videos 874 LSC Hysterosacropexy – Level I suspension, keep it safe and simple

Non Discussion Abstract Session 33 Read by Title 877 Urinary Tract Injuries during Obstetrics and Gynecological Surgical Procedures at Aga Khan University Hospital Karachi, Pakistan. (A 20 Year Review)

Non Discussion Abstract Session 33 Read by Title 879 Effect of Dutasteride on bladder wall hypetrophy in patients with benign prostatic obstruction : a 24-week open-label, single-arm pilot study

Non Discussion Abstract Session 33 Read by Title 880 Early treatment with anticholinergic medication due to persistent storage symptoms following laser prostatectomy: Comparison between potassium-titanyl-phosphate photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP)

Non Discussion Abstract Session 33 Read by Title 881 Significant improvements of LUTS (Lower Urinary Tract Symptoms) after the treatment of BPH (Benign Prostatic Hyperplasia) using the LFD (Leveled Field Density) Therapy

Non Discussion Abstract Session 33 Read by Title 882 Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms

Non Discussion Abstract Session 33 Read by Title 883 The clinical significance of bladder contractility index in treating BPH

Non Discussion Abstract Session 33 Read by Title 885 COMPARISON OF DIFFERENT DOSES OF NAFTOPIDIL FOR OVERACTIVE BLADDER ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA: A PROSPECTIVE, RANDOMAIZED CONTROLLED STUDY.

Non Discussion Abstract Session 33 Read by Title 887 A COMPARATIVE STUDY ON THE CLINICAL EFFECTS OF SILODOSIN AND NAFTOPIDIL IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

Podium Poster Session 10 Miscellaneous I 89 Prospective evaluation of surgical outcomes of robotic-assisted colpo- and cervicosacropexy for the management of apical pelvic support defects

Non Discussion Abstract Session 33 Read by Title 892 Acupuncture for women with refractive Overactive Bladder Syndrome in a resource limited setting.

Non Discussion Abstract Session 33 Read by Title 894 An open label pilot study investigating the safety and efficacy of Botox® in 20 female patients with refractory symptoms of high urinary voiding frequency without incontinence

Non Discussion Abstract Session 33 Read by Title 895 Timing of repeat Botulinum Toxin A Injections for Detrusor Overactivity: Patients’ perspective

Non Discussion Abstract Session 33 Read by Title 899 Measurement of the thickness of the urethrovaginal space in women with mixed urinary incontinence; a preliminary study

Podium Poster Session 10 Miscellaneous I 90 Prospective-Randomized Study Comparing High Uterosacral Vault Suspension vs. Abdominal Sacrocolpopexy for the Repair of Apical Defects and Vaginal Vault Prolapse.

Non Discussion Abstract Session 33 Read by Title 900 VALIDATED OUTCOME AND URODYNAMIC MEASURES FOR THE TREATMENT OF DO WITH INTRAVESICAL INJECTIONS OF BOTULINUM TOXIN A.

Non Discussion Abstract Session 33 Read by Title 902 Posterior Tibial Nerve Stimulation for the Treatment of Overactive Bladder in Men: Quality of life questionnaire (I-QoL), Overactive Bladder Symptoms questionnaires (OAB-q), International Prostatic Symptoms Score (IPSS), and 3 days bladder diary evaluation.

Non Discussion Abstract Session 33 Read by Title 903 CARDIOVASCULAR RISK FACTORS AND DISEASE IN WOMEN WITH OVERACTIVE BLADDER VS STRESS INCONTINENCE CONTROLS

Non Discussion Abstract Session 33 Read by Title 904 Epidemiology of female urinary incontinence and its impact on quality of life in a cluster populatiop in United Kingdom

Non Discussion Abstract Session 33 Read by Title 905 CARDIOVASCULAR RISK FACTORS AND DISEASE IN WOMEN WITH OVERACTIVE BLADDER “WET” VS “DRY”

Non Discussion Abstract Session 33 Read by Title 908 The prevalence of benign prostatic hyperplasia in elderly men in Korea: A community-based study

Non Discussion Abstract Session 33 Read by Title 909 Not Just the Bladder- everyone is an unreliable witness!

Podium Poster Session 10 Miscellaneous I 91 Primary Obstetric Fistula in Niamey, Niger: Surgical Outcomes in 305 patients

Non Discussion Abstract Session 33 Read by Title 911 Factoring values into outcomes evaluation

Non Discussion Abstract Session 33 Read by Title 912 Nocturia, Age, Body Mass Index and treatment of Women with Urinary Incontinence

Non Discussion Abstract Session 33 Read by Title 914 Pelvic reconstructive surgery in octogenarians

Non Discussion Abstract Session 33 Read by Title 915 The availability and access to new technologies and procedures for female patients with pelvic floor prolapse and stress urinary incontinence by gynecologists, urogynecologists and urologists

Non Discussion Abstract Session 33 Read by Title 916 Prevalence of urinary symptoms in women with chronic pelvic pain

Non Discussion Abstract Session 33 Read by Title 917 SEARCH OF MEDICAL CARE BY CLIMACTERIC NORTHEASTERN BRAZILIAN WOMEN WITH STRESS URINARY INCONTINENCE

Podium Poster Session 10 Miscellaneous I 92 Relaxin and gonadal steroid receptors in uterosacral ligaments of women with and without pelvic organ prolapse

Non Discussion Abstract Session 33 Read by Title 920 Prevalence of urinary incontinence after Delivery and its Relation to the Mode of Delivery

Non Discussion Abstract Session 33 Read by Title 923 Uro-vaginal Fistulae in Urologic practice

Non Discussion Abstract Session 33 Read by Title 925 THE UROLOGIC COMPLICATIONS AFTER ROBOTIC GYNAECOLOGIC SURGERIES: THE EXPERIENCE OF A TERTIARY CARE FACILITY

Podium Poster Session 10 Miscellaneous I 93 Surgical management of apical pelvic support defects: Evaluation of the introduction of robotic technology

Non Discussion Abstract Session 33 Read by Title 931 Ultrasound assessment 6 months following vaginal prolapse surgery using polypropylene implants and a vaginal support device

Non Discussion Abstract Session 33 Read by Title 933 Preoperative pelvic floor ultrasound measurements are not different between patients with and without de novo recurrence of an anterior repair – a retrospective study

Non Discussion Abstract Session 33 Read by Title 934 Is there a difference in bladder wall thickness between continent and women with stress urinary incontinence or overactive bladder ?

Non Discussion Abstract Session 33 Read by Title 935 Is there a role for a flexible cystoscopy service in a urogynaecology setting?

Non Discussion Abstract Session 33 Read by Title 937 THE NATIONAL UROLOGY RESIDENT PRECEPTORSHIP PROGRAM IN FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY: A 5-YEAR TREND IN EXPOSURE OF THIS FIELD DURING UROLOGY RESIDENCY IN THE UNITED STATES AND CANADA

Non Discussion Abstract Session 33 Read by Title 938 Sonographic assessment of urethral length and its correlation with age and other anthropometric factors

Podium Poster Session 10 Miscellaneous I 94 Prescribing antimuscarinics for overactive bladder; how many chances do we have to get it right?

Non Discussion Abstract Session 33 Read by Title 943 Indigo carmin test to verify the ureteral indemnity after McCall culdoplasty in the prevention of prolapse after hysterectomy.

Non Discussion Abstract Session 33 Read by Title 945 A new ultrasound technique of the pelvic floor to assist in site specific repair selection and mesh complication management

Non Discussion Abstract Session 33 Read by Title 946 PELVIC DYSFUNCTION PATIENTS INSPECTION METHODS

Non Discussion Abstract Session 33 Read by Title 948 Obstetric Anal Sphincter Injury in HIV-positive and HIV-negative patients: prospective cohort study of healing and functional outcomes.

Non Discussion Abstract Session 33 Read by Title 952 The Role of Alpha 1(A) Adrenoceptor Antagonist Tamsulosin for the Treatment of Patients with Benign Prostatic Hyperplasia: The Effect of Nocturia and Sleep Quality

Non Discussion Abstract Session 33 Read by Title 954 The effect of anticholinergics to benign prostatic hyperplasia patients with overactive bladder symptoms and the risk factors to affect patient’s satisfaction

Non Discussion Abstract Session 33 Read by Title 958 Lower tract urinary symptoms in patients with uterine myomas

Non Discussion Abstract Session 33 Read by Title 959 Mid-term recurrence rate and re-treatment in female patients with overactive bladder symptoms

Podium Session 11 Surgery Pelvic Organ Prolapse 96 A Randomized controlled trial of anterior colporraphy and Perigee™ as a primary surgical correction of symptomatic cystocele.

Non Discussion Abstract Session 33 Read by Title 961 A Pilot Study of Urinary symptoms in Ex-ketamine Users

Non Discussion Abstract Session 33 Read by Title 962 Urodynamic analysis of voiding symptoms in female patients

Non Discussion Abstract Session 33 Read by Title 963 Questionnaire: Female genital circumcision (FGC)

Non Discussion Abstract Session 33 Read by Title 964 Relationship between patient-reported symptom grades and urodynamic parameters in assessing incontinence severity of female stress urinary incontinence

Non Discussion Abstract Session 33 Read by Title 965 TIME TO LOOK BEYOND URETHRAL DILATATION FOR FEMALE URETHRAL STENOSIS

Non Discussion Abstract Session 33 Read by Title 966 The changes of overactive bladder symptoms after mid-urethral sling surgery in patients with stress urinary incontinence plus overactive bladder symptoms : long-term results

Non Discussion Abstract Session 33 Read by Title 969 The reality research destination of incontinence of urine of healthy women where they were collected in health education of incontinence of urine

Non Discussion Abstract Session 33 Read by Title 971 Peri-urethral Electromyography Recorded by Using the Stimulating Electrode of an Implantable Stimulation Device (Accessa™) in Rats

Non Discussion Abstract Session 33 Read by Title 972 Afferent nerve distribution in the bladder wall of young mice.

Non Discussion Abstract Session 33 Read by Title 973 Intra-Detrusor Botulinum Neuro-Toxin A Injection Prevents Rat Bladder Fibrosis Secondary to Bladder Outlet Obstruction

Podium Session 11 Surgery Pelvic Organ Prolapse 98 Should we pack it in? A prospective randomised double blind study assessing the effect of vaginal packing in pelvic floor surgery

Non Discussion Abstract Session 33 Read by Title 987 A new experimental model for inducing interstitial cystitis by oxidative stress using bladder instillation of a nitric oxide donor gel

Non Discussion Abstract Session 33 Read by Title 989 PREVALENCE OF OVERACTIVE BLADDER SYNDROME IN A COHORT OF SPANISH PATIENTS SUFFERING FROM FIBROMYALGIA

Non Discussion Abstract Session 33 Read by Title 992 Polypoid cystitis: prevalence and clinical findings.

Non Discussion Abstract Session 33 Read by Title 994 A novel highly effective and safe medical therapy for painful bladder syndrome/interstitial cystitis

Non Discussion Abstract Session 33 Read by Title 995 Glycosaminoglycans in bladder biopsies and in urine as possible markers for Intestitial Cystitis/Painfull Bladder Syndrome

Non Discussion Abstract Session 33 Read by Title 997 Treatment of Urethral pain syndrome with extra potent corticosteroid and lidocaine.

Non Discussion Abstract Session 33 Read by Title 998 Management of women with chronic cystitis: An audit of outcome

Non Discussion Abstract Session 33 Read by Title 999 The clinical effectiveness of intravesical Cystistat® (Hyaluronic acid) in patients with refractory painful bladder syndrome or recurrent urinary tract infections

ICS 2009

Podium Session 2 Pelvic Organ Prolapse 10 A randomized controlled trial on prophylactic antibiotics and pelvic organ prolapse surgery

Podium Poster Session 10 Neurourology (Basic Science) 102 ROLE OF SUPRASPINAL AND SPINAL a1-ADRENERGIC RECEPTOR SUBTYPES IN THE MICTURITION REFLEX IN CONSCIOUS RATS

Podium Poster Session 10 Neurourology (Basic Science) 108 FUNCTIONAL ROLE OF THE TRPV4 CATION CHANNEL IN STRETCH-EVOKED Ca2+ INFLUX AND ATP RELEASE IN MOUSE UROHELIAL PRIMARY CULTURES

Podium Session 3 Neurourology I 11 The Effect of Acute and Chronic Stress and Anxiety-like Behaviour on Bladder Motor and Sensory Function

Podium Poster Session 11 Gerontology & BPH 111 Are the effects of oxybutynin on cognition dependent upon the route of administration – topical or oral? A double-blind placebo controlled study employing sensitive cognitive and psychomotor testing

Podium Poster Session 11 Gerontology & BPH 116 Effect of age on caveolae-mediated signaling pathways in bladder smooth muscle

Podium Poster Session 11 Gerontology & BPH 117 The background characteristics of patients with benign prostatic hyperplasia who received early treatment with anti-cholinergics after undergoing a transurethral resection of the prostate

Podium Session 3 Neurourology I 12 Urethral Neuromuscular Injury Following Simulated Childbirth Injury in a Rat Model

Podium Session 12 Epidemiology 124 Environmental Factors versus Genetics In Women With Fecal Incontinence: A Classical Twin Study of Identical and Non-Identical Twins

Podium Session 12 Epidemiology 126 How does weight gain during pregnancy affect risk of urinary incontinence?

Podium Poster Session 13 Physiology 131 Establishing a rodent model for characterization of natural in vivo bladder regeneration

Podium Poster Session 13 Physiology 134 Altered cAMP-mediated potassium channel currents in detrusor myocytes from diabetic rats

Podium Poster Session 13 Physiology 142 A therapeutic approach for rhabdosphincter regeneration by autologous adult stem cells

Podium Poster Session 14 Epidemiology 144 Incidence of and risk factors for changes in urinary incontinence status in a prospective cohort of middle-aged and older women

Podium Poster Session 14 Epidemiology 148 The epidemiology of nocturnal polyuria (incidence and prevalence): a longitudinal community based study in men between 50 and 78 years of age

Podium Poster Session 14 Epidemiology 150 The Association Between Specific Parturition Events and Urinary Incontinence in Later Life: Results from a Retrospective Cohort Study

Podium Poster Session 15 LUTS in Women II 155 Lower Urinary Tract Symptoms in Female Patients with Hyperthyroidism

Podium Video Session 4 Videos - Surgical Techniques I 16 ADVANTAGES ON URINARY CONTINENCE USING THE CAPIO RP SUTURING DEVICE FOR VESICO-URETHRAL ANASTOMOSIS AFTER RADICAL RETROPUBIC PROSTATECTOMY

Podium Poster Session 15 LUTS in Women II 162 Safety and Tolerability of Duloxetine in the Treatment of Female Stress Urinary Incontinence (SUI) in General Practice in Germany - Results from a Large Observational Study

Podium Poster Session 15 LUTS in Women II 165 Subcapsular relocation for sacral neuromodulation pulse generator implant revision

Podium Poster Session 15 LUTS in Women II 166 SACRAL NEUROMODULATION IN URINARY RETENTION SECONDARY TO PELVIC ENDOMETRIOSIS ERADICATION

Podium Poster Session 16 Lower Urinary Tract, Physiology & Treatment 171 Quality of life and voiding function and following neobladder formation

Podium Poster Session 16 Lower Urinary Tract, Physiology & Treatment 174 The correlation of estimated and isotope GFR in patients with bowel in the urinary tract

Podium Poster Session 16 Lower Urinary Tract, Physiology & Treatment 175 Release of ATP and NO from rat prostate: an in vitro and in vivo assessment of adrenergic receptor stimulation

Podium Poster Session 16 Lower Urinary Tract, Physiology & Treatment 176 Alteration of caveolae-mediated signalling pathways in obstructed bladder

Podium Video Session 17 Videos - Surgical Techniques II 179 Video demonstration of vaginal surgery for prolapse using mesh implants and a vaginal support device

Podium Video Session 4 Videos - Surgical Techniques I 18 Optimizing results of suburethral sling operations among males using suburethral hyaluronic acid injections

Podium Video Session 17 Videos - Surgical Techniques II 180 Anterior Prolapse (Cystocele and Vault) Repair with Mesh: Single incision approach with new minimally invasive fixation system

Podium Video Session 17 Videos - Surgical Techniques II 183 LAPAROSCOPICALLY ASSISTED VAGINAL REPAIR OFVESICO-VAGINAL FISTULA - Initial clinical report

Podium Poster Session 18 Detrusor Overactivity Non-Clinical 185 Inhibition of Bladder Overactivity by Transcutaneous Stimulation Targeting the Pudendal Nerve in Cats

Podium Video Session 4 Videos - Surgical Techniques I 19 Transposition of distal urethra in female patients with recurrent lower UTI associated with sexual intercourse

Podium Poster Session 18 Detrusor Overactivity Non-Clinical 190 Bladder dysfunction in a new animal model of increased levels of superoxide ions

Podium Poster Session 19 Rehabilitation 197 Simultaneous perineal ultrasound and vaginal pressure measurement proves the efficacy of electrical pudendal nerve stimulation in treating female stress incontinence

Podium Video Session 4 Videos - Surgical Techniques I 20 Suprameatal Urethrolysis with Martius Flap

Podium Poster Session 19 Rehabilitation 200 Transplantation of muscle-derived stem cell plus fibrin glue restores urethral function in a pudendal nerve-transected rat model

Podium Poster Session 20 Pain Syndromes 201 Axonopathic changes of visceral nerve endings in urinary bladder in interstitial cystitis – an ultrastructural study

Podium Poster Session 20 Pain Syndromes 204 ASSESSMENT OF PATIENT OUTCOMES FOLLOWING SUBMUCOSAL INJECTION OF TRIAMCINOLONE FOR TREATMENT OF HUNNER’S ULCER SUBTYPE INTERSTITIAL CYSTITIS

Podium Poster Session 20 Pain Syndromes 205 Investigation of the function of integrin-mediated bacterial adherence proteins and their receptors in women with recurrent bacterial cystitis and interstitial cystitis

Podium Poster Session 20 Pain Syndromes 208 Painful bladder and urinary tract pathology associated with long term ketamine use

Podium Video Session 4 Videos - Surgical Techniques I 21 Urethrovaginal Fistula Repair with Martius Flap

Podium Session 21 Detrusor Overactivity 210 Quality of Life in a Randomized, Double-Blind, Placebo-Controlled Study of Oxybutynin Chloride Topical Gel Treatment of Patients With Overactive Bladder

Podium Session 22 Neurourology II 215 Brain regions and effective connectivity in voluntary control of bladder sensations: an fMRI study

Podium Session 23 Reconstructive Surgery LUT 218 The Impact of Urethroplasty on Voiding Symptoms and Sexual Function

Podium Session 23 Reconstructive Surgery LUT 219 A new collagen-based urothelial transplant for reconstructive surgery of the lower urinary tract

Podium Video Session 4 Videos - Surgical Techniques I 22 Single-Port Transvesical Excision of Foreign Bodies

Podium Poster Session 24 Urodynamic Techniques & BOO 221 Computer model based dynamic urethrovaginal support assessment for female SUI

Podium Poster Session 24 Urodynamic Techniques & BOO 224 Performance of Disposable Pressure-sensing Catheters during Simulated Urodynamic Events

Podium Video Session 4 Videos - Surgical Techniques I 23 SURGICAL PROCEDURE WITH LOCAL ANESTHESIA FOR THE TREATMENT OF STRESS URINARY INCONTINENCE: A SINGLE INCISION TOT

Podium Poster Session 25 Basic Pharmacology 234 Role of urothelium on beta-3-adrenoceptor mediated relaxation in human detrusor muscle

Podium Video Session 4 Videos - Surgical Techniques I 24 ROBOTIC-ASSISTED LAPAROSCOPIC RETROPUBIC URETHROLYSIS FOR INTRADETRUSOR TVT SLING

Podium Poster Session 26 Neuromodulation (Basic & Clinical) 240 Urethral Sphincter EMG controlled dorsal penile/clitoral nerve stimulation to treat NDO

Podium Poster Session 26 Neuromodulation (Basic & Clinical) 243 Sacral Neuromodulation in Diabetic Patients: Success and Complications in the Treatment of Voiding Dysfunction

Podium Poster Session 26 Neuromodulation (Basic & Clinical) 244 Sacral Nerve Stimulation for Fecal Incontinence, a prospective, multicentre, Scottish study

Podium Poster Session 27 Pelvic Floor & Lower Bowel 246 PREVALENCE OF URINARY AND BOWEL PROBLEMS IN GYNAECOLOGIC MALIGNANCIES – A CROSS SECTIONAL STUDY

Podium Video Session 4 Videos - Surgical Techniques I 25 SOLYX SIS System: Procedural Video

Podium Poster Session 28 Pregnancy/Childbirth & Outcome 253 Urinary incontinence in nulliparous women: incidence and associated risk factors

Podium Video Session 4 Videos - Surgical Techniques I 26 Novel rectus crossover for enhanced continence of catheterizable urinary diversion

Podium Poster Session 29 Painful Bladder Syndrome / IC 262 CXCR3 AND RELATED CHEMOKINES AS POSSIBLE BIOMARKERS FOR ULCERATIVE INTERSTITIAL CYSTITIS

Podium Poster Session 29 Painful Bladder Syndrome / IC 265 Differential Diagnosis of Painful Bladder Syndrome/Interstitial Cystitis Using Infrared Microspectroscopy

Podium Poster Session 30 Anatomy & Imaging 270 The Clinical Importance of Pudendal Nerve Course

Podium Poster Session 30 Anatomy & Imaging 271 Course of the Dorsal Nerve of the Clitoris

Podium Poster Session 30 Anatomy & Imaging 272 Perineal approach to vascular anatomy during transobturator cystocele repair

Podium Poster Session 30 Anatomy & Imaging 274 UNILATERAL CORONAL DIAMETERS OF THE LEVATOR HIATUS: BASELINE DATA FOR THE AUTOMATED DETECTION OF AVULSION OF THE PUBORECTALIS MUSCLE

Podium Poster Session 30 Anatomy & Imaging 275 THREE-DIMENSIONAL VIRTUAL-REALITY RECONSTRUCTION OF PELVIC FLOOR STRUCTURE FOR PATIENTS WITH FEMALE STRESS URINARY INCONTINENCE

Podium Poster Session 31 Nocturia & Incontinence 278 The Effect of Nocturia on Health-related Quality of Life and MOS Sleep Score in Female

Podium Poster Session 31 Nocturia & Incontinence 279 The incidence and prevalence of nocturia (increased nocturnal voiding frequency): results from a community based cohort study in older men

Podium Poster Session 5 Neurourology (Clinical) 28 Patient Age Predicts Success in Patients Undergoing Sacral Neuromodulation for Voiding Dysfunction

Podium Poster Session 31 Nocturia & Incontinence 282 The age of recovery from enuresis correlates with the natural course of OAB in adults

Non Discussion Poster Session 32 285 Virtual reality of the female pelvis dimensions of women with pelvic organ prolapse

Podium Poster Session 5 Neurourology (Clinical) 29 RESULTS OF SACRAL NERVE MODULATION FOR THE TREATMENT OF BLADDER DYSFUNCTIONS IN MULTIPLE SCLEROSIS PATIENTS

Non Discussion Poster Session 32 290 A randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of new, highly selective a1A-adrenoceptor antagonist Silodosin in Korean patients with benign prostatic hyperplasia

Non Discussion Poster Session 32 294 ASSOCIATION OF MMP1 PROMOTER VARIANT WITH STRESS URINARY INCONTINENCE AND PELVIC ORGAN PROLAPSE IN WOMEN

Non Discussion Poster Session 32 296 Collagen type III biosynthesis by pubo-cervical fascia fibroblasts cultured with mono and multifilament polypropylene mesh after estrogens and tamoxifen treatment

Non Discussion Poster Session 32 304 Effect of Prolyl 4-hydroxylase Inhibitor on the Bladder Function, Bladder Hypertrophy, and Expresssion of Prolyl 4-hydroxylase, Collagen Subtype in the Rat Model with Partial Bladder Outlet Obstruction

Non Discussion Poster Session 32 305 Adipose-derived Stem Cell Transplantation for the Treatment of Stress Urinary Incontinence

Non Discussion Poster Session 32 306 The store-operated Ca2+ entry negatively regulates the distention-elicited ATP release from urothelium

Non Discussion Poster Session 32 307 Altered ATP signalling in urothelium of OAB patients with exacerbated symptoms

Non Discussion Poster Session 32 316 100 VS. 150 UNITS OF INTRA-DETRUSOR BOTOX: DOSE DIFFERENCES IN OAB-WET PATIENTS?

Non Discussion Poster Session 32 318 Home-based Hypnotherapy for Urge Urinary Incontinence

Non Discussion Poster Session 32 320 Influence of detrusor overactivity on storage symptoms following potassium-titanyl-phosphate photoselective vaporization of the prostate

Non Discussion Poster Session 32 327 The use of Intravesical Injection of Botulinum Toxin-A for Urgency Urinary Incontinence over a 5 year period in a large district general hospital

Non Discussion Poster Session 32 331 Tolterodine improves the compliance and cystometric capacity of adult neurogenic bladders secondary to spinal cord injury

Non Discussion Poster Session 32 337 Cost-effectiveness of fesoterodine in the treatment of patients with overactive bladder

Podium Poster Session 5 Neurourology (Clinical) 34 Can 100 units of botulinum toxin A preserve the ability of voluntary voiding and improve overactive bladder symptoms in patients suffering from multiple sclerosis?

Non Discussion Poster Session 32 343 Cost effectiveness and cost utility analysis of Sacral Neuromodulation, Optimized Medical Treatment and Botulinum Neurotoxin in the treatment of idiopathic Overactive Bladder in Spain

Non Discussion Poster Session 32 345 Using an electronic pelvic floor questionnaire to increase discussion rates of urinary incontinence (UI) in primary care: a randomized controlled trial

Non Discussion Poster Session 32 349 Prevalence and Correlates of Urinary Incontinence in Community Dwelling Older Latinos

Non Discussion Poster Session 32 352 URODYNAMIC TRENDS IN THE FEMALE AGING POPULATION: DETRUSOR OVERACTIVITY WITH IMPAIRED CONTRACTILITY, TWO CONDITIONS OR ONE?

Non Discussion Poster Session 32 355 Physiological aging and bladder function: in vivo and in vitro studies in male rats

Non Discussion Poster Session 32 356 DETECTION OF CONGENITAL URETHRAL STRICTURE USING THREE-DIMENSIONAL IMAGE PROCESSED FROM THE ENDOSCOPIC VIDEO IMAGE

Non Discussion Poster Session 32 357 Comparison of the urethra and levator ani function anatomy in women with and without stress urinary incontinence

Podium Poster Session 5 Neurourology (Clinical) 36 THE EFFECT OF DEEP BRAIN STIMULATION ON VOIDING DYSFUNCTION IN PARKINSON’S DISEASE AND ESSENTIAL TREMOR

Non Discussion Poster Session 32 361 Anatomical variability of the puboperineal and puborectal muscles in non-obese nulliparous women - a 3D ultrasound study

Non Discussion Poster Session 32 363 A variety of vascular changes in the urinary bladder during urodynamic study in women with various types of long-standing urinary symptoms: Preliminary study using 3-dimensional color and power Doppler sonography

Non Discussion Poster Session 32 364 PATIENT SATISFACTION AFTER ARTIFICIAL URINARY SPHINCTER PLACEMENT FOR URINARY INCONTINENCE: RETROSPECTIVE REVIEW WITH 18 YEAR FOLLOW-UP

Non Discussion Poster Session 32 369 ARTIFICIAL URINARY SPHINCTER (AMS 800) ™ OUTCOME IN COMPLICATED PROSTATE CANCER PATIENTS

Podium Poster Session 5 Neurourology (Clinical) 37 THE INCIDENCE OF VOIDING DIFFICULITY AND CONSTIPATION IN PATIENTS WITH ESSENTIAL TREMOR COMPARED TO PARKINSON’S DISEASE

Non Discussion Poster Session 32 375 PATIENT SELECTION CRITERIA AND OUTCOMES FOR SURGICAL MANAGEMENT OF POST-PROSTATECTOMY INCONTINENCE

Non Discussion Poster Session 32 376 15 years of experience with the artificial urinary sphincter: changing indications and long-term outcomes

Non Discussion Poster Session 32 377 Influence of intraoperative bleeding on urinary function after nerve-sparing radical prostatectomy

Non Discussion Poster Session 32 378 The impact of a stoma for bowel management after SCI

Non Discussion Poster Session 32 382 The co-Prevalence of Chronic Constipation and Faecal Incontinence with Overactive Bladder (OAB)

Non Discussion Poster Session 32 386 Comparison of bladder contractility values estimated with the non-invasive condom catheter method and pressure-flow studies

Non Discussion Poster Session 32 391 A MOUSE MODEL OF CONDITIONAL SMOOTH MUSCLE-SPECIFIC DELETION OF THE MANGANESE SUPEROXIDE DISMUTASE GENE ALLOWS EXAMINATION ROLE OF OXIDATIVE STRESS IN DIABETIC BLADDER DYSFUNCTION

Non Discussion Poster Session 32 399 Average shapes of uroflow curves of adult men

Podium Session 1 Surgery for Stress Incontinence Retropubic TVT vs transobturator outside-in TOT and inside-out TVT-O – One-year results from our prospective randomized study

Podium Poster Session 5 Neurourology (Clinical) 40 Evaluation of Renal Function by Serum Cystatin C for the Patient with Neurogenic Bladder having a Central Nerve System Disorder

Non Discussion Poster Session 32 403 Mid-term recurrence rate and re-treatment in female patients with overactive bladder symptoms

Non Discussion Poster Session 32 404 Depression, Anxiety, Stress perception and Coping Strategy in Female Overactive Bladder Patients

Non Discussion Poster Session 32 405 The Effect of Tamsulosin HCl (0.2mg) on Female Lower Urinary Tract Symptoms with Maximal Urinary Flow Rate Less Than 12ml/sec

Non Discussion Poster Session 32 410 Suppression of the stretch-evoked ATP and PGE2 release from the bladder urothelium by cyclooxygenase inhibitors

Non Discussion Poster Session 32 412 SYNERGISTIC EFFECT BY CO-ADMINISTRATION OF TAMSULOSIN AND SOLIFENACIN ON BLADDER ACTIVITY IN RATS

Non Discussion Poster Session 32 416 Contributions of dehydroepiandrosterone at neurotransmitter receptors in the central nervous system on bladder function in male rats

Non Discussion Poster Session 32 418 Changes in purinergic and nitrergic sensory signals in female rats during early diabetes

Non Discussion Poster Session 32 419 Evolution of bladder dysfunction in a model of unilateral dopaminergic neurons lesion

Podium Poster Session 5 Neurourology (Clinical) 42 Urethral Innervation Better in Continent Women than Stress Incontinent Women

Non Discussion Poster Session 32 422 Serotonin in the spine is associated with bladder hypersensitivity caused by estrogen deficiency in rats

Podium Poster Session 6 Quality of Life & Epidemiology 43 Hysterectomy does not impair incontinence – A Swedish Quality register study

Non Discussion Poster Session 32 432 INFLUENCE OF PROPIVERINE, AN ANTICHOLINERGIC AGENT, ON MICTURITION REFLEX, BLOOD PRESSURE, AND PLASMA CATECHOLAMINE LEVEL IN YOUNG AND ELDERLY RATS

Non Discussion Poster Session 32 433 Urothelium is the primary source of ATP and NO release in the rat urinary bladder: A novel method for an urothelium free preparation

Non Discussion Poster Session 32 440 Early diabetes impairs non-adrenergic non-cholinergic contractions in the urinary bladder of female rats

Non Discussion Poster Session 32 441 Differential effects of darifenacin and tolterodine on heart rate (HR) and heart rate variability (HRV): A three-way crossover, randomised study in healthy subjects

Non Discussion Poster Session 32 442 Sacral Neuromodulation for the Treatment of Women with Non-Obstructive Urinary Retention

Podium Poster Session 6 Quality of Life & Epidemiology 45 Fecal Incontinence: A population based study of severity and quality of life

Non Discussion Poster Session 32 450 NOCTURNAL INCONTINENCE IS A SIGNIFICANT PROBLEM AFTER ORTHOTOPIC BLADDER SUBSTITUTION IN WOMEN

Non Discussion Poster Session 32 453 Botulinum Toxin A for Treatment of Neurourological Patients: a Safe Poison

Non Discussion Poster Session 32 457 BLADDER AND RECTAL ASPECTS OF SPINAL CORD INJURY: RESULTS FROM THE CENSUS PERFORMED IN AN ITALIAN DISTRICT

Non Discussion Poster Session 32 458 Characterising the phenotype of the painful bladder syndrome in patients presenting with lower urinary tract symptoms

Non Discussion Poster Session 32 459 Life Impact of Urologic Pain Syndromes

Podium Poster Session 6 Quality of Life & Epidemiology 46 Menopause and its Impact on Pelvic floor Disorders, Stress and Depression

Non Discussion Poster Session 32 463 Increase in arachidonic acid metabolites in the urine of female rats with cyclophosphamide-induced cystitis

Non Discussion Poster Session 32 464 A new experimental model for inducing interstitial cystitis by oxidative stress using bladder instillation of a nitric oxide donor gel

Non Discussion Poster Session 32 465 Recurrence of Urethral Diverticula: A Contemporary Series

Non Discussion Poster Session 32 466 RELIABILITY AND VALIDITY OF ICIQ-CLUTS: THE FIRST SCREENING QUESTIONNAIRE FOR PAEDIATRIC LOWER URINARY TRACT SYMPTOMS

Podium Poster Session 6 Quality of Life & Epidemiology 47 Characterization of Pelvic Floor Symptoms in Women of Northeastern Liberia

Non Discussion Poster Session 32 471 Stem Cell Homing Cytokine Upregulation in Lysyl Oxidase Like 1 (LOXL1) Knockout Mice after Vaginal Distension

Non Discussion Poster Session 32 475 The function of the pelvic floor muscles before und after the reconstructive pelvic floor surgery

Non Discussion Poster Session 32 477 4D/3D sonographic description of the squeeze mechanism in the anal sphincter

Non Discussion Poster Session 32 478 Constrictor and elevator functions of the pelvic floor are distinct: evidence from studies in patients with fecal Incontinence

Non Discussion Poster Session 32 482 Comparison between transabdominal ultrasound and perineometry for assessment of pelvic floor muscle contraction in women with stress urinary incontinence

Non Discussion Poster Session 32 483 A clinically-relevant model of stress urinary incontinence: What is the effect of material properties on the finite element simulation of the bladder, urethra and support structures during a cough

Non Discussion Poster Session 32 485 Is there any difference between voluntary and electrical stimulated pelvic floor contractions?

Non Discussion Poster Session 32 486 A randomised study to compare the PelvicToner Device against standard pelvic floor exercises in the treatment of stress urinary incontinence in women

Non Discussion Poster Session 32 487 Management of Incontinence and Pelvic Reconstructive Surgery: Practice Patterns of AUA Urologists

Podium Poster Session 6 Quality of Life & Epidemiology 49 Validation of the German version of the “ICIQ Vaginal Symptoms Questionnaire” (The ICIQ-VS German): The German translation of the ICIQ-VS- an observational study

Non Discussion Poster Session 32 490 THE MUSCARINIC RECEPTOR ANTAGONIST PROPIVERINE BINDS TO HUMAN ALPHA-1-ADRENOCEPTORS AND RELAXES THE HUMAN PROSTATE

Non Discussion Poster Session 32 491 BETA–ADRENOCEPTOR-MEDIATED ACTIVATION OF BKCa CHANNELS IN URINARY BLADDER SMOOTH MUSCLE CELLS

Non Discussion Poster Session 32 495 In vitro and in vivo effects of mirabegron (YM178) on urinary bladder function in rats

Non Discussion Poster Session 32 496 Urodynamic Effects of a Novel Peripheral Selective Cannabinoid-2-Receptor Agonist (Cannabinor) on Bladder Function in Conscious Rats

Non Discussion Poster Session 32 497 Duloxetine counteracts bladder overactivity induced by intravesical acetic acid in anesthetized female guinea-pigs through activation of 5-HT receptors

Non Discussion Poster Session 32 499 THE EFFECTS OF E2110, A NOVEL SELECTIVE 5-HT1A RECEPTOR ANTAGONIST, ON THE MICTURITON REFLEX IN CEREBRAL INFRACTED RATS AND SPONTANEOUSLY HYPERTENSIVE RATS

Podium Poster Session 6 Quality of Life & Epidemiology 50 RESPONSIVENESS OF THE PFDI-20 AND PFIQ-7, 12 MONTHS FOLLOWING VAGINAL PROLAPSE REPAIR AUGMENTED BY MESH AND A VAGINAL SUPPORT DEVICE

Non Discussion Poster Session 32 500 Comparative analysis of the effects of tolterodine on the urodynamic parameters in non-human primates and rodents

Non Discussion Poster Session 32 502 TRK-380, A NOVEL ß3-ADRENOCEPTOR (AR) AGONIST WITH POTENT AGONISTIC ACTIVITY, FUNCTIONALLY RELAXES DETRUSOR STRIPS IN SOME SPECIES INCLUDING HUMANS

Non Discussion Poster Session 32 505 TRK-380, A NOVEL ß3 ADRENOCEPTOR (AR) AGONIST, DECREASES VOIDING FREQUENCY IN RATS WITH FORMALIN-INDUCED POLLAKIURIA AND SUPPRESSES THE NON-VOIDING CONTRACTIONS(NVCS) IN BLADDER OUTLET OBSTRUCTION (BOO)

Non Discussion Poster Session 32 507 Time-dependent alteration of pharmacologically relevant receptors in the bladder of streptozotocin-induced diabetic rats

Non Discussion Poster Session 32 512 Urinary incontinence after obstetric anal sphincter injury: is there a relationship?

Non Discussion Poster Session 32 515 A 10-Year analysis of Non-surgical interventions in the Treatment of Symptomatic Obstetric Anal Sphincter Injuries

Non Discussion Poster Session 32 519 Psychological burden related to urge urinary incontinence predicts and its change correlates with therapeutic response to biofeedback in older women

Podium Poster Session 6 Quality of Life & Epidemiology 52 Effect of Childbirth versus Parenting Pressure on Sexual Function

Non Discussion Poster Session 32 523 A Study on Symptoms and Quality of Life on Chinese Women with Uterine Prolapse

Non Discussion Poster Session 32 525 Pelvic Health Perspectives Among Low Income, Minority Women on Chicago’s Westside

Non Discussion Poster Session 32 526 Quality of life after pelvic floor reconstructive surgery using synthetic implants: 1-year follow-up

Non Discussion Poster Session 32 527 A randomised cross-over study of silver-coated silicone Foley’s catheter and 100 Silicone Foley’s catheter in patients requiring long term indwelling catheters

Non Discussion Poster Session 32 529 Long term follow up of quality of life after antiincontinent surgery

Podium Poster Session 6 Quality of Life & Epidemiology 53 Does long-term treatment of overactive bladder result in clinically meaningful improvement in health related quality of life in real world clinical practice?

Non Discussion Poster Session 32 530 Quality of life related voiding symptoms and sexual function decrease in women with menopause

Non Discussion Poster Session 32 533 PRESENTATION AND MANAGEMENT OF IATROGENIC FOREIGN BODIES OF THE LOWER URINARY TRACT FOLLOWING PELVIC SURGERY

Non Discussion Poster Session 32 537 A New Trocar-Free Procedure For Vaginal Prolapse Repair Using Mesh And A Vaginal Support Device: 1 Year Anatomic, Functional and Device Performance Results

Non Discussion Poster Session 32 540 Risk of Unanticipated Abnormal Gynecologic Pathology at the Time of Surgery for Uterovaginal Prolapse

Non Discussion Poster Session 32 542 Sexual impairment in patients with pelvic organ prolapse and the influence on sexuality after laparoscopic sacropexy: A hospital based cohort study

Non Discussion Poster Session 32 545 Anatomic and functional outcomes of sacral colpopexy with or without concomitant posterior colporrhaphy in women with pelvic organ prolapse

Non Discussion Poster Session 32 546 VESICO-URETHRAL ANASTOMOSIS AFTER RADICAL RETROPUBIC PROSTATECTOMY USING THE CAPIO RP SUTURING DEVICE.ADVANTAGES ON URINARY CONTINENCE AND POST SURGICAL STENOSIS RATES

Non Discussion Poster Session 32 549 RELATIONSHIP BETWEEN FOOT INVERSION AND EVERSION AND PELVIC FLOOR MUSCLE ACTIVITY : PRELIMINARY RESULTS FROM A PILOT STUDY USING ADAPTABLE REMOVABLE INSOLES IN CONTINENT WOMEN

Non Discussion Poster Session 32 554 DOES CONCOMITANT REPAIR AT THE TIME OF MIDURETHRAL SLING AFFECT RECURRENCE RATES OF INCONTINENCE?

Non Discussion Poster Session 32 556 Factors affecting the results of midurethral sling for mixed urinary incontinence women

Non Discussion Poster Session 32 560 Sexual function and health-related quality of life following anterior vaginal wall surgery for SUI and POP: a longitudinal study

Non Discussion Poster Session 32 564 Three-year outcome after trans-section of synthetic suburethral sling tape for treating obstructive voiding symptoms following anti-incontinence surgery

Non Discussion Poster Session 32 567 Efficacy and safety of a low elasticity polypropylene transobturator midurethral sling in the treatment of female stress urinary incontinence in a large multi-center European registry with mid-term follow-up

Non Discussion Poster Session 32 568 DETERMINANTS OF FAILURE AFTER SLING SURGERY FOR FEMALE STRESS URINARY INCONTINENCE

Podium Poster Session 6 Quality of Life & Epidemiology 57 The Brindley bladder stimulator improves quality of life and clinical outcomes in spinal cord injured patients as compared to a matched control group

Non Discussion Poster Session 32 570 Is abdominal straining seen on urodynamics a normal variant of female voiding or an artifact?

Non Discussion Poster Session 32 579 Urodynamic features of Hautmann orthotopic ileal neobladder using standard and ambulatory urodynamics. Preliminary results

Podium Poster Session 6 Quality of Life & Epidemiology 58 NEUROPHYSIOLOGICAL MODIFICATION OF PELVIC FLOOR PARAMETERS DURING SACRAL NERVE NEUROMODULATION

Non Discussion Poster Session 32 582 DEVICE AND METHOD FOR MINIMALLY INVASIVE URODYNAMIC ASSESSMENT IN MEN

Non Discussion Poster Session 32 583 Urethral Function of Women with Detrusor Overactivity is Intermediate that of Continent and Stress Incontinent Women

Non Discussion Poster Session 32 584 Urodynamic Ratios: A Novel Consideration for Female Stress Continence

Non Discussion Poster Session 32 588 URODYNAMICS: TELEMENTORING AS A NEW WAY TO REMOTE TEACHING

Non Discussion Poster Session 32 593 Non-obstetric risk factors for symptomatic pelvic organ prolapse- a population-based cross-sectional study in Sweden

Non Discussion Video Session 33 Non-Discussion Videos 594 Transrectal ultrasound-guided ProACT™ system implantation under local anesthesia in patients with post-radical prostatectomy stress urinary incontinence: surgical technique

Non Discussion Video Session 33 Non-Discussion Videos 595 A LESS INVASIVE APPROACH FOR FASCIAL SLING IN BOYS WITH NEUROGENIC INCONTINENCE

Non Discussion Video Session 33 Non-Discussion Videos 596 Video demonstration of suprapubic cystoscopic management of bladder mesh erosion and suture repair of bladder wall defect: "natural orifice surgery"

Non Discussion Video Session 33 Non-Discussion Videos 597 TELEMENTORING: NEW WINDOWS TO TEACH URODYNAMICS

Podium Session 1 Surgery for Stress Incontinence PRE AND POST-OPERATIVE PREDICTORS OF SATISFACTION FOLLOWING SURGICAL TREATMENT OF STRESS URINARY INCONTINENCE

Podium Poster Session 7 LUTS in Women I 60 Long-term use of antimuscarinic medication in the real world: Results of a community-based prospective study of patients with overactive bladder

Non Discussion Video Session 33 Non-Discussion Videos 600 Endoscopic cystocele surgery: Lateral repair with polypropylene mesh

Non Discussion Video Session 33 Non-Discussion Videos 603 TRANS-UMBILICAL LAPAROENDOSCOPIC SINGLE SITE SURGERY IN VESICO-VAGINAL FISTULA REPAIR - First experience

Non Discussion Video Session 33 Non-Discussion Videos 604 Optimizing results of suburethral sling operations among females using suburethral hyaluronic acid injections

Non Discussion Abstract Session 34 Read by Title 606 A COMPARATIVE STUDY ON THE CLINICAL EFFECTS OF SILODOSIN AND NAFTOPIDIL IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

Non Discussion Abstract Session 34 Read by Title 612 Role of a specific 1,4,5 inositol triphosphate blocker on the bladder smooth muscle contractions – Results from in vitro and in vivo studies

Non Discussion Abstract Session 34 Read by Title 614 Clinical value of the involuntary detrusor contractions in OAB patients

Non Discussion Abstract Session 34 Read by Title 615 Botulinum Toxin Injection to the Bladder; An Audit to Assess its Efficacy and Value in the Treatment of Detrusor Overactivity Incontinence

Non Discussion Abstract Session 34 Read by Title 616 BOTOX® FOR IDIOPATIC OVERACTIVE BLADDER PATIENTS REFRACTORY TO ANTIMUSCARINIC THERAPY

Non Discussion Abstract Session 34 Read by Title 617 Obesity is Associated with a More Severe Overactive Bladder Disease State that is Effectively treated with Once-daily Administration of Trospium Chloride Extended Release

Non Discussion Abstract Session 34 Read by Title 618 The effectiveness of electrical stimulation (ES) for takeout in outpatients with overactive bladder

Non Discussion Abstract Session 34 Read by Title 619 The Profile of Women with Overactice Bladder attended in a Public Medical Hospital in the city of São Paulo, Brazil

Non Discussion Abstract Session 34 Read by Title 620 The Socioeconomic Costs of Overactive Bladder and Stress Urinary Incontinence in Korea

Non Discussion Abstract Session 34 Read by Title 621 DOES “MILITARY SELECTION” CORRELATE TO THE SPHINCTER MATURATION DISTURBANCES DURING CHILDHOOD? A QUESTIONNAIRE-BASED SURVEY IN 218 YOUNG ADULTS

Non Discussion Abstract Session 34 Read by Title 623 Does Clinical Assessment Correlate with Multi-channel Urodynamic Findings?

Non Discussion Abstract Session 34 Read by Title 629 Factors Influencing Post-Operative Outcomes from VVF Repairs in a Community Hospital in Liberia

Non Discussion Abstract Session 34 Read by Title 630 Hormonal treatment for vesicouterine fistula in women of reproductive age is both effective and safe

Non Discussion Abstract Session 34 Read by Title 631 Obstetric vesicovaginal fistula – still a reality in developing countries in Today’s time

Non Discussion Abstract Session 34 Read by Title 634 Complex urogenital fistulas: principles of surgical repair

Non Discussion Abstract Session 34 Read by Title 636 Ultrasonic assessment of MiniArc™

Non Discussion Abstract Session 34 Read by Title 638 Outcome after a failed bulbourethral sling procedure in men with postprostatectomy incontinence and a repeat bulbourethral sling

Non Discussion Abstract Session 34 Read by Title 640 ARGUS® an adjustable sling for the treatment of post prostatectomy incontinence, 84 patients, 45 months follow up, an unicenter study

Non Discussion Abstract Session 34 Read by Title 641 TRANSCORPORAL ARTIFICIAL URINARY SPHINCTER PLACEMENT IN THE CHALLENGING URETHRA

Non Discussion Abstract Session 34 Read by Title 642 New Enhancements of the Transverse Scrotal Surgical Technique For Placement of Artificial Urinary Sphincter Allows More Proximal Placement of Cuffs

Non Discussion Abstract Session 34 Read by Title 643 Stress urinary incontinence after radical prostatectomy: Long term effects of endoscopic injection with dextranomer/hylauronic acid copolymer

Non Discussion Abstract Session 34 Read by Title 645 Effectiveness of Sacral Nerve Stimulation for Fecal Incontinence in Patients with Double Incontinence

Non Discussion Abstract Session 34 Read by Title 647 Estimated cost of bowel management in people with spinal cord injury

Non Discussion Abstract Session 34 Read by Title 648 Insertion of temporary electrodes for sacral nerve stimulation testing under local anaesthetic is reliable and cost effective

Non Discussion Abstract Session 34 Read by Title 649 Faecal incontinence symptom severity scores fluctuate over time without treatment

Non Discussion Abstract Session 34 Read by Title 655 The impact of radical prostatectomy on lower urinary tract symptoms: predictive value of pressure flow study

Non Discussion Abstract Session 34 Read by Title 657 Correlation of male overactive bladder with intravesical prostatic protrusion

Non Discussion Abstract Session 34 Read by Title 658 The Factors Affecting The Compliance Of Anticholinergic Treatment In The Patients With Benign Prostatic Hyperplasia

Non Discussion Abstract Session 34 Read by Title 662 Clinical and urodynamic parameters associated with detrusor overactivity in patients with benign prostatic hyperplasia/low urinary tract symptoms

Non Discussion Abstract Session 34 Read by Title 665 Analysis of initial baseline clinical parameters predicting medical treatment failure of Benign Prostatic Hyperplasia

Non Discussion Abstract Session 34 Read by Title 669 User Appreciation of the Characteristics and Packaging of the VaPro® Intermittent Catheter Design

Non Discussion Abstract Session 34 Read by Title 671 The Mirror neurons and the neurophysiology of modesty

Non Discussion Abstract Session 34 Read by Title 675 Comparison of urodynamics between ischemic and hemorrhagic stroke patients; Can we suggest the category of urinary dysfunction in patients with cerebrovascular accident according to type of stroke?

Non Discussion Abstract Session 34 Read by Title 679 IS FLUOROSCOPY NECESSARY FOR PLACEMENT OF INTERSTIM DEVICE FOR MANAGEMENT OF REFRACTORY URGE URINARY INCONTINENCE BY THE EXPERIENCED SURGEON?

Podium Poster Session 7 LUTS in Women I 68 Affect of Diabetes on the Prevalence of Lower Urinary Tract Symptoms (LUTS) in Women

Non Discussion Abstract Session 34 Read by Title 681 Sacral Neuromodulation in Neurologically Impaired Women with Detrusor Areflexia

Non Discussion Abstract Session 34 Read by Title 686 AMITRIPTYLINE (A) AND PENTOSAN POLYSULFATE SODIUM (PPS) THERAPY FOR NEW ONSET INTERSTITIAL CYSTITIS / PAINFUL BLADDER SYNDROME (IC / PBS)

Non Discussion Abstract Session 34 Read by Title 690 New aspects on the classification of enuresis

Non Discussion Abstract Session 34 Read by Title 691 Assessment of pelvic floor muscle function in standing and lying positions using transabdominal ultrasound: Difference between continent and stress incontinent women

Non Discussion Abstract Session 34 Read by Title 692 Mid urethral slings and pubo urethral ligaments: an anatomic comparison

Non Discussion Abstract Session 34 Read by Title 695 Changes of Pelvic Floor Muscle Strength Before and After Normal Vaginal Delivery

Non Discussion Abstract Session 34 Read by Title 699 Utility of an Ambulatory Pessary Trial to Unmask Occult Stress Urinary Incontinence

Non Discussion Abstract Session 34 Read by Title 701 Transurethral Radiofrequency Collagen Denaturation (Renessa®) for Treatment of Stress Urinary Incontinence in Women: Interim Urogenital Distress Inventory Results of a 36-Month Study

Non Discussion Abstract Session 34 Read by Title 703 Effect of a speculum blade on dynamic MRI evaluation of pelvic organ prolapse

Non Discussion Abstract Session 34 Read by Title 706 Use of Mesh for pelvic organ prolapse repair: a survey of attitudes among Israeli Urogynecologists. Are we jumping the gun?

Non Discussion Abstract Session 34 Read by Title 707 EFFECT OF TRK-380, A NOVEL ß3-ADRENOCEPTOR (AR) AGONIST, ON CARBACHOL-INDUCED BLADDER CONTRACTIONS IN ANESTHETIZED DOGS

Non Discussion Abstract Session 34 Read by Title 709 Pharmacokinetic and pharmacodynamic analysis of distigmine bromide for the treatment of underactive bladder

Non Discussion Abstract Session 34 Read by Title 710 Efficacy and Safety of Fesoterodine for Overactive Bladder in a Double-Blind, Head-to-Head Comparison Trial With Tolterodine ER and Placebo

Non Discussion Abstract Session 34 Read by Title 712 Efficacy and Tolerability of Fesoterodine in Subjects Stratified by Dose Escalation in an Open-Label Flexible-Dose Study

Non Discussion Abstract Session 34 Read by Title 713 Efficacy of a Supersaturated Calcium Phosphate Oral Rinse (Caphosol) in the Treatment of Xerostomia Secondary to Antimuscarinic Treatment for the Bladder

Non Discussion Abstract Session 34 Read by Title 714 Effects of Oral Magnesium Hydroxide on Urinary Symptoms in Urge Incontinent Women

Non Discussion Abstract Session 34 Read by Title 715 A Double-Blind, Placebo-Controlled Trial of Flexible-Dose Fesoterodine for Overactive Bladder

Non Discussion Abstract Session 34 Read by Title 717 Pharmacokinetic Variability Is Lower Following Administration of Fesoterodine Compared With Tolterodine

Podium Poster Session 7 LUTS in Women I 72 Relationship of the severity of urgency according to the degree of stress urinary incontinence

Non Discussion Abstract Session 34 Read by Title 720 Long-term anal continence and quality of life following anal sphincter injury

Non Discussion Abstract Session 34 Read by Title 722 Does induction of labour change the mode of delivery for macrosomic babies?

Non Discussion Abstract Session 34 Read by Title 723 Minimally invasive surgical treatment of complex genital prolapse in elderly women – impact on quality of life

Non Discussion Abstract Session 34 Read by Title 724 Anxiety and pain associated with urodynamic study in female patients

Non Discussion Abstract Session 34 Read by Title 725 A Study on Symptoms and Quality of Life on Chinese Women with Urinary Symptoms

Non Discussion Abstract Session 34 Read by Title 726 A Proposal to Characterize the Mid-Vagina in POP-Q

Non Discussion Abstract Session 34 Read by Title 729 Uterine preservation in treating pelvic organ prolapse: the modified Manchester-Fothergill procedure

Non Discussion Abstract Session 34 Read by Title 730 A LIGHT-WEIGHT MESH SYSTEM FOR TRANS-VAGINAL MESH REPAIR: INTERIM 3-MONTH RESULTS

Non Discussion Abstract Session 34 Read by Title 734 Mesh implants in treatment of pelvic organ prolapse: one year follow-up

Non Discussion Abstract Session 34 Read by Title 735 Laparoscopic hysteropexy: initial results of a new uterine suspension procedure for uterine prolapse

Non Discussion Abstract Session 34 Read by Title 740 Intermediate-term outcome after laparoscopic sacropexy: Complication rate, re-prolapse rate and functional results - A hospital based cohort study

Non Discussion Abstract Session 34 Read by Title 743 ISOLATED POSTERIOR PELVIC ORGAN PROLAPSE: WHAT CLINICAL OR URODYNAMIC FINDINGS DRIVE PATIENTS TO SEEK SURGICAL CORRECTION?

Non Discussion Abstract Session 34 Read by Title 746 Long term follow up of occult stress urinary incontinence

Non Discussion Abstract Session 34 Read by Title 747 EFFICACY AND SAFETY OF TRANSVAGINAL MESH REPAIR OF SEVERE PELVIC ORGAN PROLAPSE WITH THE PERIGEE-APOGEE SYSTEM: MID TERM DATA

Non Discussion Abstract Session 34 Read by Title 751 Surgical treatment of vaginal anterior, posterior and vault prolapse using Prolift® system

Non Discussion Abstract Session 34 Read by Title 752 Anatomic Repair of Vaginal Wall Prolapse Without Mesh is Associated With Lasting Improvement In Urinary Quality of Life

Non Discussion Abstract Session 34 Read by Title 753 Reducing Length of Stay in Pelvic Organ Prolapse Repair

Non Discussion Abstract Session 34 Read by Title 754 MESH EROSION AFTER TRANSVAGINAL MESH KIT PLACEMENT

Non Discussion Abstract Session 34 Read by Title 755 SHORT AND INTERMEDIATE-TERM COMPLICATIONS OF THE PROLIFT® TRANSVAGINAL MESH PROCEDURE

Non Discussion Abstract Session 34 Read by Title 756 Transvaginal cystocele repair by the transobturator approach. Medium-term anatomic and functional results

Non Discussion Abstract Session 34 Read by Title 757 Anterior repair with mesh graft via transobturator approach:With or without prior repair

Non Discussion Abstract Session 34 Read by Title 758 Title: Outcome of 71 procedures using Perigee-Apogee meshes for vaginal repair

Non Discussion Abstract Session 34 Read by Title 759 Pelvic Organ Prolapse after Surgical Correction. Recurrence risk

Non Discussion Abstract Session 34 Read by Title 760 Apical ligament specific repair with Nazca-R

Non Discussion Abstract Session 34 Read by Title 761 Six year review of sacrospinous vault suspensions in district hospital

Non Discussion Abstract Session 34 Read by Title 762 Evaluation of outcomes following repair of pelvic organ prolapsed using Prolift™ transvaginal mesh: A retrospective review

Non Discussion Abstract Session 34 Read by Title 765 Influence of Trans Vaginal Mesh procedure on quality of life in patients with pelvic organ prolapse: short-term observation

Non Discussion Abstract Session 34 Read by Title 767 SUCCESS OF ENDOSCOPIC PROCEDURES AND URETHROPLASTY FOR BULBAR AND PENILE URETHRAL STRICTURES

Non Discussion Abstract Session 34 Read by Title 768 SURVEY ABOUT PRESCRIPTION AND DISTRIBUTION OF CATHETERS FOR CLEAN INTERMITTENT CATHETERIZATION IN NORTH-EAST OF ITALY

Non Discussion Abstract Session 34 Read by Title 769 Rehabilitation vs Drug Therapy for Urge Urinary Incontinence, the Short and the Long Term Outcome

Non Discussion Abstract Session 34 Read by Title 770 Association between activities of daily living and voiding dysfunctions: Assessment and management of 749 inpatients’ voiding dysfunctions

Non Discussion Abstract Session 34 Read by Title 772 Exercises Treatment to Reduce the Urine Leakage in Elderly Community-Dwelling Japanese Women with Stress, Urge, and Mixed Urinary Incontinence

Non Discussion Abstract Session 34 Read by Title 776 Micturition Disorders in Elderly Stroke Patients admitted to Rehabilitation Facilities in Hong Kong

Non Discussion Abstract Session 34 Read by Title 777 The Role of Physiotherapy in the Management of Urinary Incontinence; An Audit of the Experience from the Urogynaecology Department of a UK hospital

Non Discussion Abstract Session 34 Read by Title 780 PREDICTORS OF A FAILED VOIDING TRIAL AFTER SLING AND CONCOMITANT SURGERY

Non Discussion Abstract Session 34 Read by Title 781 Evaluating Outcomes of Anti-incontinence Procedures: Development of a Mail-based Pad Kit

Non Discussion Abstract Session 34 Read by Title 782 Preoperative Urinary Hesitancy is Associated with Surgical Failure and Postoperative Voiding Dysfunction Following Burch Colposuspension or Pubovaginal Rectus Fascial Sling Surgery

Non Discussion Abstract Session 34 Read by Title 783 Efficacy outcomes of a low elasticity polypropylene transobturator midurethral sling for the treatment of female stress urinary incontinence: final data combined from two multi-center prospective clinical studies

Non Discussion Abstract Session 34 Read by Title 784 TWELVE-MONTH OBJECTIVE AND SUBJECTIVE OUTCOMES FROM A WORLDWIDE REGISTRY OF TENSION-FREE VAGINAL TAPES IN WOMEN WITH STRESS URINARY INCONTINENCE

Non Discussion Abstract Session 34 Read by Title 785 Menopausal status does and BMI does not influence to outcome of midurethral slings

Non Discussion Abstract Session 34 Read by Title 786 MULTICENTER STUDY FOR THE SURGICAL TREATMENT OF STRESS URINARY INCONTINENCE IN WOMEN WITH A SINGLE INCISION TOT TECHNIQUE. TWO YEARS FOLLOW UP

Podium Poster Session 8 Pelvic Floor 79 A high resolution 3D study of the female pelvis reveals important anatomical and pathological details of the pelvic floor

Non Discussion Abstract Session 34 Read by Title 790 Treatment of moderate to severe female stress Urinary incontinence with the Adjustable Continence Therapy device (ACT) after failed surgical repair

Non Discussion Abstract Session 34 Read by Title 793 MINIMIZING THE COST OF SURGICAL CORRECTION OF STRESS URINARY INCONTINENCE AND PROLAPSE

Non Discussion Abstract Session 34 Read by Title 795 Abdominal pressure transmission devices for urethral sphincters: in vitro effects and clinical outcomes

Non Discussion Abstract Session 34 Read by Title 798 Cost-effectiveness of outside-in transobturator slings (TOT) compared to retropubic slings (TVT) for treatment of female stress urinary incontinence

Podium Poster Session 8 Pelvic Floor 80 Development of a Tool for Visual Inspection of Pelvic Floor Muscle Coordination

Non Discussion Abstract Session 34 Read by Title 800 A two center experience with the transobturatory male sling system in patients with urinary incontinence following radical prostatectomy, early and midtime results of 171 patients

Non Discussion Abstract Session 34 Read by Title 801 HOME IN 3 HOURS: CONTEMPORARY LENGTH OF STAY WHEN USING A PERI-OPERATIVE CARE PATHWAY FOR MID-URETHRAL SLING SURGERY

Non Discussion Abstract Session 34 Read by Title 802 Salvage option for treatment of Stress Urinary Incontinence after a Failed Sling or Bladder Neck Suspension: The Bone-Anchored Sling

Non Discussion Abstract Session 34 Read by Title 809 Long term results of the Adjustable Continence Therapy (ACT®) for recurrent female stress urinary incontinence

Non Discussion Abstract Session 34 Read by Title 810 IS SLING STIFFNESS ASSOCIATED WITH POSTOPERATIVE VOIDING DYSFUNCTION? A COMPARISION OF TWO POLYPROPYLENE MIDURETHRAL SLINGS

Non Discussion Abstract Session 34 Read by Title 814 CLINICAL OUTCOMES IN PATIENTS UNDERGOING TVT-SECURTM FOR STRESS URINARY INCONTINENCE

Non Discussion Abstract Session 34 Read by Title 818 Cadaveric Assesment of Synthetic Mid-Urethral Sling Placement

Non Discussion Abstract Session 34 Read by Title 819 IS SHORT URETHRA LENGTH A NEGATIVE PREDICTOR FOR TOT-PROCEDURE OUTCOME?

Podium Poster Session 8 Pelvic Floor 82 Dynamic assessment of the vaginal high pressure zone using high definition manometry, 3-dimensional ultrasound & magnetic resonance imaging of the pelvic floor

Non Discussion Abstract Session 34 Read by Title 821 SUCCESS OF BULKING INJECTIONS FOR PATIENTS WITH SUBOPTIMAL RESPONSE TO SURGERY FOR STRESS URINARY INCONTINENCE (SUI)

Non Discussion Abstract Session 34 Read by Title 822 Assessment of the tape used in TVT-O surgery using transperineal 3D ultrasonography

Non Discussion Abstract Session 34 Read by Title 823 WHY BROAD BASED DOUBLE FORCED SLING BY USING ULTRAPROMESH ?

Non Discussion Abstract Session 34 Read by Title 825 Minimally invasive treatment for stress urodynamic incontinence after radical prostatectomy and salvage radiotherapy

Non Discussion Abstract Session 34 Read by Title 826 Adjustable incontinence therapy of fourty severe recurrent incontinence cases with the Remeex- System

Non Discussion Abstract Session 34 Read by Title 827 MiniArc single incision sling:1 year follow-up on a new minimally invasive treatment for female SUI

Non Discussion Abstract Session 34 Read by Title 829 The effect of body mass index on the result of the SPARC in patients with stress urinary incontinence

Non Discussion Abstract Session 34 Read by Title 831 A Novel "Needleless" Single-Incision Sling System: Results of 20 patients

Non Discussion Abstract Session 34 Read by Title 832 Does body mass index impact successful voiding following midurethral sling procedures for stress urinary incontinence?

Non Discussion Abstract Session 34 Read by Title 833 Transobturator suburethral tape versus single incision sling system: Comparison of efficacy for stress urinary incontinence with urgency

Non Discussion Abstract Session 34 Read by Title 835 Section and partial removal of tension-free vaginal tape used in the surgical treatment of Stress Urinary Incontinence. Causes and clinical results

Podium Poster Session 8 Pelvic Floor 84 Smooth muscle anchors the pelvic organs to the pelvic floor

Non Discussion Abstract Session 34 Read by Title 842 Long-term outcome of the tension-free vaginal tape for treatment of stress urinary incontinence in Southeast of China: results of efficacy and analysis of failure

Non Discussion Abstract Session 34 Read by Title 843 Referral Patterns and Complications of Midurethral Slings

Non Discussion Abstract Session 34 Read by Title 845 Mean Five-Year Follow-up of the Tension-Free Vaginal Tape Procedure for Treatment of Urinary Incontinence

Non Discussion Abstract Session 34 Read by Title 846 Five-year Outcomes of the IRIS procedure for Treatment of Female Stress Urinary Incontinence: Comparison with TVT procedure

Non Discussion Abstract Session 34 Read by Title 847 MiniArc™: short term results

Podium Poster Session 8 Pelvic Floor 85 Real 3D biomechanical models of pelvis and pelvic floor as the way to improve knowledge about incontinence

Non Discussion Abstract Session 34 Read by Title 851 SATISFACTION AND SAFETY WITH TVT-SECURE: A DISTRICT GENERAL HOSPITAL EXPERIENCE

Non Discussion Abstract Session 34 Read by Title 852 Ophira mini sling System: technique and results of a multicentre international clinical trial

Non Discussion Abstract Session 34 Read by Title 855 Long-term Follow-up of the Intravaginal Slingplasty (IVS) for Female Stress Urinary Incontinence

Non Discussion Abstract Session 34 Read by Title 856 Early results of transobturator sling suspension for male stress urinary incontinence

Non Discussion Abstract Session 34 Read by Title 858 Anterior prolapse surgery and Stress Urinary Incontinence. Is it worth to prevent?

Non Discussion Abstract Session 34 Read by Title 859 Midterm Data on Tension-Free Vaginal Tape Obturator Procedure for the Treatment of Stress Urinary Incontinence

Non Discussion Abstract Session 34 Read by Title 860 The results of redo operation of recurred incontinence in surgically managed patients

Non Discussion Abstract Session 34 Read by Title 863 Implantation of Adjustable Continence Therapy (ACT) for treatment of stress urinary incontinence in adults with neobladders

Non Discussion Abstract Session 34 Read by Title 864 SHOULD WE FEEL ‘SECUR’ USING SINGLE INCISION TAPE FOR URODYNAMIC STRESS INCONTINENCE?

Non Discussion Abstract Session 34 Read by Title 866 Effect of radiation therapy on patients implanted with ProACT : a preliminary report

Non Discussion Abstract Session 34 Read by Title 867 URODYNAMIC PROCEDURES ARE ON THE RISE IN THE UNITED STATES

Non Discussion Abstract Session 34 Read by Title 868 Bladder sensitivity index as a new urodynamic parameter in OAB patients

Non Discussion Abstract Session 34 Read by Title 873 Non invasive measurement of Valsalva leak point pressure – A new and innovative device

Non Discussion Abstract Session 34 Read by Title 876 A technically reduced urodynamic measuring method compared with a conventional urodynamic study

Non Discussion Abstract Session 34 Read by Title 877 Open Sacrocolpopexy and Rectopexy for Advanced Pelvic Organ & Rectal Prolapse with TVT/TVTO: Results and Complications

Non Discussion Abstract Session 34 Read by Title 878 Mini Sling: Does it Work for Low Cough Leak Point Pressures?

Non Discussion Abstract Session 34 Read by Title 879 Transcoccygeal Sacropexy using Nazca-R for posterior and apical vaginal prolapses

Non Discussion Abstract Session 34 Read by Title 880 Total Transvaginal Polypropylene Prolapse Repair with Sacrospinous Fixation & TVTO: Minimum 1-Year Follow-up

Non Discussion Abstract Session 34 Read by Title 881 Intermediate-term outcome after modified laparoscopic sacropexy: Improvement of vaginal symptoms and subjective success rates - A hospital based cohort study

Non Discussion Abstract Session 34 Read by Title 883 Short term outcomes of cystocele repair using the Perigee® polypropylene mesh kit

Podium Session 2 Pelvic Organ Prolapse COMPLICATIONS OF MESH KITS FOR PELVIC ORGAN PROLAPSE: A REVIEW OF MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE (MAUDE) DATABASES

Podium Poster Session 9 Male Incontinence 91 CORRELATION OF PENILE SHAFT AND URETHRAL GIRTH MEASUREMENTS: IMPLICATIONS FOR ARTIFICIAL URINARY SPHINCTER CUFF PLACEMENT

Podium Poster Session 9 Male Incontinence 92 SEVERE BLADDER NECK CONTRACTURE AND STRESS URINARY INCONTINENCE IN PATIENTS STATUS POST PROSTATECTOMY, RADIATION AND CRYOTHERAPY: SUCCESSFUL MANAGEMENT USING A TWO-STAGED APPROACH

Podium Poster Session 9 Male Incontinence 94 Urodynamic and clinical results of adjustable sling for male urinary incontinence - 32 months follow up - ARGUS® is effective also in severe cases

Podium Poster Session 9 Male Incontinence 95 OPTIMIZING ADVANCE™ SLING OUTCOMES VIA INTRAOPERATIVE URETHROSCOPIC CONFIRMATION OF SLING POSITIONING

Podium Poster Session 9 Male Incontinence 98 TRANSRECTAL ULTRASOUND-GUIDED IMPLANTATION OF THE PROACT™ SYSTEM IN PATIENTS WITH POST-RADICAL PROSTATECTOMY STRESS URINARY INCONTINENCE: CLINICAL RESULTS AFTER A MEAN FOLLOW UP OF 2 YEARS

ICS 2008

Podium Session 2 LUTS in Men 10 ANTIOXIDANT SUPPLEMENTATION INHIBITS THE PROCESS OF APOPTOSIS IN THE BLADDER WALL SUBJETED TO ANDROGEN DEPRIVATION

Podium Poster Session 12 Clinical Neurourology 100 Is a PVC-free catheter as well tolerated as a PVC catheter?A randomised multi-centre double blind study in experienced users of Clean Intermittent Catheterisation

Podium Poster Session 12 Clinical Neurourology 101 PNE vs 1st stage tined lead: which one is a better screening test for sacral neuromodulation?

Podium Poster Session 12 Clinical Neurourology 102 SACRAL NERVE MODULATION: RESULTS IN DOUBLE PELVIC FLOOR DYSFUNCTION

Podium Poster Session 13 Epidemiology 105 Genetic and Environmental Influences on Stress Urinary Incontinence: Results of a Large Population-Based Classical Twin Study

Podium Poster Session 13 Epidemiology 106 Nocturia is associated with chronic kidney disease

Podium Poster Session 13 Epidemiology 107 Prevalence and Risk Factors of Overactive Bladder in Korean Children 5-13 years old: A Nationwide Multicenter Study

Podium Poster Session 13 Epidemiology 109 An Epidemiological Study of Voiding and Defecation Habits in Korean Children 5-13 years old: A Nationwide Multicenter Study

Podium Poster Session 3 Male Incontinence & Voiding Dysfunction 11 Associations of lower urinary tract symptoms with prostate-specific antigen levels and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study

Podium Session 14 Basic Science 116 Adrenergic alpha1 receptor activation to heal damaged urothelium might contribute to normal micturition reflex

Podium Poster Session 3 Male Incontinence & Voiding Dysfunction 12 Is pressure-flow study useful to predict the outcome of transurethral resection of prostate?

Podium Poster Session 15 Stress Incontinence Surgery (2) 122 Does tape tension have an effect on the success rate of transobturator tape surgery?

Podium Poster Session 15 Stress Incontinence Surgery (2) 123 How can we determine proper tension for new minimally invasive sling surgery (TVT-secur)? : Prospective randomized study

Podium Poster Session 15 Stress Incontinence Surgery (2) 126 The results of SPARC procedure for female stress urinary incontinence stratified by preoperative Valsalva leak point pressure

Podium Poster Session 16 Paediatric Urology / Overactive Bladder 127 Nocturnal polyuria and nocturnal arginine vasopressin (AVP): a key factor in the patho-physiology of monosymptomatic nocturnal enuresis

Podium Poster Session 16 Paediatric Urology / Overactive Bladder 130 ALTERED MODULATION OF ADRENERGIC SIGNALING BY SMOOTH MUSCLE CAVEOLAE IN DETRUSOR OVERACTIVITY

Podium Poster Session 16 Paediatric Urology / Overactive Bladder 131 Microcirculation in the urinary bladder wall in OAB female patients

Podium Session 17 Pelvic Floor (2) 137 Assessing Pelvic Floor Dysfunction: Combined analysis of Static and Dynamic Magnetic Resonance Imaging Findings

Non Discussion Video Session 18 Video 139 Intraspinal nerve re-routing to reestablish bladder function in spinal cord injured patients

Podium Poster Session 3 Male Incontinence & Voiding Dysfunction 14 Determinant Factors affecting successful voiding trial without catheter (TWOC) after single intermittent catheterization for the acute urinary retention patients due to benign prostatic obstruction

Non Discussion Video Session 18 Video 141 Anterior and Posterior Vaginal Pelvic Floor Defect Repair with the Avaulta Biosynthetic Support System

Non Discussion Video Session 18 Video 142 The gentle laparoscopic sacrocolpopexy: Additional video presentation of the german method

Non Discussion Video Session 18 Video 146 Fast Implantation of an Artificial Urethral Sphincter Through a Peno-scrotal Approach

Non Discussion Video Session 18 Video 147 Implantation of an urethral artificial sphincter in a female patient

Non Discussion Video Session 18 Video 148 New surgical technique to implant InterStim lead guide by three dimensional multislice computer tomography

Non Discussion Video Session 18 Video 150 Application of EndoFast Reliant™ System - a novel soft tissue fastening technique for Pelvic Organ Prolapse repair

Non Discussion Video Session 18 Video 151 To Form Urethra-Vesical Angle for Treatment of Female Stress Urinary Incontinence: A Novel Technique

Non Discussion Video Session 18 Video 152 Implantation of two Interstim II neurostimulators with abdominal or buttock positioning

Non Discussion Video Session 18 Video 153 Sacrospinous ligament suspension treatment for severe hysterocele: a new technique "hysteropexy without mesh

Non Discussion Video Session 18 Video 156 Male Bulbourethral Sling with Tissue Fixation System (TFS): an option to urinary incontinence due to intrinsic sphincter deficiency

Non Discussion Poster Session 19 157 Levator Ani or Pelvic Diaphragm - What is in the name?

Non Discussion Poster Session 19 159 Histological assessment of vaginal wall at different stages of Pelvic Organ Prolapse

Non Discussion Poster Session 19 160 Topohistology of the female perineal membrane and cavernous nerve: a study using pelvic floor semiserial sections from elderly nulliparous and multiparous women

Non Discussion Poster Session 19 161 Perineal length: relationship between the length of the perineum and ethnic origin

Non Discussion Poster Session 19 162 Mid-Urethral Slings for Stress Urinary Incontinence: Applying Urethro-vesical Junction Descent to Predict Outcome

Non Discussion Poster Session 19 163 Proteomic analysis of vaginal tissues in women with pelvic organ prolapse using two-dimensional gel electrophoresis and mass spectrometry

Non Discussion Poster Session 19 166 Differences in the sensory innervation of the bladder base and bladder neck

Non Discussion Poster Session 19 167 The distribution of sensory fibres in the mouse bladder: possibly different classes of sensory nerve

Non Discussion Poster Session 19 169 The location and role of prostaglandin receptors (type 1: EP1) in the bladder and urethra

Podium Poster Session 3 Male Incontinence & Voiding Dysfunction 17 Early continence recovery after laparoscopic radical prostatectomy with or without restoration of posterior aspect of the rhabdosphincter

Non Discussion Poster Session 19 170 The localisation of cyclo-oxygenase immuno-reactivity (COX I-IR) in the urothelium and in the sub-urothelial interstitial cells of the bladder

Non Discussion Poster Session 19 171 THE PREVENTIVE EFFECTS OF VITAMIN E IN AGED DIABETIC RATS BLADDER AGAINST OXIDATIVE DAMAGE

Non Discussion Poster Session 19 173 Polymorphisms of COLIA1 and MMP-9 and risk of pelvic organ prolapse

Non Discussion Poster Session 19 174 Effects of pregnancy and delivery in the NGF expression in urethra rats

Non Discussion Poster Session 19 175 Interstitial cell nodes; a new structure in the normal bladder

Non Discussion Poster Session 19 177 Differential regional expression of connexin isotypes in bladder smooth muscle

Non Discussion Poster Session 19 179 SOLifenacin Alone and with simplified bladder Re-training in overactive bladder syndrome: the prospective, randomised SOLAR Study

Podium Poster Session 3 Male Incontinence & Voiding Dysfunction 18 Repair of iatrogenic sphincter damage and urinary incontinence by autologous skeletal muscle derived cells (MDC)

Non Discussion Poster Session 19 181 CB1 and CB2 Receptors in the Urinary Bladder of Different Species: Morphological and Functional Characterization

Non Discussion Poster Session 19 185 Solifenacin is not associated with cognitive impairment or sedation in the elderly: the randomised, double-blind SCOPE study

Non Discussion Poster Session 19 186 Solifenacin use in elderly patients with overactive bladder: VOLT and VERSUS data

Non Discussion Poster Session 19 187 FUNCTIONAL SELECTIVITY OF SVT-40776 A NEW SELECTIVE M3 ANTAGONIST FOR THE TREATMENT OF OVERACTIVE BLADDER

Non Discussion Poster Session 19 188 Influence of intravesical trospium chloride on the cholinergic activity of the isolated pig urinary bladder

Non Discussion Poster Session 19 189 MEASUREMENT OF DNA DAMAGE IN URINARY BLADDER TRANSITIONAL CELLS INDUCED BY LOW ESTROGEN LEVELS: INSIGHTS ON THE MENOPAUSAL STATUS

Podium Poster Session 3 Male Incontinence & Voiding Dysfunction 19 The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence

Non Discussion Poster Session 19 191 Detrusitol And multicomponent behavioral training For Overactive Bladder Syndrome: Are They Synergistic?

Non Discussion Poster Session 19 192 The efficacy of solifenacin 5/10mg on ‘urgency’ endpoints in different OAB patient populations: subanalysis of results from the randomised, double-blind SUNRISE study

Non Discussion Poster Session 19 193 Can Transdermal Oxybutynin Patches Reduce The Needs For Intravesical Botox Injections?

Non Discussion Poster Session 19 196 PATIENT CONTROLLED VERSUS AUTOMATIC STIMULATION TO TREAT NEUROGENIC DETRUSOR OVERACTIVITY

Non Discussion Poster Session 19 198 Prophylactic antibiotic use and urinary tract infections in patients receiving Botulinum Toxin injections into detrusor

Non Discussion Poster Session 19 199 Role of urgency in clinical manifestations of overactive bladder

Non Discussion Poster Session 19 200 Our experience with intradetrusor injection of Botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity

Non Discussion Poster Session 19 202 Incident morbidity and incontinence in nursing homes

Non Discussion Poster Session 19 203 Baseline data from a 15 years prospective cohort study of urinary incontinence in middle-aged women

Non Discussion Poster Session 19 204 Change in continence status in nursing home patients

Non Discussion Poster Session 19 206 Improvement in Quality of Life in Women Two Years after Undergoing the Burch Colposuspension or Fascial Sling Procedure

Non Discussion Poster Session 19 208 Learning with the Amerindians: strength of the pelvic floor muscle and prevalence of organ pelvic prolapse among indigenous women who lives in the Xingu Indigenous Park, MT, Brazil

Podium Poster Session 3 Male Incontinence & Voiding Dysfunction 21 LOW TESTOSTERONE LEVELS LEAD TO THE DEVELOPMENT OF OXIDATIVE STRESS AND COLLAGEN DEPOSITION IN THE MALE RAT URETHRAL SPHINCTER

Non Discussion Poster Session 19 215 LOW BODY MASS INDEX IS AN INDEPENDENT RISK FACTOR FOR FEMALE NOCTURIA

Non Discussion Poster Session 19 216 UROGYNECOLOGY TRIAGE CLINIC:OPTIMAL MODEL OF HEALTHCARE DELIVERY?

Non Discussion Poster Session 19 219 Incontinence, breathing disorders and back pain: an inseparable triad?

Non Discussion Poster Session 19 220 The Risk Factors for Female Urinary Incontinence among Middle-aged Korean Women

Non Discussion Poster Session 19 221 Detection and Prevalence of Urinary Incontinence in Low-Income and Minority Female Patients

Non Discussion Poster Session 19 222 DOES MATURATION OF BLADDER/BOWEL SPHINCTER CONTROL IN CHILDHOOD AFFECT VOIDING HABITS IN ADULT LIFE? A QUESTIONNAIRE BASED STUDY IN 130 YOUNG ADULTS

Non Discussion Poster Session 19 225 Urethral incontinence in post repair genitourinary obstetric fistula

Non Discussion Poster Session 19 226 Experience with complex vesico-vaginal fistula repair: Is the vaginal surgery always granted ?

Podium Poster Session 4 Basic Neurourology 23 Temporal expression of muscarinic and purinergic receptors in diabetic rat bladder

Non Discussion Poster Session 19 230 NOCTURIA IS THE MAIN IRRITATIVE SYMPTOM THAT BRINGS THE OLDER MEN TO THE UROLOGIST

Non Discussion Poster Session 19 231 Urinary incontinence in nursing home residents: is it being promoted by nursing home staff?

Non Discussion Poster Session 19 233 The use of absorbent pads increases the risk for lower urinary tract infections in nursing homes residents

Non Discussion Poster Session 19 234 Older peoples' experiences of living with a long-term urinary catheter

Non Discussion Poster Session 19 235 Information needs of older people with urinary incontinence aged 60 and older

Non Discussion Poster Session 19 237 Persistent anal sphincter defects after primary repair of Obstetric Anal Sphincter Injuries (OASIS) - Does it affect quality of life?

Non Discussion Poster Session 19 239 Translabial ultrasound compared to International Continence Society POPQ scoring system and Colpo-cysto-defecography in clinically relevant patients

Non Discussion Poster Session 19 240 Dynamic MR Imaging Before and After Pelvic Reconstruction Surgery for Patients with Pelvic Organ Prolapse

Non Discussion Poster Session 19 241 Three-dimensional pelvis: new method of teching female pelvic anatomy

Non Discussion Poster Session 19 243 Reconstruction of Three Dimensional Structure of the Urethra from Endoscopic Video Image

Non Discussion Poster Session 19 244 Significance of fibrosis around and/or at external urinary sphincter on pelvic magnetic resonance imaging in patients with postprostatectomy incontinence

Non Discussion Poster Session 19 245 COMPARISON OF OESTRADIOL AND OESTRIOL INFLUENCE ON PULSATILITY INDICES IN PERIURETHRAL VESSELS IN WOMEN SUFFERING FROM URINARY STRESS INCONTINENCE

Non Discussion Poster Session 19 246 ANGULATION OF THE PROSTATIC URETHRA IS RELATED TO VOIDING SYMPTOMS IN BENIGN PROSTATIC HYPERPLASIA

Non Discussion Poster Session 19 249 3D-endovaginal ultrasound in the assessment of the pelvic floor structures in nulliparous and primiparous women-a preliminary study

Non Discussion Poster Session 19 250 Perineal ultrasound parameters in women with stress urinary incontinence before and after TVT-O procedure

Non Discussion Poster Session 19 251 German Artificial Sphincter Systems -GASS III:The first generation of a remote-controlled artificial sphincter prosthesis for the therapy of high-grade fecal- and urinary - incontinence

Non Discussion Poster Session 19 252 ARGUS®. a new adjustable sling in the low invasive treatment ofpost prostatectomy incontinence

Non Discussion Poster Session 19 257 Long term follow-up of the Male Readjustable Sling (Male Remeex System) for the surgical treatment of Male urinary incontinence

Non Discussion Poster Session 19 258 Dislodged Screws after Bone-anchored Sub-urethral Sling procedure: a considerable cause of sling failure

Non Discussion Poster Session 19 259 Transrectal ultrasound guided ProACT system implantation under local anaesthesia in patients with post-radical prostatectomy stress urinary incontinence: evaluation of objective pain, subjective discomfort and patient satisfaction

Podium Poster Session 4 Basic Neurourology 26 GRC 6211, a new oral TRPV1 antagonist, decreases neurogenic detrusor overactivity in a rat model of spinal cord transection

Non Discussion Poster Session 19 260 Radical prostatectomy (RP) and sphincter damage - What can we learn from pitfalls ?

Non Discussion Poster Session 19 264 ARGUS adjustable male sling - a new surgical method in the treatment of urinary incontinence in men

Non Discussion Poster Session 19 265 Physiotherapeutic for Treatment of Post Radical Prostatectomy Urinary Incontinence

Non Discussion Poster Session 19 266 Obstetric Anal Sphincter Injury In The UK And Its Effect On Bowel, Bladder And Sexual Function in 2008

Non Discussion Poster Session 19 267 Improvements In Bowel Dysfunction, Sexual And Prolapse Symptoms Following Posterior Avaulta

Podium Poster Session 4 Basic Neurourology 27 TRANSIENT RECEPTOR POTENTIAL A1 (TRPA1) ION CHANNEL ACTIVITY IN THE HUMAN URETHRA - EVIDENCE FOR A FUNCTIONAL ROLE FOR TRPA1 IN THE OUTFLOW REGION

Non Discussion Poster Session 19 270 Can sensory and motor reactions during Peripheral Nerve Evaluation predict outcome of Sacral Nerve Modulation?

Non Discussion Poster Session 19 271 LOW LEVELS OF TESTOSTERONE INDUCE THE GENERATION OFF FREE RADICALS AS WELL AS APOPTOSIS IN THE ANAL SPHINCTER, WHICH CAN BE AVOIDED TROUGH ALPHA TOCOFEROL SUPPLEMENTATION

Non Discussion Poster Session 19 275 Functional and morphological effects of urinary diversion in rat

Non Discussion Poster Session 19 277 The role of nitric oxide in the origin of lower urinary tract symptoms and the potential of PDE5 inhibitors for treatment of void dysfunction

Non Discussion Poster Session 19 278 ANTIOXIDANT SUPPLEMENTATION DECREASES THE CELL DEATH IN THE PROSTATIC STROMAL TISSUE IN LONG-TERM CASTRATED RATS

Non Discussion Poster Session 19 281 The relationship between lower urinary tract symptom and metabolic syndrome in a community based elderly population

Non Discussion Poster Session 19 282 The role of sub-clinical prostatitis on symptoms of BPH patients

Non Discussion Poster Session 19 284 COMPARISON OF LOWER URINARY TRACT SYMPTOMS (LUTS) BETWEEN MEN UNDERGOING SCREENING FOR PROSTATE DISEASE AND OUTPATIENTS WITH LUTS

Non Discussion Poster Session 19 286 The Effect of Periurethral Prostatic Calculi on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia

Podium Poster Session 4 Basic Neurourology 29 EFFECTS OF AN ANTI-MUSCARINIC AGENT AND AN ALPHA-1 RECEPTOR ANTAGONIST ON PLASMA MONOAMINE LEVELS, URINARY ATP LEVEL AND BLADDER ACTIVITY AFTER BLADDER STIMULATION IN RATS

Non Discussion Poster Session 19 290 Impacts of Diabetic Conditions on Lower Urinary Tract Symptoms (LUTS) in Patient with Diabetes

Non Discussion Poster Session 19 294 Effect of Tamsulosin in Benign Prostatic Hyperplasia Patients Who were Treated with Spinal Anesthesia: Preventing the Acute Urinary Retention

Non Discussion Poster Session 19 297 The effectiveness and safety of Transurethral resection of prostate(TURP) in combination with Photoselective vaporization(PVP) of BPH patients with a greater than 45cc

Non Discussion Poster Session 19 299 Clinical efficacy of naftopidil in the treatment of lower urinary tract symptoms after radical prostatectomy

Non Discussion Poster Session 19 302 Risk Factors and Urodynamic Features Associated with Fecal Incontinence in Women with Lower Urinary Tract Symptoms

Non Discussion Poster Session 19 308 STRESS URINARY INCONTINENCE AND OTHER LOWER URINARY TRACT SYMPTOMS (LUTS) IN ELITE VOLLEYBALL FEMALE ATHLETES

Non Discussion Poster Session 19 310 Risk factors for overactive bladder syndrome in women during the late reproductive years

Non Discussion Poster Session 19 311 Patient perceptions of overactive bladder and the effect on compliance with drug therapy

Non Discussion Poster Session 19 312 Bladder symptoms in the young menopausal women: A District General Hospital experience

Non Discussion Poster Session 19 313 Sacral Neuromodulation and Cardiac Pacemakers

Non Discussion Poster Session 19 323 Is IPSS worthy in the evaluation of women with stress urinary incontinence ?

Non Discussion Poster Session 19 325 Relationships between reproductive hormones, lower urinary tract symptoms, menopause symptoms and quality of life among a sample of women 40 to 60 years of age

Non Discussion Poster Session 19 327 THE EFFECT OF TAMSULOSIN ON BLADDER MICROCIRCULATION IN BLADDER ISCHEMIC/REPERFUSION MODEL RATS

Non Discussion Poster Session 19 329 Neuroselective Stimulation of Autonomic Afferent Pathways of the Rat Bladder

Podium Poster Session 4 Basic Neurourology 33 Effects of intrathecal of serotonin on bladder activity, urethral activity, and amino acid levels in the lumbosacral cord of rat

Non Discussion Poster Session 19 330 EFFECTS OF N-ARACHIDONOYL-(2-METHYL-4-HYDROXYPHENYL) AMINE (VDM11), AN ANANDAMIDE TRANSPORTER INHIBITOR, ON THE MICTURITION REFLEX IN URETHANE-ANESTHETIZED RATS

Non Discussion Poster Session 19 332 Role of Varenicline on the voiding function in rat

Non Discussion Poster Session 19 333 COMPARATIVE STUDIES OF MUSCARINIC-MEDIATED CONTRACTILE RESPONSES OF DETRUSOR SMOOTH MUSCLE FROM CONTROL AND NEUROGENIC BLADDER DYSFUNCTION PATIENTS

Non Discussion Poster Session 19 334 BLADDER FUNCTIONS RECOVERY IN TRAUMATIC SPINAL CORD INJURY AFTER TRANSPLANTATION OF NEURONAL-GLIAL RESTRICTED PRECURSORS OR BONE MARROW STROMAL CELLS

Non Discussion Poster Session 19 337 Temporal Effects of Vaginal Distension and Bilateral Pudendal Nerve Transection on Leak-Point Pressure and Urethral Anatomy in Female Mice

Non Discussion Poster Session 19 339 EFFERENT PROJECTIONS FROM MICTURITION SUPPRESSING REGION IN THE PERIAQUEDUCTAL GRAY OF THE MESENCEPHALON

Non Discussion Poster Session 19 342 The Effect of Cyclohexenonic Long-Chain Fatty Alcohol on STZ-Induced Diabetic Rats

Non Discussion Poster Session 19 346 Schwann cells - The new hope in urinary bladder wall graft innervation, Schwann cells isolation method

Non Discussion Poster Session 19 347 pCREB immunohistochemical staining of dorsal root ganglia after acute and repeated urinary pathogenic E. coli infection into rat bladder

Non Discussion Poster Session 19 348 Standardization of Laparoscopic Bladder Autoaugmentation in Dogs

Non Discussion Poster Session 19 355 Myelomeningocele (MMC):can we trust on the clinical history of children who refer good sphincterian control and preserved micturition

Non Discussion Poster Session 19 357 Dysfunctionality of the sense of spatial orientation in the Alzheimer's process in the base of the frequent incontinence

Non Discussion Poster Session 19 359 COMPARISON OF CONVENTIONAL AND AMBULATORY URODYNAMIC FINDINGS IN PATIENTS WITH SPINAL CORD INJURY

Non Discussion Poster Session 19 360 Intermittent catheterization in long period of time: problems and benefits

Non Discussion Poster Session 19 361 Histopathology of interstitial cystitis - hydrodistension matters?

Non Discussion Poster Session 19 365 A proposal of a new animal model for the evaluation of bladder pain in rats

Non Discussion Poster Session 19 367 RETROSPECTIVE CHART REVIEW OF PATIENTS TREATED WITH SANS (STOLLER AFFERENT NERVE STIMULATION) AND OR TENS (TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION) FOR THE TREATMENT OF INTERSTITIAL CYSTITIS / PAINFUL BLADDER SYNDROME (IC/PBS)

Non Discussion Poster Session 19 368 The long term effect of electrostimulation of the pelvic floor on painful bladder syndrome/interstitial cystitis patients

Non Discussion Poster Session 19 370 THE EFFECT OF FAMILIAL AGGREGATION ON THE CHILDREN WITH PRIMARY NOCTURNAL ENURESIS

Non Discussion Poster Session 19 371 Urinary Bladder Overdistension May Impair the Voiding Function of Kindergarten Children

Non Discussion Poster Session 19 373 Variability in Post-Void Residual Urine of Preschool Children

Non Discussion Poster Session 19 375 Effect of School Environment on Voiding and Defecation Habits in Korean Children 5-13 years old: A Nationwide Multicenter Study

Non Discussion Poster Session 19 376 Increased secretion levels of prostaglandin E2 in the urinary bladder of boys less than 4 years of age

Non Discussion Poster Session 19 379 Validating ultrasound genitohiatal parameters for assessment of pelvic floor muscle function

Non Discussion Poster Session 19 380 Factors affecting pelvic floor muscle endurance - results from a population study

Non Discussion Poster Session 19 381 Relationship between abdominal and pelvic muscles electromyographic activity at rest and during maximal pelvic floor muscle contraction changing ankle inclination in standing position in women with and without stress urinary incontinence

Non Discussion Poster Session 19 383 Patients with stage 2 or more cystocele or rectocele following primary POP surgery report only limited pelvic floor dysfunction

Non Discussion Poster Session 19 384 Expression of progesterone receptor and estrogen receptor alpha and beta in vaginal wall and periurethral tissue in urogynecological patients

Non Discussion Poster Session 19 386 What factors affect pelvic floor strength?

Non Discussion Poster Session 19 389 POST-RADICAL PROSTATECTOMY INCONTINENCE: ULTRASONOGRAPHIC CHANGES OF THE STRIATED URETHRAL SPHINCTER AFTER PELVIC FLOOR MUSCLE TRAINING

Podium Poster Session 5 Pelvic Floor (1) 39 3D modelling of pelvic floor pressures using MRI for evaluating prolapse and obstructed defecation versus asymptomatic controls

Non Discussion Poster Session 19 390 Breathing with the pelvic floor: Coordinated activity of the pelvic floor muscles during inspiratory and expiratory efforts

Non Discussion Poster Session 19 391 Considerations upon the Kinesiology of The Pelvic Floor Striated Muscles

Non Discussion Poster Session 19 392 Can Primary Care Nurses be taught to provide pelvic floor muscle training in the community?

Non Discussion Poster Session 19 393 COMPARISON OF THE EFFECTS OF ANTIMUSCARINIC AGENTS ON AUTONOMIC NERVOUS SYSTEM, URINARY ATP LEVEL AND BLADDER ACTIVITY IN RATS

Non Discussion Poster Session 19 394 M2 receptor activation modulates detrusor contractions via cAMP inhibition

Non Discussion Poster Session 19 396 Comprehensive studies of ATP-sensitive potassium channels in pig and human detrusor smooth muscle cells

Non Discussion Poster Session 19 397 Proliferation activity of cultured pubocervical fascia fibroblasts obtained from menopausal women suffered from stress urinary incontinence

Non Discussion Poster Session 19 398 Inhibitory effect of L-type voltage dependent calcium channel (VDCC) blocker and ethanol on the urinary bladder contraction of rat

Podium Session 1 Stress Incontinence Surgery (1) LEAKAGES CIRCUMSTANCES: NEW FACTORS INFLUENCING THE OUTCOME OF SUBURETHRAL SLING PROCEDURES FOR FEMALE URINARY INCONTINENCE

Non Discussion Poster Session 19 401 Luminal but not basolateral ATP affects urothelial transepithelial potential and ionic flux

Non Discussion Poster Session 19 403 IMPROVEMENT OF DETRUSOR OVERACTIVITY BY ALPHA-1 ADRENOCEPTOR ANTAGONIST VIA SUPPRESSION OF ATP RELEASE FROM THE BLADDER EPITHELIUM IN AGED SPONTANEOUSLY HYPERTENSIVE RATS

Non Discussion Poster Session 19 404 Is any difference produced in urodynamic studies when conducted with water and own urine?

Non Discussion Poster Session 19 407 Title: Korean red ginseng reduces ischemia/reperfusion-induced oxidant stress and dysfunction of bladders via increased SOD expression in the rats

Non Discussion Poster Session 19 409 Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity

Podium Poster Session 5 Pelvic Floor (1) 41 Female sexual dysfunction: are urogynaecologists ready for it?

Non Discussion Poster Session 19 412 The effect of insulin on the contraction response of the smooth muscle of the bladder in spontaneously hypertensive rats

Non Discussion Poster Session 19 413 Relaxant effects of Udenafil (DA-8159) on the bladder and urethra: an in-vitro and in-vivo study

Non Discussion Poster Session 19 415 Effect of Ginsenoside-Rg1 on the Proliferation of Paraurethral Fascia Fibroblasts Derived from Women Suffering from Stress Urinary Incontinence

Non Discussion Poster Session 19 416 Effects of Tamsulosin and Tolterodine extended release on lower urinary tract symptoms developed from ureteral stent: prospective study

Non Discussion Poster Session 19 419 PHARMACODYNAMICS OF SVT-40776 IN OVERACTIVE BLADDER PATIENTS

Podium Poster Session 5 Pelvic Floor (1) 42 MANAGEMENT OF PELVIC ORGAN PROLAPSE BY VAGINAL PESSARIES - ONE YEAR FOLLOW UP

Non Discussion Poster Session 19 421 EVALUATION OF BLADDER FUNCTION AFTER SPINAL ANESTHESIA FOR CESAREAN SECTION

Non Discussion Poster Session 19 422 A retrospective study of perineal trauma following vaginal delivery

Non Discussion Poster Session 19 423 Audit on perineal injury involving anal sphincter complex and epithelium (fourth degree perineal tears) at child birth

Non Discussion Poster Session 19 424 Evaluation of the Management of Postpartum Voiding Dysfunction

Non Discussion Poster Session 19 425 Specialist Perineal Midwifery: Development and Evaluation of a New Innovative Service for Women with Peripartum Pelvic Floor Dysfunction and Childbirth Injury

Non Discussion Poster Session 19 428 Pathophysiological correlates of subjective measures of symptom severity for stress urinary incontinence

Non Discussion Poster Session 19 429 A simple quality of life questionnaire for patients with faecal incontinence

Non Discussion Poster Session 19 432 The evaluation of urinary incontinence among Brazilian female athletes who participated in XV Pan American Games, 2007

Non Discussion Poster Session 19 436 THE IMPACT OF CLEAN INTERMITENT SELF CATHETERIZATION ON QUALITY OF LIFE OF NEUROGENIC AND NON-NEUROGENIC PATIENTS

Non Discussion Poster Session 19 437 Have Trends in Help Seeking Behavior for Urinary Incontinence Improved?

Non Discussion Poster Session 19 439 Implant materials used as scaffold for rat mesenchimal stem cells growth: an in vitro study

Podium Poster Session 5 Pelvic Floor (1) 44 Modified collagen matrix versus standard polypropylene: biomechanical fate and inflammatory response over the two years period in a rabbit abdominal wall model for fascial reconstruction

Non Discussion Poster Session 19 441 Total Prolift System® surgery for treatment of vaginal cuff prolapse - do we treat both: anatomy and function?

Non Discussion Poster Session 19 442 Magnetic resonance imaging of abdominal versus vaginal prolapse surgery with mesh

Non Discussion Poster Session 19 443 Transverse colon for continent urinary diversion: experimental study comparing two techniques

Non Discussion Poster Session 19 444 UNDIAGNOSED ACUTE OBSTETRIC ANAL SPHINCTER INJURIES (OASIS) - AN OPPORTUNITY LOST?

Non Discussion Poster Session 19 447 One day versus three day suprapubic catheterisation after vaginal prolapse surgery: a randomized controlled trial

Non Discussion Poster Session 19 450 Predictors of therapeutic effects of the primary endoscopic urethral realignment in male urethral injury

Non Discussion Poster Session 19 453 2-points, half-sized vs. 4-points, full-sized anterior transobturator polypropylene mesh in the correction of anterior vaginal wall prolapse

Non Discussion Poster Session 19 455 Management of Mesh Erosion Following Prolapse and Continence Surgery

Non Discussion Poster Session 19 459 Tension free vaginal mesh: A hope for cure or a harbinger of trouble?

Non Discussion Poster Session 19 460 Polypropylene mesh in surgical repair of pelvic organ prolapses

Non Discussion Poster Session 19 463 Efficacy of sacrospinous ligament fixation for apical prolapse

Non Discussion Poster Session 19 464 OUTCOME OF ANTERIOR VAGINAL WALL SPARING DURING FEMALE RADICAL CYSTECTOMY WITH ORTHOTOPIC URINARY DIVERSION

Non Discussion Poster Session 19 465 Long Term Follow Up after Undiversion of the Urinary Tract

Podium Poster Session 6 Lower Urinary Tract Assessment 47 Effect of Prolyl 4-hydroxylase Inhibitor on the Bladder Fibrosis in the Rat Model with Partial Bladder Outlet Obstruction

Non Discussion Poster Session 19 470 Analysis of clinical factors for recovery or not from urinary retention after non-urologic surgery

Non Discussion Poster Session 19 472 HOW DOES THE PAIN INTERFERE ON THE PATIENT´S ADHERENCE TO CLEAN INTERMITENT SELF CATHETERIZATION?

Non Discussion Poster Session 19 474 INTENSIVE PELVIC FLOOR REHABILITATION IN FEMALE URINARY INCONTINENCE: 10 YEARS LATER

Non Discussion Poster Session 19 475 Effects of ankle inclination on abdominal and pelvic muscles electromyographic activity at rest and during maximal pelvic floor muscle contraction in supine position in women with and without stress urinary incontinence

Non Discussion Poster Session 19 476 HOW TO EXPLAIN PATIENT´S ADHERENCE TO A CLEAN INTERMITENT SELF- CATHETERIZATION PROGRAM?

Non Discussion Poster Session 19 477 Application of Korean traditional dance to treat stress incontinence - possibility for being a complement and substitute for pelvic muscle exercises

Podium Poster Session 6 Lower Urinary Tract Assessment 48 SOMATOSTATIN RECEPTOR SUBTYPE 4-MEDIATED REGULATION OF MICTURITION REFLEX IN URETHANE-ANESTHETIZED RATS

Non Discussion Poster Session 19 481 The SPARC procedure for the treatment of female stress urinary incontinence in the elderly

Non Discussion Poster Session 19 483 One Year Results of the Adjustable Continence Therapy (ACT®) System in the North America ACT® Clinical Study Group

Non Discussion Poster Session 19 484 Retropubic or transobturator out-in or in-out sling? A prospective randomized study!

Non Discussion Poster Session 19 489 Raz needle suspension of the bladder neck for stress urinary incontinence: medium-term and long-term results

Non Discussion Poster Session 19 490 Observational Study On The Implantation of the TVT-SECUR Under Local Anesthesia

Non Discussion Poster Session 19 492 Managements of voiding difficulty immediately after midurethral sling procedure in female stress urinary incontinence

Non Discussion Poster Session 19 493 Preliminary results of peri-operative and 3-month outcomes from a world-wide observational registry of tension-free vaginal tapes in women with stress urinary incontinence

Non Discussion Poster Session 19 494 FlowSecure Artificial Urinary Sphincter: Clinical Experience, Management and Results

Non Discussion Poster Session 19 496 Can Preoperative Valsalva Leak Point Pressure Predict Outcome of Mid-Urethral Slings?

Non Discussion Poster Session 19 497 Day case trans-obturator tape insertion: the patient preference

Non Discussion Poster Session 19 498 TOA adjustable mesh for surgical treatment of female stress urinary incontinence

Non Discussion Poster Session 19 499 Macroplastique® Implantation System for the treatment of urodynamic stress urinary incontinence caused by urethral hypermobility in adult women after non-successful conservative treatment: a randomized clinical trial

Podium Session 2 LUTS in Men Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study

Non Discussion Poster Session 19 500 Intraoperative measurement of maximal urethral closing pressure: A new technique for tape tension adjustment during TOT surgery

Non Discussion Poster Session 19 501 An Early Clinical Evaluation of the MiniArc Performed Under General or Local Anesthesia for the Treatment of Stress Urinary Incontinence

Non Discussion Poster Session 19 504 The implications of periurethral Zuidex on subsequent tension free tape insertion

Non Discussion Poster Session 19 505 Clinical effectiveness of retropubic versus transobturator tape in women with intrinsic sphincter defficiency (ISD) - two centers data

Non Discussion Poster Session 19 506 The effect of transobturator tape for treatment of stress urinary incontinence on female sexual functioning

Non Discussion Poster Session 19 507 Effects of mesh shortening in failed midurethral sling procedures in female stress urinary incontinence

Non Discussion Poster Session 19 509 TVT-Obturator for Urinary Stress Incontinence: higher cure rate with concomitant colporraphy

Non Discussion Poster Session 19 510 Mid-term results of the readjustable sling system in female patients with stress urinary incontinence

Non Discussion Poster Session 19 513 Sexual function in women before and after suburethral slingoperation for stress urinary incontinence

Non Discussion Poster Session 19 515 Clinical effectiveness of retropubic (IVS-02) and transobturator (IVS-04) slings in the treatment of female stress urinary incontinence - a semi-randomized trial on 398 patients

Non Discussion Poster Session 19 517 Pubo-vaginal sling using cadaveric fascia lata in the treatment of female stress urinary incontinence due to a sphincteric deficiency: our experience with a 10-year follow-up

Non Discussion Poster Session 19 518 The Remeex System For Refractory Female Stress Urinary Incontinence

Podium Poster Session 6 Lower Urinary Tract Assessment 52 Electromyography and Voiding Cystourethrography Are Both Necessary for Detection of Detrusor Sphincter Dyssynergia

Non Discussion Poster Session 19 520 POST RADICAL HYSTERECTOMY URINARY INCONTINENCE: A PROSPECTIVE STUDY OF TRANSURETHRAL BULKING AGENTS INJECTION

Non Discussion Poster Session 19 526 Factors Influencing Success of Periurethral injection of Macroplastique

Non Discussion Poster Session 19 527 Systemic and Local Inflammatory Response in Collagen vs. Polypropylene Tapes for Stress Urinary Incontinence: is there any difference?

Non Discussion Poster Session 19 528 Changes of voiding pattern after transobturator tape operation in patients with female stress urinary incontinence

Non Discussion Poster Session 19 529 Experience of REMEEX system for the treatment of female urinary incontinence, intrinsic sphinteric deficiency and neurogenic bladder

Podium Poster Session 6 Lower Urinary Tract Assessment 53 Viability of a novel electrode to record activity of the male Rhabdosphincter

Non Discussion Poster Session 19 531 A NOVEL MAGNETIC DEVICE TO PREVENT URINARY INCONTINENCE

Non Discussion Poster Session 19 533 Treatment of female stress urinary incontinence with three different tapes - a four-year experience

Non Discussion Poster Session 19 536 Outcomes of Tension-free Vaginal Tape Procedure performed simultaneously with Vaginal Hysterectomy for Female Stress Urinary Incontinence

Non Discussion Poster Session 19 537 TVT secur® - first experiences after a follow-up of 17 months

Non Discussion Poster Session 19 539 Role of urodynamic examination on the evaluation of non-neurological female urinary incontinence

Non Discussion Poster Session 19 540 The long term follow up of myelodysplastic patients with Videourodynamic findings after augmentation Ileocystoplasty: is warranted?

Non Discussion Poster Session 19 541 Higher Index of Suspicion for Neurologic Disease Is Warranted if Rectal Contractions Occur During Urodynamic Testing

Non Discussion Poster Session 19 542 The additional value of ambulatory urodynamic studies in patients with an overactive bladder syndrome and patients with an acontractile detrusor

Non Discussion Poster Session 19 546 Screening for UTI before urodynamics - Are we doing the right test?

Non Discussion Poster Session 19 547 UROFLOWMETRIC EVALUATION PRE AND POST TRANSOBTURATOR SLING IN PATIENTS WITH PURE AND MIXED STRESS URINARY INCONTINENCE

Non Discussion Poster Session 19 548 RECTAL CONTRACTIONS DURING URODYNAMICS. AN ARTIFACT OR SIGN OF NEUROPATHY?

Non Discussion Poster Session 19 549 Relation between Intra-abdominal pressure variation and urethral hypermobility : the urethral mobility index

Podium Poster Session 6 Lower Urinary Tract Assessment 55 Can pressure flow study predict the clinical outcome after photoselective vaporization prostatectomy?

Non Discussion Poster Session 19 553 False Negative Rate of Urodynamic Testing in Diagnosing Occult Incontinence in Patients with Advance Prolapse

Non Discussion Poster Session 19 554 URODYNAMIC DIFFERENCES BETWEEN DETRUSOR OVERACTIVITY CAUSED BY MULTIPLE SCLEROSIS AND IDIOPATHIC DETRUSOR OVERACTIVITY

Non Discussion Poster Session 19 555 Is A Closed Bladder Neck On Preoperative Videourodynamic Finding An Important Factor For Continence Following Augmentation Ileocystoplasty In Myelodysplastic Patients?

Non Discussion Poster Session 19 559 IS THE URODYNAMIC A RELIABLE TEST TO EVALUATE POST VOID URINARY RESIDUAL AND BLADDER CAPACITY?

Non Discussion Poster Session 19 564 Combined pelvic reconstructive surgery with and without using Perigee trans-obturator mesh in women with severe prolapse: a comparison in a minimum follow up of one year

Non Discussion Poster Session 19 570 Significance of Positive Urine Dipstick In Asymptomatic Patients with Advance Prolapse

Non Discussion Poster Session 19 571 Patients’ preference in treatment of vaginal vault prolapse. Pessary use versus prolapse surgery

Non Discussion Poster Session 19 572 Role of Uterine Position in Occult Incontinence Among Patient with Advance Prolapse

Non Discussion Poster Session 19 575 RCOG Clinical Standards in Urogynaecology and Menopause- A Postal Questionnaire Study

Non Discussion Poster Session 19 578 Transvaginal surgery with biologic and synthetic meshes for anterior vaginal wall prolapse - a four-year experience

Non Discussion Poster Session 19 579 Endo-anal or transperineal rectocele repair? A single centre experience

Podium Poster Session 6 Lower Urinary Tract Assessment 58 Long term urodynamics results in sigmoid orthotopic neobladder

Non Discussion Poster Session 19 580 Transvaginal sacrcospinous ligament fixation for pelvic organ prolapse

Non Discussion Abstract Session 20 Read by Title 581 Treatment with Oxybutynin, Imipramine and Doxazosin in patients with refractory detrusor overactivity: results and side effects

Non Discussion Abstract Session 20 Read by Title 582 Patients reporting severe overactive bladder symptoms: Effects of solifenacin treatment on objective measures and patient-reported outcomes

Non Discussion Abstract Session 20 Read by Title 583 Assessment method of severity OAB symptoms

Non Discussion Abstract Session 20 Read by Title 584 Tolterodine Immediate Release improves sexual function in women with overactive bladder

Non Discussion Abstract Session 20 Read by Title 585 OAB patient satisfaction and improved perception of bladder condition with darifenacin

Non Discussion Abstract Session 20 Read by Title 586 Effect of Anticholinergics on Female Sexual Function

Podium Session 7 Anatomy & Imaging 59 Anatomy of the Urethral Supporting Ligaments Defined by Dissection,Histology, and MRI of Female Cadavers and MRI of Healthy Nulliparous Women

Non Discussion Abstract Session 20 Read by Title 591 Farsi Translation of the Short Form of Over Active Bladder Questionnaire (OABQ_SF)

Non Discussion Abstract Session 20 Read by Title 594 Urgency is the key symptom of overactive bladder symptoms, as demonstrated by a community-based survey and statistical analysis

Non Discussion Abstract Session 20 Read by Title 596 Prevalence of Urinary Incontinence in Men and Women aged 65 and over in the city of São Paulo, Brazil

Non Discussion Abstract Session 20 Read by Title 597 LOWER URINARY TRACT SYMPTOMS, SEX AND QUALITY OF LIFE RELATED ISSUES IN HEALTHY YOUNG WOMEN

Non Discussion Abstract Session 20 Read by Title 599 The Effect Of Triple Medication Treatment For Bladder-Sphincter Dyssynergia On The Development Of Complications In Persons With Spinal Cord Injury

Podium Session 2 LUTS in Men Longitudinal non-invasive follow-up of changes in urinary bladder function secondary to benign prostatic enlargement. Results of the first observation interval

Non Discussion Abstract Session 20 Read by Title 601 Fistula Camp (Out reach Program), Rehabilitation and Community Fistula Advocates Orientation Program in Bangladesh

Non Discussion Abstract Session 20 Read by Title 604 SOCIO-SANITARY SURVEY ON URINARY INCONTINENCE IN SPAIN, 2008

Non Discussion Abstract Session 20 Read by Title 606 Correlation between lower urinary tract symptoms and sexual function in benign prostatic hyperplasia

Non Discussion Abstract Session 20 Read by Title 608 A comparative study on the clinical effects of silodosin and naftopidil in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia

Podium Session 7 Anatomy & Imaging 61 Comparative study of the pubovisceral muscle at rest using three dimensional perineal ultrasound and magnetic resonance imaging

Non Discussion Abstract Session 20 Read by Title 611 The Development and Effect of Ubiquitous Program for Female Patients with Overactive Bladder: Prospective, Randomized 8-weeks follow up with Questionnaire and voiding diary based assessment

Non Discussion Abstract Session 20 Read by Title 612 Associations between personal habits and urinary incontinence among a sample of women 40 to 60 years of age

Non Discussion Abstract Session 20 Read by Title 613 Relationships between lower urinary tract symptoms and quality of life among a sample of women 40 to 60 years of age

Non Discussion Abstract Session 20 Read by Title 614 POSTERIOR TIBIAL NERVE STIMULATION TWICE A WEEK IN FEMALE PATIENTS WITH LOWER URINARY TRACT SYMPTOMS

Non Discussion Abstract Session 20 Read by Title 616 Satisfaction with and experiences of patients who received Sacral Neuromodulation

Non Discussion Abstract Session 20 Read by Title 617 Enuresis and overactive bladder: efficacy of behavioural therapy

Non Discussion Abstract Session 20 Read by Title 618 Twelve-Month Durability of Effectiveness of Transurethral Radiofrequency Collagen Denaturation (Renessa®) for Treatment of Stress Urinary Incontinence in Women

Non Discussion Abstract Session 20 Read by Title 619 The effect of hydrogen peroxide on the contraction response of the smooth muscle in the bladder of rats

Non Discussion Abstract Session 20 Read by Title 621 The change of cognitive function after administration of Tolterodine in brain disease patients with OAB

Non Discussion Abstract Session 20 Read by Title 622 EFFECT OF PREGNANCY ON URETHRAL PRESSURE PROFILE IN LATE PREGNANCY STAGE

Non Discussion Abstract Session 20 Read by Title 623 Impact on Quality of Life Following Traditional Surgeries for Pelvic Organ Prolapse

Non Discussion Abstract Session 20 Read by Title 624 Efficacy of Overactive Bladder Symptom Score(OABSS) as an index of therapeutic responsiveness by antimuscarinic drug in patients with OAB

Non Discussion Abstract Session 20 Read by Title 628 Tension free vaginal mesh (TVM) - A patient’s view

Non Discussion Abstract Session 20 Read by Title 630 Improvements In Prolapse And Sexual Symptoms Following Anterior Avaulta For Recurrent Cystocele

Non Discussion Abstract Session 20 Read by Title 631 HOW HEALTH PROFESSIONALS IDENTIFY AND TREAT WOMAN WITH URINARY INCONTINENCE

Non Discussion Abstract Session 20 Read by Title 632 A Phase II exploratory cluster randomised controlled trial (RCT) of a group mobility training and staff education intervention to promote urinary continence in UK care homes

Non Discussion Abstract Session 20 Read by Title 634 Intravaginal electric stimulation in the treatment of chronic pelvic pain syndrome

Non Discussion Abstract Session 20 Read by Title 636 THE SHORT-TERM EFFECT OF INTENSIVE BIOFEEDBACK COMBINED WITH HOME PELVIC FLOOR TRAINING ON FEMALE GENUINE STRESS URINARY INCONTINENCE

Non Discussion Abstract Session 20 Read by Title 638 Results of the Uretex TO® transobturator tape for treatment of stress urinary incontinence in women

Non Discussion Abstract Session 20 Read by Title 639 Patient´s Goals and Satisfaction after different minimal-invasive incontinence surgery

Podium Session 7 Anatomy & Imaging 64 Correlation between three dimensional translabial pelvic floor ultrasonography and anal manometry in female patients with faecal incontinence

Non Discussion Abstract Session 20 Read by Title 642 Is there a seasonal variation to patients failing to attend for urodynamic study appointment?

Podium Poster Session 8 Urodynamics 65 Maximum urethral closure pressure in continent and incontinent women: analysis of 8,987 cases

Podium Poster Session 8 Urodynamics 72 Inter-observer variability in simple cystometry compared with video cystometry interpretation: the influence on further management

Podium Poster Session 9 Lower Bowel Dysfunction 74 EXTERNAL ANAL SPHINCTER PLICATION: A NOVEL SURGICAL TECHNIQUE TO ENHANCE THE ANAL CANAL CONTINENCE FUNCTION IN AN EXPERIMENTAL ANIMAL MODEL

Podium Poster Session 9 Lower Bowel Dysfunction 76 Is the St. Mark’s scoring system suitable for assessment of anal incontinence following repair of obstetric anal sphincter injuries (OASIS)?

Podium Poster Session 9 Lower Bowel Dysfunction 79 Can Intra-operative Anorectal Manometry Predict Change In Bowel Dysfunction Following Posterior Colporrhaphy?

Podium Poster Session 10 Pregnancy & Childbirth 82 Deformation analysis on pelvic floor induced by the passage of a fetus

Podium Poster Session 10 Pregnancy & Childbirth 83 How much does the puborectalis muscle have to stretch during childbirth?

Podium Poster Session 10 Pregnancy & Childbirth 84 The effect of childbirth on the dimensions of the levator hiatus

Podium Poster Session 10 Pregnancy & Childbirth 85 Perineal Repair by Midwives: A Survey of Skills, Knowledge and Experience

Podium Poster Session 11 Ageing 90 NOCTURIA IS NOT A URINARY SYMPTOM ASSOCIATED WITH FALLS IN OLDERS PEOPLE - RESULTS FROM A 2143 GERIATRIC POPULATION STUDY

Podium Poster Session 11 Ageing 92 Effects of age on levator function and morphometry

ICS 2007

Podium Poster Session 13 Botulinum Toxin Treatment:Room: Jurriaanse Zaal - Chairs: Manfred Stohrer & Dirk de Ridder 106 Botulinum toxin into the trigone in neurogenic overactive bladder non responder to detrusor injection

Podium Poster Session 13 Botulinum Toxin Treatment:Room: Jurriaanse Zaal - Chairs: Manfred Stohrer & Dirk de Ridder 107 A RANDOMIZED CONTROLLED TRIAL OF BACILLUS CALMETTE-GUERIN AND BOTULINUM TOXIN-A FOR THE TREATMENT OF REFRACTORY INERSTITIAL CYSTITIS

Podium Session 14 Male Voiding Dysfunction:Room: Grote Zaal - Chairs: Klaus Hofner & Bert Messelink 108 Normal values of frequency volume parameters in 788 asymptomatic volunteers compared to volunteers with elevated I-PSS

Podium Session 14 Male Voiding Dysfunction:Room: Grote Zaal - Chairs: Klaus Hofner & Bert Messelink 109 The Natural History of Nocturia 10 years long-term follow-up in male patients aged 40 years and above

Non Discussion Poster Session 17 116 Functional Aspects of the Pelvic Muscles in Urinary Continence

Non Discussion Poster Session 17 117 Arterial and venous macro vascular anatomy of the miniature pig urinary bladder

Non Discussion Poster Session 17 118 Are age-related changes in the pelvic connective tissue related to function?

Podium Poster Session 3 Urodynamics:Room: Grote Zaal - Chairs: Gordon Hosker & Peter Rosier 12 WHAT IS THE PREDICTIVE VALUE OF URODYNAMICS WHEN COMPARED TO CLINICAL HISTORY?

Non Discussion Poster Session 17 120 Does cytokine profile may be the prognostic factor for polypropylene mesh erosion?

Non Discussion Poster Session 17 123 Human bladder possesses a network of N-cadherin positive cells; the substrate for detrusor overactivity?

Non Discussion Poster Session 17 124 A Multi-centre, Randomised, Placebo-controlled, Double-blind, Parallel-group Study to Evaluate Whether Tolterodine Extended Release Can Reverse the Increased Bladder Wall Thickness in Women With Overactive Bladder

Non Discussion Poster Session 17 126 Is sacral neuromodulation still effective after botuline-A toxin injections for the treatment of non-neurogenic urinary dysfunction -a prospective ongoing study

Podium Poster Session 3 Urodynamics:Room: Grote Zaal - Chairs: Gordon Hosker & Peter Rosier 13 A qualitative study of patients’ experience during non-invasive urodynamics

Non Discussion Poster Session 17 130 Solifenacin treatment in patients reporting severe symptom bother while taking tolterodine: Effects on patient-reported outcomes

Non Discussion Poster Session 17 131 Patient-reported outcomes in 3 cohorts of patients defined by length of time as acute or chronic overactive bladder: an analysis of more than 2200 patients in the VESIcare Open-Label Trial (VOLT)

Non Discussion Poster Session 17 132 Treatment satisfaction and improvements in bladder condition are closely linked to a reduction in urgency bother in patients with overactive bladder syndrome

Non Discussion Poster Session 17 134 The Impact of Variation in Symptoms of Overactive Bladder on Change in Adaptive Behavior in a Population Based Longitudinal Study

Non Discussion Poster Session 17 135 Variation in Incontinence and Overactive Bladder (OAB) Symptoms in a Population Based Longitudinal Study

Non Discussion Poster Session 17 141 Comorbidities Associated with Overactive Bladder: Results From the EPIC Study

Non Discussion Poster Session 17 143 Epidemiological assessment of LUTS and related health problems among middle-aged Japanese

Non Discussion Poster Session 17 151 Improving Continence Identification and Referral In Older Adults At Risk Of Falling

Non Discussion Poster Session 17 155 MRI anatomy of Lysyl Oxidase Like-1 deficient (LOXL1 KO) mice with and without pelvic organ prolapse (POP): A Pilot Study

Non Discussion Poster Session 17 156 Are anal sphincter injuries related with levator abnormalities?

Non Discussion Poster Session 17 157 Periurethral Inflammatory and Collagen Remodelling May Account for Preserved Anti-Incontinence Effects of a Cut Sling in a Rat Model

Non Discussion Poster Session 17 158 Three-dimensional transperineal ultrasonographic characteristics of the anal sphincter complex in nulliparous women

Non Discussion Poster Session 17 160 Morphologic characteristics and functional correlates of tension free vaginal tape obturator (TVTO) procedure

Non Discussion Poster Session 17 162 Evaluation of pelvic floor reconstructive surgery using tridimentional helical CT

Non Discussion Poster Session 17 163 Effect of parturition, age, weight and anterior vaginal wall defect on morphology of urethral rhabdosphincter in 3-D transvaginal ultrasound examination in women with stress urinary incontinence - preliminary study

Non Discussion Poster Session 17 165 COST-EFFECTIVENESS ANALYSIS OF SACRAL NERVE STIMULATION (SNS) WITH INTERSTIM™ FOR FECAL INCONTINENCE PATIENTS IN THE NETHERLANDS

Non Discussion Poster Session 17 169 The effect of spinal anaesthesia on urethral function

Podium Poster Session 3 Urodynamics:Room: Grote Zaal - Chairs: Gordon Hosker & Peter Rosier 17 Perineal noise recording related to bladder outlet obstruction?

Non Discussion Poster Session 17 171 The Effect of Vaginal Distension on Bladder and Urethral Function in Nulliparous Lysyl Oxidase Like-1 Knockout and C57Bl6 Mice

Non Discussion Poster Session 17 172 The effects of L-arginine and L-NAME on the response to chronic partial bladder outlet obstruction in the rabbit

Non Discussion Poster Session 17 173 ALFUZOSIN, BUT NOT TAMSULOSIN, RELIEVES BLADDER HYPERTROPHY IN RATS DESPITE A PERSISTENT BLADDER OUTLET OBSTRUCTION

Non Discussion Poster Session 17 174 NOCTURIA IN THE ELDERLY: AGE DIFFERENCES IN MAXIMUM CYSTOMETRIC CAPACITY

Non Discussion Poster Session 17 175 CHANGES IN THE SMOOTH MUSCLE OF THE CORPORA CAVERNOSUM RELATED TO PARTIAL BLADDER OUTLET OBSTRUCTION IN RABBITS

Non Discussion Poster Session 17 180 Diuretic agent as second-line treatment of nocturia in men with lower urinary tract symptoms: a pilot study

Non Discussion Poster Session 17 181 New Method for a Minimally Invasive Urodynamic Assessment in Men

Non Discussion Poster Session 17 184 Characterization of Sexual Function in Women With Overactive Bladder and Urgency Urinary Incontinence at Baseline and After Treatment With Tolterodine Extended Release

Non Discussion Poster Session 17 189 Consider a diagnosis of Obstructive Sleep Apnea in patients with nocturia, even when daytime overactive bladder syndrome is present

Non Discussion Poster Session 17 191 Anatomical distribution of prostatic peripheral nerve tissue -A notable portion located on the dorsal surface of the apex

Non Discussion Poster Session 17 195 Role of spinal glutamatergic mechanisms in sneeze-induced urethral continence reflex in rats

Non Discussion Poster Session 17 197 Effects of corticotropin-releasing factor receptor antagonists on bladder overactivity induced by psychological stress in rats

Non Discussion Poster Session 17 201 Alpha adrenoceptor antagonists inhibit the sensory afferent activation during the storage phase in rat urinary bladder

Non Discussion Poster Session 17 205 Alterations to the network of cyclic guanosine monophosphate responsive interstitial cells induced by outlet obstruction in the guinea pig bladder

Non Discussion Poster Session 17 206 NEURONAL AND NON-NEURONAL ACETYLCHOLINE AND ATP RELEASES IN RATS WITH SPINAL CORD INJURY

Non Discussion Poster Session 17 207 Novel Quantification Method using Voided Stain on Paper Technique for Voiding Analysis in the Mouse

Non Discussion Poster Session 17 208 KRP-204, a selective beta3-adrenoceptor agonist, suppresses licking behavior induced by intravesical instillation of capsaicin in rats

Non Discussion Poster Session 17 212 Sacral Nerve Stimulation for the Treatment of Refractory Urinary Retention: Long-term Efficacy and Durability

Non Discussion Poster Session 17 219 CLINICAL OUTCOMES OF EARLY INTERVENTION BASED ON URODYNAMIC RISK FACTORS FOR INFANTS WITH SPINA BIFIDA

Non Discussion Poster Session 17 223 The detrusor glycogen content of a de-obstructed bladder reflects the functional history of that bladder during PBOO

Non Discussion Poster Session 17 224 Potential for recovery in bladder function after removing a urethral obstruction

Non Discussion Poster Session 17 225 "Desmopressin Response In the treatment of Primary Nocturnal Enuresis in the United Kingdom" DRIP UK: An open-label, randomised comparative study of oral desmopressin versus enuresis alarm

Non Discussion Poster Session 17 228 "Desmopressin Response In the treatment of Primary Nocturnal Enuresis" DRIP: An open-label, multi-national study

Non Discussion Poster Session 17 229 EFFICACY OF PERCUTANEOUS TIBIAL NERVE STIMULATION TO TREAT LOWER URINARY TRACT DYSFUNCTION IN CHILDREN

Podium Poster Session 4 Lifestyle:Room: Jurriaanse Zaal - Chairs: Katherine Moore & Ulli Haase 23 Preferences for involvement in urinary incontinence treatment decision-making among Norwegian women

Non Discussion Poster Session 17 232 Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Are women at increased risk for pelvic floor disorders?

Non Discussion Poster Session 17 235 Topographic sagittal anatomy of the perineum in women

Non Discussion Poster Session 17 238 A Community Intervention Study of Female Pelvic Floor Condition and Knowledge of Pelvic Floor Exercises: Part 2 Randomised Controlled Trial of Pelvic Floor Muscle Training in Women with a Weak Pelvic Floor

Non Discussion Poster Session 17 243 Inhibitory effects of ß-adrenoceptor agonists on detrusor contraction involve the ß3-adrenoceptor in pig bladder dome

Non Discussion Poster Session 17 247 Is it possible to induce urinary frequency by stimulating the epithelial sodium channel?

Non Discussion Poster Session 17 249 CHRONIC TREATMENT WITH BESIPIRDINE INCREASED BLADDER CAPACITY IN CONSCIOUS FEMALE RATS SUBJECTED TO BLADDER OUTLET OBSTRUCTION - RELATIONSHIP WITH PLASMA CONCENTRATION

Non Discussion Poster Session 17 251 CARDIAC ION CHANNEL EFFECTS OF PROPIVERINE

Non Discussion Poster Session 17 252 THERAPEUTIC EFFECTS OF ENDOTHELIN RECEPTOR ON BLADDER OVERACTIVITY IN RATS WITH CHRONIC SPINAL CORD INJURY

Non Discussion Poster Session 17 254 Rat urinary bladder-derived relaxant factor: studies on its nature, release and relaxant effect by coaxial bioassay system

Non Discussion Poster Session 17 255 Urothelial Nicotinic Receptor Function in Both Normal and Pathological Rat Bladders

Non Discussion Poster Session 17 256 The effect of different severity in bladder dysfunction on corpous cavernosum smooth muscle and Rho-kinase in rabbits

Non Discussion Poster Session 17 257 COMPARISON FOR PHARMACOLOGICAL EFFECTS OF VARIOUS ANTIMUSCARINIC DRUGS ON HUMAN ISOLATED URINARY BLADDER

Non Discussion Poster Session 17 259 MURINE DETRUSOR RELAXATION IS MEDIATED THROUGH BETA 2-ADRENOCEPTORS AND UNRELATED TO CAVEOLAE

Podium Poster Session 4 Lifestyle:Room: Jurriaanse Zaal - Chairs: Katherine Moore & Ulli Haase 26 Gender differences in performance of and preferences for absorbent products for men and women with moderate-heavy urinary incontinence: a randomized cross-over clinical trial

Non Discussion Poster Session 17 262 Direct quantification of muscarinic receptor subtypes in human detrusor muscle, mucosa and parotid gland by irreversible inactivation of M3 receptors by 4-DAMP mustard

Non Discussion Poster Session 17 263 EFFECTS OF AN ANTI-MUSCARINIC AGENT AND AN ALPHA-1 RECEPTOR ANTAGONIST ON URINARY ATP LEVELS AND BLADDER ACTIVITY AFTER BLADDER STIMULATION IN RATS

Non Discussion Poster Session 17 265 M3 muscarinic receptor like immuno-reactivity (M3-IR) patterns in the normal and pathological guinea pig bladder

Non Discussion Poster Session 17 266 Effect of nitric oxide depletion in the bladder and urethral function

Non Discussion Poster Session 17 274 One Europe… How Many Definitions of Mediolateral Episiotomy?

Non Discussion Poster Session 17 275 BEHAVIORAL GROUP-BASED THERAPY IMPROVES QUALITY OF LIFE RELATED TO URINARY INCONTINENCE IN MEN RECOVERING FROM RADICAL PROSTATECTOMY

Non Discussion Poster Session 17 276 Development of a Self-Assessment Goal Attainment (SAGA) Questionnaire in Overactive Bladder

Non Discussion Poster Session 17 278 Transvaginal mesh repair of pelvic organ prolapse: short term outcomes from a prospective multicenter study

Non Discussion Poster Session 17 279 Rate of De Novo Stress Urinary Incontinence after Urethral Diverticulum Repair

Podium Poster Session 5 Lower Bowel Dysfunction:Room: Grote Zaal - Chairs: Ranee Thakar & JanWillem de Leeuw 28 Results after submucous bulking therapy with NASHA/Dx for anal incontinence in relation to pretreatment clinical characteristics

Non Discussion Poster Session 17 282 Comparison of the two different approaches for the treatment of female stress urinary incontinence

Non Discussion Poster Session 17 283 Randomised trial of tension-free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women

Non Discussion Poster Session 17 284 Factors influencing the outcome after mid-urethral sling procedures in female urinary incontinence

Non Discussion Poster Session 17 285 A Clinical Evaluation of the GYNECARE TVT Obturator System for the Treatment of Stress Urinary Incontinence

Non Discussion Poster Session 17 287 Treatment of obstructive voiding dysfunction after transobturator sling surgery: Results of multicenter study

Non Discussion Poster Session 17 288 Transobturator vs retropubic vaginal tape for female stress urinary incontinence: one year follow-up in 296 patients

Non Discussion Poster Session 17 291 Male sling and Health Related Quality of Life for stress urinary incontinence: Are the long term results maintained?

Non Discussion Poster Session 17 297 Urodynamic evaluation pre and post transobturator sling in patients with stress urinary incontinence

Non Discussion Poster Session 17 299 Is there an association between a history of hysterectomy and urethral pressures?

Non Discussion Poster Session 17 300 THE URODYNAMICS OF FEMALE MIXED URINARY INCONTINENCE: COMPARISON WITH PATIENT SELF-REPORTING AND CLINICAL EVALUATION

Non Discussion Poster Session 17 302 Validation of a real- time urodynamic measure of urinary urgency

Non Discussion Poster Session 17 303 Parity is a significant determinant of pelvic organ prolapse in LOXL1-deficient mice

Non Discussion Abstract Session 19 Read By Title 304 Urethral Motion Profile: A Novel Method To Study Urethral Mobillity

Non Discussion Abstract Session 19 Read By Title 307 The effects of estrogen on nNOS, eNOS expression and histologic composition in the rat bladder and urethra

Podium Poster Session 5 Lower Bowel Dysfunction:Room: Grote Zaal - Chairs: Ranee Thakar & JanWillem de Leeuw 31 Assessing interventions for neurogenic bowel management using anorectal manometry

Non Discussion Abstract Session 19 Read By Title 314 Increased basal and stimulated spontaneous activity in diabetic overactive bladder

Non Discussion Abstract Session 19 Read By Title 317 Short-term outcomes of a randomized, double-blind placebo controlled trial of Botulinum A toxin for the management of severe idiopathic detrusor overactivity incontinence

Non Discussion Abstract Session 19 Read By Title 319 Intravesical instillation of oxybutynin and resiniferatoxin: Comparison of the effectiveness on bladder storage function and health-related quality of life

Podium Poster Session 5 Lower Bowel Dysfunction:Room: Grote Zaal - Chairs: Ranee Thakar & JanWillem de Leeuw 32 A randomised controlled trial of a progressive protocol for neurogenic bowel management

Non Discussion Abstract Session 19 Read By Title 320 Population-Based Survey of Urinary Incontinence, Overactive Bladder and Other Lower Urinary Tract Symptoms (LUTS) in Korea : Results of the EPIC Study

Non Discussion Abstract Session 19 Read By Title 322 Prevalence and impact of overactive bladder in the French general population

Non Discussion Abstract Session 19 Read By Title 325 Epidemiology and Public Awareness of the Overactive Bladder in Hong Kong

Non Discussion Abstract Session 19 Read By Title 329 Patterns and Predictors of Discontinuing Overactive Bladder Medications

Podium Poster Session 5 Lower Bowel Dysfunction:Room: Grote Zaal - Chairs: Ranee Thakar & JanWillem de Leeuw 33 Cost-effectiveness of transanal irrigation versus conservative bowel management for spinal cord injury patients

Non Discussion Abstract Session 19 Read By Title 330 DOES MATURATION OF BLADDER/BOWEL SPHINCTER CONTROL IN CHILDHOOD AFFECT VOIDING HABITS IN ADULT LIFE? A QUESTIONNAIRE-BASED STUDY IN 130 YOUNG ADULTS

Non Discussion Abstract Session 19 Read By Title 331 Patterns and Predictors of Restarting Overactive Bladder Medications

Non Discussion Abstract Session 19 Read By Title 332 ANALYSIS OF LOWER URINARY TRACT AND BOWEL SYMPTOMS FOLLOWING STROKE IN THE EARLY STAGE OF REHABILITATION

Non Discussion Abstract Session 19 Read By Title 333 Associations of obesity with lower urinary tract symptoms in Korean elderly men

Non Discussion Abstract Session 19 Read By Title 336 Low body mass index is an independent positive risk factor for nocturia

Non Discussion Abstract Session 19 Read By Title 337 The health-related quality of life of patients with a neurogenic overactive bladder treated with Tolterodine ER: a real-life study

Non Discussion Abstract Session 19 Read By Title 339 SURGICAL REPAIR OF COMPLEX RECTO-URETHRAL FISTULA WITH THE PRESERVATION OF URINARY AND BOWEL FUNCTION

Podium Poster Session 5 Lower Bowel Dysfunction:Room: Grote Zaal - Chairs: Ranee Thakar & JanWillem de Leeuw 34 Is injury to the levator ani nerve preventable in rectal surgery?

Non Discussion Abstract Session 19 Read By Title 342 Sling operation for the treatment of Stress Urinary Incontinence in elderly patients

Non Discussion Abstract Session 19 Read By Title 347 BLADDER WALL THICKNESS AND ULTRASOUND ESTIMATED BLADDER WEIGHT IN HEALTHY ADULTS WITH PORTATIVE ULTRASOUND DEVICE

Non Discussion Abstract Session 19 Read By Title 349 The bone-anchored perineal male sling for post-prostatectomy incontinence: results at 3 years

Podium Poster Session 6 The Overactive Bladder Syndrome:Room: Jurriaanse Zaal - Chairs: Vikram Khullar & Karel Everaert 35 Overactive bladder symptoms are not related to Detrusor Overactivity

Non Discussion Abstract Session 19 Read By Title 351 The scope of Clinical Assessment by the ICIQ-MLUTS questionnaire as compared with the IPSS questionnaire

Non Discussion Abstract Session 19 Read By Title 352 Double cuff AMS 800 artificial urinary sphincter and sacral neuromodulation in complex situation of male incontinence

Non Discussion Abstract Session 19 Read By Title 354 Mathematical Model to Analyse Physiotherapeutic Treatment in Post Radical ProstatectomyUrinary Incontinence

Non Discussion Abstract Session 19 Read By Title 357 Implantation of the ProACT™ system under local anaesthesia in patients with post-radical prostatectomy stress urinary incontinence: a feasibility pilot study

Non Discussion Abstract Session 19 Read By Title 361 INCONTINENCE RELATED TO HIFU FOR GLEASON 8-10 PROSTATE CANCER

Non Discussion Abstract Session 19 Read By Title 363 Defecation proctography and translabial ultrasound in the investigation of defecatory disorders

Non Discussion Abstract Session 19 Read By Title 364 When to Repair? A cost-effectiveness analysis of primary and delayed sphincteroplasty for anal sphincter injury

Non Discussion Abstract Session 19 Read By Title 365 Biofeedback is effective in faecal incontinence and evacuatory disorders

Non Discussion Abstract Session 19 Read By Title 366 A retrospective evaluation of rectal irrigation in the treatment of evacuatory disorders

Non Discussion Abstract Session 19 Read By Title 367 Anorectal and Bowel Dysfunction Associated with Pelvic Organ Prolapse (POP) in Egyptian Women: Prevalence and Correlation with MRI Findings

Non Discussion Abstract Session 19 Read By Title 369 LOWER URINARY TRACT SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA IN DEVELOPING COUNTRIES: IS BOTULINUM TOXIN-A COMPLEMENTARY OR COMPETITIVE TO ETHANOL INJECTION?

Podium Poster Session 6 The Overactive Bladder Syndrome:Room: Jurriaanse Zaal - Chairs: Vikram Khullar & Karel Everaert 37 RELATIONSHIP BETWEEN DETRUSOR OVERACTIVITY, AGE AND BLADDER OUTLET OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA

Non Discussion Abstract Session 19 Read By Title 373 The Epidemiology of Lower Urinary Tract Symptoms and Sexual Dysfunction in Men: A Systematic Review

Non Discussion Abstract Session 19 Read By Title 374 The antioxidant diet protects the bladder against the detrusor damage induces by the chronic infravesical obstruction: results from a model of Benign Prostatic Hyperplasia

Non Discussion Abstract Session 19 Read By Title 378 Female voiding dysfunction: A tertiary centre experience

Non Discussion Abstract Session 19 Read By Title 379 In women with mixed incontinence, urge incontinence episode frequency is the only predictor of QOL

Non Discussion Abstract Session 19 Read By Title 380 Nocturia as clinical predictor of Obstructive Sleep Apnea

Non Discussion Abstract Session 19 Read By Title 381 Parameters predicting the response to intradetrusor Botulinum A Toxin injections in patients with Idiopathic Detrusor Overactivity

Non Discussion Abstract Session 19 Read By Title 383 Intermittent pelvic floor stimulation for Over Active Bladder patients

Non Discussion Abstract Session 19 Read By Title 386 Propiverine treatment improves quality of life in female patients with wet overactive bladder

Podium Poster Session 6 The Overactive Bladder Syndrome:Room: Jurriaanse Zaal - Chairs: Vikram Khullar & Karel Everaert 39 Tolterodine Extended Release and Sexual Quality of Life, Anxiety, and Depression Among Women With Overactive Bladder and Urgency Urinary Incontinence

Non Discussion Abstract Session 19 Read By Title 390 Differential expression of Angiotensin II type-1 receptor in the rat detrusor muscle with partial bladder outlet obstruction and diabetes mellitus model

Non Discussion Abstract Session 19 Read By Title 394 The effect of ischemia on bladder function, and acetylcholine and ATP releases from bladder in Watanabe heritable hyperlipidemic rabbits

Non Discussion Abstract Session 19 Read By Title 395 Impact of Acupuncture Stimulation to Sacral Region on Bladder Function in Conscious Rats

Non Discussion Abstract Session 19 Read By Title 396 The influences of ovariectomy and long-term estrogen replacement on bladder sensitivity in the rat

Non Discussion Abstract Session 19 Read By Title 397 The Role of Elastin Fibers in the Bladder and Bladder Functions- Related with Bladder Outlet Obstruction

Podium Poster Session 6 The Overactive Bladder Syndrome:Room: Jurriaanse Zaal - Chairs: Vikram Khullar & Karel Everaert 40 Title

Non Discussion Abstract Session 19 Read By Title 400 Relaxant effects of estradiol through non-genomic pathways in male and female pig bladder smooth muscle: insights into the treatment of the Overactive Bladder Syndrome

Non Discussion Abstract Session 19 Read By Title 401 Inhibition of Sacral Acupuncture on Bladder Irritation Induced by Acetic Acid in Conscious Rats

Non Discussion Abstract Session 19 Read By Title 405 Modulation of Anterior Cingulate, Hippocampal, and Pontine Activity Associated With Sacral Nerve Root Stimulation Therapy

Podium Poster Session 6 The Overactive Bladder Syndrome:Room: Jurriaanse Zaal - Chairs: Vikram Khullar & Karel Everaert 41 Heart Rates in OAB Patients Prior to Initiation of Treatment with Antimuscarinics

Non Discussion Abstract Session 19 Read By Title 416 Temporary sacral nerve block (TSNB) of S3 segment: a minimally invasive diagnostic tool for painful bladder syndrome/interstitial cystitis (PBS/IC)

Non Discussion Abstract Session 19 Read By Title 417 A NEW COMBINED INTRAVESICAL THERAPY FOR THE TREATMENT OF REFRACTORY INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME: CHONDROITIN SULPHATE AND HYALURONIC ACID. PRELIMINARY RESULTS

Non Discussion Abstract Session 19 Read By Title 418 IS URINE AN IMPORTANT FACTOR IN THE DEVELOPMENT OF BLADDER INFLAMMATION?

Non Discussion Abstract Session 19 Read By Title 419 COMPARISON OF RAT CYSTITIS MODELS IN FREELY MOVING, CONSCIOUS CONDITIONS; CYCLOPHOSPHAMIDE AND ACETONE INDUCED ALTERATIONS IN VOIDING FUNCTION AND PAIN BEHAVIOR

Non Discussion Abstract Session 19 Read By Title 420 Interstitial Cystitis and pelvic floor neuromuscular stimulation

Non Discussion Abstract Session 19 Read By Title 421 Prevalence of interstitial cystitis (IC/PBS) in adult women in the general population in Japan

Non Discussion Abstract Session 19 Read By Title 426 Adjuvant intravesical dimethylsulfoxide instillations after hydrodistension and holmiumlasering in the treatment of interstitial cystitis

Non Discussion Abstract Session 19 Read By Title 429 Variety of the congenital urethral lesions in boys with lower urinary tract symptoms and results of endoscopic treatment

Non Discussion Abstract Session 19 Read By Title 431 Evaluation of Urethral Obstruction in Boys with Enuretic Syndrome by Pressure Flow Study

Non Discussion Abstract Session 19 Read By Title 434 Ballooning: How to define abnormal distensibility of the levator hiatus

Non Discussion Abstract Session 19 Read By Title 438 Relationship between ankle inclination in standing position and pelvic floor muscle activity in continent and incontinent women: preliminary result from a pilot study

Non Discussion Abstract Session 19 Read By Title 440 INTER-OBSERVER RELIABILITY OF THREE DIFFERENT METHODS OF ASSESSING URETHRAL MOBILITY

Non Discussion Abstract Session 19 Read By Title 441 Successful Therapy for the Challenging Patient: Transvaginal Biofeedback and Electrical Stimulation in Urinary Urgency and Frequency associated with Pelvic Floor Muscle Spasm

Non Discussion Abstract Session 19 Read By Title 442 Parity and pelvic organ prolapse leads to reduced leak point pressure in LOXL1-deficient mice

Non Discussion Abstract Session 19 Read By Title 443 Retrospective analysis of efficacy and safety of pelvic organ prolapse repair with transobturator anterior and/or posterior polypropylene mesh implantation

Non Discussion Abstract Session 19 Read By Title 445 Transobturator (TO) T-Sling (Herniamesh) for the treatment of Stress Urinary Incontinence: 3 years follow up study

Non Discussion Abstract Session 19 Read By Title 446 How reliable is a self administered questionnaire in detecting sexual abuse: a retrospective study in patients with pelvic floor complaints

Non Discussion Abstract Session 19 Read By Title 448 EFFECTS OF INTRAVESICAL INSTILLATION OF RESINIFERATOXIN ON BLADDER FUNCTION AND NOCICEPTIVE BEHAVIOR IN FREELY MOVING, CONSCIOUS RATS

Non Discussion Abstract Session 19 Read By Title 449 The effects of exogenous prostaglandins and the identification of cyclo-oxygenase immuno- reactive cells in the normal guinea pig bladder

Non Discussion Abstract Session 19 Read By Title 451 Arginase inhibition suppresses bladder overactivity in rats with chronic spinal cord injury by enhancing NO production

Non Discussion Abstract Session 19 Read By Title 453 Propiverine and oxybutynin inhibit Ca2+ influx mediated by the activation of a specific receptor, transient receptor potential vanilloid subtype 1 (TRPV1)

Non Discussion Abstract Session 19 Read By Title 456 MUSCARINIC RECEPTOR-MEDIATED CONTRACTION IN JUVENILE AND ADULT PORCINE DETRUSOR

Non Discussion Abstract Session 19 Read By Title 459 SINGLE- AND MULTIPLE-DOSE PHARMACOKINETICS OF ONCE-DAILY TROSPIUM CHLORIDE 30 MG IN HEALTHY ELDERLY SUBJECTS

Non Discussion Abstract Session 19 Read By Title 460 PRELIMINARY EFFICACY DATA OF SVT-40776, A NEW BLADDER SELECTIVE M3 MUSCARINIC ANTAGONIST

Non Discussion Abstract Session 19 Read By Title 461 Understanding Symptom Bother Caused by Overactive Bladder and Other Lower Urinary Tract Symptoms From a Population Perspective

Non Discussion Abstract Session 19 Read By Title 462 Improvements in health-related quality of life with fesoterodine in subjects with overactive bladder: pooled data from two randomized controlled studies

Non Discussion Abstract Session 19 Read By Title 463 A Swedish prospective, observational study of health related quality of life over 6 months in patients with overactive bladder starting treatment with Tolterodine SR

Non Discussion Abstract Session 19 Read By Title 468 Quality of Life and Sexual Function Following Tension-Free Vaginal Tape versus the "In-to-Out" Tension-Free Vaginal Tape Obturator

Non Discussion Abstract Session 19 Read By Title 469 Quality of life -King’s Health Questionnaire- outcomes one year after inside-out transobturator tape (TVT-O) surgery for treatment of recurrent stress urinary incontinence

Podium Session 7 Continence Services and Physiotherapy:Room: Grote Zaal - Chairs: Grace Dorey & Marijke Slieker 47 Feasibility and reliability of physiotherapists measuring prolapse using the pelvic organ prolapse quantitation (POP-Q) system

Non Discussion Abstract Session 19 Read By Title 471 Tension Free Urinary Continence Services - A First Step towards Integrated Continence Care in Northern Ireland

Non Discussion Abstract Session 19 Read By Title 473 Stress Urinary Incontinence after Transobturator Mesh for Cystocele Repair

Non Discussion Abstract Session 19 Read By Title 474 Quality of Life and Surgical Satisfaction Following Vaginal Reconstructive versus Obliterative Surgery for the Treatment of Advanced Pelvic Organ Prolapse

Non Discussion Abstract Session 19 Read By Title 475 Sexual functioning after Tension free Vaginal Mesh procedure (Prolift®) for pelvic organ prolapse

Non Discussion Abstract Session 19 Read By Title 477 Objective and Subjective results on Tension free Vaginal Mesh procedure (Prolift®) for pelvic organ prolapse

Non Discussion Abstract Session 19 Read By Title 479 Anatomical and Functional Outcomes of Secondary Vaginal prolapse surgery using the Porcine Subintestinal Submucosa (SIS) Graft

Non Discussion Abstract Session 19 Read By Title 482 Genital floor repair using polypropylene meshes :a comparative study

Non Discussion Abstract Session 19 Read By Title 483 Impact of Sacrospinous Vault Fixation in POP-Q and LUTS: A prospective analysis

Non Discussion Abstract Session 19 Read By Title 484 The impact of laparoscopic sacrocolpopexy on lower urinary tract function and symptoms

Non Discussion Abstract Session 19 Read By Title 486 TRANS-PERINEAL PELVIC ORGAN PROLAPSE REPAIR: PRELIMINARY RESULTS WITH SYNTHETIC MESH

Non Discussion Abstract Session 19 Read By Title 487 PELVIC FLOOR RECONSTRUCTIVE SURGERY (CYSTOCELE AND CYSTORECTOCELE REPAIR) USING MESH IMPLANTS - EARLY RESULTS

Non Discussion Abstract Session 19 Read By Title 488 Efficacy of Prolift System in the treatment of pelvic floor disorders - experience after first hundred cases

Non Discussion Abstract Session 19 Read By Title 489 Long-term quality of life outcome of ileocystoplasty with continent abdominal stoma

Non Discussion Abstract Session 19 Read By Title 493 Can Resting Tone of the Pubovisceral Muscle be assessed digitally?

Non Discussion Abstract Session 19 Read By Title 495 The effect of ankle inclination in supine position on the electromyigraphic activity of pelvic floor muscles in women with and without stress urinary incontinence: preliminary results from a pilot study

Non Discussion Abstract Session 19 Read By Title 498 Transobturator tape ARIS for Female Stress Urinary Incontinence: A multicentric tracker study

Non Discussion Abstract Session 19 Read By Title 501 Tension adjustable mesh for stress incontinence treatment

Non Discussion Abstract Session 19 Read By Title 503 THE EFFECT OF POSTERIOR COMPARTMENT REPAIR ON OUTCOME OF SUB-URETHRAL SLING

Non Discussion Abstract Session 19 Read By Title 505 The efficacy of different sling operations among female patients with intrinsic sphincter deficiency

Non Discussion Abstract Session 19 Read By Title 506 TRANSABDOMINAL TENSION FREE TAPES AND TRANSOBTURATOR TAPES IN THE TREATMENT OF STRESS URINARY INCONTINENCE: A COMPARASION STUDY

Non Discussion Abstract Session 19 Read By Title 507 Long time follow up results of non-animal stabilized dextranomer/hyaluronic acid (NASHA/DX) for post-prostatectomy stress urinary incontinence

Non Discussion Abstract Session 19 Read By Title 509 Evaluation of female sexual function after transobturator tape technique for urinary stress incontinence

Non Discussion Abstract Session 19 Read By Title 510 Tension-free vaginal tape (TVT), suprapubic arc (SPARC) sling and transobturator tape (TOT) in the treatment of mixed urinary incontinence in women

Non Discussion Abstract Session 19 Read By Title 512 Adverse Events from a Randomized Trial for the Surgical Treatment of Stress Urinary Incontinence

Non Discussion Abstract Session 19 Read By Title 513 The usefulness of transurethral resection for the treatment of intravesical tape erosion with bladder stone following tension-free vaginal tape(TVT) procedure

Non Discussion Abstract Session 19 Read By Title 516 A NEW MINIMAL INVASIVE SURGICAL TECHNIQUE WIHTOUT NEEDLES FOR THE SURGICAL TREATMENT OS STRESS URINARY INCONTINENCE: PRELIMINARY RESULTS NEEDLELESS SLING

Non Discussion Abstract Session 19 Read By Title 517 The Effectiveness of a Modified Transurethral Collagen Injection Technique for the Management of Stress Urinary Incontinence

Non Discussion Abstract Session 19 Read By Title 518 Inside-out transobturator tape (TVT-O) surgery for treatment of recurrent stress urinary incontinence

Non Discussion Abstract Session 19 Read By Title 520 Zuidex in the management of urinary incontinence

Non Discussion Abstract Session 19 Read By Title 525 The Effect of Valsalva Leak Point Pressures in Deciding Surgical Procedures : Tension-free Vaginal Tape or Trans-Obturator Tape

Non Discussion Abstract Session 19 Read By Title 526 USE OF POLYPROPYLENE MESH AS SPIRAL TRANS OBTURATOR TAPE IN MANAGEMENT OF FEMALE INCONTINENCE DUE TO NONFUNCTIONAL URETHRA

Non Discussion Abstract Session 19 Read By Title 527 Experience at a district general hospital after TVTO introduction

Non Discussion Abstract Session 19 Read By Title 528 Distal Urethral Polypropylene Sling (DUPS) Surgical Management for Stress Urinary Incontinence in Korean women

Non Discussion Abstract Session 19 Read By Title 529 Urinary flow rate strongly predicts the outcome of TVT "Tension-free Vaginal Tape" operation in urodynamic stress urinary incontinence (SUI)

Non Discussion Abstract Session 19 Read By Title 532 Does the presence of transurethral cystometry catheter affect the measurement of abdominal leak point pressure (ALPP) in women with stress urinary incontinence (SUI)?

Non Discussion Abstract Session 19 Read By Title 534 Pressure measurement during filling cystometry using a single lumen catheter

Non Discussion Abstract Session 19 Read By Title 537 Non-invasive urodynamic parameters as predictor variables for developing voiding problems

Non Discussion Abstract Session 19 Read By Title 538 Development of a Urodynamic Trainer

Non Discussion Abstract Session 19 Read By Title 539 PREOPERATIVE URODYNAMIC INVESTIGATION AND OBJECTIVE OUTCOME AFTER LAPAROSCOPIC COLPOSUSPENSION. IS A DIFFERENT APPROACH POSSIBLE ?

Non Discussion Abstract Session 19 Read By Title 541 Video Urodynamic Evaluation of a Nonsurgical Transurethral Radiofrequency Collagen Denaturation Treatment for Stress Urinary Incontinence

Non Discussion Abstract Session 19 Read By Title 543 PATIENT SATISFACTION WITH URODYNAMICS. WHAT ROLE DOES STAFF SUPPORT AND PATIENT INFORMATION LEAFLET HAVE ON PSYCHOLOGICAL MORBIDITY?

Non Discussion Abstract Session 19 Read By Title 547 Prolapse worsens with age, doesn't it?

Non Discussion Abstract Session 19 Read By Title 549 Prevalence and impact of sexual problems amongst women with pelvic organ prolapse: a review of the literature

Non Discussion Abstract Session 19 Read By Title 550 Initial outcomes following laparoscopic uterine sling suspension: a new surgical technique for the treatment of prolapse

Non Discussion Abstract Session 19 Read By Title 552 NAZCA: A monoprosthesis for the simultaneous management of cystocele and stress urinary incontinence: a prospective multicentric study

Non Discussion Abstract Session 19 Read By Title 553 Infracoccygeal sacropexy for vault prolapse with modifications for uterovaginal prolapse: an initial experience

Podium Poster Session 8 Pharmacology, Basic and Clinical:Room: Grote Zaal - Chairs: Karl Erik Andersson & Martin Michel 56 COMPARISON OF THE EFFECTS OF BESIPIRDINE, ITS MAIN METABOLITE AND DULOXETINE ON URETHRAL PRESSURE IN ANESTHETIZED FEMALE RATS

Podium Poster Session 8 Pharmacology, Basic and Clinical:Room: Grote Zaal - Chairs: Karl Erik Andersson & Martin Michel 58 URODYNAMIC ASSESSMENT IN SPINAL CORD INJURIED MALE AFTER VARDENAFIL ADMINISTRATION

Podium Poster Session 9 Lower Urinary Tract Symptoms:Room: Jurriaanse Zaal - Chairs: Sherif Mourad & JeanJacques Wyndaele 59 TESTING ACCURACY OF THE ICIQ-LUTS-C: A NEW INSTRUMENT TO SCREEN LOWER URINARY TRACT SYMPTOMS IN CHILDREN

Podium Session 1 Urogenital Prolapse:Room: Grote Zaal - Chairs: Stefano Salvatore & Jan Deprest PROSPECTIVE RANDOMIZED CONTROLLED STUDY BETWEEN TWO DIFFERENT PROCEDURES TO SUSPEND THE VAGINAL VAULT: HIGH LEVATOR MYORRAPHY AND UTEROSACRAL VAGINAL VAULT SUSPENSION

Podium Poster Session 9 Lower Urinary Tract Symptoms:Room: Jurriaanse Zaal - Chairs: Sherif Mourad & JeanJacques Wyndaele 60 Patients understanding of LUTS: a new questionnaire

Podium Poster Session 9 Lower Urinary Tract Symptoms:Room: Jurriaanse Zaal - Chairs: Sherif Mourad & JeanJacques Wyndaele 61 Does the bladder have a memory? Is Childhood Dysfunctional Voiding related to bladder and pelvic floor dysfunction in adult women?

Podium Poster Session 9 Lower Urinary Tract Symptoms:Room: Jurriaanse Zaal - Chairs: Sherif Mourad & JeanJacques Wyndaele 63 Analysis of the prognostic factors for overactive bladder syndrome following surgical treatment in patients with symptomatic benign prostatic enlargement

Podium Poster Session 10 Experimental Physiology:Room: Grote Zaal - Chairs: Naoki Yoshimura & Gommert van Koeveringe 68 Autonomous activity is modified following damage to the bladder neck

Podium Poster Session 10 Experimental Physiology:Room: Grote Zaal - Chairs: Naoki Yoshimura & Gommert van Koeveringe 74 Urodynamic Function and Expression of Neurotrophins after a Maternal Childbirth Injury Model of Vaginal Distension and Pudendal Nerve Crush in Rats

Podium Poster Session 10 Experimental Physiology:Room: Grote Zaal - Chairs: Naoki Yoshimura & Gommert van Koeveringe 76 EFFECTS OF DULOXETINE, NOREPINEPHRINE AND SEROTONIN REUPTAKE INHIBITOR, ON THE SNEEZE-INDUCED URETHRAL CONTINENCE REFLEX IN RATS

Podium Poster Session 10 Experimental Physiology:Room: Grote Zaal - Chairs: Naoki Yoshimura & Gommert van Koeveringe 77 SUPPRESSION OF DETRUSOR OVERACTIVITY AND DETRUSOR-SPHINCTER DYSSYNERGIA BY GABA-RECEPTOR ACTIVATION AT THE LUMBOSACRAL SPINAL CORD IN SPINAL CORD INJURY RATS

Podium Poster Session 10 Experimental Physiology:Room: Grote Zaal - Chairs: Naoki Yoshimura & Gommert van Koeveringe 79 In vivo analysis of brain muscarinic receptor occupancy after oral oxybutynin in conscious rhesus monkey by using positron emission tomography (PET)

Podium Poster Session 11 Pelvic Floor Dysfunction:Room: Jurriaanse Zaal - Chairs: Victor Nitti & Guus Lycklama a Nijeholt 83 Sexual function and vaginal anatomy in women before and after surgery for pelvic organ prolapse

Podium Poster Session 11 Pelvic Floor Dysfunction:Room: Jurriaanse Zaal - Chairs: Victor Nitti & Guus Lycklama a Nijeholt 86 URODYNAMIC INCONTINENCE CORRELATES WITH SEXUAL DYSFUNCTION IN FEMALE PATIENTS WITH VOIDING DYSFUNCTION

Podium Session 2 The Brain and the Bladder:Room: Grote Zaal - Chairs: Tony Stone & Gert Holstege EVIDENCE FOR CENTRAL HYPEREXITABILITY IN PATIENTS WITH INTERSTITIAL CYSTITIS

Podium Poster Session 11 Pelvic Floor Dysfunction:Room: Jurriaanse Zaal - Chairs: Victor Nitti & Guus Lycklama a Nijeholt 90 A pilot study on weg-based monitoring BPH patients using the personal BPH control program(PBCP)

Podium Poster Session 11 Pelvic Floor Dysfunction:Room: Jurriaanse Zaal - Chairs: Victor Nitti & Guus Lycklama a Nijeholt 91 Combination of alfuzosin and tadalafil exerts additive relaxant effect on human prostate

Podium Poster Session 12 Pregnancy and Childbirth:Room: Grote Zaal - Chairs: Bob Freeman & Harry Vervest 93 How do incontinence status in pregnancy and delivery mode affect urinary incontinence 6 months post partum?

Podium Poster Session 12 Pregnancy and Childbirth:Room: Grote Zaal - Chairs: Bob Freeman & Harry Vervest 96 Planned cesarean versus planned vaginal delivery : a comparison of lower urinary tract symptoms

ICS 2006

Podium Session 1 Pregnancy & Childbirth:Main Auditorium Parity is not related to myelinated axon content of levator ani nerve while parturition transiently affects volume and magnetic resonance contrast intensity of pelvic floor muscles in the squirrel monkey

Podium Session 2 ICS Controversies:Main Auditorium 10 Do Different Disease-Specific QoL Instruments Measure The Same Thing?

Podium Poster Session 12 Imaging & Urodynamics:James Hay 100 Is Objective Measurement Of Bladder Sensation During Repeated Filling Cystometry Reproducible?

Podium Poster Session 12 Imaging & Urodynamics:James Hay 101 THE SIGNIFICANCE OF NATURAL FILLING BY THE PRODUCTION OF URINE DURING CYSTOMETRY

Podium Poster Session 12 Imaging & Urodynamics:James Hay 102 Maximum urethral closure pressure as a selection criterion for midurethral sling type

Podium Poster Session 12 Imaging & Urodynamics:James Hay 103 Home uroflow device: Basic but more accurate than standard in-clinic uroflowmetry?

Podium Poster Session 12 Imaging & Urodynamics:James Hay 104 EXPERIMENTAL EVIDENCE FOR THE BLADDER CONTRACTILITY MODELS OF SCHAFER AND GRIFFITHS

Podium Poster Session 12 Imaging & Urodynamics:James Hay 105 The origin of the penile compression release index – a video urodynamic analysis

Podium Poster Session 12 Imaging & Urodynamics:James Hay 106 Urodynamics in the Octogenarian: Is it Worthwhile?

Podium Poster Session 13 Neurophysiology:James Hay 107 NEUROPHYSIOLOGICAL EVALUATION OF THE EXTERNAL URETHRAL SPHINCTER AFTER RADICAL RETROPUBIC PROSTATECTOMY COMPARED TO CONTINENCE: A PROSPECTIVE STUDY OF 44 PATIENTS.

Podium Poster Session 13 Neurophysiology:James Hay 108 Does acute posterior tibial nerve stimulation suppress bladder contractions in MS patients?

Podium Poster Session 13 Neurophysiology:James Hay 109 Renal function and urodynamic evaluations in myelomeningocele related neurogenic bladder managed with clean intermittent catheterization

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 11 Prevalence, incidence, progression and regression of pelvic organ prolapse in a community cohort: Results of a 5-year longitudinal study

Podium Poster Session 13 Neurophysiology:James Hay 110 Variations in the female pelvic floor innervation: an anatomic study

Podium Poster Session 13 Neurophysiology:James Hay 111 Multiple-Chemical Sensitivity: Is This Condition Related to Painful Bladder Syndrome?

Podium Poster Session 13 Neurophysiology:James Hay 112 NEURONAL AND NON-NEURONAL ACETYLCHOLINE AND ATP RELEASES IN PARTIAL OUTLET OBSTRUCTION IN RATS

Podium Poster Session 13 Neurophysiology:James Hay 113 Intraprostatic Botulinum Toxin A Administration Produces Analgesic and Antiinflammatory Effects Against Capsaicin Induced Prostatitis Model In Rats

Podium Poster Session 13 Neurophysiology:James Hay 114 New neurophysiological aspects after passageric sacral nerve block of S3 segment

Podium Poster Session 13 Neurophysiology:James Hay 115 Identification of interneurons in spinal circuits that regulate micturition

Podium Poster Session 13 Neurophysiology:James Hay 116 ABNORMAL SUPRASPINAL CONTROL PATHWAYS IN URGE INCONTINENCE

Podium Poster Session 13 Neurophysiology:James Hay 117 Selective frontal brain response in correlation to bladder filling in Parkinson’s patients under deep-brain-stimulation. An urodynamic controlled PET-scan study.

Podium Poster Session 13 Neurophysiology:James Hay 118 The Role of ProstaglandineE2 (PGE2) in Cerebral Infarction associated the detrusor overactivity. An Experimental Study in Occurrence Nerve Reversibility.

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 119 ROLE OF PROSTAGLANDIN E2 AND EP-1 RECEPTOR ON DETRUSOR OVERACTIVITY IN SPINAL CORD INJURY

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 12 The classification of major morphological abnormalities of the pubovisceral muscle

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 120 Mutation of β3-Adrenoceptor Gene: A Genetic Marker for Overactive Bladder

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 121 Comparative evaluation of human mucosa and detrusor muscarinic receptor binding by anticholinergic agents in the treatment of overactive bladder

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 122 Time-dependent changes in nitric oxide synthase isoforms in the spinal cord in a rat model of detrusor overactivity induced by bladder irritation

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 123 Solifenacin Improved Warning Time Significantly Compared to Placebo in Patients with Overactive Bladder

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 124 The effects of darifenacin and tolterodine on heart rate (HR) in patients with overactive bladder (OAB)

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 125 Efficacy, tolerability and safety of long-term darifenacin treatment in older patients with overactive bladder: analysis of results from a 2-year, open-label extension study

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 126 EFFICACY OF ANTIMUSCARINICS IN WOMEN WITH ANTERIOR VAGINAL WALL PROLAPSE: IS IT THE SAME?

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 127 Duloxetine Compared with Placebo for the Treatment of Women with Symptoms of Bladder Overactivity

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 128 Histological changes in the human bladder urothelium and suburothelium following injections of Botulinum neurotoxin type A (BoNT/A) for the treatment of neurogenic versus idiopathic detrusor overactivity (NDO/IDO)

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 129 The Use of Intravesical Botulinum Toxin in Overactive Bladder Syndrome: A Systematic Review.

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 13 Correlation between urogenital symptoms and Pelvic Organ Prolapse Quantification (POPQ) findings in women.

Podium Poster Session 14 Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium 130 A double-blind, placebo controlled study investigating efficacy of botulinum toxin type A (Dysport®) in MS related overactive bladder syndrome (OAB): Provisional 36 week results.

Podium Session 15 Sex in the Afternoon:Main Auditorium 131 Generic and disease-specific health-related quality of life in women with coital incontinence: a prospective, multi-center study

Podium Session 15 Sex in the Afternoon:Main Auditorium 132 Psychometric Testing of the Sexual Function and Influence of Urinary Incontinence Questionnaire (SF-IUIQ) in women.

Podium Session 15 Sex in the Afternoon:Main Auditorium 133 Are Sexual Activity and Satisfaction Impacted by Pelvic Floor Disorders? Analysis of a Community Based Survey.

Podium Session 15 Sex in the Afternoon:Main Auditorium 134 Sexual activity and satisfaction in relation to pelvic floor dysfunction and the influence on quality of life

Podium Session 15 Sex in the Afternoon:Main Auditorium 135 Sexual function before and after vaginal prolapse surgery with allograft reinforcement.

Podium Session 15 Sex in the Afternoon:Main Auditorium 136 Impact of overactive bladder on frequency of sexual activity and erectile dysfunction in men: results from the EPIC study

Non Discussion Poster Session 17 137 ANATOMICAL PELVIC MEASURES IN RELATION TO SURGICAL TECHNIQUES THROUGH THE OBTURATOR FORAMEN

Non Discussion Poster Session 17 138 A small outlet dimension of squirrel monkey bony pelvis is associated with development of pelvic organ prolapse

Non Discussion Poster Session 17 139 Does Relaxin Contribute to Stress Urinary Incontinence by Altering Transforming Growth Factor Beta (TGF-B) Expression?

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 14  A comparison of pelvic floor function in nulliparous Elite athletes and nulliparous controls

Non Discussion Poster Session 17 140 Functional and Molecular Changes of bladder in OLETF Diabetic Rat with Age

Non Discussion Poster Session 17 141 Changes of Calcium-activated Potassium Channel Expressions in Rat Bladder and Ureter After Relieving Partial Baldder Outlet Obstruction

Non Discussion Poster Session 17 142 Cellular characterization of cadherin within detrusor smooth muscle cells and suburothelial myofibroblasts in human bladder

Non Discussion Poster Session 17 143 MEASUREMENT OF BLADDER TISSUE LEVELS OF ISOPROSTANE 8-ISO-PGF2alpha IN HUMANS – PRELIMINARY RESULTS

Non Discussion Poster Session 17 144 The Effect of Detrusor Overactivity and Artificial Bladder Filling on Voiding Parameters in Females?

Non Discussion Poster Session 17 145 Will Suburothelial Injection of a Small Dose of Botulinum A Toxin Have Similar Therapeutic Effects and Less Adverse Events for Refractory Detrusor Overactivity ?

Non Discussion Poster Session 17 146 “Still an unreliable witness ?” The use of a new scoring system as a predictive tool for detrusor overactivity

Non Discussion Poster Session 17 147 DORSAL GENITAL NERVE STIMULATION FOR THE TREATMENT OF REFRACTORY OVERACTIVE BLADDER SYMPTOMS

Non Discussion Poster Session 17 148 longer term assessment of treatment of the overactive bladder by detrusor myectomy with special reference to postpubertal nocturnal/diurnal enuresis

Non Discussion Poster Session 17 149 DETRUSOR WALL THICKNESS AS A TEST FOR DETRUSOR OVERACTIVITY IN WOMEN

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 15 Assessment of Pelvic Floor Dysfunction in Nulliparous Women: A Comparative Study

Non Discussion Poster Session 17 150 Two years experience of intra-detrusor Botulinum A toxin for Idiopathic Detrusor Overactivity: duration of action, quality of life and frequency/volume measurements

Non Discussion Poster Session 17 151 The impact of hip replacement surgery on urgency related urinary incontinence

Non Discussion Poster Session 17 152 Pilot study using a novel electronic urgency assessment device to measure storage parameters including the intervoid-interval in healthy volunteers

Non Discussion Poster Session 17 153 ARE DETRUSOR OVERACTIVITY AND INCREASED BLADDER SENSATION BOTH PART OF THE SAME SPECTRUM OF BLADDER DYSFUNCTION?

Non Discussion Poster Session 17 154 Efficacy and Complications of the Intradetrusor injection of Dysport (Botulinum Toxin A) in patients with Refractory OAB

Non Discussion Poster Session 17 155 Solifenacin Improves Urgency Symptoms as Assessed by Voiding Diaries and Patient-reported Outcomes (PRO) in Patients with Overactive Bladder

Non Discussion Poster Session 17 156 Patients with increased expression of TRPV1 in bladder benefit from resiniferatoxin intravesical instillations for refractory detrusor overactivity

Non Discussion Poster Session 17 157 Adjusting for the effect of 24-hour volume improves bladder diary detection of decreased voided volume in detrusor overactivity

Non Discussion Poster Session 17 158 SERUM CHOLINESTERASE LEVELS IN PATIENTS WITH OR WITHOUT OVERACTIVE BLADDER AND/OR NEUROGENIC BLADDER

Non Discussion Poster Session 17 159 The effects on catheters for self-catheterization following daily loading

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 16 LEVATOR CO-ACTIVATION IS A SIGNIFICANT CONFOUNDER OF PELVIC ORGAN DESCENT ON VALSALVA

Non Discussion Poster Session 17 160 Prevalence of Urinary Incontinence and Incontinence-related Quality of Life among Korean Women: A Population-based Study

Non Discussion Poster Session 17 161 Analysing count data

Non Discussion Poster Session 17 162 Leakage volume per leakage episode: a novel approach to assessing urinary leakage episodes and assessing leakage pathophysiology.

Non Discussion Poster Session 17 163 RACE/ETHNIC DIFFERENCES IN SYMPTOMS AND IMPACTS OF URINARY INCONTINENCE IN WOMEN UNDERGOING STRESS INCONTINENCE SURGERY

Non Discussion Poster Session 17 164 Attitude toward elimination problem in disaster preparedness

Non Discussion Poster Session 17 165 A feasibility study into the prevalence of bowel and bladder problems in women prisoners in the UK

Non Discussion Poster Session 17 166 A symptom questionnaire to collectively assess lower urinary tract symptoms - Comprehensive Lower Urinary Tract Symptom Score (CLUTSS)

Non Discussion Poster Session 17 167 Association between overactive bladder and depressive status in the elderly: A community-based study in Japan.

Non Discussion Poster Session 17 168 FREQUENCY AND NOCTURIA AFTER RENAL TRANSPLANTATION IN ADULTS: CAUSES AND CONSEQUENCES FOR THE RENAL TRANSPLANT

Non Discussion Poster Session 17 169 A quantitative study, to identify the incidence of bladder and/or anal incontinece and/or low mood at six weeks or nine months postnatal

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 17 Passive response of the pelvic floor to the increase of the intra-abdominal pressure during a Valsalva

Non Discussion Poster Session 17 170 National Audit of Continence Care for Older People: Organisation of Care for older people within England, Wales and N. Ireland.

Non Discussion Poster Session 17 171 History and assessment for older people with urinary incontinence: Data from the National Audit of Continence Care for Older People:

Non Discussion Poster Session 17 172 Two-dimensional ultrasound imaging of the posterior vaginal wall descent

Non Discussion Poster Session 17 173 Bladder weight in women: a measurement with diagnostic value?

Non Discussion Poster Session 17 174 Ultrasound imaging as a diagnostic tool for assessing a new artificial urinary sphincter

Non Discussion Poster Session 17 175 BLADDER NECK ELEVATION DURING DIFFERENT PELVIC FLOOR ACTIVATION TECHNIQUES: AN MRI STUDY

Non Discussion Poster Session 17 176 Brain responses during the urge to void in normal male volunteer: A positron emission tomography study

Non Discussion Poster Session 17 177 SPIRAL COMPUTED TOMOGRAPHY SCAN EVALUATION OF THE ADJUSTABLE CONTINENCE THERAPY (ACT) IMPLANT IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE

Non Discussion Poster Session 17 178 ADJUSTABLE CONTINENCE THERAPY FOR THE TREATMENT OF MALE URODYNAMIC STRESS URINARY INCONTINENCE – SINGLE CENTRE STUDY.

Non Discussion Poster Session 17 179 The (ProACT™) for the Treatment of Post-Prostatectomy Stress Urinary Incontinence: A Comparison of Two techniques with a Minimum of Six Months Follow Up.

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 18 Influence of intra-abdominal pressure on the validity of pelvic floor dynamometric measurements

Non Discussion Poster Session 17 180 DOES BLADDER SHAPE ON CYSTOURETHROGRAPHY PREDICT STORAGE FUNCTION OF THE BLADDER AND POST-OPERATIVE URINARY INCONTINENCE IN PATIENTS UNDERGOING LAPAROSCOPIC RADICAL PROSTATECTOMY?

Non Discussion Poster Session 17 181 Pathophysiological aspects of nocturia in a Danish population of men and women aged 60-80 years

Non Discussion Poster Session 17 182 Factors affecting nocturnal polyuria in the elderly patients

Non Discussion Poster Session 17 183 EFFECTS OF DEHYDROEPIANDROSTERONE IN THE CENTRAL NERVOUS SYSTEM ON BLADDER FUNCTION IN MALE RATS

Non Discussion Poster Session 17 184 Effects of intrathecal and peripheral injections of α-1 adrenergic receptor subtype selective and non-selective antagonists, on bladder activity in rat models with partial urethral obstruction

Non Discussion Poster Session 17 185 Effects of 4-DAMP on cholinergic mechanisms activating phasic activity in the isolated bladder.

Non Discussion Poster Session 17 186 Is an elevated post-void residual a risk factor for bacteriuria?

Non Discussion Poster Session 17 187 The immunohistochemical study for the expression of ICAM-1, neutrophil, macrophage and iNOS in rats with partially obstructed bladder outlet.

Non Discussion Poster Session 17 188 Can uroflowmetry parameters predict bladder outlet obstruction in men?

Non Discussion Poster Session 17 189 PRESERVATION OF ANTEGRADE EJACULATION AND IMPROVEMENT OF VOIDING FUNCTION USING MODIFIED TRANSURETHRAL INCISION OF BLADDER NECK IN YOUNG MEN WITH PRIMARY BLADDER NECK OBSTRUCTION

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 19 A Feasibility Study for a Randomised Controlled Trial of a Pelvic Floor Muscle Training Intervention for Women with Pelvic Organ Prolapse

Non Discussion Poster Session 17 190 Discontinuation of drug treatment in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Non Discussion Poster Session 17 191 The Safety and Effects of Desmopressin in the Treatment of Elderly Patients with Nocturia for 1-year Follow-Up.

Non Discussion Poster Session 17 192 Association between the symptoms and quality of life (QOL) with objective parameters in patients with lower urinary tract symptoms (LTUS) suggestive of benign prostatic enlargement (BPE)

Non Discussion Poster Session 17 193 Diagnosis and Treatment of Lower Urinary Tract Symptoms, Overactive Bladder, and Benign Prostatic Hyperplasia in Men in UK General Practice

Non Discussion Poster Session 17 194 A Shorter 2-day Voiding Diary is as Reliable as the 3-day Voiding Diary

Non Discussion Poster Session 17 195 The Effects of Cyclical Estrogen on Bladder Structure

Non Discussion Poster Session 17 196 Urge on bladder palpation as a predictor of detrusor overactivity

Non Discussion Poster Session 17 197 EVOLUTION AND QOL IMPACT OF LUTS IN WOMEN FOLLOWED AT UROLOGY CENTERS IN ITALY: 2-YEARS FOLLOW-UP OF THE FLOW STUDY

Non Discussion Poster Session 17 198 Presenting Symptoms and Management of Cough-Induced Detrusor Contractions

Non Discussion Poster Session 17 199 Fowler syndrome-clinical characteristics and studies on ovarian innervation.

Podium Session 1 Pregnancy & Childbirth:Main Auditorium An epidemiological study to assess prevalence and risk factors for pelvic floor dysfunction in primigravidae delivered 20 years earlier

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 20 The uterosacral ligament in postmenopausal women with or without pelvic organ prolapse

Non Discussion Poster Session 17 200 THE SIGNIFICANCE OF 1-HOUR PAD TEST IN THE PATIENT WITH STRESS URINARY INCONTINENCE

Non Discussion Poster Session 17 201 Linguistic Validation and Psychometric Properties of the Korean Version of the King's Health Questionnaire Instrument in Women with Stress Urinary Incontinence

Non Discussion Poster Session 17 202 The benefit of the intraoperative electrical stimulation of pelvic splanchnic nerves during nerve-sparing radical hysterectomy

Non Discussion Poster Session 17 203 A prospective study of the usefulness of cystoscopy and bladder biopsy, in the diagnosis and management of lower urinary tract disorders in women.

Non Discussion Poster Session 17 204 Comparison of lower urinary tract symptoms (LUTS) reported in voiding diary and its agreement to urologist and nurse assessment

Non Discussion Poster Session 17 205 Redesigning the continence pathway: the right patient with the right practitioner

Non Discussion Poster Session 17 206 The effectiveness of dietary intervention in the management of women with faecal incontinence.

Non Discussion Poster Session 17 207 Predicting successful outcome of transanal irrigation for treatment of bowel dysfunction in spinal cord injury patients

Non Discussion Poster Session 17 208 CHOLINERGIC COMPONENT OF MICTURITION CONTRACTIONS INCREASE IN MICE WITH MILD BLADDER OUTLET OBSTRUCTION: CONSCIOUS CYSTOMERTIC STUDY.

Non Discussion Poster Session 17 209 CHANGES OF MUSCARINIC AND PURINERGIC RECEPTOR EXPRESSION IN UROTHELIUM OF RATS WITH DETRUSOR OVERACTIVITY INDUCED BY BLADDER OUTLET OBSTRUCTION

Podium Poster Session 3 Pelvic Floor Function & Dysfunction:Main Auditorium 21 Relation between the end of a rectal sensation, contraction in the internal anal sphincter and a reversed flow of rectal contents in the anal canal; a sonographic study

Non Discussion Poster Session 17 210 METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 1 (mGluR-1) KNOCKOUT MICE EXHIBIT DETRUSOR-SPHINCTER DYSSYNERGIA DURING MICTURITION

Non Discussion Poster Session 17 211 ACTIVATION OF TRANSIENT RECEPTOR POTENTIAL CHANNEL A1 CAUSES HYPERREFLEXIC MICTURITION BY AFFECTING BLADDER AFFERENT ACTIVITY IN RATS

Non Discussion Poster Session 17 212 The short- and long term effects of a single dose of apomorphine on micturition function in uni- and bi-lateral 6-hydroxydopamine treated Parkinson’s disease model rats

Non Discussion Poster Session 17 213 ARE METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPES 1 AND 5 (mGluR-1 AND -5) INVOLVED IN AFFERENT PROCESSING OF DETRUSOR OVERACTIVITY INDUCED BY CHEMICAL IRRITATION IN MICE?

Non Discussion Poster Session 17 214 The effect of intravesical Resiniferatoxin, Oxybutynine, and Lidocaine on the afferent autonomic Vesical Sensory Threshold using a novel bladder electrode in rat

Non Discussion Poster Session 17 215 Bladder Dysfunction in Experimental Autoimmune Encephalitis: A Mouse Model for Studying Bladder Dysfunction in Demyelinating Disease

Non Discussion Poster Session 17 216 Effects of suplatast tosilate, an antiallergy agent , on bladder pain response of conscious rat model of HCl-induced chronic cystitis.

Non Discussion Poster Session 17 217 THE PROCESS OF CHROMIC ISCHEMIA-INDUCED BLADDER DYSFUNCTION IN WATANABE HERITABLE HYPERLIPIDEMIC (WHHL-MI) RABBITS

Non Discussion Poster Session 17 218 THE EFFECTS OF OVARIECTOMY AND ESTROGEN REPLACEMENT ON NERVE STIMULATION AND PASSIVE STRETCH INDUCED ACETYLCHOLINE RELEASE IN RAT BLADDER.

Non Discussion Poster Session 17 219 AMILORIDE-SENSITIVE ION CHANNELS MODULATE THE STRETCH-EVOKED ATP RELEASE FROM THE RAT BLADDER EPITHELIUM

Podium Poster Session 4 Male LUTS & Physiology:James Hay 22 Applied anatomy of nerves to male urethral membrane sphincter

Non Discussion Poster Session 17 220 The effect of resiniferatoxin on the sensory nerve of the rat prostate

Non Discussion Poster Session 17 221 MOLECULAR BASIS OF URGENCY: VANILLOID RECEPTOR EXPRESSION IN THE HUMAN BLADDER

Non Discussion Poster Session 17 222 Inhibitory effects of intravesical alpha1-adrenoceptor agonist instillation on the micturition reflex in the rat

Non Discussion Poster Session 17 223 New methods for evaluation of afferent activity from lower urinary tract in mice

Non Discussion Poster Session 17 224 Effects of intrathecal cholinesterase inhibitor application on bladder overactivity induced by cyclophosphamide and acetic acid

Non Discussion Poster Session 17 225 Neurophysiological nociceptive flexion (RIII) reflex evaluation during intravescically administration of N/OFQ: hypothesis on mechanism and site of action in humans.

Non Discussion Poster Session 17 226 URODYNAMIC EFFECTS OF A NOVEL EP1 RECEPTOR ANTAGONIST IN NORMAL RATS AND RATS WITH BLADDER OUTLET OBSTRUCTION

Non Discussion Poster Session 17 227 Bladder function in mice lacking TRPV4

Non Discussion Poster Session 17 228 Acute Pudendal Nerve Stimulation Improves Cystometric Volumes in Urge Incontinent Patients

Non Discussion Poster Session 17 229 Recovery of Detrusor Function after Urethral Botulinum A Toxin Injection in Patients with Idiopathic Low Detrusor Contractility and Voiding Dysfunction

Podium Poster Session 4 Male LUTS & Physiology:James Hay 23 THE INNERVATION OF THE PELVIC FLOOR MUSCLES: A REAPPRAISAL FOR THE LEVATOR ANI NERVE

Non Discussion Poster Session 17 230 The natural history of urinary urgency following intradetrusor injections of Botulinum neurotoxin A – a comparison between patients with neurogenic (NDO) and idiopathic (IDO) detrusor overactivity (DO)

Non Discussion Poster Session 17 231 Variation between clinical and urodynamic responses in patients receiving intradetrusor botulinum A for refractory neurogenic overactivity

Non Discussion Poster Session 17 232 Urethral Instability and Sacral Nerve Stimulation (SNS): towards explaning it's efficacy

Non Discussion Poster Session 17 233 SURGICAL INTERVENTIONS FOLLOWING INTERSTIM® SACRAL NERVE MODULATION IMPLANT – 11 YEARS EXPERIENCE.

Non Discussion Poster Session 17 234 The effects of amantadine on lower urinary tract dysfunction and nocturnal polyuria in parkinsonian patients

Non Discussion Poster Session 17 235 The voiding function of down syndrome

Non Discussion Poster Session 17 236 PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS): RESULTS AT LONG TERM FOLLOW-UP

Non Discussion Poster Session 17 237 Hypnotherapy as a complementary treatment of Interstitial Cystitis/ Chronic Pelvic Pain Syndrome

Non Discussion Poster Session 17 238 Urinary ATP is the predictive marker for the effect of hydrodistension in the interstitial cystitis patients

Non Discussion Poster Session 17 239 Vascular endothelial growth factor (VEGF) up-regulation in sever intestitial cystitis

Podium Poster Session 4 Male LUTS & Physiology:James Hay 24 IDENTIFICATION OF A MICTURITION SUPPRESSING REGION IN THE PERIAQUEDUCTAL GRAY OF THE MESENCEPHALON

Non Discussion Poster Session 17 240 ASSOCIATION BETWEEN SYMPTOM REDUCTION AND SATISFACTION WITH PENTOSAN POLYSULFATE SODIUM IN PATIENTS WITH INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME

Non Discussion Poster Session 17 241 THE EFFECT OF DMSO ON RAT NORMAL BLADDER MUCOSA AND ON BLADDER INFLAMMATION AFTER PROTAMINE SULFATE INSTILLATION

Non Discussion Poster Session 17 242 Is the effect of hydrodistension temporal? ―5year follow-up of 170 painful bladder syndrome patients―

Non Discussion Poster Session 17 243 VIDEO-URODYNAMIC EVALUATION OF NEGATIVE PROGNOSTIC FACTORS FOR SPONTANEOUS RESOLUTION OF PRIMARY VESICO-URETERAL REFLUX IN MALE INFANTS

Non Discussion Poster Session 17 244 Pelvic floor function outcome after nerve-sparing radical prostatectomy

Non Discussion Poster Session 17 245 Dynamic Characteristics of the Vaginal High Pressure Zone Assessed by 3-Dimensional Ultrasound Images of the Pelvic Floor

Non Discussion Poster Session 17 246 Activity of the pelvic floor muscles during a range of abdominal manoeuvres

Non Discussion Poster Session 17 247 Postural response of the pelvic floor muscles is affected by stress urinary incontinence

Non Discussion Poster Session 17 248 The effect of different postures on the resting activity of the pelvic floor muscles

Non Discussion Poster Session 17 249 THE EFFECT OF SITTING POSTURE ON RESTING PELVIC FLOOR AND ABDOMINAL MUSCLE ACTIVITY IN WOMEN WITH AND WITHOUT STRESS URINARY INCONTINENCE.

Podium Poster Session 4 Male LUTS & Physiology:James Hay 25 CORRELATION BETWEEN LOWER URINARY TRACT SYMPTOMS AND SERUM LEVELS OF SEX HORMONES IN MEN

Non Discussion Poster Session 17 250 A Survey Of The Educational Needs Of Continence Nurse Specialists For The Use Of Neuromuscular Electrical Stimulation Therapy

Non Discussion Poster Session 17 251 Characterization of the Mechanical Parameters Associated with Pelvic Floor Muscles Contractions

Non Discussion Poster Session 17 252 Local application with suplatast tosilate improves bladder dysfunction and suppresses afferent nerve activity in chemical-induced cystitis rats

Non Discussion Poster Session 17 253 Effects of menthol on micturition in rats with spinal cord injury

Non Discussion Poster Session 17 254 SMP-986, a Na+-channel blocker and a muscarinic receptor antagonist, showed increased voiding efficiency in anesthetized dogs

Non Discussion Poster Session 17 255 Propiverine and metabolites: Binding to muscarinic receptors, effects on intracellular calcium-release and human detrusor contraction

Non Discussion Poster Session 17 256 Cholinergic functional changes in the cyclophosphamide-induced cystitis of the rat urinary bladder

Non Discussion Poster Session 17 257 Large species differences in contribution of calcium-influx via L-type calcium currents during muscarinic receptor mediated detrusor contraction

Non Discussion Poster Session 17 258 Is the Urothelium-derived Inhibitory Factor an endogenous steroid?

Non Discussion Poster Session 17 259 CAN MUSCARINIC RECEPTOR ANTAGONISTS INCREASE URINE STORING FUNCTION WITHOUT REDUCING VOIDING FUNCTION ?

Podium Poster Session 4 Male LUTS & Physiology:James Hay 26 The normal voiding pattern assessed by a frequency volume chart (FVC)

Non Discussion Poster Session 17 260 Muscarinic and purinergic receptors are altered in the bladder of rat models with interstitial cystitis

Non Discussion Poster Session 17 261 IMPROVEMENT IN BLADDER STORAGE FUNCTION BY ALPHA1-BLOCKER DEPENDS ON SUPPRESSION OF C-FIBER URETHRAL AFFERENT ACTIVITY IN RATS

Non Discussion Poster Session 17 262 MECHANISMS FOR STRETCH-INDUCED NON-NEURONAL ATP AND ACECHYLCHOLINE RELEASES FROM HUMAN BLDDER

Non Discussion Poster Session 17 263 Effects of beta3-agonist, AJ-9677, on mediating relaxation of the rat, monkey and human urinary bladder in vitro.

Non Discussion Poster Session 17 264 EFFECT OF GOSHA-JINKI-GAN, A HERBAL MEDICINE, ON BLADDER ACTIVITY AND THE AUTONOMIC NERVOUS SYSTEM IN RATS.

Non Discussion Poster Session 17 265 The active metabolite (DPr-P-4(N→O)) of propiverine hydrochloride may contribute to the bladder selectivity of this drug to treat patients with overactive bladder

Non Discussion Poster Session 17 266 THE OUTWARD POTASSIUM CURRENT IS INCREASED BY BETA AGONISTS IN CULTURED HUMAN URINRAY BLADDER SMOOTH MUSCLE CELLS

Non Discussion Poster Session 17 267 TYPE 4 PHOSPHODIESTERASE INHIBITOR SHOWS ANTI-INFLAMMATORY EFFECTS AND REDUCES URINARY FREQUENCY IN THE HYDROCHLORIDE INDUCED INTERSTITIAL CYSTITIS RAT MODEL

Non Discussion Poster Session 17 268 Expression of cyclic AMP and cyclic GMP phosphodiesterase (PDE) isoenzmymes in the human prostate: an immunohistochemical study

Non Discussion Poster Session 17 269 ANTIMUSCARINIC DRUG INHIBITS DETRUSOR OVERACTIVITY INDUCED BY TOPICAL APPLICATION OF PROSTAGLANDIN E2 TO THE LOWER URINARY TRACT WITH A REDUCTION IN URETHRAL PRESSURE

Podium Poster Session 4 Male LUTS & Physiology:James Hay 27 Measuring Urinary Outcomes after Radical Prostatectomy – The Need for a Simple Standard

Non Discussion Poster Session 17 270 Effect of Zolpidem tartrate on urine volume in rats

Non Discussion Poster Session 17 271 Spontaneous contractions of the pig bladder: effect of the ATP-dependent potassium channel opener cromakalim and influence of the urothelium.

Non Discussion Poster Session 17 272 EFFECTS OF TRPA1 RECEPTOR-AGONISTS ON THE ISOLATED DETRUSOR AND ON MICTURITION IN RATS

Non Discussion Poster Session 17 273 ALPHA1D-ADRENOCEPTOR ANTAGONIST NAFTOPIDIL INHIBITS PROSTATE GROWTH WITHOUT APOPTOSIS IN BENIGN PROSTATIC HYPERPLASIA MODEL RAT

Non Discussion Poster Session 17 274 ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONATE (AMPA) GLUTAMATE RECEPTOR ANTAGONIST CAN INHIBIT PREMICTURITION CONTRACTIONS IN RATS WITH BLADDER OUTLET OBSTRUCTION

Non Discussion Poster Session 17 275 Nicorandil, a KATP channel opener and nitric oxide donor, was effective to reduce the bladder overactivity

Non Discussion Poster Session 17 276 The effective and safe dose-escalating method in patients with concomitant benign prostatic hyperplasia and antihypertensive medications after initial doxazosin GITS 4 mg: Doxazosin GITS 8 mg versus combined therapy with doxazosin GITS 4 mg and tamsulosin 0.2 mg

Non Discussion Poster Session 17 277 The effect of desmopressin in the treatment of mixed nocturia having nocturnal polyuria and low nocturnal bladder capacity.

Non Discussion Poster Session 17 278 A comparison of the pharmacokinetics of trospium chloride 60 mg extended release given under a fasted condition to the pharmacokinetics when given with concurrent antacid and when given with a high-fat meal.

Non Discussion Poster Session 17 279 PROPIVERINE HYDROCHLORIDE REDUCED FREQUENCY AND PERCEPTION OF URGENCY IN TREATMENT OF OVERACTIVE BLADDER: A 12 WEEK PROSPECTIVE, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY

Podium Poster Session 4 Male LUTS & Physiology:James Hay 28 What is the most precise cut-off value of detrusor wall thickness measurement to classify bladder outlet obstruction?

Non Discussion Poster Session 17 280 The effects of tolterodine on carbachol-induced contraction in human bladder smooth muscles in normal state and in detrusor overactivity associated with benign prostatic hyperplasia

Non Discussion Poster Session 17 281 Solifenacin significantly reduces both urgency severity and bother: results from the flexible dose, placebo controlled, multinational SUNRISE study

Non Discussion Poster Session 17 282 Urinary incontinence during pregnancy and after the first labour

Non Discussion Poster Session 17 283 A study to involve older continence service users in the development of quality standards in continence services

Non Discussion Poster Session 17 284 PATIENT QUALITY OF LIFE AFTER AUGMENTATION CYSTOPLASTY FOR NEUROGENIC BLADDER DYSFUNCTION

Non Discussion Poster Session 17 285 Quality of life and work impairment in nocturia patients before and after antidiuretic treatment.

Non Discussion Poster Session 17 286 Evaluation of the quality of life of women with stress urinary incontinence using King’s College Health Questionnaire after pelvic floor muscle exercise.

Non Discussion Poster Session 17 287 Quality of life in the families who care for aging patients with urinary management.

Non Discussion Poster Session 17 288 COMBINED OBTURATOR - PRE PUBIC ANTERIOR VAGINAL WALL PROLAPSE REPAIR: REPORT OF A MULTICENTRIC CLINICAL TRIAL

Non Discussion Poster Session 17 289 Apoptotic response to xenogenic acellular collagen implant and polypropylene in a murine model

Podium Poster Session 4 Male LUTS & Physiology:James Hay 29 Stress incontinence after radical prostatectomy: a randomized controlled trial on combination of duloxetine and rehabilitation versus rehabilitation alone

Non Discussion Poster Session 17 290 Adjuvant Alloderm Graft for Advanced Anterior Compartment Prolapse: Comparison to Standard Anterior Colporrhaphy at 1-Year

Non Discussion Poster Session 17 291 PROSPECTIVE CLINICAL ASSESSMENT OF THE TRANS VAGINAL MESH (TVM) TECHNIQUE FOR TREATMENT OF PELVIC ORGAN PROLAPSE – ONE YEAR RESULTS OF 175 PATIENTS.

Non Discussion Poster Session 17 292 Augmentation cystoplasty in patients with multiple sclerosis – long term follow-up

Non Discussion Poster Session 17 293 Bladder enterocystoplasty and renal transplantation

Non Discussion Poster Session 17 294 POST-ORTHOTOPIC NEO-BLADDER FEMALE URINARY INCONTINENCE: 10 YEARS EXPERIENCE

Non Discussion Poster Session 17 295 A meta-analysis of pelvic floor muscle training for treatment of women with urinary incontinence

Non Discussion Poster Session 17 296 EFFECT OF BIOFEEDBACK THERAPY ON PSYCHOLOGICAL BURDEN IN OLDER WOMEN WITH URGE URINARY INCONTINENCE

Non Discussion Poster Session 17 297 Continence status five years after cessation of organised pelvic floor muscle training

Non Discussion Poster Session 17 298 Neurophysiological guidance in infiltrative therapy for pudendal neuralgia.

Non Discussion Poster Session 17 299 Proactive continence care by nurses: a study of their decision making and the evaluation of an educational intervention

Podium Session 1 Pregnancy & Childbirth:Main Auditorium DOES DELAYED CHILDBEARING INCREASE THE RISK OF LEVATOR INJURY IN LABOUR?

Podium Poster Session 4 Male LUTS & Physiology:James Hay 30 A randomized, placebo-controlled, double-blind study of electrical stimulation with pelvic floor muscle training for the treatment of urinary incontinence after radical prostatectomy

Non Discussion Poster Session 17 300 Reducing The Symptoms Of Overactive Bladder And Urinary Incontinence: Results Of A Two-Month Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Non Discussion Poster Session 17 301 2 Year Follow-up Data on 147 Patients Implanted with the Monarc Transobturator Sling for Treatment of Stress Urinary Incontinence

Non Discussion Poster Session 17 302 A two-year follow-up of a new readjustable transobturator approach for surgical treatment of female stress urinary incontinence

Non Discussion Poster Session 17 303 Which preoperative variables predict 3 year subjective cure after TVT operation ?

Non Discussion Poster Session 17 304 ARTIFICIAL URINARY SPHINCTER AND THE BULBAR MALE SLING IN THE TREAMENT OF POST-PROSTATECTOMY INCONTINENCE: A COMPARISON STUDY

Non Discussion Poster Session 17 305 USE OF THE ADJUSTABLE CONTINENCE THERAPY FOR THE TREATMENT OF RECURRENT FEMALE URODYNAMIC STRESS URINARY INCONTINENCE

Non Discussion Poster Session 17 306 Safety of inside-out transobturator approach for urinary stress incontinence treatment : Prospective multicentric study of 994 patients – French TVT-O registry.

Non Discussion Poster Session 17 307 RELIABILITY OF PEAK FLOW RATE OBTAINED FROM A VOIDING CYCLE INTERRUPTED BY INFLATION OF A PENILE CUFF

Non Discussion Poster Session 17 308 URGENCY TIP ; A PORTABLE PATIENT-ACTIVATED DEVICE FOR OBJECTIVE MEASUREMENT OF BLADDER SENSATION.

Non Discussion Poster Session 17 309 ASSESSMENT OF TIME TO ONSET: THE EFFECT OF SINGLE ORAL DOSE OF TOLTERODINE ON NEUROGENIC DETRUSOR OVERACTIVITY IN SPINAL CORD INJURY PATIENTS

Podium Poster Session 4 Male LUTS & Physiology:James Hay 31 Pelvic Floor Muscle Training Before Transurethral Resection of the Prostate

Non Discussion Poster Session 17 310 RESIDUAL URINE VOLUMES IN WOMEN WITH LOWER URINARY TRACT SYMPTOMS: PREVALENCE,ASSOCIATIONS AND LEVEL PREDISPOSING TO RECURRENT URINARY TRACT INFECTIONS.

Non Discussion Poster Session 17 311 Can we safely limit the use of invasive urodynamics in the preoperative evaluation of stress urinary incontinence in women?

Non Discussion Poster Session 17 312 Effect of 8-OHDPAT on External Urethral Sphincter (EUS) Activity in Pudendal Nerve Injury Rats

Non Discussion Poster Session 17 313 Can pressure flow study and non-invasive studies predict the clinical outcome after transurethral resection of prostate?

Non Discussion Poster Session 17 314 DIAGNOSIS OF OBSTRUCTION – PLAYING THE ODDS

Non Discussion Poster Session 17 315 Reliability of clinical judgement in predicting urodynamics results

Non Discussion Poster Session 17 316 Quality Control: A comparison of urodynamic traces before and after attendance at an established urodynamic course

Non Discussion Poster Session 17 317 Using external camera and colour filling fluid in Valsalva leak point pressure detection with subsequent introital ultrasonography - new possibilities in diagnostics of female stress urinary incontinence

Non Discussion Poster Session 17 318 Urine production rate and bladder function in the normal pig

Non Discussion Poster Session 17 319 The Role Of Ambulatory Urodynamic Investigation In Patients With Urinary Incontinence (Can It Become a Standard Clinical Investigation?)

Podium Poster Session 4 Male LUTS & Physiology:James Hay 32 Outcomes of Artificial Urinary Sphincter Placement in Elderly Men

Non Discussion Poster Session 17 320 IS Three Repeated Filling Cystometries Necessary For Patients With Detrusor Overactivity?

Non Discussion Poster Session 17 321 Urodynamic changes during intra vaginal electro stimulation with a frequency of 8 Hz

Non Discussion Poster Session 17 322 THE EFFECT OF ALPHA-ADRENERGIC BLOCKER ON PROSTATIC ENLARGEMENT: NON INVASIVE ULTRASOUND URODYNAMIC EVALUATION OF VELOCITY-FLOW PLOTS

Non Discussion Poster Session 17 323 Establishing a Mean Post-Void Residual Volume in Asymptomatic Peri- and Post-Menopausal Women

Non Discussion Poster Session 17 324 IS DETRUSOR HYPERTROPHY IN WOMEN ASSOCIATED WITH SYMPTOMS AND SIGNS OF VOIDING DYSFUNCTION?

Non Discussion Poster Session 17 325 The Effect of Physical Activity on Pelvic Organ Prolapse.

Non Discussion Poster Session 17 326 WHAT'S 'NORMAL' PELVIC ORGAN DESCENT- AND WHAT'S 'PROLAPSE'?

Non Discussion Abstract Session 19 Read By Title 327 Distribution of elastin fiber in prostate

Non Discussion Abstract Session 19 Read By Title 328 Effect of alpha-lipoic acid on reduction and oxidation process of bladder in a diabetic animal model

Non Discussion Abstract Session 19 Read By Title 329 EXPRESSION OF NITRIC OXIDE SYNTHASE ISOFORMS AND PROTEIN NITRATION OF RABBIT URINAYR BLADDER FOLLOWING BLADDER OUTLET OBSTRUCTION

Podium Poster Session 4 Male LUTS & Physiology:James Hay 33 A comparative study of two types of urinary sheath: A randomised, prospective, crossover clinical study

Non Discussion Abstract Session 19 Read By Title 330 DETRUSOR WALL THICKNESS IN WOMEN WITH A HISTORY OF CHILDHOOD NOCTURNAL ENURESIS

Non Discussion Abstract Session 19 Read By Title 331 Patients Bothered by Incontinence Report Improvements Following Treatment with Solifenacin in the VOLT Trial

Non Discussion Abstract Session 19 Read By Title 332 Solifenacin Reduces Overactive Bladder Symptoms and Improves Health-related Quality of Life in Patients Previously Treated with Tolterodine

Non Discussion Abstract Session 19 Read By Title 333 DOES PROPIVERINE CAUSE POST VOID RESIDUAL URINE ? A STUDY REVIEW IN PATIENTS WITH OAB, OAB AND BPS, AND NEUROGENIC DETRUSOR OVERACTIVITY

Non Discussion Abstract Session 19 Read By Title 334 Darifenacin – what does it add? Real life experiences in different patient groups

Non Discussion Abstract Session 19 Read By Title 335 Tibial neuromodulation in patients with neurogenic detrusor overactivity and Parkinson`s disease who stopped anticholinergic therapy due to side effects

Non Discussion Abstract Session 19 Read By Title 336 Up to date treatment results of drug refactorical non neurogenic overactive bladder with transurethral intramural intravesical injection of botulinum toxin A

Non Discussion Abstract Session 19 Read By Title 337 CAN WE CLARIFY THE CLINICAL AND URODYNAMIC PROFILE OF THE WOMAN WITH DETRUSOR OVERACTIVITY?

Non Discussion Abstract Session 19 Read By Title 338 The age distribution of pelvic organ prolapse surgery in the United States

Non Discussion Abstract Session 19 Read By Title 339 Racial characteristics of women undergoing surgery for stress urinary incontinence in the United States

Podium Poster Session 5 Reconstructive Pelvic Floor Surgery:Main Auditorium 34 Systematic review and meta-analysis of randomised controlled trials on surgery for pelvic organ prolapse

Non Discussion Abstract Session 19 Read By Title 340 PATIENT-REPORTED HEALTH OUTCOMES WHILE TAKING TOLTERODINE ER AND SOLIFENACIN: HEALTH UTILITY, WORK PRODUCTIVITY, AND MEDICAL CARE UTILIZATION

Non Discussion Abstract Session 19 Read By Title 341 Health burden of lower urinary tract symptom (LUTS) in Japanese male

Non Discussion Abstract Session 19 Read By Title 342 The aetiology of overactive bladder in women: evaluation of diet and lifestyle factors related to diabetes and obesity.

Non Discussion Abstract Session 19 Read By Title 343 Incidence of Disability of Oral Medication in Patients with Frequency /Urinary Incontinence or Urinary Urgency

Non Discussion Abstract Session 19 Read By Title 344 Prevalence of nocturnal enuresis among primary school children in Spain

Non Discussion Abstract Session 19 Read By Title 345 Prevalence of urinary incontinence (UI) and overactive bladder (OAB) among institutionalized persons over the age of 65 in Spain

Non Discussion Abstract Session 19 Read By Title 346 NASHA/DX Gel (ZuidexTM) for the treatment of Stress Urinary Incontinence, how long does last?

Non Discussion Abstract Session 19 Read By Title 347 Body mass index and the prevalence of nocturia in Japanese elderly men

Non Discussion Abstract Session 19 Read By Title 348 Surgical repair of simple and complicated vesico- and urethrovaginal fistulae

Non Discussion Abstract Session 19 Read By Title 349 Urinary incontinence and smoking, studied longitudinally in women born 1930 and 1940

Podium Poster Session 5 Reconstructive Pelvic Floor Surgery:Main Auditorium 35 An Incontinence Procedure performed at the Time of Prolapse Repair might be unnecessary Surgery.

Non Discussion Abstract Session 19 Read By Title 350 Treatment for older people with urinary incontinence: Data from the National Audit of Continence Care for Older People:

Non Discussion Abstract Session 19 Read By Title 351 Study of Low Bladder Volume Measurement Using 3D Ultrasonographic Device

Non Discussion Abstract Session 19 Read By Title 352  Change of Detrusor Muscle on MRI in Male Patients with Lower Urinary Tract Symptom (LUTS).

Non Discussion Abstract Session 19 Read By Title 353 Ultrasound evaluation of lower urinary tract and perineo-enterocele

Non Discussion Abstract Session 19 Read By Title 354 Voiding Sonography - A reliable way to observe pelvic floor activity in women.

Non Discussion Abstract Session 19 Read By Title 355 Three-dimensional ultrasound of the puborectal muscle before and after vaginal delivery.

Non Discussion Abstract Session 19 Read By Title 356 Can cystourethrography (CUG) predict the outcome of suburethral sling procedure for the treatment of stress urinary incontinence?

Non Discussion Abstract Session 19 Read By Title 357 MR Imaging of Pelvic Floor of Postoperative patients with Ulcerative Colitis in the Sitting Position

Non Discussion Abstract Session 19 Read By Title 358 The Significance of Ultrasound Diagnosis of Paravaginal Defects

Non Discussion Abstract Session 19 Read By Title 359 The use of Spiral Computed Tomography in pro-ACT (Adjustable Continence Therapy) implant failures

Podium Poster Session 5 Reconstructive Pelvic Floor Surgery:Main Auditorium 36 Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: Trans-obturator approach (Monarc) versus retropubic approach (TVT)

Non Discussion Abstract Session 19 Read By Title 360 LAPAROSCOPIC AND OPEN RADICAL PROSTATECTOMY: FUNCTIONAL RESULTS IN A SINGLE CENTRE SERIES

Non Discussion Abstract Session 19 Read By Title 361 Treatment of male urinary incontinence with male sling: long term follow-up

Non Discussion Abstract Session 19 Read By Title 362 Outcomes following the Transcorporal Placement of an Artificial Urinary

Non Discussion Abstract Session 19 Read By Title 363 STRESS URINARY INCONTINENCE FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE IN PATIENTS WHO HAVE UNDERGONE RADIATION THERAPY FOR PROSTATE CANCER

Non Discussion Abstract Session 19 Read By Title 364 PHASIC NON-MICTURITION ACTIVITY IN THE BLADDER OF THE ANAESTHETISED AND AWAKE RAT

Non Discussion Abstract Session 19 Read By Title 365 Predictive Factors Affecting Urethral Stricture Development After Transurethral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia

Non Discussion Abstract Session 19 Read By Title 366 THE USEFULNESS OF ICE-WATER TEST IN THE PATIENT WITH SYMPTOMATIC BPH ASSOCIATED WITH OVERACTIVE BLADDER

Non Discussion Abstract Session 19 Read By Title 367 Effect of alpha-blocker before TURP in terms of its dosing period

Non Discussion Abstract Session 19 Read By Title 368 INFLUENCE OF BLADDER CONTRACTILITY ON SHORT-TERM OUTCOMES OF HIGH-POWER POTASSIUM-TITANYL-PHOSPHATE PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE

Non Discussion Abstract Session 19 Read By Title 369 BASED ON URODYNAMIC RESULTS, WHAT IS THE ROLE OF OBSTRUCTION OR OVERACTIVE DETRUSOR ON OBSTRUCTION AND OVERACTIVE DETRUSOR’S COMBINATION IN MALE PATIENTS

Podium Poster Session 5 Reconstructive Pelvic Floor Surgery:Main Auditorium 37 High levator myorraphy to correct superior vaginal segment prolapse: a new proposal with a long-term follow-up

Non Discussion Abstract Session 19 Read By Title 370 Study of Symptoms in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Non Discussion Abstract Session 19 Read By Title 371 Comparison of conventional urodynamic study and ultrasound findings in men with lower urinary tract symptoms

Non Discussion Abstract Session 19 Read By Title 372 Measurement of urethral compliance

Non Discussion Abstract Session 19 Read By Title 373 INFLUENCE OF LOWER URINARY TRACT SYMPTOMS ON QUALITY OF LIFE IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA -EVALUATION USING BOTHER SCORES-

Non Discussion Abstract Session 19 Read By Title 374 Treatment of symptomatic overactive bladder in men with tamsulosin: a prospective multicenter trial

Non Discussion Abstract Session 19 Read By Title 375 Urodynamic evaluation of patients with lower urinary tract symptoms and prostate volume less than 40 ml

Non Discussion Abstract Session 19 Read By Title 376 Transurethral resection of prostate for large benign prostatic hyperplasia: a comparative study with open prostatectomy

Non Discussion Abstract Session 19 Read By Title 377 CAN A DANGER INDEX OF OBSTRUCTION HELP CATEGORIZING PATIENTS WITH BENIGN PROSTATIC ENLARGEMENT AT RISK FOR ACUTE URINARY RETENTION?

Non Discussion Abstract Session 19 Read By Title 378 Clinical efficacy and tolerability of Gosha-jinki-gan, Chinese traditional herbal medicine, in females with overactive bladder

Non Discussion Abstract Session 19 Read By Title 379 Efficacy and Safety of Tamsulosin for the Treatment of Non-neurogenic Voiding Dysfunction in Female: A 8 Week Prospective Study.

Podium Poster Session 5 Reconstructive Pelvic Floor Surgery:Main Auditorium 38 Transobturator mesh anchoring for the repair of large or recurrent cystocele

Non Discussion Abstract Session 19 Read By Title 380 Urinary Incontinence as a Result of Labial Agglutination

Non Discussion Abstract Session 19 Read By Title 381 PRELIMINARY CLINICAL OUTCOME OF TREATMENT FOR WOMEN WITH INCREASED DAYTIME URINARY FREQUENCY

Non Discussion Abstract Session 19 Read By Title 382 Nurse-led telephone follow-up in women with LUTS. Evaluation of a novel service delivery strategy.

Non Discussion Abstract Session 19 Read By Title 383 Capsaicin sensitive afferent nerve activity during bladder distension in normal and TRPV1 mutant mice.

Non Discussion Abstract Session 19 Read By Title 384 Effects of Anti-Muscarinic Agents on Acetic Acid-prepared Rat Model of Increased Urinary Frequency

Non Discussion Abstract Session 19 Read By Title 385 The Effects of a Cyclohexenon Derivative (MM-101) on the Vesical Function of Rats with Experimental Chronic Diabetes

Non Discussion Abstract Session 19 Read By Title 386 Neurophysiological and clinical long term follow up in sacral neuromodulation: a hypothesis of neuroplasticity.

Non Discussion Abstract Session 19 Read By Title 387 Neurophysiological assessment of afferent pudendal nerve activity during pudendal nerve neuromodulation for lower urinary tract dysfunction.

Non Discussion Abstract Session 19 Read By Title 388 ERECTILE DYSFUNCTION PREVALENCE IN A MALE MULTIPLE SCLEROSIS PATIENTS COHORT: PILOT, OBSERVATIONAL STUDY.

Non Discussion Abstract Session 19 Read By Title 389 PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS) IN THE TREATMENT OF LUTS SECUNDARY TO PARKINSON’S DISEASE

Podium Poster Session 5 Reconstructive Pelvic Floor Surgery:Main Auditorium 39 PERSPECTIVE RANDOMIZED CONTROLLED STUDY BETWEEN THE USE OF A SYNTHETIC MESH (GYNEMESH) AND A BIOLOGICAL MESH (PELVICOL)IN RECURRENT CYSTOCELE

Non Discussion Abstract Session 19 Read By Title 390 Urinary tract Infections in patients with neurogenic bladder undergoing clean intermittent self-catheterization training. Urinary tract Infections in patients with neurogenic bladder undergoing clean intermittent self-catheterization training.

Non Discussion Abstract Session 19 Read By Title 391 Outcomes of alpha1-blocker treatment in neurogenic and non-neurogenic patients with bladder emptying disorders

Non Discussion Abstract Session 19 Read By Title 392 Differencial improvement between voiding and motor function of lower extremity after the conservative therapies for the patients of Human T-Cell Lymphotrophic Virus Type 1-Associated Myelopathy.

Non Discussion Abstract Session 19 Read By Title 393 UK experience of 2-stage Sacral Neuromodulation for women with urinary retention

Non Discussion Abstract Session 19 Read By Title 394 Sacral Neuromodulation for the Treatment of Voiding Dysfunction in Adults with Cerebral Palsy

Non Discussion Abstract Session 19 Read By Title 395 PERCUTANEOUS TIBIAL NERVE STIMULATION AND SHORT LATENCY SOMATOSENSORY EVOKED POTENTIALS: PRELIMINARY REPORTS

Non Discussion Abstract Session 19 Read By Title 396 Experience for botulinum-A toxin injection in bladder wall or urethra to treat detrusor overactivity or detrusor-sphincter dyssynergia in patients with neurogenci bladder.

Non Discussion Abstract Session 19 Read By Title 397 INTRAVESICAL BOTULINUM TOXIN A: AN ALTERNATIVE PROCEDURE OF ADMINISTRATION

Non Discussion Abstract Session 19 Read By Title 398 INITIAL TREATMENT PATTERNS OF INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME WITHIN THE FIRST 30 OR 365 DAYS AFTER DIAGNOSIS: A LARGE POPULATION-BASED STUDY

Non Discussion Abstract Session 19 Read By Title 399 EVALUATION OF SYMPTOM AND PROBLEM INDEX IN PAINFUL BLADDER SYNDROME

Podium Session 1 Pregnancy & Childbirth:Main Auditorium Obstetric anal sphincter injury- a prospective study at two years, following standardised management in a dedicated Perineal Clinic at a tertiary hospital

Podium Poster Session 5 Reconstructive Pelvic Floor Surgery:Main Auditorium 40 Vesicovaginal Fistula: Our experience with 1,084 surgical repairs

Non Discussion Abstract Session 19 Read By Title 400 The effect of intravesical dimethyl sulfoxide for interstitial cystitis after hydrodistension.

Non Discussion Abstract Session 19 Read By Title 401 REDUCTION IN SYMPTOMS IS ASSOCIATED WITH IMPROVED SEXUAL FUNCTIONING AND SLEEP IN PATIENTS WITH INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME

Non Discussion Abstract Session 19 Read By Title 402 An audit of the use of intra-vesical steroid injection for the treatment of interstitial cystitis.

Non Discussion Abstract Session 19 Read By Title 403 A Simple Test to Aid in the Diagnosis of Interstitial Cystitis

Non Discussion Abstract Session 19 Read By Title 404 BOTULINUM A TOXIN INTRAVESICAL PASSIVE ADMINISTRATION IN THE TREATMENT OF PAINFUL BLADDER SYNDROME: PRELIMINARY RESULTS

Non Discussion Abstract Session 19 Read By Title 405 PHYSICAL AND PSYCHOLOGICAL COMPLEXITY IN PATIENTS WITH INTERSTITIAL CYSTITIS WARRANTS A MULTIDISCIPLINARY APPROACH TO CARE

Non Discussion Abstract Session 19 Read By Title 406 PAIN CHARACTERISTICS OF WOMEN WITH INTERSTITIAL CYSTITIS (IC)

Non Discussion Abstract Session 19 Read By Title 407 PRIMARY NOCTURNAL ENURESIS: A COMBINED PROPIVERINE AND DESMOPRESSIN TREATMENT REGIMEN IMPROVES OUTCOMES

Non Discussion Abstract Session 19 Read By Title 408 Influence of increased cough intensity on the activation timing and contractile force of associated pelvic floor muscle contraction in continent women

Non Discussion Abstract Session 19 Read By Title 409 Is Bladder Base Elevation a Sign for Pelvic Floor Hypertonicity in Women with Lower Urinary Tract Symptoms ?

Podium Poster Session 6 Basic Physiology:James Hay 41 Functional properties of TRPV1 expressed in human urothelial cells

Non Discussion Abstract Session 19 Read By Title 410 Characteristics of the lower urinary tract function in patients with high-grade cystocele

Non Discussion Abstract Session 19 Read By Title 411 Pelvic floor physiotherapeutic assessment: a valuable clinical tool

Non Discussion Abstract Session 19 Read By Title 412 Feasibility study for a randomised controlled trial evaluating the use of absorbable mesh, polydioxanone and polyglactin sutures for anterior and posterior vaginal wall prolapse repairs

Non Discussion Abstract Session 19 Read By Title 413 The influence of sitting to the activity of pelvic floor muscle activity

Non Discussion Abstract Session 19 Read By Title 414 Voiding Dysfunction symptoms relief by pelvic floor stimulation

Non Discussion Abstract Session 19 Read By Title 415 Observation of internal urethral orfice immediately before and during urination using real-time 4D imaging echogram

Non Discussion Abstract Session 19 Read By Title 416 The effect of whole body vibration training on women with stress urinary incontinence

Non Discussion Abstract Session 19 Read By Title 417 The Influence of the Epithelium on Contractile Responses of the Internal Anal Sphincter

Non Discussion Abstract Session 19 Read By Title 418 The Urothelium-derived inhibitory factor is dependant on extracellular calcium

Non Discussion Abstract Session 19 Read By Title 419 ESTROGEN INDUCES ANGIOGENESIS GROWTH INTO SMOOTH MUSCLE CELLS OF FEMALE RABBIT BLADDER

Podium Poster Session 6 Basic Physiology:James Hay 42 UROTHELIAL CELLS ISOLATED FROM URINE OF FEMALE SUBJECTS RELEASE ATP IN RESPONSE TO ACID

Non Discussion Abstract Session 19 Read By Title 420 Effects of solifenacin succinate on learning and memory: A comparative study.

Non Discussion Abstract Session 19 Read By Title 421 Nitric oxide and anticholinergic effects in normal and inflamed urinary bladders in anaesthetized rats

Non Discussion Abstract Session 19 Read By Title 422 DIFFERENCE PROPERTIES OF ANTI-CHOLINERGIC AGENTS ON ACETIC ACID-INDUCED URINARY FREQUNCY AND HIGH-VOLTAGE ACTIVATED Ca2+ CHANNEL CURRENTS IN BLADDER AFFERNT NEUORNS IN RATS

Non Discussion Abstract Session 19 Read By Title 423 COMPARISON OF EFFECTS OF VARIOUS ANTIMUSCARINIC DRUGS ON CYSTOMETRIC FINDINGS IN CHRONIC SPINAL RATS

Non Discussion Abstract Session 19 Read By Title 424 EVALUATION OF ANDROGENIC SUPPLEMENTATION THERAPY ON PELVIC FLOOR ACTIVITY IN NORMAL POSTMENOPAUSAL WOMEN

Non Discussion Abstract Session 19 Read By Title 425 Efficacy and safety of a once-daily extended-release ciprofloxacin tablet formulation for empirical treatment of symptomatic uncomplicated cystitis in Korean women

Non Discussion Abstract Session 19 Read By Title 426 EFFICACY AND TOLERABILITY OF SOLIFENACIN 5 MG ONCE DAILY IN THE TREATMENT OF OAB SYNDROME

Non Discussion Abstract Session 19 Read By Title 427 A study on the efficacy and safety of combination therapy with alpha-blockers and anticholinergics in the benign prostatic hyperplasia patients accompanied with overactive bladder symptoms.

Non Discussion Abstract Session 19 Read By Title 428 Doxazosin for treating voiding dysfunction in men with Parkinson´s disease

Non Discussion Abstract Session 19 Read By Title 429 Grade of OASIS (Obstetric Anal Sphincter Injuries) – does it make a difference to outcome?

Podium Poster Session 6 Basic Physiology:James Hay 43 Different types of mechanoreceptors in the bladder

Non Discussion Abstract Session 19 Read By Title 430 Antepartum Urinary Incontinence: A Comparison Between Nulliparous and Multiparous Hong Kong Chinese Women

Non Discussion Abstract Session 19 Read By Title 431 Anal and urinary incontinence in multiparous women nine months after childbirth.

Non Discussion Abstract Session 19 Read By Title 432 Overactive bladder symptoms associated with a negative impact on work productivity: results from the EPIC study

Non Discussion Abstract Session 19 Read By Title 433 Men and women with overactive bladder symptoms report higher prevalence of depression and lower quality of life: results from the EPIC study

Non Discussion Abstract Session 19 Read By Title 434 Does CIC deserve a better reputaion in patients with voiding dysfunction?

Non Discussion Abstract Session 19 Read By Title 435 Quality of Life in Men Following Treatment for Overactive Bladder

Non Discussion Abstract Session 19 Read By Title 436 Urinary symptoms and quality of life in South Asian women in Leicester

Non Discussion Abstract Session 19 Read By Title 437 Quality of life measurement in children with myelomeningocele and incontinence treated with the Pippi-Salle technique.

Non Discussion Abstract Session 19 Read By Title 438 QOL investigation in aging male at urology outpatient clinic; Which has a more influence on QOL , lower urinary tract symptom (LUTS) or late-onset hypogonadism (LOH)?

Non Discussion Abstract Session 19 Read By Title 439 Surgery for pelvic organ prolapse using mesh and a new vaginal support device. A 12 month follow up.

Podium Poster Session 6 Basic Physiology:James Hay 44 RESTORATION OF BLADDER FUNCTION BY BONE MARROW CELL TRANSPLANTATION IN RATS WITH UNDERACTIVE BLADDER BY BLADDER OUTLET OBSTRUCTION.

Non Discussion Abstract Session 19 Read By Title 440 Porcine dermis graft enhances apical suspension for post-hysterectomy vaginal prolapse repair

Non Discussion Abstract Session 19 Read By Title 441 Infracoccygeal sacropexy (posterior IVS) in the treatment of female pelvic floor disorders.

Non Discussion Abstract Session 19 Read By Title 442 OUTCOME (POP-Q) OF PELVIC ORGAN PROLAPSE WITH PROLIFT® PROSTHESIS vs COLLAGEN PROSTHESIS (PELVICOL®) vs CLASSICAL ANTERIOR AND/OR POSTERIOR COLPORAPHY– PROSPECTIVE STUDY

Non Discussion Abstract Session 19 Read By Title 443 Short-term safety and efficacy of the ApogeeTM and PerigeeTM mesh systems for the surgical treatment of women with recurrent vaginal prolapse.

Non Discussion Abstract Session 19 Read By Title 444 LAPAROSCOPIC PARAVAGINAL REPAIR WITH CONCOMITANT BURCH COLPOSUSPENSION OR SPARC SLING.

Non Discussion Abstract Session 19 Read By Title 445 Stress urinary incontinence after reconstructive surgery procedure, retrospective observational study

Non Discussion Abstract Session 19 Read By Title 446 Uterine preservation for the surgical treatment of advanced uterovaginal prolapse

Non Discussion Abstract Session 19 Read By Title 447 Twenty-two Cases of Post-Operative Iatrogenic Foreign Bodies of the Bladder and Urethra: An Update on Techniques for Removal of Sutures and Mesh

Non Discussion Abstract Session 19 Read By Title 448 Tape rejection - local process or general reaction of the organism.

Non Discussion Abstract Session 19 Read By Title 449 Comparison of Electric Stimulation and Oxybutynin Chloride in the Management of Overactive Bladder with Special Reference to Urinary Urgency: A Randomized Placebo-controlled Trial

Podium Poster Session 6 Basic Physiology:James Hay 45 Mouse Bone Marrow-Derived Cells Can Reconstruct Smooth Muscle Layer-Like Structures in Injured Urinary Bladder Walls

Non Discussion Abstract Session 19 Read By Title 450 Chinese Continence Audiotape Project

Non Discussion Abstract Session 19 Read By Title 451 Results of Physiotherapeutic Treatment in Children with Nocturnal Enuresis

Non Discussion Abstract Session 19 Read By Title 452 Single Center Experience with Extra Corporal Magnetic Innervation Therapy (ExMI) treating Stress-, Urge- Incontinence and Pelvic Pain Symptoms

Non Discussion Abstract Session 19 Read By Title 453 Treatment with intravesical electrical stimulation of adults with underactive detrusor muscle.

Non Discussion Abstract Session 19 Read By Title 454 Daily-living self-management of persistent urinary incontinence: Comparisons between the self-management practices of people with UI and the recommendations of continence nurse specialists

Non Discussion Abstract Session 19 Read By Title 455 Effectiveness of non-invasive, static, magnetic stimulation of the pelvis in the control of urinary incontinence

Non Discussion Abstract Session 19 Read By Title 456 Incontinence: Do patients and health professionals share coherent views regarding treatment?

Non Discussion Abstract Session 19 Read By Title 457 Functional Electrical Stimulation for the Treatment of Female Urinary Incontinence: Attitudes and Practices of American Urogynecologic Society Physicians

Non Discussion Abstract Session 19 Read By Title 458 Effects of the new neuromodulation system, sacral surface therapeutic electrical stimulation, for refractory urinary incontinence

Non Discussion Abstract Session 19 Read By Title 459 Motor skill training of the pelvic floor muscles using visual versus tactile feedback

Podium Poster Session 6 Basic Physiology:James Hay 46 SELECTION OF SUITABLE INTERNAL STANDARDS FOR MOLECULAR STUDIES IN THE HUMAN BLADDER

Non Discussion Abstract Session 19 Read By Title 460 Transobturator tape (T.O.T.) for surgical treatment of stress urinary incontinence: efficacy and complications

Non Discussion Abstract Session 19 Read By Title 461 Changes in values of Urethral Closure Pressure and its position after Burch colposuspension, and differences in urethra mobility between subgroups of women with various operation results.

Non Discussion Abstract Session 19 Read By Title 462 Short term complications following Tension-free Vaginal Tape™ vs Transobturator Tape (Obtryx™)

Non Discussion Abstract Session 19 Read By Title 463 Urethrolysis more likely after proximal migration of midurethral sling

Non Discussion Abstract Session 19 Read By Title 464 Tape exposure after trans-obturator tape (TOT) procedure: Incidence and treatment

Non Discussion Abstract Session 19 Read By Title 465 Early results on the prepubic approach to the placement of a synthetic midurethral sling for the treatment of female stress urinary incontinence

Non Discussion Abstract Session 19 Read By Title 466 Long Term Results of the the Acellular Human Dermal Allograft Sling with Transvaginal Bone Anchors

Non Discussion Abstract Session 19 Read By Title 467 Results of a prospective observational study on function and safety of the TOT-SAFYRE® (TOT/S), a composite silicone-polypropylene sling system for the treatment of stress urinary incontinence (SUI)

Non Discussion Abstract Session 19 Read By Title 468 RECURRENT STRESS URINARY INCONTINENCE AFTER TVT. RISK ANALYSIS.

Non Discussion Abstract Session 19 Read By Title 469 VAGINAL INTER-PUBIC PERINEORAPHY (VIPP) FOR TREATMENT OF FEMALE STRESS URINARY INCONTINENCE: A NEW TECHNIQUE

Podium Poster Session 6 Basic Physiology:James Hay 47 Expression of large conductance, voltage- and Ca2+ -activated K+ (Maxi K) channel in human urinary bladder: identification of Maxi K channel subunits and differences between normal and bladder outlet obstruction.

Non Discussion Abstract Session 19 Read By Title 470 Urethral closure pressure; does the value influence outcome in stress incontinence surgery in the long-term?

Non Discussion Abstract Session 19 Read By Title 471 Tension-free vaginal tape (TVT) sling insertion alongside other gynaecological operations

Non Discussion Abstract Session 19 Read By Title 472 Voiding dysfunction after tension-free vaginal tape (TVT) sling insertion

Non Discussion Abstract Session 19 Read By Title 473 The Result of 5 year follow-up of Tension-Free Vaginal Tape (TVT) Procedure in Korea

Non Discussion Abstract Session 19 Read By Title 474 Comparison of Surgical Treatments for Post Prostatectomy Incontinence

Non Discussion Abstract Session 19 Read By Title 475 A SAFETY AND QUALITY OF LIFE ANALYSIS OF INTRAVAGINAL SLINGPLASTY IN FEMALE STRESS INCONTINENCE: A PROSPECTIVE, OPEN LABEL, MULTICENTER, AND OBSERVATIONAL STUDY

Non Discussion Abstract Session 19 Read By Title 476 Midurethral tissue fixation system sling in treatment of stress urinary incontinence in women

Non Discussion Abstract Session 19 Read By Title 477 Tension-Free Vaginal Tape – Transobturator (TVT-O): Six months results

Non Discussion Abstract Session 19 Read By Title 478 Short-medium term results with 250 TVT-Obturator inside out operations

Non Discussion Abstract Session 19 Read By Title 479 Experience with the Zuidex™ system in clinical practice: introduction of a modified injection technique

Podium Poster Session 6 Basic Physiology:James Hay 48 Role of TGF-beta1 in cell phynotype modulation and extracellular matrix production in cultured human prostate stromal cells.

Non Discussion Abstract Session 19 Read By Title 480 A Short term comparison of 3 different transobturator vaginal tape procedures - TVT-O, MONARC, IRIS-TOT - for the treatment of female stress and mixed urinary incontinence in Korea

Non Discussion Abstract Session 19 Read By Title 481 Tension free vaginal tape (TVT) Vs less invasive free tape (LIFT) - A randomized multicentric study of suburethral sling surgery

Non Discussion Abstract Session 19 Read By Title 482 Follow up of the effect of porcine dermal sling (Pelvicol®) in the treatment of stress urinary incontinence.

Non Discussion Abstract Session 19 Read By Title 483 Development of a tool to predict adaptors and non adaptors to surgery for stress incontinence

Non Discussion Abstract Session 19 Read By Title 484 Results of Midurethral Slings in Patients Undergoing Gynecologic Reconstruction

Non Discussion Abstract Session 19 Read By Title 485 EVEN UNEXPOSED, URETHRAL TEGRESS™ MAY INITIALLY INCREASE URINARY INCONTINENCE

Non Discussion Abstract Session 19 Read By Title 486 Early experience of tension–free vaginal tape (TVT), an efficient and safe surgical procedure for stress urinary incontinence

Non Discussion Abstract Session 19 Read By Title 487 Short-term safety and efficacy of the MonarcTM trans-obturator tape for the surgical treatment of urodynamic stress incontinence.